fibrinogen has been researched along with Hemorrhage in 1059 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 400 (37.77) | 18.7374 |
| 1990's | 81 (7.65) | 18.2507 |
| 2000's | 131 (12.37) | 29.6817 |
| 2010's | 315 (29.75) | 24.3611 |
| 2020's | 132 (12.46) | 2.80 |
| Authors | Studies |
|---|---|
| Beckett, A; Callum, J; Carroll, J; da Luz, LT; Engels, PT; Grewal, D; Hucke, HP; Karkouti, K; Nathens, AB; Parry, N; Peng, H; Petrosoniak, A; Scales, D; Schwartz, B; Tien, H | 1 |
| An, H; Chen, C; Huang, C; Jin, S; Li, M; Li, S; Li, T; Li, X; Xu, Z; Ying, B; Zhang, J; Zhou, T | 1 |
| Curry, N | 1 |
| Niroula, R; Pelcovits, A; Schiffman, F | 1 |
| Charbonneau, H; Mayeur, N; Savy, N | 1 |
| Kietaibl, SA; Scarlatescu, E; Tomescu, DR | 1 |
| Ajjan, RA; Kearney, KJ; Pechlivani, N | 1 |
| Majek, P; Pecankova, K; Sovova, Z; Suttnar, J | 1 |
| Celeny, D; Neerman-Arbez, M; Richard, M | 1 |
| Getrajdman, CS; Hira, SK; Katz, DJ; Sison, ML | 1 |
| Allen, TK; James, AH; Weikel, D; Yurashevich, M | 1 |
| Alexander, PM; Ankola, AA; Bailly, DK; Bell, MJ; Berg, RA; Berger, J; Carcillo, J; Dalton, H; Dean, JM; Doctor, A; Garcia-Filion, P; Harrison, R; Heidemann, S; Meert, KL; Moler, FW; Muszynski, JA; Newth, C; Nicholson, C; Pollack, MM; Reeder, RW; Wessel, D; Zuppa, AF | 1 |
| Chandler, J; Ghasabyan, A; Meizoso, JP; Moore, EE; Namias, N; Pieracci, FM; Saberi, RA; Sauaia, A | 1 |
| Lillyblad, MP; Melamed, RR; Qadri, GA; Smith, CS; St Hill, C; Tierney, DM; Weise, BE | 1 |
| Barquero López, M; Campos Serra, A; De la Rosa Estadella, M; Gil Velázquez, A; Martínez Cabañero, J; Muñoz Valencia, A; Navarro Soto, S; Pujol Caballé, G; Puyana, JC; Sáez Ibarra, C | 1 |
| Chafa, O; de Mazancourt, P; Fischer, AM; Frigaa, I; Guenounou, K; Hadjali-Saichi, S; Helley, D; Mirault, T; Tapon-Bretaudière, J | 1 |
| Araki, Y; Goto, S; Hattori, M; Izumi, T; Matsushita, T; Nishihori, M; Saito, R; Suzuki, N; Tamura, S; Uda, K; Yokoyama, K | 1 |
| George, S; Gibbons, K; Jansen, M; Maconachie, S; Paasilahti, A; Roy, J; Wake, E; Winearls, J; Wiseman, G | 1 |
| Fang, S; Shi, J; Wang, C; Wang, Y; Zuo, N | 1 |
| DeSancho, MT; Dev, H; Lane, EG; Margolis, DJ; Prince, MR | 1 |
| Hu, Z; Li, J; Wu, R; Ye, L | 1 |
| Bartoszko, J; Callum, J; Karkouti, K; Martinez-Perez, S | 1 |
| Doyle, MB; Drobish, J; Jarasvaraparn, C; Khan, A; Kulkarni, S; Nadler, M; Rusch, C; Stoll, J | 1 |
| Anand, T; Ditillo, M; Douglas, M; Friese, R; Gries, L; Joseph, B; Nelson, A; Obaid, O; Reina, R; Stewart, C | 1 |
| Ding, B; Ding, Q; Li, Y; Wang, X | 1 |
| Chen, R; Guo, Y; Huang, Y; Jiang, J; Li, Y; Ren, J; Zhao, Q; Zhou, J | 1 |
| Djambas Khayat, C; Knaub, S; Kruzhkova, I; Lohade, SD; Peyvandi, F; Solomon, C; Zekavat, OR | 1 |
| Guo, L; Hee, HI; Khoo, CEH; Long, MH; Shi, L | 1 |
| Brzezińska, J; Czajkowska, S; Gil, L; Rupa-Matysek, J; Surdacka, A | 1 |
| Casini, A; Moerloose, P; Neerman-Arbez, M | 1 |
| Wagener, G | 1 |
| Artang, R; Brod, C; Nielsen, JD | 1 |
| Kikuchi, A; Matsunaga, S; Nakamura, E; Takai, Y | 1 |
| Chandika, P; Choi, IW; Je, JY; Jung, WK; Kang, HW; Kim, CS; Kim, HW; Kim, JI; Kim, SC; Kim, TH; Kim, YM; Lee, B; Park, WS; Ryu, B; Tennakoon, P; Yi, M | 1 |
| Kar, R; Rajkumar, B; Ramasubramani, P; Vishwanath Vinod, K | 1 |
| Benger, J; Brohi, K; Curry, N; Davenport, R; Deary, A; Edwards, A; Evans, A; Foley, C; Green, L; Lucas, J; Morris, S; Stanworth, SJ; Thomas, H | 1 |
| Doelare, SAN; Ebben, HP; Ergin, K; Hoksbergen, AWJ; Jongkind, V; Lely, RJ; Oukrich, S; Wiersema, AM; Yeung, KK | 1 |
| Abdul-Kadir, R; Malinowski, AK | 1 |
| Ausset, S; Duranteau, J; Garrigue-Huet, D; Godier, A; Hamada, SR; Hanouz, JL; Legros, V; Pirracchio, R; Roquet, F; Vardon-Bounes, F; Vigué, B | 1 |
| Abrahamyan, L; Bartoszko, J; Callum, J; Carcone, S; Grewal, D; Karkouti, K; Krahn, M; Tomlinson, G | 1 |
| Boorman, D; Brown, AC; Downey, LA; Guzzetta, NA; Moiseiwitsch, N; Nellenbach, KA | 1 |
| Jan, KM; Mohapatra, S; Moon, TS | 1 |
| Carrier, FM; Zaouter, C | 1 |
| Azarkeivan, A; Baghaipour, MR; Jazebi, M; Menegatti, M; Moazezi, S; Mohsenian, S; Palla, R; Peyvandi, F; Seidizadeh, O | 1 |
| Hagisawa, K; Ishida, O; Kearney, BM; Kinoshita, M; Nakashima, H; Takeoka, S; Tsutsumi, K; Yamanaka, N | 1 |
| Blaine, KP; Nathwani, R; Proumen, A | 1 |
| Hayakawa, M; Hirano, S; Itagaki, Y; Takahashi, Y; Yamakawa, K | 1 |
| Dorman, B; Kozar, RA; Wu, F; Zeineddin, A | 1 |
| Arévalo, AG; Blasi, A; Cendrós, JM; Colom, H; Montoro, B; Sabaté, A | 1 |
| Diagil, I; Karnabeda, O; Melnyk, U; Sergeieva, A; Stupakova, Z | 1 |
| Horst, JA; Josephson, CD; Leeper, CM; Leonard, JC; Spinella, PC | 1 |
| Brohi, K; Davenport, R; Rossetto, A; Wohlgemut, JM | 1 |
| Chen, L; Chen, W; Liu, Q; Pan, Y; Peng, Z; Sha, Y; Wang, Y; Wang, Z | 1 |
| Asato, C; Bennett, JC; Han, CY; Ringgold, K; St John, A; Stern, SA; Wang, X; Wenthe, A; White, NJ | 1 |
| Demlova, R; Gal, R; Galko, M; Horalkova, H; Hrdy, O; Hudec, J; Kubelova, M; Repko, M; Vrbica, K | 1 |
| Burguburu, S; Camille, W; Genty, T; Imbert, A; Roman, C; Stéphan, F; Thès, J | 1 |
| Brunskill, SJ; Champaneria, R; Dorée, C; Estcourt, LJ; Geneen, LJ; Gibbs, VN; Novak, A; Palmer, AJ; Raval, P | 1 |
| Euliano, TY; Harris, NS; Marin, MJ; Mathew, CM; Pelletier, JPR; Pruitt, HD; Rajasekhar, A; Winter, WE; Zumberg, M | 1 |
| Adam, F; Bun, E; Camadro, JM; Christophe, O; Janel, N; Kandiah, J; Kauskot, A; Léger, T; Loubière, C; Moroy, G; Postic, G; Potier, MC; Sawmynaden, J; Solarz, J; Victorino, DB; Vilaire, M | 1 |
| Gross, PL; Karkouti, K | 1 |
| Bai, J; Baker, AJ; Barahi, S; Callum, J; Gomez Builes, JC; Karkouti, K; Nisenbaum, R; Sholzberg, M | 1 |
| Balle, CM; Christensen, S; Hvas, AM; Hvas, CL; Jeppesen, AN; Munk-Andersen, H | 1 |
| Biswas, A; Dargaud, Y; Delavenne, X; Desage, S; Enjolras, N; Holle, LA; Leuci, A; Singh, S; Wolberg, AS | 1 |
| Gu, C; Lin, C; Tan, M; Wang, D; Wang, S; Wu, Y | 1 |
| Benger, JR; Brohi, K; Cotton, BA; Curry, N; Davenport, R; Deary, A; Edwards, A; Evans, A; Fox, EE; Green, L; Lucas, J; Shanmugaranjan, S; Sharma, R; Stanworth, SJ; Thomas, H; Wade, CE | 1 |
| Huang, P; Yi, XY | 1 |
| Severgün, K; Zengin, I | 1 |
| Arellano-Orden, V; Casado-Méndez, M; Díaz-Martín, A; Dusseck-Brutus, R; Fernandez-Pacheco, J; Leal-Noval, SR; Pastor de Las Heras, Á; Pérez-Torres, I; Rodríguez-Martorell, FJ | 1 |
| Dalton, H; Karam, O; Nellis, ME | 1 |
| Ashizawa, M; Fujiwara, SI; Hatano, K; Hayakawa, J; Ikeda, T; Ishihara, Y; Ito, S; Kanda, Y; Kawaguchi, SI; Kawasaki, Y; Mashima, K; Minakata, D; Morita, K; Muroi, K; Nagayama, T; Nakano, H; Nakasone, H; Ochi, SI; Oh, I; Ohmine, K; Ohmori, T; Sato, K; Sugimoto, M; Toda, Y; Umino, K; Yamamoto, C; Yamasaki, R | 1 |
| Bulmer, AC; Campbell, D; Chan, E; Ho, D; Seebold, JA; Wake, E; Walters, K; Winearls, J; Wullschleger, M | 1 |
| Iwaniec, T; Klukowska, A; Mital, A; Neerman-Arbez, M; Pietrys, D; Sydor, W; Treliński, J; Undas, A; Wypasek, E; Zawilska, K; Zdziarska, J | 1 |
| Akita, T; Fujimoto, K; Ito, H; Mutsuga, M; Narita, Y; Nishi, T; Nishiwaki, K; Terazawa, S; Tokuda, Y; Usui, A | 1 |
| Grottke, O; Haas, T; Karkouti, K; Mallaiah, S; Saner, F | 1 |
| Graf, B; Gruber, M; Holzer, F; Lunz, D; Philipp, A; Redel, A | 1 |
| Antonelli, M; Barelli, R; Bianchi, M; Bocci, MG; Caricato, A; Cingolani, E; Cutuli, SL; De Candia, E; De Pascale, G; Dell'Anna, AM; Fiore, V; Grieco, DL; Maresca, M; Mercurio, G; Nardi, G; Palma, A; Rondinelli, MB; Tersali, A; Veronesi, G | 1 |
| Dahl, AB; Despotis, GJ; Dynis, M; Jackups, RR; Karnes, HE; Marchant, B; Shah, P; Thibodeaux, SR; Zhang, R | 1 |
| Casini, A; Undas, A | 1 |
| Fang, ZA; Hensch, L; Hui, SR; Navaei, AH; Teruya, J | 1 |
| Jeppsson, A; Karlsson, M; Nasic, S; Waldén, K | 1 |
| Ågren, A; Almskog, LM; Hammar, U; Östlund, A; Svensson, J; Wanecek, M; Wikman, A | 1 |
| Almeida-Souza, HO; Araujo, GR; Cardoso, R; Carvalho, CP; Correia, LIV; Dandekar, AM; Faria, PCB; Goulart, LR; Mendes, MM; Nascimento, R; Rodrigues, RS; Rodrigues, VM; Souza, JB | 1 |
| Cottle, E; George, S; Jansen, M; Maconachie, S; Ross, B; Roy, J; Winearls, J | 1 |
| Brunclíkova, M; Dobrotova, M; Grendar, M; Kolkova, Z; Kubisz, P; Lasabova, Z; Loderer, D; Simurda, T; Skornova, I; Stasko, J; Zolkova, J | 1 |
| Cap, AP; Dubick, MA; Martini, WZ; Rodriguez, CM | 1 |
| Du, WT; Li, X; Wu, ZX; Xu, DX; Yu, GF | 1 |
| Fedorova, DV; Filkova, AA; Martyanov, AA; Morozova, DS; Novichkova, GA; Panteleev, MA; Sorokina, MA; Suntsova, EV; Sveshnikova, AAN; Uzueva, SS; Zharkov, PA | 1 |
| Aponte, AM; Beard, RS; Eitnier, RA; Guo, X; Meegan, JE; Nelson, PR; Wang, F; Wu, MH; Yang, X | 1 |
| Castanon, L; Ditillo, M; Gries, L; Hanna, K; Joseph, B; Kulvatunyou, N; Sakran, J; Tang, A; Zeeshan, M | 1 |
| Aytaç, S; Bridey, F; Dahmane, A; de Moerloose, P; Djambas Khayat, C; El Khorassani, M; Harroche, A; Henriet, C; Pujol, S | 1 |
| Callum, J; Cushing, MM; Haas, T; Karkouti, K | 1 |
| Gwyther, R; Hunt, BJ; Kirkman, E; Lucca, JD; Midwinter, M; Parmar, K; Watts, S; Woolley, T | 1 |
| Casado Méndez, M; Cuenca-Apolo, D; Fernández Pacheco, J; Leal-Noval, SR; Múñoz-Gómez, M | 1 |
| Jensen, JR; Sachetto, ATA; Santoro, ML | 1 |
| Bulmer, AC; Campbell, D; Chan, E; Ho, D; McCullough, J; Wake, E; Walters, K; Winearls, J; Wullschleger, M | 1 |
| Iba, T; Levi, M; Levy, JH; Thachil, J | 1 |
| Higuchi, Y; Kaido, T; Kamijo, T; Okumura, N; Taira, C; Yoda, M | 1 |
| Goslings, JC; Juffermans, NP; Schalkers, DV; Wirtz, MR | 1 |
| Angel-Camilo, KL; Carvalho, EF; de Siqueira, RJB; Freitas, LBN; Guerrero-Vargas, JA; Havt, A; Leal, LKAM; Lima-Silva, K; Magalhães, PJC; Mota, MRL; Neves-Ferreira, AGDC; Santos, AAD; Sousa, JAC | 1 |
| D'Alton, ME; Friedman, AM; Goffman, D; Green, R; Kessler, A; Oberhardt, M; Sheen, JJ; Vawdrey, D | 1 |
| Asselta, R; Brunclikova, M; Caccia, S; Hudecek, J; Kolkova, Z; Kubisz, P; Lasabova, Z; Loderer, D; Simurda, T; Skornova, I; Stasko, J; Zolkova, J | 1 |
| Danaee, A; Doyle, AJ; Furtado, CI; Maggs, T; Miller, S; Retter, A; Robinson, SE | 1 |
| Bialkower, M; Garnier, G | 1 |
| Graif, A; Grilli, CJ; Kimbiris, G; Leung, DA; Paik, HH | 1 |
| Alagón, A; Bénard-Valle, M; D Possani, L; López-Casillas, F; Neri-Castro, E; Olvera, A; Paniagua, D; Romero, C; V Boyer, L; Zamudio, F | 1 |
| Hao, X; Lai, R; Li, J; Liu, M; Lu, Q; Mwangi, J; Shen, C; Tian, H; Xu, R | 1 |
| Estep, J; Hodges, K; Hsich, E; Insler, J; Insler, S; Mubashir, M; Soltesz, E; Tong, M | 1 |
| Artica, A; Bernanke, A; Chao, NJ; Chen, BJ; Hoffman, M; Jiao, Y; Lewis, DA; Li, Z; Liu, Y; Miller, SE; Ortel, TL; Piryani, S; Ross, JR; Sung, AD; Vo-Dinh, T; Yen, RC; Zhou, D | 1 |
| Caggiano, L; Celikag, M; Ferreira, B; Gulacsy, CE; Hounslea, E; Koeners, MP; Patinha, D; Pula, G; Tarafdar, A; Vara, D; Warren, Z | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Karpov, A; Li, SS; Stabler, SN; Vu, EN | 1 |
| Borges, RJ; Dos Santos, LD; Eulálio, MMC; Fontes, MRM; Salvador, GHM | 1 |
| Kengaiah, J; Nandish, SKM; Ramachandraiah, C; Sannaningaiah, D; Santhosh, SM; Shivaiah, A | 1 |
| Abdelghani, E; Dawson, J; Dunn, A; Hallam, M; Kumar, R; Zajo, K | 1 |
| Da Luz, LT; Levy, JH; Nascimento, B; Tien, H | 1 |
| Cohen, T; Cushing, MM; Haas, T | 1 |
| Leeper, CM; Neal, MD; Sayce, AC | 1 |
| Balla, J; Becs, G; Hurják, B; Katona, É; Muszbek, L; Pénzes, K | 1 |
| Baylis, JR; Chan, KYT; Kastrup, CJ; Ringgold, KM; St John, AE; Wang, X; White, NJ; Yong, ASM | 1 |
| D'Souza, F; Djambas Khayat, C; Knaub, S; Kruzhkova, I; Lohade, S; Peyvandi, F; Schwartz, B; Shamanur, LG; Solomon, C; Zekavat, OR | 1 |
| Agostini, V; Černý, V; Fries, D; Leal-Noval, SR; Maegele, M; Nardai, G; Nardi, G; Östlund, A; Schöchl, H | 1 |
| Kikura, M; Nishino, J; Uraoka, M | 1 |
| Amaz, C; Bernelin, H; Bochaton, T; Bonnefoy-Cudraz, E; Cartier, R; Croisille, P; Crola Da Silva, C; de Bourguignon, C; Derimay, F; Dufay, N; Espanet, S; Lassus, J; Mewton, N; Ovize, M; Paccalet, A; Prieur, C; Rioufol, G | 1 |
| Kho, BG; Kim, MS; Kim, TO; Kim, YI; Kwon, YS; Lim, SC; Park, HY; Shin, HJ | 1 |
| de Borst, GJ; Huitema, ADR; Leenstra, B; van Ginkel, DJ; Verhoeven, BAN; Vonken, EJ | 1 |
| Blumberg, SM; Conway, EE; Meltzer, JA; Reddy, SH; Stone, ME; Tama, MA | 1 |
| Bazine, M; Cholley, B; Clausse, D; Godier, A; Hamada, SR; Huche, F; Lang, E; Meslin, S | 1 |
| Carlier, MSA; Craigen, FB; Curry, N; Dasgupta, S; Morrow, GB; Mutch, NJ | 1 |
| Abe, T; Ishihara, T; Kanezaki, S; Kataoka, M; Miyazaki, M; Notani, N; Sakamoto, T; Tsumura, H | 1 |
| Hayakawa, M; Itagaki, Y; Takahashi, Y; Yamakawa, K | 1 |
| Diaz-Ricart, M; Gómez Caro, AM; Koller, T; Parera Ruiz, A | 1 |
| Prittie, J | 1 |
| Colomina, MJ; Méndez, E; Sabate, A | 1 |
| Curry, N; McQuilten, Z; Reade, MC; Winearls, J | 1 |
| Fathi, M; Lashay, A; Massoudi, N; Nik, MA; Nooraei, N | 1 |
| Ablat, N; Ablimit, M; Abudoukadier, A; Kadeer, B; Yang, L | 1 |
| Arai, S; Higuchi, Y; Kaido, T; Kamijo, T; Okumura, N; Taira, C; Yoda, M | 1 |
| Handoh, T; Miida, T; Misawa, S; Okahara, S; Sumikura, H; Wakita, M; Yamamoto, T | 1 |
| De Maistre, E; Fagnoni, P; Howlett, J; Lazzarotti, A; Prudent, C | 1 |
| Akasaka, M; Araki, S; Matsumoto, K; Nakazawa, S; Nishioka, A; Sakon, T; Sawada, H; Seo, T; Shioi, N; Watanabe, K | 1 |
| Era, S; Maeda, H; Matsunaga, S; Nakamura, E; Ono, Y; Seki, H; Takai, Y; Yamamoto, K | 1 |
| Fenger-Eriksen, C; Greisen, J; Hjortdal, V; Ingerslev, J; Sørensen, B; Tang, M; Wierup, P | 1 |
| Attias, J; Brenner, B; Crispel, Y; Ghanem, S; Kogan, I; Nadir, Y | 1 |
| Campbell, D; Cohen, J; Dyer, W; Fraser, JF; Furyk, J; Holley, A; Hurn, C; Keijzers, G; Presneill, J; Ryan, G; Shuttleworth, M; Trout, M; Wake, E; Walsham, J; Winearls, J; Wullschleger, M | 1 |
| Baumgartner, B; Gulle, H; Lewis, KM; Rousselle, S; Sweet, J; Wilson, ST | 1 |
| Boyle, MA; Breen, CM; McCallion, N; Riazat, MI | 1 |
| Apelseth, TO; Eide, GE; Hervig, T; Opheim, EN; Stanworth, SJ | 1 |
| Bailey, M; Cameron, PA; Cooper, DJ; McQuilten, ZK; Stanworth, SJ; Venardos, K; Wood, EM | 1 |
| Franchini, M; Liumbruno, GM; Marano, G; Marietta, M; Mengoli, C; Pupella, S; Vaglio, S | 1 |
| He, Q; Li, B; Liu, G; Yu, X; Zhou, B | 1 |
| Fonouni, H; Kashfi, A; Konstantinidis, L; Kraus, TW; Majlesara, A; Mehrabi, A; Oweira, H; Stahlheber, O | 1 |
| Camats, M; Coll-Vinent, B; Crespo, C; González-Porras, JR; Lecumberri, R; Marco, P; Martín, A; Mateo, J; Roldán, V; Soulard, S; Suero, C; Vicente, V | 1 |
| Caspers, M; Maegele, M; Schöchl, H | 1 |
| de Groot, PG; de Mast, Q; Gasem, MH; Isbandrio, B; Sasongko, PH; Tunjungputri, RN; Urbanus, RT; van der Does, W; van der Ven, A | 1 |
| Aguilar, E; Altes, P; Álvarez, LR; Esteban, C; García-Díaz, AM; Jiménez, PE; Monreal, M; Perez, P; Sahuquillo, JC; Sánchez Muñoz-Torrero, JF | 1 |
| Hifumi, T; Inoue, J; Kato, H; Kiriu, N; Koido, Y; Matsumoto, J; Morimoto, K; Okada, I; Takada, H; Yoshioka, H | 1 |
| Hudecek, J; Kubisz, P; Lasabova, Z; Loderer, D; Simurda, T; Skornova, I; Snahnicanova, Z; Sokol, J; Stasko, J; Zolkova, J | 1 |
| Cvetković, Z; Kulić, A; Libek, V | 1 |
| Felker, J; Lew, G; Patel, KN; Raikar, SS; Sidonio, RF | 1 |
| Beckett, A; Callum, J; Funk, C; Nascimento, B; Peng, H; Rhind, S; Rizoli, S; Sanders, S; Schmid, J; Tien, H | 1 |
| Grottke, O; Hunt, BJ; Levy, JH; Schöchl, H | 1 |
| Beattie, C; Bolton-Maggs, P; Cardigan, R; Green, L; Kallis, Y; Stanworth, SJ; Thachil, J; Zahra, S | 1 |
| Curry, N; Novak, A; Stanworth, SJ | 1 |
| Cardenas, JC; Cotton, BA; George, MJ; Holcomb, JB; Schreiber, MA; Wade, CE; White, NJ | 1 |
| Banerjee, A; Chandler, J; Moore, EE; Nunns, GR; Peltz, E; Sauaia, A; Silliman, CC; Stettler, GR | 1 |
| Curnow, E; Curry, N; Davenport, R; Deary, A; Foley, C; Hodge, R; Hopkins, V; Kellett, S; Mora, A; Moss, P; Ray, J; Reed, MJ; Stanworth, S; Wong, H; Zarankaite, A | 1 |
| Ford, PM; Nielsen, VG; Ward, TD | 1 |
| Henderson, RA; Mazzeffi, MA; Tanaka, KA | 1 |
| Farr, A; Haslacher, H; Kiss, H; Koller, V; Muin, DA; Scharrer, A | 1 |
| Greinacher, A; Hunt, BJ; Samama, CM; Thomas, W | 1 |
| Brown, AC; Guzzetta, NA; Nellenbach, K | 1 |
| Boral, LI; Crane, JE; Li, Y; Pagano, MB; Rollins-Raval, MA; Schmidt, AE; Smith, RE; Svensson, AM; Wong, ECC; Wu, Y; Yamada, C; Zantek, ND | 1 |
| Brunskill, SJ; Curry, N; Doree, C; Fabes, J; Stanworth, SJ | 1 |
| Baksaas-Aasen, K; Balvers, K; Brohi, K; Gaarder, C; Goslings, JC; Johansson, PI; Juffermans, NP; Maegele, M; Naess, PA; Stanworth, S; Stensballe, J; van Dieren, S; Wirtz, MR | 1 |
| Di Paola, J; Hu, Z; Lavik, KI; Liu, Y; Richter, CE; Shavit, JA; Vo, AH | 1 |
| Benger, J; Brohi, K; Curry, N; Davenport, R; Foley, C; Green, L; Lucas, J; Marsden, M; Rossetto, A; Stanworth, S; Thomas, H | 1 |
| Asmis, LM; Cushing, MM; DeSimone, RA; Haas, T; Harris, RM; Hill, S; Ivascu, N | 1 |
| Dunbar, NM; Gorham, JD; Thomasson, RR; Yazer, MH | 1 |
| Belteki, G; Curley, A; Foster, HR; Garner, SF; Ghevaert, C; Gibbins, JM; Kriek, N; Lantos, L; McKinney, H; Salgin, B; Sammut, A; Stanworth, SJ; Venkatesh, V; Waller, AK | 1 |
| Adjambri, E; Eeckhoudt, S; Hermans, C; Lambert, C; Lobet, S; Meité, N; Sanogo, I | 1 |
| Ageron, FX; David, JS; Decullier, E; Friggeri, A; Guth, C; Inaba, K; Vassal, O; Wey, PF | 1 |
| Moore, EC; Porter, LM; Ruha, AM | 1 |
| Ho, AK; Ho, AM; Mizubuti, GB | 1 |
| Aoki, M; Hagiwara, S; Nakamura, M; Ogura, T; Oshima, K | 1 |
| Chandler, J; Chapman, MP; Cohen, MJ; Hansen, KC; Moore, EE; Moore, HB; Pieracci, FM; Sauaia, A | 1 |
| Barac, YD; Gaca, JG; Ghadimi, K; Hashmi, NK; Levy, JH; Li, YJ; Ortel, TL; Raiff, RD; Root, AG; Srinivasan, AJ; Welsby, IJ | 1 |
| Chen, T; Lin, J; Wen, F; Yin, H; Zhang, H | 1 |
| Beckers, EAM; Henskens, YMC; Heubel-Moenen, FCJI; Schouten, HC; Verhezen, PWM; Wetzels, RJH | 1 |
| Hansson, KM; Johansson, KJ; Lindblom, A; Lövgren, A; Nelander, K; Pehrsson, S | 1 |
| Banerjee, A; Girish, A; Hickman, DA; Huang, S; Luc, N; Ma, Y; Miyazawa, K; Sekhon, UDS; Sen Gupta, A; Sun, M | 1 |
| Berntorp, E; Dow, E; Kouides, P; Peyvandi, F; Turecek, PL | 1 |
| Adachi, Y; Hasegawa, K; Kainuma, M; Maeda, S; Mori, R; Nishiwaki, K; Suzuki, S; Tamura, T | 1 |
| Dalton, WB; DeZern, AE; Ghiaur, G; Gladstone, DE; Gojo, I; Gondek, LP; Hambley, BC; Jasem, J; Levis, MJ; Norsworthy, KJ; Pratz, KW; Prince, G; Shenderov, E; Showel, MM; Smith, BD; Streiff, MB; Webster, JA; Zimmerman, JW | 1 |
| Hagisawa, K; Kinoshita, M; Saitoh, D; Sakai, H; Seki, S; Takeoka, S; Takikawa, M | 1 |
| Cushing, MM; Haas, T | 1 |
| Biasoli, C; Castaman, G; Contino, L; Giacomelli, SH; Radossi, P | 1 |
| Spahn, DR | 1 |
| Absar, S; Ahsan, F; Kwon, YM; Nahar, K | 1 |
| Kiechl, S; Kirchmayr, M; Knoflach, M; Matosevic, B; Pechlaner, R; Ruecker, M; Werner, P; Willeit, J; Zangerle, A | 1 |
| Oo, TH | 1 |
| Coletti, V; De Leonardis, F; Giordano, P; Grassi, M; Luciani, M; Santoro, N | 1 |
| Fukui, T; Sasaki, K; Tabata, M; Takanashi, S | 1 |
| Du, LM; Fang, J; North, P; Nurden, AT; Nurden, P; Valentin, N; Wilcox, DA | 1 |
| Godier, A; Samama, CM; Susen, S | 1 |
| Dubose, JJ; Jansen, JO; Midwinter, MJ; Morrison, JJ; Rasmussen, TE; Ross, JD | 1 |
| Baglin, T; Besser, M; Gerrard, C; Vuylsteke, A; Yang, L | 1 |
| Alarcon, LH; Brasel, KJ; Bulger, EM; Cohen, MJ; Cotton, BA; del Junco, DJ; Fox, EE; Holcomb, JB; Muskat, P; Myers, JG; Phelan, HA; Rahbar, MH; Schreiber, MA; Wade, CE; White, N; Zhang, X | 1 |
| Acosta, O; Maruñak, S; Peichoto, ME; Sánchez, MN; Teibler, P; Timoniuk, A | 1 |
| Alan, Z; Min, Z; Xiang, L; Yaohui, W | 1 |
| Inaba, K; Maegele, M; Ponschab, M; Schlimp, CJ; Schöchl, H; Voelckel, W | 1 |
| Casini, A; de Moerloose, P; Neerman-Arbez, M | 2 |
| Kaplan, LJ; Maung, AA | 1 |
| Cragg, AH; Ehrenwald, E; Gits, CC; Skeik, N | 1 |
| Gudmundsdottir, BR; Ingerslev, J; Larsen, OH; Onundarson, PT; Palsson, R; Sorensen, B; Vidarsson, B | 1 |
| Benjumea, DM; Patiño, AC; Pereañez, JA | 1 |
| Kanaji, S; Kanaji, T; Montgomery, RR; Newman, PJ; Patel, SB | 1 |
| Fischer, AM; Gaussem, P; Godier, A; Le Bonniec, B; Marchand-Leroux, C; Martin, AC; Samama, CM | 1 |
| Akioka, Y; Asano, T; Chikamoto, H; Hattori, M; Imamura, H; Ishizuka, K; Okumura, N; Sugawara, N; Taki, M; Terasawa, F | 1 |
| Filimonović, D; Nejković, L; Pazin, V | 1 |
| Afshari, A; Johansen, M; Lunde, J; Møller, AM; Stensballe, J; Wetterslev, J; Wikkelsø, A | 1 |
| Folliguet, T; Frotscher, B; Lecompte, T; Maureira, P; Toussaint-Hacquard, M; Vanhuyse, F; Villemot, JP | 1 |
| Cole-Sinclair, MF; Engelbrecht, S; Wood, EM | 1 |
| Lashof-Sullivan, M; Lavik, E; Shoffstall, A | 1 |
| Liu, Y; Norris, ZG; Shavit, JA; Swaroop, A; Vo, AH | 1 |
| Goodnough, LT; Levy, JH; Welsby, I | 1 |
| Calcaterra, J; Carlson, MA; Cordes, CM; Johanning, JM; Pipinos, II; Velander, WH | 1 |
| Blombäck, M; He, S; Hultenby, K; Johnsson, H; Wallén, H; Zabczyk, M | 1 |
| Baaten, CC; Feijge, MA; Heemskerk, JW; Kuiper, GJ; Lancé, MD; Marcus, MA; Ninivaggi, M; Ten Cate, H; van der Meijden, PE | 1 |
| Maegele, M; Schlimp, CJ; Schöchl, H | 1 |
| Braunschweig, T; Czaplik, M; Daniels, M; Grottke, O; Rossaint, R; Tolba, R; Zentai, C | 1 |
| Brennan, SO; Faed, JM; Mangos, H | 1 |
| Cantatore, S; De Salvia, A; Di Battista, B; Fineschi, V; Neri, M; Pomara, C; Riezzo, I; Turillazzi, E | 1 |
| Alam, A; Cserti-Gazdewich, C; Pendergrast, J | 1 |
| Baskaran, P; Berk, BC; Kim, Y; Modjeski, K; Morrell, CN; Smolock, EM; Soe, NN; Sowden, M; Wang, L; Xu, Y | 1 |
| Asega, AF; Menezes, MC; Neves-Ferreira, AG; Oliveira, AK; Serrano, SM | 1 |
| Hyon, SH; Kim, JT; Koo, MA; Kwon, BJ; Lee, DH; Lee, MH; Park, JC; Seomun, Y; You, KE | 1 |
| Aubron, C; Cooper, DJ; Fraser, JF; Reade, MC | 1 |
| Mazer, CD | 1 |
| Di Sanza, C; Fish, RJ; Neerman-Arbez, M | 1 |
| Andersen, MG; Hvas, AM; Hvas, CL; Tønnesen, E | 1 |
| Fries, D; Kozek-Langenecker, S; Spahn, DR; Zacharowski, K | 1 |
| García de Frutos, P | 1 |
| Keibl, C; Nürnberger, S; Ohlinger, W; Redl, H; Schlimp, CJ; Schöchl, H; Solomon, C; Zipperle, J | 1 |
| Cole, E; Davenport, R | 1 |
| Beltran, J; Blasi, A; Pereira, A | 1 |
| Goodnough, LT; Levy, JH | 2 |
| Alves, AF; Barbaro, KC; Santoro, ML; Yamashita, KM | 1 |
| Amlabu, W; Ebinbin, A; Emmanuel, A | 1 |
| Argo, CK; Caldwell, SH; Intagliata, NM; Northup, PG; Shah, NL | 1 |
| Abdel-Aty, AM; Wahby, AF | 1 |
| Afshari, A; Johansen, M; Lunde, J; Stensballe, J; Wikkelsø, A | 1 |
| Ackroyd, S; Alikhan, R; Bowles, L; Chowdary, P; Grainger, J; Mainwaring, J; Mathias, M; Mumford, AD; O'Connell, N | 1 |
| Kimura, S; Kimura, Y; Sumita, S; Yamakage, M | 1 |
| Doi, M; Hagisawa, K; Handa, M; Iwaya, K; Kinoshita, M; Nishida, Y; Nishikawa, K; Saitoh, D; Seki, S; Suzuki, H; Takeoka, S; Yanagawa, R | 1 |
| Komori, Y; Murakami, E; Nikai, T; Nonogaki, T; Uchiya, K | 1 |
| Jilma, B; Kulinna-Cosentini, C; Laggner, A; Röggla, M; Schober, A; Schörgenhofer, C; Schwameis, M; Thaler, J | 1 |
| Anusha, S; Chandra Nayaka, S; Girish, KS; Hemshekhar, M; Kemparaju, K; Rangappa, KS; Srinivasa, V; Sundaram, MS | 1 |
| Calogero, A; Carlomagno, N; Dumani, X; Florio, I; Jamshidi, A; Pelosio, L; Renda, A; Romagnuolo, R; Santangeloa, M; Tammaro, V; Vernillo, A | 1 |
| Boukhalfa-Abib, H; Laraba-Djebari, F | 1 |
| Achê, DC; Borges, MH; de Oliveira, F; Gimenes, SN; Gomes, MS; Guimarães, DO; Lopes, DS; Mamede, CC; Naves de Souza, DL; Rodrigues, RS; Rodrigues, VM; Yoneyama, KA | 1 |
| Balbotkina, EV; Buchinskaya, NV; Chasnyk, VG; Chikova, IA; Dubko, MF; Glebova, NI; Isupova, EA; Kalashnikova, OV; Kornishina, TL; Kostik, MM; Kuchinskaya, EM; Likhacheva, TS; Masalova, VV; Snegireva, LS | 1 |
| Audy, M; Chiche, L; Cruc, M; Freyburger, G; Quinart, A; Roullet, S; Stecken, L; Sztark, F | 1 |
| Baumgart, S; Diab, Y; Forman, KR; Luban, NL; Massaro, AN; Wong, EC | 1 |
| Capuzzo, E; Franchini, M; Liumbruno, GM; Vaglio, S | 1 |
| Chmura, A; Kosieradzki, M; Lągiewska, B; Lazowski, T; Nicińska, B; Pluta, J; Trzebicki, J; Wasiak, D | 1 |
| Eltringham-Smith, LJ; Lambourne, MD; Lei, X; Ni, H; Pryzdial, EL; Reheman, A; Sheffield, WP | 1 |
| Hedin, U; Johansson, F; Montán, C; Wahlgren, CM | 1 |
| Arellano-Orden, V; Bautista-Paloma, J; Casado, M; Cayuela, A; Dusseck, R; Leal-Noval, SR; Moreno, AP; Muñoz, M; Naranjo-Izorieta, J | 1 |
| De Waele, E; Honoré, PM; Jacobs, R; Spapen, HD; Van Gorp, V | 1 |
| Biesenbach, P; Derfler, K; Druml, W; Pablik, E; Rees, A; Zöllner, S | 1 |
| Beltran, J; Blasi, A; Pereira, A; Puig, L | 1 |
| Chen, R; Huang, P; Li, W; Li, Z; Lin, Q; Liu, Y; Pang, J; Wang, J; Ye, H; Ye, X; Zhang, LM; Zhou, Q; Zhou, Y; Zhuang, B | 1 |
| Friesecke, S; Greinacher, A; Stecher, SS | 1 |
| Gando, S; Hayakawa, M; Katabami, K; Maekawa, K; Miyamoto, D; Mizugaki, A; Ono, Y; Sawamura, A; Wada, T; Yanagida, Y | 1 |
| Chandrakala, S; Ghosh, K; Jadli, A; Mukaddam, A; Patil, R; Shetty, S | 1 |
| Schleinzer, W; Suksompong, S; von Bormann, B; Zander, R | 1 |
| Kozek-Langenecker, S | 1 |
| Mahajan, RP | 1 |
| Álamo, JM; Alvarez-Rios, AI; Barrero, L; Carmona, M; Gomez-Bravo, MA; Guerrero, JM; Hinojosa, R; Leon-Justel, A; Mellado, P; Noval-Padillo, JA; Porras, M; Vilches-Arenas, A | 1 |
| Ishihara, J; Kitamura, T; Matusmoto, T; Nojima, T; Ohmori, T; Onishi, H; Saisaka, Y; Tanaka, K; Tokioka, T; Yamamoto, K | 1 |
| Chen, GY; Gu, LN; Lu, ZJ; Ou Yang, XL; Wang, LH; Wu, JH; Yang, JH; Zhao, XZ | 1 |
| Beer, S; Brohi, K; Curry, N; Davenport, R; Deary, A; Doughty, H; Green, L; Llewelyn, C; Nordmann, G; Pankhurst, L; Rourke, C; Stanworth, S; Thomas, H | 1 |
| Beck, AW; Ross, RL | 1 |
| Sachais, BS; Shaz, BH | 1 |
| Braunschweig, T; Grottke, O; Lauritzen, B; Rossaint, R; Spronk, HM; Tolba, R; van Oerle, R; Wüst, DC | 1 |
| Kozek-Langenecker, SA | 1 |
| Dittrich, R; Kümpers, P; Mesters, R; Pavenstädt, H; Reuter, S; Thölking, G | 1 |
| Brohi, K; Gwyther, R; Kirkman, E; Midwinter, M; Nordmann, G; Poon, H; Watts, S; Wilson, C; Woolley, T | 1 |
| Costa-Filho, R; Hochleitner, G; Spahn, DR; Teruya, A; Wendt, M | 1 |
| Bye, AP; Fry, MJ; Gibbins, JM; Stainer, AR; Unsworth, AJ; Vaiyapuri, S | 1 |
| Dubick, MA; Martini, WZ | 1 |
| Gil, L; Grajek, S; Komarnicki, M; Rupa-Matysek, J; Szczepaniak-Chicheł, L; Trojnarska, O; Tykarski, A; Wojtasińska, E | 1 |
| DeRose, G; Dubois, L; Forbes, TL; Istl, A; Kribs, S; Lee, K; Mujoomdar, A; Power, AH; Wiseman, D | 1 |
| Bruynseels, D; Collins, PW; Collis, RE; Hall, JE; Hallam, A; Hamlyn, V; Solomon, C | 1 |
| Hoshino, K; Ishikura, H; Nakamura, Y; Nishida, T; Umemura, T | 1 |
| Biswas, A; Griesmacher, A; Hohenstein, K; Ivaškevičius, V; Oldenburg, J; Weigel, G; Würtinger, P; Zehetbauer, S | 1 |
| Do, SH; Na, HS; Shin, HJ | 1 |
| Chen, J; Dong, J; Jiang, J; Lin, S; Shao, L; Wang, M; Weng, Z; Zhu, Y | 1 |
| Kalish, Y; Lask, A; Rottenstreich, A; Schliamser, L; Seligsohn, U; Zivelin, A | 1 |
| Berens, C; Hertfelder, HJ; Ivaškevičius, V; Oldenburg, J; Pötzsch, B; Rühl, H | 1 |
| Klages, M; Weber, CF; Zacharowski, K | 1 |
| Eijgenraam, P; Henskens, Y; Ten Cate, H; Ten Cate-Hoek, A; van den Ham, R | 1 |
| Feng, R; Hao, XX; Wei, XL; Wei, YQ; Xu, LW; Zhou, QJ | 1 |
| Litvinov, RI; Weisel, JW | 1 |
| Ariëns, RA; Lisman, T | 1 |
| Undas, A | 1 |
| Brophy, DF; Cardenas, JC; Chung, D; Fu, X; Lim, EB; López, JA; Martin, EJ; St John, AE; Stern, SA; Wade, CE; Wang, X; Wang, Y; Ward, KR; White, NJ | 1 |
| Afshari, A; Jensen, NH; Stensballe, J | 1 |
| Ariëns, RA | 1 |
| Fenger-Eriksen, C; Fries, D; Larsen, OH; Munk-Andersen, H; Schenk, B | 1 |
| Kilgore, ML; Kim, CH; Marques, MB; Okerberg, CK; Pham, HP; Schwartz, J; Williams, LA | 1 |
| Dobrotova, M; Kubisz, P; Stanciakova, L; Stasko, J | 1 |
| Casini, A; de Moerloose, P | 2 |
| Brat, R; Gill, R; Klein, AA; Levy, JH; Mazer, CD; Okita, Y; Rahe-Meyer, N; Ranganath, R; Schmidt, DS; Schramko, A; Ueda, Y | 1 |
| Amri, Y; Becheur, M; Belaaj, H; Dabboubi, R; de Moerloose, P; Elloumi, M; Kallel, C; Kammoun, S; Messaoud, T; Toumi, Nel H | 1 |
| Henriksen, HH; Johansson, PI; Lange, T; Larsen, CF; Steinmetz, J; Stensballe, J; Sørensen, AM | 1 |
| Johansson, PI; Kofoed, KF; Olsen, PS; Rafiq, S; Steinbrüchel, DA | 1 |
| Alessi, MC; Chambost, H; Frere, C; Henneuse, A; Morange, PE; Suchon, P | 1 |
| Daniel, Y; David, JS; Escarment, J; Habas, S; Malan, L; Peyrefitte, S | 1 |
| Chee, YE; Irwin, MG; Liu, SE | 1 |
| Junge, HK; Mayer, N; Ringer, SK; Schwarzwald, CC | 1 |
| Augey, L; David, JS; Geay-Baillat, MO; Imhoff, E; Incagnoli, P; Parat, S; Tazarourte, K | 1 |
| Kim, D; Kim, JT; Kim, MS; Koo, MA; Kwon, BJ; Lee, MH; Park, JC; Seomun, Y; Seon, GM | 1 |
| Eriksson, M; Larsson, A; Lipcsey, M; Lubenow, N; Strandberg, G | 1 |
| Desborough, MJ; Jairath, V; Kahan, BC; Stanworth, SJ | 1 |
| Biswas, A; Davoli, M; Detarsio, G; Gupta, S; Ivaškevičius, V; Oldenburg, J; Pérez, S; Quartara, A; Raviola, M; Rühl, H | 1 |
| Brohi, K; Cohen, M; Davenport, RA; Frith, D; Guerreiro, M; Pearse, R; Platton, S; Rourke, C; Thiemermann, C | 1 |
| Geng, Y; He, Y; Li, D; Tang, N; Xin, X; Zhou, J | 1 |
| Lashay, A; Masoumi, N; Nooraei, N; Safarinejad, MR; Soleimani, M | 1 |
| Banadyga, L; Ebihara, H; Feldmann, H; Haddock, E; Horne, EJ; Marzi, A; Scott, DP; Shen, K; Thomas, T | 1 |
| Kameshwar, VH; Maheshwari, M; Nafeesa, Z; Nanjunda Swamy, S; Priya, BS; Sharanappa, P; Uday, P | 1 |
| Baksaas-Aasen, K; Balvers, K; Brohi, K; Eaglestone, S; Gaarder, C; Goslings, JC; Johansson, PI; Juffermans, NP; Maegele, M; Ostrowski, SR; Stanworth, S; Stensballe, J; van Dieren, S | 1 |
| Cao, Y; Ding, X; Gamariel, RR; Kong, Y; Li, ZY; Liu, TD; Liu, XD; Ming, X; Wang, CH; Xie, ZL; Zhao, Q | 1 |
| Applegate, R; Bull, BS; Gren, EC; Hay, KL; Hayes, WK; Kelln, W; Kim, CH; Lekic, T; McBride, DW; Raval, R; Sherchan, P; Tang, J; Zhang, JH | 1 |
| Furugori, S; Hagihara, Y; Hagiwara, A; Hayakawa, M; Ishikura, H; Kaneko, N; Kanemura, T; Kato, H; Kim, S; Kiyomi, F; Kudo, D; Kushimoto, S; Maekawa, K; Matsuoka, T; Mayama, G; Morimura, N; Murata, K; Nakamura, Y; Nishiyama, K; Ogura, H; Saitoh, D; Sasaki, J; Shibusawa, T; Shiraishi, A; Takasu, O; Takeda, M; Uejima, T; Yaguchi, A | 1 |
| Baird, EJ | 1 |
| Aparna, HS; Arpitha, A; Girish, KS; Rohit, AC; Sebastin Santhosh, M; Vinod, D | 1 |
| Bachelot-Loza, C; Calmette, L; Gaussem, P; Godier, A; Gouin-Thibault, I; Le Bonniec, B; Martin, AC; Zlotnik, D | 1 |
| Barraviera, B; Ferreira, RS; Palacio, TZ; Rosa, JC; Sampaio, SV; Santos-Filho, NA | 1 |
| Hamrick, SE; Josephson, CD; Pakvasa, MA; Patel, RM; Winkler, AM | 1 |
| Bailey, M; Cameron, PA; Cooper, DJ; McQuilten, ZK; Wood, EM | 1 |
| Brand, EC; de Borst, GJ; Hazenberg, CEVB; Moll, FL; Poorthuis, MHF; Schutgens, REG; Westerink, J | 1 |
| Ajjan, R; Kearney, K; Smith, K; Tomlinson, D | 1 |
| Bolan, CD; Bolan, CE; Cap, AP; Perkins, JG; Reid, TJ; Weiss, BM | 1 |
| Fujie, T; Handa, M; Ikeda, Y; Maruyama, H; Nogawa, M; Okamura, Y; Takeoka, S | 1 |
| Hamaguchi, A; Homsi-Brandeburgo, MI; Mendes, MM; Rodrigues, VM; Soares, AM; Vale, LH | 1 |
| Illoh, K; Illoh, OC | 1 |
| Bernard, M; Bologna, S; Bulabois, CE; Chevallier, P; Cornillon, J; Delain, M; Gruel, Y; Hunault-Berger, M; Ifrah, N; Lafon, I; Maakaroun, A; Padrazzi, B; Tizon, A | 1 |
| Christensen, AQ; Fenger-Eriksen, C; Ingerslev, J; Lindberg-Larsen, M; Sørensen, B | 1 |
| Eskin, T; Kitchens, C | 1 |
| Ablooglu, AJ; Ginsberg, MH; Kang, J; Petrich, BG; Shattil, SJ | 1 |
| Jen, H; Shew, S | 1 |
| Federici, AB | 1 |
| Janssen, HL; Jie, KS; Leebeek, FW; Pattynama, PM; Smalberg, JH; Spaander, MV; van Buuren, HR; van den Berg, B | 1 |
| Acharya, SS; Dimichele, DM | 1 |
| Hsieh, L; Nugent, D | 1 |
| Eto, K; Fujie, T; Handa, M; Ikeda, Y; Maekawa, I; Maruyama, H; Okamura, Y; Takeoka, S | 1 |
| Martini, WZ | 1 |
| Albert, FW; Eichler, H; Haubelt, H; Hellstern, P; Loreth, R; Matzdorff, A; Peetz, D; Pindur, G; Schinzel, H; Seyfert, U | 1 |
| Thompson, CA | 1 |
| Iba, T; Takayama, T | 1 |
| Apestegui, C; Breitenstein, S; Clavien, PA; Dutkowski, P | 1 |
| Fenger-Eriksen, C; Ingerslev, J; Jensen, KM; Jensen, TM; Kristensen, BS; Sørensen, B; Tønnesen, E | 1 |
| Arnold, E; González-Manchón, C; Green, D; Jayo, A; Lord, ST | 1 |
| Galanakis, D; Miesbach, W; Scharrer, I | 1 |
| Ganter, MT; Spahn, DR; Theusinger, OM | 1 |
| Acevedo, I; Cheng, J; Chertov, O; De La Mota, A; Dutra, A; Feltz, R; Gattis, J; Gibot, S; Gomez-Rodriguez, J; Hunter, R; Lubkowski, J; McVicar, DW; Morales, J; Pak, E; Quigley, L; Rivera, L; Schubert, RL; Schwartzberg, PL; Washington, AV | 1 |
| Devaraja, S; Goutham, YN; Kemparaju, K; Kumar, MS; Mahadeswaraswamy, YH | 1 |
| Berger, M; Guimarães, JA; Pinto, AF; Reck, J; Termignoni, C; Terra, RM | 1 |
| Al Mohareb, F; Al Qurashi, F; Al Shanqeeti, A; Al Sharif, F; Al Zahrani, H; Aljurf, M; Chaudhri, N; Iqbal, A; Nurgat, ZA; Owaidah, T; Sahovic, E; Sanz, M; Zaidi, SZ | 1 |
| Fukui, Y; Handa, M; Ikeda, Y; Kabata, K; Okamura, Y; Suzuki, H; Takeoka, S | 1 |
| Dente, CJ; Easley, K; Harris, RS; Hillyer, CD; Ling, Q; MacLeod, JB; Nicholas, J; Shaz, BH; Young, AN | 1 |
| Abbott, LS; Barnard, DR; Berman, JN; Deevska, M; Dix, D; Fernandez, CV; Fitzgerald, C; Parker, L; Price, VE; Wang, H; Yhap, M | 1 |
| Garipidou, V; Perifanis, V; Tziomalos, K; Vakalopoulou, S | 1 |
| Brenni, M; Brüesch, M; Ganter, MT; Spahn, DR; Worn, M | 1 |
| Allen, JG; Jacobson, LO; Kirschon, A; Milham, M; Sanderson, M | 1 |
| Galanakis, D; Henschen, A; Miesbach, W; Neerman-Arbez, M; Scharrer, I; Spitzer, S | 1 |
| Bortolotti, U; Celiento, M; Pratali, S; Scioti, G | 1 |
| Forster, L; Schöchl, H; Solomon, C; Voelckel, W; Woidke, R | 1 |
| Briones, Y; Casado-Rodrigo, D; Daroca-José, JM; Martínez-Ramos, D; Salvador-Sanchís, JL | 1 |
| Borges, MH; Eble, JA; Evangelista, KS; Figueiredo, SG; Richardson, M; Sanchez, EF; Schneider, FS; Yarleque, A | 1 |
| de Roodt, AR; González, ME; Lanari, LC; Liria, N; Rosset, S | 1 |
| Castelli, S; Gargioli, C; Hamza, L; Laraba-Djebari, F; Rufini, S | 1 |
| Hofer, G; Jambor, C; Kozek-Langenecker, S; Nienaber, U; Scharbert, G; Schöchl, H; Solomon, C; Voelckel, W | 1 |
| Agger, P; Hasenkam, JM; Langhoff, J; Smerup, MH | 1 |
| Braunschweig, T; Coburn, M; Grottke, O; Henzler, D; Rossaint, R; Tolba, R | 1 |
| Braunschweig, T; Coburn, M; Daheim, N; Grieb, G; Grottke, O; Rossaint, R; Tolba, R | 1 |
| Akinci, E; Bodur, H; Dagdas, S; Eren, S; Onguru, P; Ozet, G; Yilmaz, M | 1 |
| Choi, Y; Jeon, M; Kang, YA; Kim, DY; Kim, JY; Kim, SD; Lee, JH; Lee, KH; Lee, YJ; Lee, YS; Lim, SN; Seol, M | 1 |
| Marangoni, S; Martins-de-Souza, D; Ponce-Soto, LA; Torres-Huaco, FD | 1 |
| Boffard, KD; Choong, PI; Holcomb, JB; Kluger, Y; McMullin, NR; Nielsen, TG; Riou, B; Rizoli, SB; Rossaint, R; Tortella, BJ; Wade, CE; Warren, B | 1 |
| Hanke, A; Posch, A; Schöchl, H; Solomon, C; Voelckel, W | 1 |
| Jacobs, IG; Mountain, D; Sistenich, V | 1 |
| Ho, KM; Leonard, A | 1 |
| Bayer, G; Bergmeister, H; Friedl, P; Jilma, B; Mesteri, I; Petzelbauer, P; Quehenberger, P; Siller-Matula, JM | 1 |
| Gudbjartsson, T; Hreinsson, K; Onundarson, PT; Sigurbjornsson, FT; Sigurdsson, GH; Thorarinsdottir, HR | 1 |
| Braunschweig, T; Coburn, M; Grottke, O; Kopp, R; Lauritzen, B; Rossaint, R; Tolba, R; Zimmermann, L | 1 |
| Rahe-Meyer, N; Sørensen, B | 1 |
| Hollensead, SC; Math, SK; Sanders, MA | 1 |
| Hunt, BJ; Ozier, Y | 1 |
| Aboukhamis, I; Chamaa, S; de Moerloose, P; Farho, J; Fort, A; Levrat, E; Neerman-Arbez, M; Reber, G | 1 |
| Ho, KM; Leonard, AD | 1 |
| Ahmed, M; Ghani, MH; Ghori, MA; Memon, MA; Mustafa, G; Siddiqui, SA | 1 |
| Budnik, I; Einav, Y; Martinowitz, U; Misgav, M; Shenkman, B | 1 |
| Abolghasemi, H; Aghaiipour, M; Ala, F; Faranoush, M; Farsinejad, A; Hadjati, E; Jazebi, M; Kazemi, A | 1 |
| Johansson, PI; Meyer, MA; Ostrowski, SR; Windeløv, NA | 1 |
| Innerhofer, P | 1 |
| Fenger-Eriksen, C | 1 |
| Grottke, O; Rossaint, R | 2 |
| Cotton, BA; Goodnough, LT; Young, PP | 1 |
| Allen, G; Bernstein, J; Bornikova, L; Manco-Johnson, MJ; Peyvandi, F | 1 |
| Balwierz, W; Iwaniec, T; Neerman-Arbez, M; Pietrys, D; Undas, A; Vorjohann, S | 1 |
| Kanbak, M; Oc, B; Oc, M; Ocal, T; Salman, MA | 1 |
| Duchesne, JC | 1 |
| Allmaier, G; Balija, ML; Brgles, M; Halassy, B; Križaj, I; Kurtović, T; Leonardi, A; Marchetti-Deschmann, M | 1 |
| Amukele, TK; Baird, GS; Chandler, WL | 1 |
| Del Vecchio, A; Motta, M; Radicioni, M | 1 |
| Bhogaraju, A; Brennan, S; Sarode, R; Shen, YM | 1 |
| Levy, JH; Sniecienski, RM; Szlam, F; Tanaka, KA | 1 |
| Achê, DC; Borges, MH; Ferreira, FB; Gomes, MS; Naves de Souza, DL; Richardson, M; Rodrigues, RS; Rodrigues, VM | 1 |
| Glaser, M; Heindl, B; Herberger, S; Huber, T; Johanning, K; Lison, S; Spannagl, M; Strasser, T; Weiss, G | 1 |
| Bruzgo, I; Drozdowska, D; Kaczyńska, J; Markowska, A; Midura-Nowaczek, K | 1 |
| Aung, HT; Komori, Y; Nikai, T; Niwa, M; Nonogaki, T; Takaya, Y | 1 |
| Komori, Y; Masuda, K; Nikai, AT; Sakai, K | 1 |
| Aster, RH; Bakchoul, T; Bein, G; Eva, O; Giptner, A; Gitter, M; Peterson, J; Sachs, UJ; Santoso, S | 1 |
| Abdel-Aty, AM; El-Kady, EM; Wahby, AF | 1 |
| Angulo, Y; Arrieta, AB; Arroyo, Y; Barona, J; Betancur, D; Conrado, NL; Córdoba, EA; Díaz, A; Estrada, S; Fabra, P; Fernández, D; Fernández, J; Gómez, JP; Gutiérrez, JM; Herrera, M; León, G; Mosquera, DC; Ortiz, R; Otero-Patiño, R; Perea, M; Pereañez, A; Pupo, L; Quintana, JC; Ramírez, CE; Ramírez, P; Rivero, A; Segura, A; Suárez, AM; Vargas, LJ | 1 |
| Franchini, M; Lippi, G | 1 |
| Chang, H; Dunn, P; Hung, YS; Kuo, MC; Lin, TL; Shih, LY; Tang, TC; Wang, PN; Wu, JH | 1 |
| Boehne, M; Hanke, A; Jahn, W; Osthaus, WA; Rahe-Meyer, N; Schmidt, F; Sümpelmann, R; Witt, L | 1 |
| Weiskopf, RB | 1 |
| Hasegawa, M; Matsumoto, T; Nobori, T; Noma, K; Shimokariya, Y; Sudo, A; Uchida, A; Wada, H; Wakabayashi, H; Yamada, N; Yoshida, K | 1 |
| Bayer, G; Fabry, A; Gemeiner, M; Jilma, B; Mesteri, I; Miller, I; Nöbauer, K; Petroczi, K; Planchon, S; Plasenzotti, R; Quehenberger, P; Razzazi-Fazeli, E; Renaut, J; Selzer, E; Siller-Matula, JM | 1 |
| Fenger-Eriksen, C; Hochleitner, G; Moore, G; Sørensen, B | 1 |
| Bourdon, C; Gachet, C; Lanza, F; Mangin, PH; Ohlmann, P; Receveur, N; Schaff, M | 1 |
| Schardey, HM; Schopf, SK; von Ahnen, M; von Ahnen, T | 1 |
| Mackessy, SP; Weldon, CL | 1 |
| Görlinger, K; Maegele, M; Schöchl, H; Solomon, C; Voelckel, W | 1 |
| Bhakta, V; Eltringham-Smith, LJ; Gataiance, S; Sheffield, WP | 1 |
| Floyd, CT; Martin, R; Olson, CE; Risdahl, J; Rothwell, SW | 1 |
| Comerota, AJ; Davis, JP; Deng, C; Fineberg, D; Hanna, K; Marder, VJ; Shlansky-Goldberg, RD | 1 |
| Card, R; Poon, MC | 1 |
| Ruiz-Sáez, A | 1 |
| Flick, MJ; Jone, A; Kassel, KM; Luyendyk, JP; Sullivan, BP | 1 |
| Brohi, K; Curry, N; Davenport, R; Khan, S; Raza, I; Rourke, C; Stanworth, S; Taylor, R | 1 |
| Choudhry, A; DeLoughery, TG | 1 |
| Benton, A; Chilcott, J; Collins, PW; Gollop, ND; Jones, J; Rayment, R | 1 |
| Floyd, CT; Martin, R; Olson, CE; Risdahl, J; Rose, N; Rothwell, SW | 1 |
| Baron, DM; Kimberger, O; Kozek-Langenecker, S; Kraincuk, P; Metnitz, PG; Schaden, E | 1 |
| Agarwal, B; Burroughs, A; Chowdary, P; Davenport, A; Gatt, A; Jalan, R; Mallett, S; Riddell, A; Vemala, V; Wright, G | 1 |
| Ding, Z; Du, H; Liu, G; Pan, C; Wei, X; Ye, J; Zhang, S; Zhang, Y | 1 |
| Clark, SL; Costantine, MM; Hankins, GD; Pacheco, LD; Saade, GR | 1 |
| Hilbert, P; Hofmann, GO; Jakubetz, J; Stuttmann, R; Teichmann, J; zur Nieden, K | 1 |
| Bolonaki, I; Danilatou, V; Foundouli, K; Kaparou, M; Lydaki, E; Nikoloudi, I; Stathoudakis, G | 1 |
| Doi, M; Hagisawa, K; Handa, M; Iwaya, K; Katsuno, S; Kinoshita, M; Nishikawa, K; Saitoh, D; Sakamoto, T; Seki, S; Shono, S; Suzuki, H; Takeoka, S; Yanagawa, R | 1 |
| Galán, J; Girón, ME; Guerrero, B; Ibarra, C; Rodríguez-Acosta, A; Salazar, AM; Sánchez, EE | 1 |
| Rayment, R | 1 |
| Ahmed, S; Byrne, BM; Fanning, R; Flynn, CM; Harrity, C; Johnson, S; McMorrow, S; O' Riordan, JM; Varadkar, S | 1 |
| Baglin, T; Stanworth, S; Yang, L | 1 |
| Acosta-Villegas, F; Falcón-Araña, L; Fuentes-García, D; Hernández-Palazón, J; Roca-Calvo, MJ | 1 |
| Agras, PI; Alioglu, B; Dallar, Y; Karamercan, S; Ozsoy, MH; Tapci, E | 1 |
| Gao, S; Guo, M; Song, J; Wang, S; Xu, X; Yan, X; Zhang, Y | 1 |
| De-Blas, JM; Gomez-Cia, T; Guerrero, JM; Hinojosa, R; Leon-Justel, A; Noval-Padillo, JA; Polonio, F; Porras, M; Solomon, C | 1 |
| Goyert, G; Green, PM; Hanbali, A; Kuriakose, P; Lambing, A; Munoz, J; Neal, S; Raman, S; Schering, J | 1 |
| Gutiérrez, JM; Herrera, C; Rucavado, A; Warrell, DA | 1 |
| Harinstein, LM; Morgan, JW; Russo, N | 1 |
| Dharmappa, KK; Joshi, V; Kumar, RV; Sharath, BK; Venkatesha, SH; Vishwanath, BS; Yariswamy, M | 1 |
| Schulman, S | 1 |
| Callum, JL; Rizoli, S | 1 |
| Fries, D | 1 |
| Grottke, O; Rossaint, R; Spahn, DR; Zentai, C | 1 |
| Blombäck, M; Cao, H; He, S; Hultenby, K; Johnsson, H; Zabczyk, M | 1 |
| Bernardes, CP; Camacho, E; Escalante, T; Gutiérrez, JM; Lomonte, B; Menaldo, DL; Rosa, JC; Rucavado, A; Sampaio, SV | 1 |
| Bal Dit Sollier, C; Drouet, L | 1 |
| Bayly, WM; Kingston, JK; Meyers, KM; Sellon, DC; Wardrop, KJ | 1 |
| Kobayashi, J; Maeda, K; Murakami, A; Takamoto, S; Takaoka, T; Takayama, H | 1 |
| Anai, K; Kawano, J; Maruyama, M; Sugiki, M; Yoshida, E | 1 |
| Jesmok, G; Kong, M; Marder, VJ; Novokhatny, V; Stewart, D | 1 |
| Jin, Y; Lu, QM; Wang, WY; Wei, JF; Wei, Q; Xiong, YL | 1 |
| Gabazza, EC; Kushiya, F; Mori, Y; Nishikawa, M; Nobori, T; Okabayashi, K; Shiku, H; Wada, H; Watanabe, M | 1 |
| Bell, WR | 1 |
| Galán, JA; López, G; Pérez, JC; Ramírez, MS; Rodríguez-Acosta, A; Sánchez, EE | 1 |
| Chase, PB; Galán, JA; Perez, JC; Rodríguez-Acosta, A; Sánchez, EE | 1 |
| Kitchen, S; Lowe, GD; Machin, SJ; Mackie, IJ | 1 |
| Anthony, JP; Borsa, JJ; Burkart, DJ; Thurlo, SR | 1 |
| Kruskall, MS; Pantanowitz, L; Uhl, L | 1 |
| Chan, CW; Chan, MW; Chen, Y; Clark, DA; Fung, LS; Ghanekar, A; Gorczynski, RM; Grant, DR; He, W; Levy, GA; Luo, X; Marsden, PA; Mendicino, M; Miller, T; Ning, Q; Phillips, MJ; Scott, JA | 1 |
| Liu, Z; Shen, D; Wang, A; Wei, W; Yang, L; Yang, R; Yang, Y; Zhang, Y | 1 |
| Bogers, AJ; Daane, CR; Golab, HD; Meeder, JH; Wijers, MJ | 1 |
| Chiu, HC; Lee, CC; Lin, SM; Yeh, JH | 1 |
| Acosta, O; Leiva, LC; Maruñak, S; Peichoto, ME; Rey, L; Teibler, P | 1 |
| RICE, WG | 1 |
| CARPENTER, F; LEAHY, DJ; SAWITSKY, A | 1 |
| BARNETT, VH; CUSSEN, CA | 1 |
| FEENEY, JK | 1 |
| DIDDLE, AW | 1 |
| LITTLEJOHN, TW; McKAY, DG; SCHOENBUCHER, AK | 1 |
| ANDERSON, HD; WILEY, HW | 1 |
| LORINCZ, AB | 1 |
| GLENDENING, MB; OLSON, L; PAGE, EW | 1 |
| BLOMBACK, B; BLOMBACK, M; SENNING, A; WALLEN, P | 1 |
| SIBTHORPE, EM | 1 |
| KELSEY, HA; MUIRHEAD, JM | 1 |
| CENTONZE, M | 1 |
| SEGEDIN, R; SULOVIC, V; TOMIC, M | 1 |
| DUPAY, A | 1 |
| GHOSH, AK; KIMBELL, N | 1 |
| BYRNE, AD | 1 |
| OSMOND, JD; ROTTER, CW | 1 |
| REID, DE; ROBY, CC; WEINER, AE | 1 |
| BATTLE, R; CAMO, G; CAZAL, P; GRAAFLAND, R; LIEB, J | 1 |
| CAZAL, P; FISCHER, J; GRAAFLAND, R; IZARN, P; MATHIEU, M; PALEIRAC, G | 2 |
| NIESERT, HW | 2 |
| HODGKINSON, CP | 1 |
| PFAU, P; RUNGE, H | 1 |
| MARSH, C; SCHENKEN, JR; VOSE, JL | 1 |
| WILLE, P | 1 |
| DUCHAINE, P | 1 |
| FIRTH, J | 1 |
| COHEN, M; LEBOURG, P; PEREZ, C; VALENSI, G | 1 |
| LEROUX, M | 2 |
| BESEKE, M; EGLI, H; HAUPT, H; KESSELER, K | 1 |
| ELLIOTT, KA | 1 |
| BRANDT-NIELSEN, E; POULSEN, PE | 1 |
| McLENNAN, H | 1 |
| RADERECHT, HJ | 1 |
| BRANDT-NIELSEN, E; EJBY-POULSEN, P | 1 |
| ACHENBACH, W; EGLI, H; KESSELER, KH; OVERKAMP, H | 1 |
| GRONROOS, P; SALOHEIMO, A | 1 |
| GARCIA, R | 1 |
| BELLER, FK | 2 |
| Watzke, HH | 1 |
| DIAMOND, LK; MCMILLAN, CW; SURGENOR, DM | 1 |
| HASSELBACK, R; MARION, RB; THOMAS, JW | 1 |
| BIGGS, R; MATTHEWS, JM | 1 |
| THIES, HA | 1 |
| KOPPE, JG; MOCHTAR, IA | 1 |
| BAKER, CH | 1 |
| ANDERSSON, L; LINDSTEDT, E | 1 |
| FUKUI, H; YOSHIDA, K | 1 |
| LAKATOS, I | 1 |
| TAYLOR, HC | 1 |
| MARIN, HM | 1 |
| BEN-ADERETH, N; LEWENTHAL, H | 1 |
| HRUBISKO, M; HRUBISKOVA, K | 1 |
| ANDERSSON, L | 1 |
| LAZZARETTI, R | 1 |
| KING, TA; PHILLIPS, LL; SKRODELIS, V | 1 |
| DOUGLAS, AS; MCNICOL, GP | 1 |
| APPIANI, L; PEDRONETTO, S | 1 |
| CHATTERJEE, KN; TAKEDA, J; WARREN, R | 1 |
| BUDZYNSKI, AZ; KOPEC, M; KOWALSKI, E; LATALLO, ZS; LIPINSKI, B; WEGRZYNOWICZ, Z | 1 |
| MORE, JR; POLLER, L | 1 |
| FINK, LH; GARZON, AA; KARLSON, KE; SHAFTAN, GW | 1 |
| TANNER, K | 3 |
| VOURCH, G | 1 |
| PERSIANINOV, LS; PORAI-KOSHITS, KV | 1 |
| HARPER, JA; QUINN, LJ | 1 |
| PLOTKIN, D; SAWITSKY, A | 1 |
| DUPAY, A; LEMERRE, L; LEPAGE, F | 1 |
| Cornum, RL; Fitzpatrick, GM; Goodwin, CW; Harris, RA; Hess, JR; Holcomb, JB; Martinez, RS; McManus, AT; Modrow, HE; Mosebar, RH; Nelson, JH; Pusateri, AE; Reid, TJ; Sondeen, JL; Zolock, DT | 1 |
| Chen, XY; Ding, BS; Liu, JN; Sun, ZY; Tan, XY; Zhang, J; Zhang, PX; Zhou, YJ | 1 |
| Epstein, JS; Leitman, SF; Pomper, GJ; Read, EJ; Rick, ME | 1 |
| Bonnin, P; Cupa, M; Fattorutto, M; Mazoyer, E; Morin, F; Pham Tourreau, S; Raphaël, M; Samama, CM | 1 |
| Silvestri, AR; Zucchelli, P | 1 |
| Dobrovolski, R; Guimarães, JA; Pinto, AF; Veiga, AB | 1 |
| Laing, GD; Marcelo, A; Rodriguez, E; Theakston, RD; Warrell, DA; Yarleque, A | 1 |
| Connolly, RJ | 1 |
| Bellinger, D; Chan, MW; Cole, DJ; Connolly, RJ; Nichols, T; Read, M; Schwaitzberg, SD | 1 |
| Galán, JA; Pérez, JC; Rodríguez-Acosta, A; Sánchez, EE | 1 |
| Chen, RQ; Jin, Y; Li, DS; Lu, QM; Wang, WY; Wu, JB; Xiong, YL; Zhou, XD | 1 |
| Ball, C; Bergeron, AL; Dong, JF; Holcomb, JB; McBride, L; Pusiteri, AE; Wood, J; Yu, Q; Zhang, JN | 1 |
| FINE, J; FRANK, ED; FRANK, HA | 1 |
| Chandiramani, V; Gupta, AD; Gupta, T; Khodaiji, S; Mandolkar, M; Sethi, M; Soman, R | 1 |
| Fries, D; Innerhofer, P | 1 |
| Grubitzsch, H; Sander, M; Schoenfeld, H; Spies, C; von Heymann, C; Ziemer, S | 1 |
| Brenner, B; Dally, N; Haddad, N; Hoffman, R; Rowe, JM; Sarig, G | 1 |
| Ando, M; Kondo, Y; Muto, A; Nishibe, T; Sato, M; Yamashita, M | 1 |
| Dhananjaya, BL; Kemparaju, K; Nataraju, A; Raghavendra Gowda, CD; Rajesh, R; Vishwanath, BS | 1 |
| Fries, D; Haas, T; Innerhofer, P; Klima, G; Klingler, A; Krismer, A; Streif, W; Wenzel, V | 1 |
| Ingerslev, J; Sørensen, B | 1 |
| Acosta de Pérez, O; Gay, CC; Leiva, LC; Maruñak, S; Teibler, P | 1 |
| Aoki, T; Honda, S; Mihara, K; Moriguchi, A; Mutoh, S; Okubo, M; Tomiyama, Y; Yamanaka, T | 1 |
| Chakrabarty, A; Culley, NC; LeVine, SM; Mayo, MS; Pinson, DM | 1 |
| Aguejouf, O; Belon, P; Doutremepuich, C; Eizayaga, FX | 1 |
| Dippel, EJ; Kapalis, MJ; Kirchner, HL; Lemke, JH; Palabrica, T; Robken, J; Shammas, NW; Takes, V | 1 |
| Fries, D; Friesenecker, B; Innerhofer, P; Klingler, A; Reif, C; Schobersberger, W; Streif, W; Velik-Salchner, C | 1 |
| Brennan, SO; Frantz, C; Lowen, R; Mosesson, MW | 1 |
| Albassam, M; Chupka, J; McDuffie, JE; Sobocinski, G; Song, Y; Yu, X | 1 |
| Alvarez-Sabín, J; Corral, J; Fernández-Cadenas, I; González-Conejero, R; Iniesta, JA; Marti-Fabregas, J; Montaner, J; Obach, V; Vicente, V | 1 |
| Girish, KS; Kemparaju, K; Mahadeswaraswamy, YH; Nagaraju, S | 1 |
| Chinkes, DL; Dubick, MA; Martini, WZ; Sondeen, J | 1 |
| Kasirer-Friede, A; Koretzky, G; Moran, B; Nagrampa-Orje, J; Neel, BG; Ruggeri, ZM; Schraven, B; Shattil, SJ; Swanson, K | 1 |
| Ostermann, H | 1 |
| Dolan, G; Garipidou, V; Hill, M; Lefkou, E; Perifanis, V; Rizopoulou, D; Tziomalos, K; Vakalopoulou, S; Zafiriadou, E | 1 |
| Castellino, FJ; Donahue, DL; Iwaki, T | 1 |
| Angles-Cano, E; Claeyssens, S; de Mazancourt, P; Dreyfus, M; Mathonnet, F | 1 |
| Grottke, O; Henzler, D; Rossaint, R; Spahn, DR | 1 |
| Acosta, O; Gonçalves, LR; Leiva, L; Mackessy, SP; Peichoto, ME; Santoro, ML; Tanaka-Azevedo, AM; Teibler, P | 1 |
| Amanzadeh, J; Busti, AJ; Dehoney, SB; Hedges, SJ; Hooper, JS | 1 |
| Hayashi, M; Juen, H; Sagesaka, T | 1 |
| Boellaard, TN; Garcia, AA; Groot, AP; Reitsma, PH; van der Heijden, JF; van der Hoeven, NV | 1 |
| Asselta, R; Duga, S; Spena, S; Tenchini, ML | 1 |
| Fries, D; Haas, T; Innerhofer, P; Klima, G; Klingler, A; Martinowitz, U; Nussbaumer, W; Streif, W; Velik-Salchner, C | 1 |
| Aguilar, I; Girón, ME; Guerrero, B; Maria Salazar, A; Pérez, JC; Rodríguez-Acosta, A; Sánchez, EE | 1 |
| da Silva, JO; Fernandes, RS; Franco, JJ; Giuliatti, S; Mazzi, MV; Oliveira, CZ; Pereira, PS; Sampaio, SV; Soares, AM; Ticli, FK | 1 |
| Fries, D; Gütl, M; Hofmann, N; Innerhofer, P; Kneifl, W; Koscielny, J; Kozek-Langenecker, SA; Neuner, L; Perger, P; Pernerstorfer, T; Pfanner, G; Schöchl, H | 1 |
| Fujie, T; Handa, M; Ikeda, Y; Maruyama, H; Okamura, Y; Takeoka, S | 1 |
| Ablooglu, AJ; Fogelstrand, P; Ginsberg, MH; Partridge, AW; Petrich, BG; Shattil, SJ; Yousefi, N | 1 |
| Erdogan, D; van Gulik, TM | 1 |
| Badimon, L; Casaní, L; Vilahur, G | 1 |
| Aguilar, I; Arocha-Piñango, CL; Girón, ME; Guerrero, B; Pérez, JC; Rodríguez-Acosta, A; Salazar, AM; Sánchez, EE | 1 |
| Brennan, SO; Dietzel, H; Kaetzel, R; Liebscher, K; Meyer, M; Schmidt, D | 1 |
| Algra, A; Garcia, AA; Gorter, JW; Kappelle, LJ; Pruissen, DM; Rosendaal, FR | 1 |
| Gika, M; Imamura, T; Izumi, Y; Kawamura, M; Kobayashi, K; Miyabashira, S; Nozaki, C; Shinya, N | 1 |
| DILLON, WF; SCHMITZ, HE | 1 |
| Bueno, SR; Cuenca, LG; Danés, AF; Mendarte Barrenechea, L; Ronsano, JBM | 1 |
| Alston, SM; Mohammad, SF; Solen, KA; Sukavaneshvar, S | 1 |
| Bormanis, J | 1 |
| Lüscher, EF | 1 |
| Cheng, C; Garzon, AA; Karlson, KE; Lerner, B; Lichtenstein, S | 1 |
| Chu, CJ; Garzon, AA; Karlson, KE; Shaftan, GW | 1 |
| Byrom, E; Campbell, CD; Jakob, H; Pick, R; Pinsky, S; Replogle, RL | 1 |
| Meisner, H; Schmidt-Habelmann, P; Sebening, F; Struck, E | 1 |
| Haase, J | 1 |
| Holzhausen, H; Szigeti, A; Vecsey, D | 1 |
| Lambert, H; Laprevote-Heully, MC; Larcan, A | 1 |
| Lombardi, R; Mannucci, PM; Mecca, G; Pusineri, F; Remuzzi, G; Valsecchi, C; Zimmerman, TS | 1 |
| Barsotti, G; Giovannetti, S; Lecchini, L; Panicucci, F; Pinori, E; Sagripanti, A; Vispi, M | 1 |
| Kennedy, JG; Saunders, RL | 1 |
| Chang, JH; Huang, TF; Ouyang, C | 1 |
| Mahew, DE; McMillan, CW; Wilson, FC | 1 |
| Luk'ianets, BG | 1 |
| Carrillo, C; Crosby, E; Gotuzzo, E; Llosa, L; Miro Quesada, M | 1 |
| Baryshev, BA; Chermoshnik, GA; Chuslov, AG; Fedorova, ZD; Khanin, AZ | 1 |
| Babu, NS; Dixon, J; Frederiksen, R; Kaiser, AB; Kaplan, P; Page, HL; Roach, A; Tacogue, L; Tennant, SN; Venable, TC | 1 |
| Hatteland, K; Ottesen, S; Stormorken, H | 1 |
| Eidler, R; Fischer, M; Gasser, G; Kläring, W; Lurf, H; Mossig, H | 1 |
| Fomin, AN | 1 |
| Blümel, G; Buttermann, G; Kalinowski, H; Pabst, HW; Vogel, GE | 1 |
| Gaffney, PJ | 2 |
| Gangadharan, V; Goodfliesh, R; Gordon, S; Hauser, AM; Ramos, RG; Stewart, J; Timmis, GC; Westveer, DC | 1 |
| Cantaluppi, A; Casati, S; Citterio, A; Graziani, G; Mannucci, PM; Moia, M; Ponticelli, C | 1 |
| Geisinger, MA; Graor, RA; Risius, B; Ruschhaupt, WF; Smith, JA; Young, JR; Zelch, MG | 1 |
| Carvalho, AC; Geller, E; Jones, R; Khaw, BA; Rajagopalan, B; Strauss, HW; Zapol, WM | 1 |
| Deykin, D; Janson, PA; Jubelirer, SJ; Weinstein, MJ | 1 |
| Cattaneo, M; Gervasoni, W; Mannucci, PM; Viganó, S | 1 |
| Barone, C; Bartoloni, C; Grieco, A; Leone, G | 1 |
| Marengo-Rowe, AJ | 1 |
| Bandyk, DF; Berni, GA; Strandness, DE; Thiele, BL; Zierler, RE | 1 |
| Bardin, JA; Bernstein, EF; Bookstein, JJ; Dilley, RB; Donnelly, KJ; Heeney, DJ; Mori, KW; Rhodes, GA; Warmath, MA | 1 |
| Fagher, B; Lundh, B | 1 |
| Hasiba, U; Lewis, JH; Ragni, MV; Spero, JA | 1 |
| Urbaniak, SJ | 1 |
| Argirov, A; Stavreva, V; Uchikov, P | 1 |
| Lorand, L; Losowsky, MS; Miloszewski, KJ | 1 |
| Craig, RL; Poole, GV | 1 |
| Bevan, DH; Cowans, D; Kallis, P; Talbot, S; Tooze, JA; Treasure, T | 1 |
| Gurewich, V; Mannucci, PM; Moia, M; Pini, M; Prandoni, P | 1 |
| Gardell, SJ; Hare, TR; Lynch, JJ; Mellott, MJ; Ramjit, DR; Senderak, ET; Stabilito, II | 1 |
| Imanaka, Y; Iwasaki, S; Morichika, S; Nakajima, M; Shima, M; Yoshioka, A | 1 |
| Oishi, S; Takahashi, O; Watanabe, MF | 1 |
| Daugherty, CC; Degen, JL; Holmbäck, K; Jensen, NJ; Potter, S; Simon, DI; Small, K; Suh, TT | 1 |
| de Bono, DP; More, RS | 1 |
| Hirsh, J; Klement, P; Leslie, B; Weitz, JI | 1 |
| Cyran, EM; George, S; Nagabhushana, MS | 1 |
| Audibert, G | 1 |
| Baba, S; Fujimura, S; Hao, XQ; Hori, J; Kimoto, E; Rikimaru, T; Terada, S | 1 |
| Godal, HC; Sletnes, KE; Wisløff, F | 1 |
| Hawson, GA; Marsh, NA; Ray, MJ | 1 |
| Assakura, MT; Mandelbaum, FR; Reichl, AP | 1 |
| Burstein, SA | 1 |
| Colonna, G; Di Micco, B; Metafora, S; Porta, R | 1 |
| Badillo, JM; Bennett, WF; Errett, CJ; Keyt, BA; Refino, CJ; Thibodeaux, H; Thomas, GR; Zivin, JA | 1 |
| de Bono, DP | 1 |
| Brause, K; Chandler, GO; Doherty, JB; Dorn, CP; Finke, PE; Hagmann, WK; Hale, JJ; Kissinger, AL; Shah, SK; Thompson, KR | 1 |
| Essell, JH; Martin, TJ; Salinas, J; Smith, VC; Thompson, JM | 1 |
| Phillips, DA; Sheiman, RG | 1 |
| Johnson, EK; Ownby, CL | 1 |
| Anderson, K; Lee, MH; McDonagh, J; Vosburgh, E | 1 |
| Chang, IM; Hahn, BS; Kim, YS | 1 |
| Berry, CF; Hagedorn, FN; Illner, HP; Mathis, JE; Selby, JB; Shires, GT | 1 |
| Comerota, AJ; Katz, ML; White, JV | 1 |
| Bernat, A; Hérault, JP; Herbert, JM; Lormeau, JC; Meuleman, DG; Petitou, M; van Amsterdam, RG; Vogel, GM | 1 |
| Heran, CL; Schumacher, WA; Steinbacher, TE | 1 |
| Garcia, JH; Khang-Loon, H | 1 |
| Andreeff, M; Cortes, J; Kantarjian, H; Keating, M; Koller, C; Kornblau, S; O'Brien, S; Pierce, S; Sarris, A; Smith, T | 1 |
| Danton, MJ; Daugherty, CC; Degen, JL; Holmbäck, K; Suh, TT | 1 |
| Frojmovic, MM; Searcy, GP; Wong, T | 1 |
| FitzGerald, MP; Floro, C; Hernandez, E; Siegel, J | 1 |
| Fadil, MA; Marcondes, M; Româo, JE; Sabbaga, E | 1 |
| Golato, M; Liani, M; Salvati, F | 1 |
| Jacobs, HM; Kessler, CM; Szymanski, LM; Tang, Z | 1 |
| Domenech, P; Figueras, J; García-Huete, L; Jaurrieta, E; Martínez-Brotons, F; Sabaté, A | 1 |
| Bailey, JM; Kanter, KR; Levy, JH; Miller, BE; Mochizuki, T; Tam, VK; Tosone, SR | 1 |
| Bacher, H; Cerwenka, H; El-Shabrawi, A; Mischinger, HJ; Werkgartner, G | 1 |
| Montes, R; Panizo, C; Páramo, JA; Rocha, E | 1 |
| Dickfeld, T; Gawaz, M; Neumann, FJ; Pogátsa-Murray, G; Ruf, A; Schömig, A; Zohlnhöfer, D | 1 |
| Biemond, BJ; de Groot, PG; Friederich, PW; Harris, R; Heijnen, HF; Levi, M; Levin, J; Middleton, S; ten Cate, JW; Wu, YP | 1 |
| Christensen, KA; Deptula, JJ; Stammers, AH; Sydzyik, RT; Willett, LD; Zavadil, DP | 1 |
| Michels, HR | 1 |
| Maksimenko, AV; Tischenko, EG | 1 |
| Huang, QQ; Niu, LW; Teng, MK | 1 |
| Alfaro, E; Cygler, AM; Delfino, S; Felice, MS; Rose, AB; Sackmann-Muriel, F; Zubizarreta, PA | 1 |
| Jin, Y; Li, DS; Lu, QM; Wang, WY; Xiong, YL | 1 |
| Gagnon, GA; Sallah, S | 1 |
| Avvisati, G; Castaman, G; De Sanctis, V; Di Bona, E; Luce Vegna, M; Mandelli, F; Rodeghiero, F | 1 |
| Brennan, SO; Brosstad, FR; Fellowes, AP; George, PM; Holme, R; Stormorken, H | 1 |
| Bos, R; Fijnheer, R; Nieuwenhuis, HK; Oudijk, EJ | 1 |
| Hatsukami, TS; Ikari, Y; Schwartz, SM; Yee, KO | 1 |
| Diniz, CR; Estêvão-Costa, MI; Magalhães, A; Markland, FS; Sanchez, EF | 1 |
| Asselta, R; Duga, S; Giangrande, PL; Malcovati, M; Mannucci, PM; Santagostino, E; Simonic, T; Tenchini, ML | 1 |
| Brennan, SO; George, PM; May, S; Wyatt, J | 1 |
| Igarashi, T; Komiyama, N; Komiyama, Y; Maeda, T; Miwa, M; Munakata, M; Sugatani, J; Takahashi, H; Takeda, T | 1 |
| Gaugler, MH; Gourmelon, P; Mouthon, MA; Van der Meeren, A; Vandamme, M; Wagemaker, G | 1 |
| Teitel, JM | 1 |
| Beall, LD; Charles, NC; Harris, RA; Hess, JR; Holcomb, JB; MacPhee, MJ; Pusateri, AE | 1 |
| Castel, D; Freidman, M; Hedner, U; Hess, JR; Holcomb, JB; Macaitis, JM; Martinowitz, U; Onaca, N; Pusateri, AE; Stein, M | 1 |
| Komori, Y; Nikai, T; Nonogaki, T | 1 |
| Chew, DP; Moliterno, DJ; Mukherjee, D; Raymond, RE; Robbins, M; Yadav, JS | 1 |
| Aoki, Y; Kurabayashi, T; Matsushita, H; Tanaka, K; Tomita, M; Yamamoto, Y | 1 |
| Blajchman, MA | 1 |
| Gabriel, DA; Roberts, HR; Stinchcombe, TE | 1 |
| Coughlin, SR; Griffin, CT; Huang, W; Srinivasan, Y; Zheng, YW | 1 |
| Hanrahan, LR; Nguyen, NP; Sallah, S; Sigounas, G; Wan, JY | 1 |
| Borges, MH; Fransheschi, AM; Giglio, JR; Homsi-Brandeburgo, MI; Oliveira, F; Rodrigues, VM; Rucavado, A; Soares, AM | 1 |
| Chiu, HC; Yeh, JH | 1 |
| Camey, KU; Sanchez, EF; Velarde, DT | 1 |
| da Silveira, RB; Dreyfuss, JL; Gremski, W; Haoach, J; Mangili, OC; Veiga, SS; Zanetti, VC | 1 |
| Deutsch, E | 1 |
| Heidrich, R; Hindersin, P | 1 |
| Harbury, C; Kaplan, EN; Pearl, RM; Rubenstein, E; Wustrack, KO | 1 |
| Törngren, S | 1 |
| Ellman, L; Groopman, J | 1 |
| Escher, F | 1 |
| Carrico, CJ; Counts, RB; Haisch, C; Heimbach, DM; Maxwell, NG; Simon, TL | 1 |
| Chabrun, B; Conard, J; Horellou, MH; Milochevitch, R; Prestat, J; Samama, M | 1 |
| Carlson, TH; Reeve, EB; Stephens, A | 1 |
| Aledort, LM | 1 |
| Chan, KE | 2 |
| Azzam, ZA; El-Sawy, MA; Tawfik, S; Zeina, AA | 1 |
| Lasierra, J; Narvaiza, MJ; Vilades, E | 1 |
| Bergut, FA | 1 |
| Bonfils-Roberts, EA; Nealon, TF; Stutman, L | 1 |
| Cousineau, G; Higgins, R | 1 |
| Arocha-Piñango, CL; Gorzula, S; Perales, J | 1 |
| Gallus, AS; Gent, M; Hirsh, J; McBride, JA; O'Brien, SE; Tuttle, RJ | 1 |
| Kursh, ED; Persky, L; Ratnoff, OD | 1 |
| Karlova, NG; Liaĭman, OM; Minina, LT; Pushkar', LN; Troitskiĭ, VB | 1 |
| Harris, WH; Salzman, EW | 1 |
| Badin, T; Elliott, MP; Gazzaniga, AB; Pezzlo, F; Toomasian, JM | 1 |
| Khurshid, M; Whittaker, JA | 1 |
| Briasco, I; Gibelli, A | 1 |
| Spängler, HP | 1 |
| Campbell, H; Hughes, LE; Kline, A; Leach, KG; Williams, A; Zlosnick, J | 1 |
| Beall, CL; Pierce, LE | 1 |
| Aleksandrian, MA; Elipian, EN; Pogosian, AS | 1 |
| Dreiling, DA; Tuzhilin, DA | 1 |
| Beall, AC; Jordan, GL; Mattox, KL; Walker, LE | 1 |
| Bachmann, F; Gilson, JR; McKenna, R; Weinberg, M; Whittaker, B | 1 |
| Goodner, CJ; Harker, LA; Koerker, DJ | 1 |
| Rhodes, GR; Silver, D | 1 |
| Bleyl, U; Saggau, WW; Ulmer, HE | 1 |
| Vaisrub, S | 1 |
| Dymock, IW; Green, G; Poller, L; Thomson, JM | 1 |
| Beller, FK; Graubner, F; Wagner, H | 1 |
| Itani, T; Iwamoto, M; Marumoto, Y; Nawa, K; Ono, M; Sakano, K | 1 |
| Cattaneo, M; Lecchi, A; Mannucci, PM; McGregor, JL; Randi, AM | 1 |
| Bär, F; Meyer, J; Ostermann, H; Schmitz-Huebner, U; van de Loo, J; Windeler, J | 1 |
| da Silva, WD; Laing, GD; Leite, RP; Theakston, RD; Warrell, DA | 1 |
| Aguilar-Martinez, P; Branger, B; Fourcade, J; Gris, JC; Oulès, R; Sarlat, C; Schved, JF; Vécina, F | 1 |
| Califf, RM; Ellis, SG; George, BS; Kereiakes, DJ; Samaha, JK; Sigmon, K; Topol, EJ; Wall, TC; Worley, SJ | 1 |
| Flury, R; Korte, W | 1 |
| Sutherland, SK; Tibballs, J | 1 |
| Cuppini, S; Gianese, F; Maffei Faccioli, A; Meduri, F; Polistena, P; Prandoni, P; Toniato, A; Zangrandi, F | 1 |
| Bovill, EG; Califf, RM; Enney-O'Mara, LA; Greenberg, CS; Gresalfi, NJ; Oberhardt, BJ; Sane, DC | 1 |
| Assakura, MT; Mandelbaum, FR; Puorto, G; Salomão, MG | 1 |
| Bellucci, S; Bouillot, C; Cox, A; Hardisty, R; Heilmann, E; Hourdillé, P; Legrand, C; Nokes, T; Pannocchia, A; Pidard, D | 1 |
| Eijsman, L; Harder, MP; Roozendaal, KJ; van Oeveren, W; Wildevuur, CR | 1 |
| Mori, T; Sakaguchi, S; Takada, A; Takada, Y | 1 |
| el-Kaliouby, AH; Hussein, AT; Hussein, NA; Mohamed, AA; Omran, SA | 1 |
| Kerr, S; Sutherland, SK; Tibballs, J | 1 |
| Desmond, H; Hutton, RA; Kamiguti, AS; Theakston, RD | 1 |
| Boda, Z; Hársfalvi, J; Pfliegler, G; Rak, K | 1 |
| Hirche, H; Mebs, D; Paar, D; Zotz, RB | 1 |
| Benson, LN; Bentur, Y; Burrows, PE; Jacobson, S; Johnson, D; Koren, G; Levy, M; Smith, J; Strong, DK | 1 |
| Glenn, JL; Rodgers, GM; Weis, JR; Whatley, RE | 1 |
| Davenport, R | 1 |
| Berke, AD; Bovill, EG; Collen, D; Feit, F; Frederick, M; Gore, JM; Hillis, LD; Lambrew, CT; Stump, DC; Terrin, ML | 1 |
| Crane, S; Johnstone, IB; Viel, L; Whiting, T | 1 |
| Attubato, MJ; Drew, TM; Feit, F; McDonald, MJ; McKendall, GR; Sharaf, BL; Teichman, S; Thomas, ES; Williams, DO | 1 |
| Feldman, BF; Hargis, AM | 1 |
| Homma, M; Kato, C; Komori, Y; Nikai, T; Sugihara, H | 1 |
| Bucha, E; Markwardt, F; Nowak, G | 1 |
| Goldhaber, SZ; Hirsch, DR | 1 |
| Martinez, M; Molina, O; Rael, ED; Seriel, RK; Sierra, ML; Varela-Ramirez, A | 1 |
| Abrams, CS; Budzynski, AZ; Ellison, N; Shattil, SJ | 1 |
| Bean, VE; Buss, DH; Cordell, AR; Gravlee, GP; Haddon, WS; Mills, SA; Prough, DS; Rogers, AT; Rothberger, HK | 1 |
| Green, TP; Irmiter, RJ; Isham-Schopf, B; Smith, C; Steinhorn, RH | 1 |
| Ihle, E; Ziemer, S | 1 |
| Barbalinardo, RJ; Citrin, P; Franco, CD; Hobson, RW | 1 |
| Vogt, BP | 1 |
| Blanke, E; Block, T; Brendel, W; Gokel, M; Hammer, C; Schelling, G | 2 |
| Andersen, F; Hjortrup, A; Kvist, E; Luke, M | 1 |
| Fabricius, PG; Jocham, D; Permanetter, V; Unsöld, E | 1 |
| Redl, H; Schlag, G | 1 |
| Chung, SW; Nagy, AG | 1 |
| Blasko, V; Bober, J; Karoly, J; Konrád, V | 1 |
| Fleming, AW; Kram, HB; Reuben, BI; Shoemaker, WC | 1 |
| Beer, R; Hamm, KD; Pothe, H; Schreiber, D; Steube, D | 1 |
| Kram, HB; Nugent, P; Reuben, BI; Shoemaker, WC | 1 |
| Dinges, HP; Redl, H; Schlag, G; Thurnher, M; Zatloukal, K | 1 |
| Gotoh, M; Kambayashi, J; Kobayashi, K; Monden, M; Mori, T; Okamura, J; Sakon, M | 1 |
| Chartrand, C; Dumont, L; Stanley, P | 1 |
| Hata, T; Konaga, E; Tanemoto, K; Tsushima, Y | 1 |
| Ishitani, MB; McGahren, ED; Rodgers, BM; Sibley, DA; Spotnitz, WD | 1 |
| Barkagan, ZS; Chantseva, EA | 1 |
| Bennett, KA; Booth, DC; Branco, MC; DeMaria, AN; Grines, CL; Gurley, JC; Nissen, SE | 1 |
| Feuerer, W; Jeep-Tebbe, S; Neuhaus, KL; Niederer, W; Tebbe, U; Vogt, A | 1 |
| Khollan, SR | 1 |
| Achilov, ShA; Karimov, ShN; Tashpulatov, SA | 1 |
| Imai, K; Nikai, T; Ownby, CL; Sugihara, H | 1 |
| Bleifeld, W; Burmester, L; Erlemeier, HH; Mathey, DG; Schofer, J; Zangemeister, W | 1 |
| Dixon, DO; Hester, JP; Keating, MJ; Khorana, S; Ventura, GJ | 1 |
| Adachi, M; Kondo, S; Nobusawa, A; Ryo, R; Saigo, K; Sugano, W; Yamaguchi, N; Yasunaga, M; Yoneda, N; Yoshida, A | 1 |
| Alkjaersig, NK; Fletcher, AP | 1 |
| Francis, CW; Marder, VJ | 1 |
| Corrigan, J; Petersen, EA; Ray, CG; Tappero, JW | 1 |
| Bontempo, FA; Brown, B; Lewis, JH; Makaroun, MS; Ragni, MV; Spero, JA; Steed, DL; Webster, MW | 1 |
| Przybylinski, JP; Reinhart, RA | 1 |
| Forman, SA; Mueller, HS; Rao, AK | 1 |
| Conard, J; Samama, MM | 1 |
| Bell, WR; Berke, A; Jaffe, A; Knatterud, G; Ockene, I; Pratt, C; Rao, AK; Robertson, TL; Schreiber, TL; Terrin, ML | 1 |
| Abbottsmith, C; Boswick, JM; Califf, RM; Candela, R; George, BS; Kereiakes, D; Masek, R; O'Neill, WW; Sigmon, KN; Topol, EJ | 1 |
| Bloom, JC; Gries, GC; Lewis, HB; O'Brien, SR; Sellers, TS; Wheeldon, EB | 1 |
| Buchanan, GR; Clanton, MS; Rodriguez, RC | 1 |
| Hommel, M; Iddon, D; Theakston, RD | 1 |
| Bonzel, T; Chen, C; Drexler, H; Hofmann, T; Just, H; Kasper, W; Meinertz, T; Wollschläger, H; Zeiher, A | 1 |
| Hlousková, D; Kase, F; Klír, P; Pospísil, J | 1 |
| Errett, L; Walsh, G | 1 |
| Bedard, MP; Cullen, ML; Klein, MD; Philippart, AI; Sell, LL; Whittlesey, GC; Yedlin, ST | 1 |
| Fitzpatrick, PG; Francis, CW; Marder, VJ; Rothbard, RL | 1 |
| Andrew, M; Carter, CJ; Gent, M; Hirsh, J; Hull, RD; Jay, RM; Levine, MN; Powers, PJ; Turpie, AG | 1 |
| Comerota, AJ; Rubin, RN; Sherry, S; Soulen, RL; Tyson, RR; White, JV; Williams, FF | 1 |
| Chantarangkul, V; Mannucci, PM; Tripodi, A | 1 |
| Bitto, S; Brieda, M; Cassin, M; Charmet, PA; Molaro, G; Rellini, G; Zanuttini, D | 1 |
| Chanthavanich, P; Ho, M; Hutton, RA; Karbwang, J; Looareesuwan, S; Phillips, RE; Supanaranond, W; Vejcho, S; Viravan, C; Warrell, DA | 1 |
| Chernov, MI; Kostiuchenok, BM; Rudneva, VG; Shimkevich, LL | 1 |
| Kishida, M; Mori, N; Nikai, T; Sugihara, H; Tsuboi, M | 1 |
| Kato, Y; Kishida, M; Mori, N; Murakami, T; Nikai, T; Shigezane, S; Sugihara, H; Takenaka, C | 1 |
| Krebber, HJ; Mathey, D; Rodewald, G | 1 |
| Goodrum, KJ; Spitznagel, JK; Warejcka, DJ | 1 |
| Baker, WH; Hayes, AC | 1 |
| Larcan, A | 1 |
| Alford, WC; Burrus, GR; Glassford, DM; Lupinetti, FM; Petracek, MR; Stoney, WS; Thomas, CS | 1 |
| Karayalcin, G | 1 |
| Cooper, R; Joubert, JR; King, JB; Rossouw, DJ | 1 |
| Gangadharan, V; Gordon, S; Hauser, AM; Mammen, EF; Ramos, RG; Stewart, JR; Timmis, GC; Westveer, DC | 1 |
| Fedorova, ZD; Litvinov, RI; Papaian, LP; Senchilo, EA; Zubairov, DM | 1 |
| Behar, M; Cohen, N; Kaufman, S; Modai, D; Pik, A; Weissgarten, J | 1 |
| Domarus, HV | 1 |
| Kornalik, F | 1 |
| Müller, KH; Schmich, H | 1 |
| Coopland, AT; Wodzicki, AM | 1 |
| Soulier, JP | 1 |
| Fischer, M | 1 |
| Beirne, GJ; Kopp, WL; Zimmerman, SW | 1 |
| Génova, V; Georgief, Z | 1 |
| Baudo, F; de Cataldo, F; Nosari, AM; Panzacchi, G; Strinchini, A | 1 |
| Hampson, WG; Harris, FC; Jackson, PC; Lucas, HK; McCall, IW; Powell, NL; Roberts, PH; Staddon, GE | 1 |
| Brueckner, GG; Mainwaring, RL | 1 |
| Baikie, AG; Buchanan, JG; De Gruchy, GC; Hirsh, J | 1 |
| Allington, MJ; Paxton, AM; Sharp, AA; Warren, BA | 1 |
| Calne, RY; Davis, DR; Herbertson, BM; Millard, PR; Salaman, JR; Samuel, JR; White, HJ | 1 |
| Hellinger, J | 1 |
| Gaerisch, F | 1 |
| Quick, AJ | 1 |
| Boeve, NR; Merendino, KA; Winterscheid, LC | 1 |
| Colman, RW; Mihm, MC; Minna, JD; Robboy, SJ | 1 |
| Brink, S; Steytler, JG | 1 |
| Booth, PB; MacGregor, A | 1 |
| Astrup, T; Brakman, P; Henderson, ES; Snyder, J | 1 |
| Laursen, NP | 1 |
| Genova, V | 1 |
| Alcorta, E; Balibrea, JL; De la Fuente Chaos, A; Escriba, A; Villegas, A | 1 |
| Baluda, VP; Zhukova, NA | 1 |
| Boulle, J; Buffet, C; Conard, J; Levy, VG; Samama, M | 1 |
| Ekert, H; Sheers, M | 1 |
| Cornu, P; Laffay, J; Lamotte, M; Marsan, C; Morin, P; Segrestaa, JM; Soria, C; Soria, J; Strich-Mougenot, C | 1 |
| Fiedler, H | 1 |
| Douglas, AS | 1 |
| Greenberg, SD; Mattox, KL; Reul, GJ; Solis, RT; Whisennand, HH | 1 |
| Dube, B; Khanna, MN; Kulkarni, BJ | 1 |
| Adam, M; Alivizatos, P; Geisler, GF; Lambert, CJ; Leveson, J; Marengo-Rowe, AJ; Mitchel, BF; Thiele, JP | 1 |
| Satmari, VV | 1 |
| Bauer, H; Klövekorn, WP; Messmer, K; Ott, E; Pichlmaier, H; Sunder-Plassmann, L | 1 |
| Boisseau, MR | 1 |
| Kuhns, WJ | 1 |
| Clark, R; Flute, PT; Rake, MO; Williams, R | 1 |
| Goldman, JM | 1 |
| Harker, LA; Slichter, SJ | 1 |
| Impun, C; Mitrakul, C | 1 |
| Lasch, HG; Maul, FD; Müller-Berghaus, G | 1 |
| Hardisty, RM; Howard, MA; Hutton, RA | 1 |
| Seeler, RA | 1 |
| Garrison, D; Hampton, JW | 1 |
| Golovin, GV; Zhankina, GKh | 1 |
| Lyon, LJ; Nevins, MA | 1 |
| Sulek, K | 1 |
| Róka, L | 1 |
| van de Loo, J | 1 |
| Brandt, NJ; Cohn, J; Hilden, M | 1 |
| Gralnick, HR; Tan, HK | 1 |
| Gallus, AS; Hirsh, J | 1 |
| Kwaan, HC | 1 |
| Freal, C; Lardennois, B; Pire, JC; Potron, G | 1 |
| Zhankina, GKh | 1 |
| Brandon, JM; Lewis, JH; Wilson, JH | 1 |
| Albert, FW; Kreiter, H | 1 |
| Bramson, ML; de Leval, MR; Gerbode, F; Hill, JD; Mielke, CH | 1 |
| Schiff, P | 1 |
| Merskey, C | 2 |
| Golovsky, D; O'Neill, BJ; Tam, WT | 1 |
| Fischer, M; Olbert, F; Pavlik, F | 1 |
| Dugdale, M; Morgan, H; Nofzinger, JD; Robertson, JT | 1 |
| Rakower, SR; Worth, MH | 1 |
| Allardyce, M; Dawson, AA; Dhall, DP; Duthie, JS; Mahaffy, RG; Mavor, GE; Walker, MG | 1 |
| Jensen, AH; Josso, F; Minkowski, A; Monset-Couchard, M; Zamet, P | 1 |
| Bonnar, J | 1 |
| Adelstein, EH; Anderson, PC; Berger, RS | 1 |
| Hume, M; Kuriakose, TX; Turner, RH; Zuch, L | 1 |
| Kornfält, R; Nilsson, IM; Okmian, L | 1 |
| Zhitar', VD | 1 |
| D'Agata, A; Di Gregorio, L; Musumeci, S | 1 |
| Golovin, GV; Podgurskaia, RA; Zhankina, GKh | 1 |
| Camerini, G | 1 |
| Dauchot, P; Mattelaer, JJ | 1 |
| Bond, TP; Crawford, MA; Guest, MM | 1 |
| Conard, J; Samama, M | 1 |
| McCullough, J | 1 |
| Copley, AL | 1 |
| Gogate, SG; Juvale, KR; Krishna, UR; Purandare, VN | 1 |
| Arapakis, G; Gardikas, C; Papayannis, AG; Stathakis, NE | 1 |
| Hampton, JW | 1 |
| Ananchenko, VG; Zaĭtsev, VF | 1 |
| Daloze, PM; Groth, CG; Pechet, L | 1 |
| Coopland, AT | 1 |
| Calne, RY; Flute, PT; Rake, MO; Seaman, MJ; Williams, R | 1 |
| Capasso, DA | 1 |
| Maekawa, T | 1 |
| Kakkar, VV | 1 |
| Matsuoka, M | 1 |
| Belzer, FO; May, RE; Perkins, HA | 1 |
| Salaman, JR | 1 |
| Antonovych, TT; Carter, CB; Fortner, RW; Grove, RB; King, LH; Knepshield, JH; Knieser, MR; Nowakowski, A | 1 |
| Langdell, AD | 1 |
| Nilsson, IM | 1 |
| Hellem, AJ | 1 |
| Corrigan, JJ; Jordan, CM | 1 |
| Hedner, U; Nilsson, M | 1 |
| Belko, JS; Hyers, TM; McIntyre, KM; Sasahara, AA; Sharma, GV | 1 |
| Gorokhovskiĭ, BI; Novosel'skaya, VV; Tarasova, VA | 1 |
| Grüner, OP | 2 |
| Olender, A; Palester-Chlebowczyk, M; Sitkowski, W; Strzyzewska, E | 1 |
| Bell, WR; Spangler, DB; Spivak, JL | 1 |
| Bentégeat, J; Boisseau, M; de Joigny, C | 1 |
| Meyers, A | 1 |
| Bareggi, G; Girolami, A; Venturelli, R | 1 |
| Bierme, R; Boneu, B; Cathala, B; Jorda, MF; Lareng, L | 1 |
| Fleisher, R; Hague, R; Kolthammer, J; Shilkin, KB; Williams, R; Winch, J | 1 |
| Chessells, JM; Wigglesworth, JS | 2 |
| Oata, M | 1 |
| Kotsiubinskiĭ, NN; Pleshakov, VT; Tabatadze, KG; Tsybuliak, GN | 1 |
| Golovin, GV; Mentatashvili, SM; Podgurskaia, RA; Shabashova, RN; Zhankina, GKh | 1 |
| Hofmann, G; Perlick, E; Ursinus, K; Ursinus, W | 1 |
| Ashford, A; Penn, GB; Ross, JW | 1 |
| Ramot, B; Rosenthal, T; Seligsohn, U; Shapiro, Y | 1 |
| Levitskaia, SV | 1 |
| Bryceson, AD; Parry, EH; Perine, PL; Vukotich, D; Warrell, DA | 1 |
| Bryceson, AD; Kidan, TG; Parry, EH; Perine, PL; Warrell, DA | 1 |
| Gosselin, G; Long, LA; Neemeh, JA; Rochon, M | 1 |
| Flute, PT | 1 |
| Harrison, GC; Hickman, R; King, JB; Saunders, SJ; Terblanche, J | 1 |
| Duckert, F; Meili, EO; Müller, G | 1 |
| Ochiai, K; Yokokawa, M | 1 |
| Flora, G | 1 |
| Leandoer, L | 3 |
| Morton, A | 1 |
| Larsson, SO | 1 |
| Polliack, A | 1 |
| Abe, K; Endo, E; Kato, M | 1 |
| Latallo, ZS; Olender, A; Palester-Chlebowczyk, M; Sitkowski, W; Strzyzewska, E; Wegrzynowicz, Z | 1 |
| Amris, CJ; Hilden, M | 1 |
| Bauters, F; Parquet-Gernez, A | 1 |
| Mammen, E; Walt, AJ; Wilson, RF | 1 |
| Blau, HJ; Kruse, H; Schulz, K | 1 |
| De Vries, A; Grotto, L; Jerushalmy, Z | 1 |
| Stampfli, K; Tschirren, B | 1 |
| Terskaia, LV | 1 |
| Appelgren, L; Bergentz, SE; Leandoer, L | 2 |
| Hanshaw, JB; Hnilicka, JV; Miller, DR; O'Leary, DS | 1 |
| Burke, WM; Lehan, PH; Moschos, CB; Oldewurtel, HA; Regan, TJ | 1 |
| Abels, J; Meyler, L; Sibinga, CT | 1 |
| Regnault, FR | 1 |
| Podwiński, A; Sadliński, C | 1 |
| Hattersley, PG | 1 |
| Beck, EA; Hiestand, P | 1 |
| Nilsson, IM; Nylander, G; Robertson, BR | 1 |
| Mandelli, P | 1 |
| Hashimoto, Y | 1 |
| Barge, J; Fauvert, R; Guillin, MC; Ménaché, D; Rueff, B | 1 |
| Gralnick, HR; Greipp, P | 1 |
| Steichele, DF | 1 |
| Helbig, W; Perlick, E; Voigt, KG | 1 |
| Detky, B; Füsy, J; Mester, E | 1 |
| Fünfhausen, G; Richter, K | 2 |
| Ménaché, D | 1 |
| Skipetrov, VP | 1 |
| Clark, RE; Donaldson, MH | 1 |
| Mc Kay, DG | 1 |
| Johannsen, LP; Künzer, W | 1 |
| Sturm, G | 1 |
| De Tezanos Pinto, M; Pavlovsky, A | 1 |
| Berger, K; Dedomenico, M; Golaski, WM; Hartmann, JR; Sameh, AA; Sauvage, LR; Wesolowski, SA; Wood, SJ | 1 |
| Howorka, E; Wyrzykiewicz, T | 1 |
| Biró, J; Rosdy, E; Szabó, V; Szendröi, Z | 1 |
| Bergentz, SE; Leandoer, L; Nilsson, IM | 1 |
| Neerhout, RC | 1 |
| Shanbrom, E; Thelin, GM | 1 |
| Blair, AW; Jamieson, WM; Smith, GH | 1 |
| Andersson, L; Granstrand, B; Hedner, U; Melander, B; Niléhn, JE; Nilsson, IM | 1 |
| Holzknecht, F; Wilflingseder, P | 1 |
| Booth, PB; Jacobi, JE; MacGregor, A | 1 |
| Luza, E; Pstruzinová, H; Richter, V; Stamidis, L | 1 |
| Agostino, D; Cliffton, EE; Girolami, A | 1 |
| Girolami, A | 1 |
| Hellinger, J; Vogel, G | 1 |
140 review(s) available for fibrinogen and Hemorrhage
| Article | Year |
|---|---|
Fibrinogen Replacement in Haemostatic Resuscitation: Dose, Laboratory Targets and Product Choice.
Topics: Fibrinogen; Hemorrhage; Hemostasis; Hemostatics; Humans; Laboratories | 2021 |
Factor XIII Deficiency: A Review of Clinical Presentation and Management.
Topics: Blood Coagulation Tests; Factor XIII; Factor XIII Deficiency; Fibrinogen; Hemorrhage; Humans | 2021 |
Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics.
Topics: alpha-2-Antiplasmin; Anticoagulants; Carboxypeptidase B2; Complement C3; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Plasminogen Activator Inhibitor 2; Thrombosis | 2021 |
Extension of the Human Fibrinogen Database with Detailed Clinical Information-The αC-Connector Segment.
Topics: Blood Coagulation; Blood Coagulation Tests; Fibrinogen; Hemorrhage; Humans; Mutation; Thrombosis | 2021 |
Congenital (hypo-)dysfibrinogenemia and bleeding: A systematic literature review.
Topics: Afibrinogenemia; Blood Coagulation Tests; Fibrin; Fibrinogen; Fibrinogens, Abnormal; Hemorrhage; Humans; Thrombosis | 2022 |
CREST: clinical bleeding and risk evaluation in hematology-oncology patients: a systematic review and meta-analysis of thromboelastography's role.
Topics: Fibrinogen; Hematologic Neoplasms; Hematology; Hemorrhage; Humans; Platelet Transfusion; Prospective Studies; Thrombelastography | 2022 |
Transfusion of fibrinogen concentrate before dental extractions in patients with afibrinogenemia: a narrative review supported by a case report with a proposed treatment protocol.
Topics: Afibrinogenemia; Clinical Protocols; Fibrinogen; Hemorrhage; Hemostatics; Humans; Tooth Extraction | 2023 |
One Hundred Years of Congenital Fibrinogen Disorders.
Topics: Afibrinogenemia; Fibrinogen; Genotype; Hemorrhage; Hemostatics; Humans; Phenotype | 2022 |
Marine Biological Macromolecules and Chemically Modified Macromolecules; Potential Anticoagulants.
Topics: Anticoagulants; Enzyme Precursors; Fibrin; Fibrinogen; Hemorrhage; Heparin; Humans; Thrombosis | 2022 |
Planning Pregnancy and Birth in Women with Inherited Bleeding Disorders.
Topics: Female; Fibrinogen; Hemophilia A; Hemorrhage; Hemostatics; Humans; Pregnancy; von Willebrand Diseases | 2023 |
Alternative blood products in trauma.
Topics: Blood Coagulation Disorders; Fibrinogen; Hemorrhage; Hemostatics; Humans; Thrombelastography; Tranexamic Acid; Wounds and Injuries | 2023 |
Etiology and management of hypofibrinogenemia in trauma.
Topics: Afibrinogenemia; Fibrin; Fibrinogen; Hemorrhage; Hemostasis; Hemostatics; Humans | 2023 |
Emergency administration of fibrinogen concentrate for haemorrhage: systematic review and meta-analysis.
Topics: Blood Transfusion; Elective Surgical Procedures; Fibrinogen; Hemorrhage; Hemostatics; Humans | 2023 |
Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures.
Topics: Arthroplasty, Replacement; Fibrinogen; Fractures, Bone; Hemorrhage; Hemostatics; Humans; Myocardial Infarction; Pulmonary Embolism; Stroke; Tranexamic Acid; Transfusion Reaction; Venous Thrombosis | 2023 |
Fibrinogen Supplementation and Its Indications.
Topics: Blood Component Transfusion; Fibrinogen; Hemorrhage; Humans; Plasma; Point-of-Care Systems; Randomized Controlled Trials as Topic; Risk Factors; Thrombelastography; Transfusion-Related Acute Lung Injury | 2020 |
Hemostatic Management of Extracorporeal Circuits Including Cardiopulmonary Bypass and Extracorporeal Membrane Oxygenation.
Topics: Anticoagulants; Cardiopulmonary Bypass; Extracorporeal Membrane Oxygenation; Factor VIII; Fibrinogen; Hemorrhage; Hemostasis; Hemostatics; Heparin; Humans; Plasma; Platelet Transfusion; Thrombosis | 2020 |
Viscoelastic haemostatic assays and fibrinogen in paediatric acute traumatic coagulopathy: A comprehensive review.
Topics: Blood Coagulation Disorders; Child; Fibrinogen; Hemorrhage; Hemostatics; Humans; Prospective Studies; Wounds and Injuries | 2020 |
Current perspective on fibrinogen concentrate in critical bleeding.
Topics: Coagulants; Factor VIII; Fibrinogen; Hemorrhage; Hemostatics; Humans; Point-of-Care Testing; Randomized Controlled Trials as Topic | 2020 |
Coagulopathy in COVID-19.
Topics: Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; COVID-19; Cytokines; Disseminated Intravascular Coagulation; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostasis; Humans; Inflammation; Lung; Lymphocytes; Partial Thromboplastin Time; Protease Inhibitors; Prothrombin Time; Sepsis; Thrombosis | 2020 |
The impact of blood product ratio and procoagulant therapy on the development of thromboembolic events in severely injured hemorrhaging trauma patients.
Topics: Antifibrinolytic Agents; Blood Coagulation Factors; Blood Component Transfusion; Factor VIIa; Fibrinogen; Hemorrhage; Humans; Plasma; Recombinant Proteins; Thromboembolism; Tranexamic Acid; Trauma Severity Indices; Wounds and Injuries | 2020 |
Genetic Variants in the
Topics: Afibrinogenemia; Blood Coagulation Tests; Factor XIII; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostasis; Hemostatics; Humans; Phenotype; Thrombosis | 2020 |
Fibrinogen Diagnostics in Major Hemorrhage.
Topics: Fibrinogen; Hemorrhage; Humans | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Use of fibrinogen concentrate for trauma-related bleeding: A systematic-review and meta-analysis.
Topics: Blood Coagulation Factors; Fibrinogen; Hemorrhage; Hemostatics; Humans; Randomized Controlled Trials as Topic; Wounds and Injuries | 2020 |
Cryoprecipitate transfusion in bleeding patients.
Topics: Blood Transfusion; Factor VIII; Fibrinogen; Hemorrhage; Humans; Prospective Studies | 2020 |
The strengths and weaknesses of viscoelastic testing compared to traditional coagulation testing.
Topics: Abciximab; Algorithms; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Transfusion; Clinical Decision-Making; Cohort Studies; Computer Systems; Cytochalasin B; False Negative Reactions; False Positive Reactions; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Point-of-Care Systems; Reproducibility of Results; Thrombelastography | 2020 |
Viscoelastic monitoring in trauma resuscitation.
Topics: Adolescent; Adult; Algorithms; Anticoagulants; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Component Transfusion; Child; Child, Preschool; Fibrinogen; Fibrinolysis; Forecasting; Hemorrhage; Humans; Infant; Practice Guidelines as Topic; Resuscitation; Thrombelastography; Validation Studies as Topic; Wounds and Injuries; Young Adult | 2020 |
Variations and obstacles in the use of coagulation factor concentrates for major trauma bleeding across Europe: outcomes from a European expert meeting.
Topics: Blood Coagulation Disorders; Blood Coagulation Factors; Fibrinogen; Hemorrhage; Hemostatics; Humans; Tranexamic Acid | 2022 |
Role of fibrinogen concentrates for treatment of critical perioperative hemorrhage.
Topics: Blood Component Transfusion; Fibrinogen; Hemorrhage; Hemostatics; Humans; Plasma | 2021 |
The role of cryoprecipitate in human and canine transfusion medicine.
Topics: Animals; Blood Coagulation Disorders; Blood Transfusion; Dog Diseases; Dogs; Factor VIII; Fibrinogen; Hemorrhage; Humans | 2021 |
Altered Fibrinolysis during and after Surgery.
Topics: Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostatics; Humans | 2021 |
Fibrinogen in traumatic haemorrhage.
Topics: Blood Coagulation Disorders; Blood Transfusion; Fibrinogen; Hemorrhage; Hemostatics; Humans; Wounds and Injuries | 2021 |
The use of fibrinogen concentrate for the management of trauma-related bleeding: a systematic review and meta-analysis.
Topics: Disease-Free Survival; Female; Fibrinogen; Hemorrhage; Humans; Male; Survival Rate; Trauma Severity Indices; Wounds and Injuries | 2017 |
[Viscoelasticity-based treatment of bleeding injuries].
Topics: Algorithms; Antifibrinolytic Agents; Blood Coagulation Factors; Blood Coagulation Tests; Blood Transfusion; Blood Viscosity; Consensus; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Monitoring, Physiologic; Multiple Trauma; Platelet Aggregation; Platelet Transfusion; Point-of-Care Testing; Resuscitation; Shock, Hemorrhagic; Thrombosis | 2017 |
Fibrinogen Concentrate in the Special Operations Forces Environment.
Topics: Canada; Fibrinogen; Hemorrhage; Humans; Military Personnel; Resuscitation; Warfare | 2018 |
British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding.
Topics: Blood Component Transfusion; Factor VIII; Fibrinogen; Hematology; Hemorrhage; Humans; Plasma; Societies, Medical; United Kingdom | 2018 |
Do we still need cryoprecipitate? Cryoprecipitate and fibrinogen concentrate as treatments for major hemorrhage - how do they compare?
Topics: Factor VIII; Fibrinogen; Hemorrhage; Humans; Practice Guidelines as Topic | 2018 |
Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia.
Topics: Blood Coagulation Factors; Cause of Death; Factor XIII; Fibrinogen; Hemorrhage; Hemostatics; Humans; Randomized Controlled Trials as Topic | 2018 |
Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factor.
Topics: Blood Coagulation Factors; Disease Management; Drug Combinations; Factor VIII; Fibrinogen; Hemorrhage; Humans; Recombinant Proteins; von Willebrand Diseases; von Willebrand Factor | 2019 |
Fibrinogen concentrate for perioperative bleeding: what can we learn from the clinical trials?
Topics: Clinical Trials as Topic; Fibrinogen; Hemorrhage; Humans; Thrombosis | 2019 |
Congenital fibrinogen disorders: an update.
Topics: Afibrinogenemia; Animals; Fibrinogen; Genetic Association Studies; Genotype; Hemorrhage; Humans; Mutation; Thrombosis | 2013 |
Role of fibrinogen in massive injury.
Topics: Afibrinogenemia; Animals; Antifibrinolytic Agents; Blood Component Transfusion; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostasis; Hemostatic Techniques; Humans; Multicenter Studies as Topic; Plasma; Randomized Controlled Trials as Topic; Tranexamic Acid; Wounds and Injuries | 2014 |
Fibrinogen concentrate in bleeding patients.
Topics: Adult; Blood Transfusion; Cardiac Surgical Procedures; Child; Elective Surgical Procedures; Fibrinogen; Hemorrhage; Humans; Randomized Controlled Trials as Topic | 2013 |
Intravenous hemostats: challenges in translation to patients.
Topics: Animals; Antifibrinolytic Agents; Complement System Proteins; Erythrocytes; Fibrinogen; Hemorrhage; Humans; Injections, Intravenous; Lactic Acid; Liposomes; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2013 |
Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy.
Topics: Factor VIII; Fibrinogen; Hemorrhage; Hemostasis; Humans; Orthopedic Procedures; Plasma; Wounds and Injuries | 2014 |
Tranexamic acid, fibrinogen concentrate, and prothrombin complex concentrate: data to support prehospital use?
Topics: Antifibrinolytic Agents; Blood Coagulation; Blood Coagulation Factors; Blood Transfusion; Brain Injuries; Emergency Medical Services; Emergency Medicine; Fibrinogen; Hemorrhage; Hemostasis; Humans; Platelet Count; Randomized Controlled Trials as Topic; Tranexamic Acid; Treatment Outcome; Vitamin K; Wounds and Injuries | 2014 |
Efficacy and safety of fibrinogen concentrate in trauma patients--a systematic review.
Topics: Fibrinogen; Hemorrhage; Hemostatics; Humans; Observational Studies as Topic; Prospective Studies; Retrospective Studies; Safety; Wounds and Injuries | 2014 |
Blood conservation in cardiac surgery: guidelines and controversies.
Topics: Anemia; Anticoagulants; Blood Loss, Surgical; Blood Preservation; Cardiac Surgical Procedures; Factor VIIa; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Hemostasis; Humans; Perioperative Period; Recombinant Proteins; Risk; Transfusion Reaction | 2014 |
Procoagulant therapeutics in liver disease: a critique and clinical rationale.
Topics: Antifibrinolytic Agents; Coagulants; Deamino Arginine Vasopressin; Erythrocyte Transfusion; Factor VIIa; Factor VIII; Fibrinogen; Hemorrhage; Humans; Liver Diseases; Plasma; Recombinant Proteins; Vitamin K | 2014 |
Fibrinogen concentrate for bleeding--a systematic review.
Topics: Fibrinogen; Hemorrhage; Humans | 2014 |
Fibrinogen and catheter-directed thrombolysis.
Topics: Animals; Biomarkers; Catheterization, Peripheral; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Humans; Practice Guidelines as Topic; Predictive Value of Tests; Risk Assessment; Risk Factors; Thromboembolism; Thrombolytic Therapy; Thrombosis; Treatment Outcome | 2014 |
Fluids and coagulation.
Topics: Blood Coagulation; Blood Loss, Surgical; Critical Care; Crystalloid Solutions; Fibrinogen; Fluid Therapy; Hemorrhage; Humans; Hydroxyethyl Starch Derivatives; Hypovolemia; Isotonic Solutions; Thrombelastography | 2015 |
Over 50 Years of Fibrinogen Concentrate.
Topics: Anniversaries and Special Events; Fibrinogen; Hemorrhage; History, 20th Century; History, 21st Century; Humans | 2016 |
Coagulation management in trauma-associated coagulopathy: allogenic blood products versus coagulation factor concentrates in trauma care.
Topics: Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Blood Component Transfusion; Fibrinogen; Hemorrhage; Hemostasis; Humans; Plasma; Transplantation, Homologous; Wounds and Injuries | 2016 |
Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders.
Topics: Afibrinogenemia; Animals; Fibrinogen; Hemorrhage; Humans; Mutation, Missense; Thrombosis | 2016 |
What Is the Biological and Clinical Relevance of Fibrin?
Topics: Animals; Fibrin; Fibrinogen; Hemorrhage; Hemostasis; Humans; Infections; Inflammation; Mice; Mice, Knockout; Wound Healing; Wounds and Injuries | 2016 |
Alterations in Fibrin Structure in Patients with Liver Diseases.
Topics: Fibrin; Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis; Protein Processing, Post-Translational; Thrombosis | 2016 |
How to Assess Fibrinogen Levels and Fibrin Clot Properties in Clinical Practice?
Topics: Fibrin; Fibrinogen; Hemorrhage; Humans; Prothrombin Time | 2016 |
Comparing efficacy and safety of fibrinogen concentrate to cryoprecipitate in bleeding patients: a systematic review.
Topics: Blood Transfusion; Factor VIII; Fibrinogen; Hemorrhage; Humans; Randomized Controlled Trials as Topic | 2016 |
Novel mechanisms that regulate clot structure/function.
Topics: Animals; Blood Coagulation; Factor XIII; Fibrin; Fibrinogen; Hemorrhage; Humans; Thrombosis | 2016 |
Congenital afibrinogenemia: from etiopathogenesis to challenging clinical management.
Topics: Afibrinogenemia; Blood Coagulation Tests; Diagnosis, Differential; Disease Management; Female; Fibrinogen; Fibrinolytic Agents; Genetic Counseling; Hemorrhage; Humans; Liver Transplantation; Male; Phenotype; Pregnancy; Prenatal Diagnosis; Prevalence | 2016 |
Can the phenotype of inherited fibrinogen disorders be predicted?
Topics: Afibrinogenemia; Blood Coagulation Tests; Fibrinogen; Genotype; Hemorrhage; Humans; Phenotype; Thrombosis | 2016 |
Tactical damage control resuscitation in austere military environments.
Topics: Antifibrinolytic Agents; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Component Transfusion; Blood Transfusion; Coagulants; Fibrinogen; Freeze Drying; Hemorrhage; Humans; Military Medicine; Military Personnel; Plasma; Point-of-Care Testing; Resuscitation; Shock, Hemorrhagic; Tranexamic Acid; Wounds and Injuries | 2016 |
Management of bleeding in vascular surgery.
Topics: Anticoagulants; Blood Coagulation Factors; Blood Transfusion; Factor VIIa; Fibrinogen; Fluid Therapy; Hemorrhage; Humans; Plasma; Platelet Aggregation Inhibitors; Point-of-Care Systems; Recombinant Proteins; Vascular Surgical Procedures; Vitamin K | 2016 |
Identification and Management of Obstetric Hemorrhage.
Topics: Blood Coagulation Disorders; Blood Transfusion; Female; Fibrinogen; Hemorrhage; Humans; Postpartum Hemorrhage; Pregnancy; Pregnancy Complications | 2017 |
Plasma fibrinogen level as a potential predictor of hemorrhagic complications after catheter-directed thrombolysis for peripheral arterial occlusions.
Topics: Aged; Biomarkers; Catheterization, Peripheral; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Peripheral Arterial Disease; Risk Assessment; Risk Factors; Thrombolytic Therapy; Treatment Outcome | 2017 |
Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Thrombosis | 2017 |
Massive transfusion and nonsurgical hemostatic agents.
Topics: Acidosis; Antifibrinolytic Agents; Bandages; Blood Coagulation Disorders; Blood Transfusion; Cause of Death; Critical Care; Deamino Arginine Vasopressin; Factor VIIa; Factor VIII; Fibrinogen; Hemorrhage; Hemostatics; Humans; Hyperkalemia; Hypocalcemia; Hypothermia; Military Medicine; Recombinant Proteins; Resuscitation; Risk Factors; Transfusion Reaction; United States; Wounds and Injuries; Zeolites | 2008 |
Prophylaxis of bleeding episodes in patients with von Willebrand's disease.
Topics: Clinical Trials as Topic; Deamino Arginine Vasopressin; Drug Administration Schedule; Drug Combinations; Epistaxis; Factor VIII; Female; Fibrinogen; Gastrointestinal Hemorrhage; Hemarthrosis; Hemorrhage; Humans; Male; Multicenter Studies as Topic; Prospective Studies; Retrospective Studies; Secondary Prevention; von Willebrand Diseases; von Willebrand Factor | 2008 |
Rare inherited disorders of fibrinogen.
Topics: Adult; Afibrinogenemia; Blood Coagulation; Coagulants; Factor VIII; Female; Fibrinogen; Genotype; Hemorrhage; Humans; Infant, Newborn; Iran; Italy; Male; MEDLINE; Mutation; North America; Phenotype; Pregnancy; Pregnancy Complications, Hematologic; Prenatal Diagnosis; Rare Diseases | 2008 |
Factor XIII deficiency.
Topics: Abortion, Spontaneous; Aged; Aged, 80 and over; Amino Acid Substitution; Blood Coagulation; Blood Coagulation Factor Inhibitors; Blood Coagulation Tests; DNA Mutational Analysis; Factor VIII; Factor XIII; Factor XIII Deficiency; Female; Fibrinogen; Hemorrhage; Humans; Infant, Newborn; Male; Middle Aged; Mutation; Plasma; Polymorphism, Single Nucleotide; Pregnancy; Pregnancy Complications, Hematologic; Severity of Illness Index; Wound Healing | 2008 |
Fibrinogen metabolic responses to trauma.
Topics: Acidosis; Blood Coagulation Factors; Fibrinogen; Hemorrhage; Humans; Hypothermia; Wounds and Injuries | 2009 |
Transfusion in trauma: why and how should we change our current practice?
Topics: Algorithms; Blood Coagulation Factors; Blood Transfusion; Factor VIIa; Factor XIII; Fibrinogen; Hemorrhage; Humans; Recombinant Proteins; Transfusion Reaction; Wounds and Injuries | 2009 |
Treatment of congenital fibrinogen deficiency: overview and recent findings.
Topics: Afibrinogenemia; Blood Coagulation; Blood Coagulation Tests; Blood Component Transfusion; Coagulants; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Male; Mutation; Postoperative Hemorrhage; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Treatment Outcome | 2009 |
Fibrinogen concentrates for bleeding trauma patients: what is the evidence?
Topics: Blood Component Transfusion; Fibrinogen; Hemorrhage; Humans; PubMed; Randomized Controlled Trials as Topic; Wounds and Injuries | 2011 |
Massive transfusion protocols for patients with substantial hemorrhage.
Topics: Academic Medical Centers; Algorithms; Blood Banks; Blood Coagulation Disorders; Blood Component Transfusion; Blood Transfusion; Clinical Protocols; Cohort Studies; Factor VIII; Fibrinogen; Forecasting; Hemorrhage; Humans; Military Medicine; Organizational Policy; Prescriptions; Resuscitation; Shock, Hemorrhagic; Surgery Department, Hospital; Trauma Centers; Treatment Outcome; Wounds and Injuries | 2011 |
Fibrinogen replacement therapy for congenital fibrinogen deficiency.
Topics: Adolescent; Adult; Afibrinogenemia; Child; Child, Preschool; Female; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Humans; Infant; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Hematologic; Thrombosis; Young Adult | 2011 |
Lyophilized fibrinogen for hemorrhage after trauma.
Topics: Blood Coagulation; Fibrinogen; Fluid Therapy; Hemorrhage; Humans; Resuscitation; Wounds and Injuries | 2011 |
Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding.
Topics: Animals; Blood Component Transfusion; Blood Loss, Surgical; Factor VIII; Fibrinogen; Hemorrhage; Hemostasis; Hemostatic Techniques; Hemostatics; Humans; Postoperative Hemorrhage; Treatment Outcome | 2012 |
Fibrinogen replacement therapy: a critical review of the literature.
Topics: Fibrinogen; Hemorrhage; Humans | 2012 |
Early and individualized goal-directed therapy for trauma-induced coagulopathy.
Topics: Algorithms; Anticoagulants; Blood Coagulation Disorders; Blood Viscosity; Fibrinogen; Hemorrhage; Humans; Needs Assessment; Platelet Function Tests; Thrombelastography; Wounds and Injuries | 2012 |
Hemophilia management in transfusion medicine.
Topics: Blood Component Transfusion; Factor IX; Factor VIII; Fibrinogen; Hemophilia A; Hemorrhage; Humans; Plasma; Quality of Life | 2012 |
Bleeding and thrombosis in acute promyelocytic leukemia.
Topics: Antifibrinolytic Agents; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blood Coagulation Tests; Clinical Trials as Topic; Combined Modality Therapy; Cysteine Endopeptidases; Disseminated Intravascular Coagulation; Factor VIIa; Factor VIII; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Leukemia, Promyelocytic, Acute; Multicenter Studies as Topic; Neoplasm Proteins; Oxides; Plasma; Platelet Count; Platelet Transfusion; Recombinant Proteins; Thromboplastin; Thrombosis; Treatment Failure; Tretinoin | 2012 |
The role of massive transfusion protocols in obstetrics.
Topics: Blood Platelets; Blood Transfusion; Erythrocytes; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Obstetric Labor Complications; Plasma; Pregnancy; Transfusion Reaction | 2013 |
Cryoprecipitate: an outmoded treatment?
Topics: Afibrinogenemia; Factor VIII; Factor XIII; Fibrinogen; Fibronectins; Hemorrhage; History, 20th Century; Humans; von Willebrand Factor | 2012 |
Treatment of dabigatran-associated bleeding: case report and review of the literature.
Topics: Aged, 80 and over; Algorithms; Antithrombins; Benzimidazoles; Dabigatran; Factor VIIa; Factor VIII; Fibrinogen; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Male; Plasma; Pyridines; Renal Dialysis; Treatment Outcome | 2013 |
Pharmacologic tools to reduce bleeding in surgery.
Topics: Administration, Oral; Antifibrinolytic Agents; Deamino Arginine Vasopressin; Factor Xa Inhibitors; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hematology; Hemorrhage; Hemostasis; Heparin; Heparin, Low-Molecular-Weight; Humans; Models, Biological; Orthopedics; Protamines; Recombinant Proteins; Thrombelastography; Tranexamic Acid; Vitamin K | 2012 |
Assessment and management of massive bleeding: coagulation assessment, pharmacologic strategies, and transfusion management.
Topics: Adult; Aged; Blood Coagulation; Blood Transfusion; Clinical Trials as Topic; Female; Fibrinogen; Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Military Medicine; Platelet Transfusion; Postpartum Hemorrhage; Postpartum Period; Pregnancy; Risk; Thoracic Surgery; Wounds and Injuries | 2012 |
The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding.
Topics: Blood Coagulation Factors; Blood Component Transfusion; Factor VIIa; Fibrinogen; Hemorrhage; Humans; Recombinant Proteins; Trauma Severity Indices; Wounds and Injuries | 2013 |
Nonsurgical techniques to control massive bleeding.
Topics: Antifibrinolytic Agents; Blood Coagulation Factors; Embolization, Therapeutic; Factor VIIa; Fibrinogen; Hemorrhage; Humans; Tourniquets; Wounds and Injuries | 2013 |
[Fibrinogen: factor and marker of cardiovascular risk].
Topics: Alternative Splicing; Amino Acid Sequence; Biomarkers; Cardiovascular Diseases; Fibrinogen; Hemorrhage; Humans; Inflammation; Risk Factors; Sequence Alignment; Thrombosis | 2002 |
Present-day thrombolytic therapy: therapeutic agents--pharmacokinetics and pharmacodynamics.
Topics: Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Plasminogen; Thrombolytic Therapy | 2002 |
Clinical significance of gene-diagnosis for defects in coagulation factors and inhibitors.
Topics: Adolescent; Adult; Anticoagulants; Blood Coagulation Factors; Child; DNA, Complementary; Exons; Factor IX; Factor V; Factor VIII; Factor XIII; Female; Fibrinogen; Genetic Linkage; Genetic Predisposition to Disease; Genetic Techniques; Hemophilia A; Hemophilia B; Hemorrhage; Homozygote; Humans; Introns; Logistic Models; Male; Mutation; Odds Ratio; Point Mutation; Polymorphism, Genetic; Pregnancy; Prenatal Diagnosis; Pulmonary Embolism; Risk Factors; Thrombophilia; Thrombosis; Venous Thrombosis | 2003 |
THROMBOLYTIC THERAPY.
Topics: Aminocaproates; Aminocaproic Acid; Anticoagulants; Biomedical Research; Deoxyribonuclease I; Drug Therapy; Fibrinogen; Fibrinolysin; Hemorrhage; Humans; Plasminogen; Pulmonary Embolism; Streptodornase and Streptokinase; Streptokinase; Thrombolytic Therapy; Thrombophlebitis; Thrombosis; Toxicology | 1964 |
[Coagulation failure: diagnosis, management and therapeutic consequences].
Topics: Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Factors; Blood Coagulation Tests; Diagnosis, Differential; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Humans; Liver Diseases | 2006 |
[Coagulopathy in multiple trauma: new aspects of therapy].
Topics: Acidosis; Antifibrinolytic Agents; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Substitutes; Blood Transfusion; Deamino Arginine Vasopressin; Factor VIIa; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostasis; Humans; Hypothermia; Multiple Trauma; Plasma; Platelet Transfusion; Preoperative Care; Prothrombin | 2007 |
[Procedure for critical nonsurgical bleeding].
Topics: Algorithms; Antifibrinolytic Agents; Aprotinin; Blood Coagulation Disorders; Blood Coagulation Tests; Embolization, Therapeutic; Emergencies; Erythrocyte Transfusion; Factor VIIa; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Humans; Multiple Organ Failure; Platelet Transfusion; Thrombelastography; Wounds and Injuries | 2007 |
Evidence-based treatment recommendations for uremic bleeding.
Topics: Deamino Arginine Vasopressin; Erythropoietin; Estrogens, Conjugated (USP); Evidence-Based Medicine; Factor VIII; Fibrinogen; Hemorrhage; Humans; Practice Guidelines as Topic; Renal Dialysis; Renal Insufficiency; Uremia; von Willebrand Factor | 2007 |
Molecular genetics of quantitative fibrinogen disorders.
Topics: Afibrinogenemia; Blood Coagulation Tests; Fibrinogen; Genotype; Hemorrhage; Humans; Mutation; Phenotype; Protein Structure, Secondary | 2007 |
Evolution of fibrinogen-coated collagen patch for use as a topical hemostatic agent.
Topics: Animals; Aprotinin; Bandages; Collagen; Fibrinogen; Hemorrhage; Hemostatic Techniques; Hemostatics; Humans; Tissue Adhesives | 2008 |
Development of a massive transfusion protocol.
Topics: Acidosis; Blood Coagulation Disorders; Blood Component Transfusion; Calcium Chloride; Clinical Protocols; Factor VIIa; Factor VIII; Fibrinogen; Hemorrhage; Humans; Hypothermia | 2008 |
[Clinical use of thrombolytic agents].
Topics: Arterial Occlusive Diseases; Blood Coagulation Tests; Drug Therapy, Combination; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Hemostasis; Heparin; Humans; Streptokinase; Thromboembolism; Urokinase-Type Plasminogen Activator | 1983 |
Approach to the bleeding patient.
Topics: Anticoagulants; Blood Group Antigens; Disseminated Intravascular Coagulation; Erythrocyte Transfusion; Extracorporeal Circulation; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Intraoperative Period; Leukocytes; Liver Diseases; Plasma; Platelet Transfusion; Postoperative Complications; Pregnancy; Pregnancy Complications, Hematologic; Transfusion Reaction; Vitamin K Deficiency | 1982 |
[Spinal canal bleeding in hemophilia A].
Topics: Adolescent; Blood Coagulation Factors; Extremities; Factor VIII; Fibrinogen; Fibronectins; Hemophilia A; Hemorrhage; Humans; Male; Paralysis; Spinal Canal; Spinal Diseases | 1995 |
Prevention and management of bleeding complications after thrombolysis.
Topics: Aprotinin; Clinical Trials as Topic; Coronary Angiography; Coronary Disease; Drug Interactions; Fibrinogen; Hemorrhage; Heparin; Humans; Incidence; Plasma; Risk Factors; Thrombolytic Therapy; Tranexamic Acid | 1993 |
Effects of interleukin 6 on megakaryocytes and on canine platelet function.
Topics: Animals; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cell Differentiation; Cells, Cultured; Clinical Trials as Topic; Dogs; Dose-Response Relationship, Drug; Fibrinogen; Hemorrhage; Humans; Interleukin-6; Megakaryocytes; Platelet Activation; Platelet Count | 1994 |
Complications of thrombolysis and their clinical management.
Topics: Anticoagulants; Drug Hypersensitivity; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Hemostasis; Humans; Risk Factors; Thrombolytic Therapy | 1993 |
Carotid atherosclerosis. Definition, pathogenesis, and clinical significance.
Topics: Arteriosclerosis; Calcinosis; Carotid Artery Diseases; Carotid Artery Thrombosis; Cell Division; Cholesterol; Collagen; Fibrinogen; Hemorrhage; Humans; Hypercholesterolemia; Hypertension; Lipids; Macrophages; Monocytes; Muscle, Smooth, Vascular; Proteoglycans; Risk Factors; Smoking; Ulcer | 1996 |
Acute generalized, widespread bleeding. Diagnosis and management.
Topics: Acute Disease; Algorithms; Antibodies, Monoclonal; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Factors; Blood Coagulation Tests; Contraindications; Cytokines; Diagnosis, Differential; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hematologic Diseases; Hemorrhage; Heparin; Humans; Infections; Liver Diseases; Neoplasms; Plasma; Platelet Transfusion; Thrombophilia | 1998 |
New thrombolytic strategy: bolus administration of tPA and urokinase-fibrinogen conjugate.
Topics: Animals; Dogs; Drug Combinations; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Recurrence; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1999 |
Novel platelet products, substitutes and alternatives.
Topics: Animals; Blood Platelets; Blood Preservation; Blood Substitutes; Cell Membrane; Clinical Trials as Topic; Cryopreservation; Disease Models, Animal; Dogs; Erythrocytes; Factor VIIa; Factor X; Fibrinogen; Freeze Drying; Furocoumarins; Hemorrhage; Hemostatic Techniques; Histocompatibility; Humans; Ligands; Liposomes; Microspheres; Oligopeptides; Photochemistry; Platelet Transfusion; Ultraviolet Rays | 2001 |
The dysfibrinogenaemias.
Topics: Afibrinogenemia; Blood Coagulation Tests; Carcinoma, Hepatocellular; Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis; Liver Neoplasms; Mutation; Thrombosis | 2001 |
Prophylaxis of postoperative deep venous thrombosis. Studies on low-dose heparin, blood coagulation, infection as a risk factor and the half-life of fibrinogen in patients after gastrointestinal surgery.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Blood Coagulation Tests; Clinical Trials as Topic; Digestive System Surgical Procedures; Double-Blind Method; Female; Fibrinogen; Half-Life; Hemorrhage; Heparin; Humans; Injections, Subcutaneous; Male; Middle Aged; Postoperative Complications; Risk; Thrombophlebitis | 1979 |
Acute promyelocytic leukemia.
Topics: Blood Coagulation Disorders; Bone Marrow; Cell Line; Chromosome Banding; Daunorubicin; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Leukemia, Myeloid, Acute; Prognosis; Prothrombin Time; Thromboembolism; Vitamin B 12 | 1979 |
[Changes in the blood coagulation system and fibrinolysis during growth and metastasis of malignant neoplasms].
Topics: Blood Coagulation; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Neoplasm Metastasis; Neoplasms; Thromboplastin; Thrombosis | 1976 |
Non-coronary thrombolysis.
Topics: Arterial Occlusive Diseases; Combined Modality Therapy; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Intracranial Embolism and Thrombosis; Recurrence; Thrombin Time; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator | 1990 |
Fibrin sealant in orthopedic surgery.
Topics: Animals; Aprotinin; Bone and Bones; Cartilage; Dogs; Drug Combinations; Factor XIII; Fibrin; Fibrin Tissue Adhesive; Fibrinogen; Fractures, Bone; Hemophilia A; Hemorrhage; Hemostasis; Humans; Rabbits; Tendon Injuries; Thrombin; Tissue Adhesives; Wound Healing | 1988 |
The hematologic consequences of thrombolytic therapy.
Topics: Animals; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Drug Evaluation; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Plasminogen Activators; Streptokinase; Thrombin; Thromboembolism | 1986 |
Concepts of clot lysis.
Topics: alpha-2-Antiplasmin; Animals; Blood Coagulation; Blood Coagulation Disorders; Disseminated Intravascular Coagulation; Dogs; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Homeostasis; Humans; Iatrogenic Disease; Plasminogen; Plasminogen Activators; Rabbits; Streptokinase; Thrombosis; Urokinase-Type Plasminogen Activator | 1986 |
Theoretic and practical considerations on laboratory monitoring of thrombolytic therapy.
Topics: Blood Coagulation Tests; Blood Specimen Collection; Clinical Laboratory Techniques; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Monitoring, Physiologic; Plasminogen; Streptokinase; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1987 |
Postirradiation changes of plasma coagulation factors and inhibitors of coagulation.
Topics: Animals; Antithrombin III; Blood Coagulation Factors; Fibrinogen; Hemorrhage; Heparin Antagonists; Humans; Prothrombin; Radiation Injuries; Syndrome | 1987 |
Heparin prophylaxis trials of venous thrombosis: a critical review.
Topics: Blood Coagulation Tests; Clinical Trials as Topic; Fibrinogen; Hematoma; Hematuria; Hemorrhage; Heparin; Humans; Phlebography; Placebos; Postoperative Complications; Pulmonary Embolism; Random Allocation; Thrombophlebitis | 1985 |
Current concepts in the management of hemophilia.
Topics: Acquired Immunodeficiency Syndrome; Analgesics; Anti-Inflammatory Agents; Antifibrinolytic Agents; Blood Transfusion; Child; Child, Preschool; Danazol; Deamino Arginine Vasopressin; Factor IX; Factor VIII; Fibrinogen; Hemarthrosis; Hemophilia A; Hemorrhage; Humans; Infant; Infant, Newborn; Male; Plasma; von Willebrand Diseases | 1985 |
Hemostasis in surgical procedures.
Topics: Acetylcholine; Antimetabolites; Aspirin; Autonomic Nervous System; Blood Circulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Calcium; Cell Aggregation; Clot Retraction; Dicumarol; Epinephrine; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Fibrin; Fibrinogen; Hemorrhage; Hemostasis; Humans; Prothrombin; Prothrombin Time; Surgical Procedures, Operative; Thrombin; Vasoconstrictor Agents; Vasodilator Agents; Vitamin K | 1969 |
[Factor XIII, its physiological significance (a review of the literature)].
Topics: Animals; Blood Coagulation; Blood Protein Electrophoresis; Calcium; Enzyme Activation; Factor XII; Factor XIII; Factor XIII Deficiency; Fibrin; Fibrinogen; Fibrinolysin; Half-Life; Hemorrhage; Hemorrhagic Disorders; Hemostasis; Heparin; Humans; Molecular Weight; Rats; Sulfhydryl Compounds; Thrombin | 1973 |
Management of thrombotic diseases.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Coumarins; Dextrans; Dipyridamole; Drug Antagonism; Drug Hypersensitivity; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Heart Valve Prosthesis; Hemorrhage; Heparin; Histamine H1 Antagonists; Humans; Hydrocortisone; Indenes; Intracranial Embolism and Thrombosis; Iodine Isotopes; Platelet Adhesiveness; Prostaglandins; Reserpine; Rheumatic Heart Disease; Streptokinase; Sulfinpyrazone; Thrombosis | 1971 |
Congenital "hypoprothrombinemias". Deficiency of factors II, VII, and X.
Topics: Factor VII Deficiency; Fibrinogen; Hemorrhage; Humans; Hypoprothrombinemias; Prothrombin; Prothrombin Time | 1972 |
Fibrinogen and fibrin-stabilizing factor.
Topics: Adult; Afibrinogenemia; Blood Coagulation; Blood Protein Disorders; Blood Transfusion; Child; Child, Preschool; Factor XIII; Female; Fibrin; Fibrinogen; Glutaminase; Hemorrhage; Humans; Infant, Newborn; Male; Prothrombin Time | 1972 |
[Posthemorrhagic changes in the properties of fibrinogen].
Topics: Afibrinogenemia; Animals; Blood Coagulation Disorders; Carcinoma; Dogs; Female; Fibrinogen; Gastrectomy; Gastrointestinal Hemorrhage; Hemorrhage; Hemostasis; Humans; Leiomyoma; Male; Peptic Ulcer Hemorrhage; Pregnancy; Prothrombin Time; Thrombophlebitis; Uterine Hemorrhage; Uterine Neoplasms | 1972 |
Prevention of thromboembolism after hip fracture.
Topics: Aged; Anticoagulants; Aspirin; Bandages; Coumarins; Dextrans; Exercise Therapy; Femoral Neck Fractures; Fibrinogen; Fractures, Bone; Hemorrhage; Hip Injuries; Humans; Iodine Isotopes; Physical Exertion; Postoperative Care; Postoperative Complications; Pulmonary Embolism; Thromboembolism; Thrombophlebitis; Warfarin | 1973 |
[Schedule for diagnostic-therapeutic management of hemorrhagic diathesis].
Topics: Aminocaproates; Aprotinin; Blood Coagulation Tests; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Heparin; Humans; Vitamin K | 1973 |
The diagnosis and prevention of post operative venous thrombosis.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Platelets; Depression, Chemical; Dextrans; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostasis; Heparin; Humans; Iodine Radioisotopes; Physical Examination; Plethysmography, Impedance; Postoperative Complications; Pulmonary Embolism; Radionuclide Imaging; Thrombophlebitis; Ultrasonography | 1973 |
Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism.
Topics: Anemia, Hemolytic; Animals; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Blood Viscosity; Drug Resistance; Female; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Hydrolysis; Iodine Radioisotopes; Peptide Hydrolases; Plasminogen; Pregnancy; Snake Venoms; Thrombin; Thromboembolism; Urokinase-Type Plasminogen Activator; Wound Healing | 1973 |
[Significance of thrombogenesis in the pathogenesis of arteriosclerosis (literature review)].
Topics: Animals; Aorta; Arteriosclerosis; Blood Coagulation; Blood Coagulation Disorders; Blood Vessels; Endocrine Glands; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Heparin Antagonists; Hepatitis; Humans; Lipid Metabolism; Lipoprotein Lipase; Liver; Liver Cirrhosis; Stress, Physiological; Thrombin; Thrombosis; Triglycerides | 1967 |
Blood clotting abnormalitis in relation to pre-eclampsia: a review.
Topics: Abruptio Placentae; Adrenal Glands; Aminocaproates; Animals; Basement Membrane; Biopsy; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Brain; Female; Fibrin; Fibrinogen; Fibrinolysis; Fluorescent Antibody Technique; Hemorrhage; Hemorrhagic Disorders; Heparin; Humans; Hypertension, Malignant; Kidney Cortex Necrosis; Kidney Failure, Chronic; Kidney Glomerulus; Liver; Maternal Mortality; Microscopy, Electron; Myocardium; Placental Extracts; Pre-Eclampsia; Pregnancy; Rabbits; Shwartzman Phenomenon; Thromboplastin; Thrombosis | 1969 |
[On hemorrhagic syndromes due to fibrinogen deficiency].
Topics: Afibrinogenemia; Blood Coagulation Tests; Child, Preschool; Fibrinogen; Hemorrhage; Humans; Infant; Infant, Newborn | 1967 |
[Hemorrhagic diathesis].
Topics: Anticoagulants; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Diagnosis, Differential; Fibrin; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Prothrombin; Prothrombin Time; Thromboplastin; Vascular Resistance | 1969 |
[Blood coagulation and hemostasis].
Topics: Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Blood Vessels; Capillary Permeability; Fibrin; Fibrinogen; Hemorrhage; Hemostasis; Humans | 1969 |
Recent advances in diagnosis and treatment of hemophilia and related diseases.
Topics: Aminocaproates; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Blood Transfusion; Factor V Deficiency; Factor VII Deficiency; Factor VIII; Fibrinogen; Freezing; Hemophilia A; Hemophilia B; Hemorrhage; Hemostasis; Humans; Hypoprothrombinemias; Plasma; Plasma Volume; Prothrombin; Prothrombin Time; Thromboplastin; Vitamin K | 1970 |
Metabolic disorders of platelets.
Topics: Adenine; Blood Platelet Disorders; Blood Platelets; Blood Proteins; Cell Aggregation; Clofibrate; Fibrinogen; Hemorrhage; Hemostasis; Humans; Phospholipids; Prostaglandins; Purpura, Thrombocytopenic; Serotonin; Thrombocytopenia; Uremia; von Willebrand Diseases; Wiskott-Aldrich Syndrome | 1971 |
60 trial(s) available for fibrinogen and Hemorrhage
| Article | Year |
|---|---|
Protocol for a multicentre, randomised, parallel-control, superiority trial comparing administration of clotting factor concentrates with a standard massive haemorrhage protocol in severely bleeding trauma patients: the FiiRST 2 trial (a 2020 EAST multice
Topics: Blood Coagulation Disorders; Blood Transfusion; Fibrinogen; Hemorrhage; Hemostatics; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
Fibrinogen Early In Severe paediatric Trauma studY (FEISTY junior): protocol for a randomised controlled trial.
Topics: Blood Coagulation Disorders; Child; Fibrinogen; Hemorrhage; Hemostatics; Humans; Infant; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic | 2022 |
A randomized controlled study of vitrectomy combined with recombinant tissue-type fibrinogen activator submacular injection for the treatment of polypoid choroidal vasculopathy complicated with massive submacular hemorrhage.
Topics: Combined Modality Therapy; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Retinal Hemorrhage; Retrospective Studies; Tomography, Optical Coherence; Vitrectomy | 2023 |
Impact of cardiopulmonary bypass duration on efficacy of fibrinogen replacement with cryoprecipitate compared with fibrinogen concentrate: a post hoc analysis of the Fibrinogen Replenishment in Surgery (FIBRES) randomised controlled trial.
Topics: Adult; Afibrinogenemia; Blood Coagulation Disorders; Blood Transfusion; Cardiopulmonary Bypass; Fibrinogen; Hemorrhage; Hemostatics; Humans | 2022 |
The CRYOSTAT2 trial: The rationale and study protocol for a multi-Centre, randomised, controlled trial evaluating the effects of early high-dose cryoprecipitate in adult patients with major trauma haemorrhage requiring major haemorrhage protocol activatio
Topics: Adult; Fibrinogen; Hemorrhage; Hospitalization; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic | 2023 |
Cost-effectiveness of Fibrinogen Concentrate vs Cryoprecipitate for Treating Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients.
Topics: Adult; Afibrinogenemia; Cardiac Surgical Procedures; Cost-Benefit Analysis; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Male; Middle Aged; Ontario | 2023 |
Effect of Prophylactic Fibrinogen Concentrate In Scoliosis Surgery (EFISS): a study protocol of two-arm, randomised trial.
Topics: Child; Fibrinogen; Hemorrhage; Hemostatics; Humans; Pilot Projects; Randomized Controlled Trials as Topic; Scoliosis; Treatment Outcome | 2023 |
Pharmacology, Efficacy and Safety of a Triple-Secured Fibrinogen Concentrate in Children Less than or Equal to 12 Years with Afibrinogenaemia.
Topics: Afibrinogenemia; Blood Loss, Surgical; Child; Child, Preschool; Chromatography, Ion Exchange; Dose-Response Relationship, Drug; Female; Fibrinogen; Follow-Up Studies; Hemorrhage; Hemostasis; Humans; Infant; Infusions, Intravenous; Male; Postoperative Hemorrhage | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Association of myocardial hemorrhage and persistent microvascular obstruction with circulating inflammatory biomarkers in STEMI patients.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Coronary Circulation; Female; Fibrinogen; Hemorrhage; Humans; Interleukin-6; Leukocyte Count; Male; Microcirculation; Middle Aged; Myocardium; Prospective Studies; ST Elevation Myocardial Infarction | 2021 |
Fibrinogen prophylaxis for reducing perioperative bleeding in patients undergoing radical cystectomy: A double-blind placebo-controlled randomized trial.
Topics: Cystectomy; Double-Blind Method; Fibrinogen; Hemorrhage; Hemostatics; Humans; Iran; Male; Middle Aged | 2021 |
Fibrinogen Early In Severe Trauma studY (FEISTY): study protocol for a randomised controlled trial.
Topics: Blood Transfusion; Clinical Protocols; Factor VIII; Feasibility Studies; Fibrinogen; Hemorrhage; Hemostasis; Hemostatic Techniques; Hemostatics; Humans; Pilot Projects; Queensland; Research Design; Time Factors; Treatment Outcome; Wounds and Injuries | 2017 |
TEG Lysis Shutdown Represents Coagulopathy in Bleeding Trauma Patients: Analysis of the PROPPR Cohort.
Topics: Adult; alpha-2-Antiplasmin; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Retrospective Studies; Thrombelastography; Thrombophilia | 2019 |
Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multi-centre, randomised, double blind, placebo-controlled pilot trial.
Topics: Adult; Double-Blind Method; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Male; Middle Aged; Pilot Projects; Placebos; Pragmatic Clinical Trials as Topic; Secondary Prevention; Treatment Outcome; United Kingdom; Wounds and Injuries | 2018 |
Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction.
Topics: Adult; Aged; Female; Fibrinogen; Hemorrhage; Heparin; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Retrospective Studies; Risk Factors | 2019 |
Early cryoprecipitate for major haemorrhage in trauma: a randomised controlled feasibility trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Transfusion; Feasibility Studies; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Trauma Centers; United Kingdom; Wounds and Injuries; Young Adult | 2015 |
FIBTEM provides prediction of massive bleeding in total hip replacement arthroplasty.
Topics: Adult; Arthroplasty, Replacement, Hip; Blood Coagulation; Blood Coagulation Tests; Blood Loss, Surgical; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Prognosis; Retrospective Studies | 2016 |
Fibrinogen concentrate improves clot strength in patients with haematological malignancies requiring platelet transfusion.
Topics: Adolescent; Adult; Aged; Blood Coagulation; Female; Fibrinogen; Hematologic Neoplasms; Hemorrhage; Humans; Male; Middle Aged; Platelet Transfusion | 2016 |
Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy.
Topics: Adult; Aged; Aged, 80 and over; Blood Transfusion; Cardiopulmonary Bypass; Cardiovascular Surgical Procedures; Double-Blind Method; Female; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Hemostatics; Humans; Male; Middle Aged; Young Adult | 2016 |
Pilot Randomized trial of Fibrinogen in Trauma Haemorrhage (PRooF-iTH): study protocol for a randomized controlled trial.
Topics: Adult; Clinical Protocols; Double-Blind Method; Fibrinogen; Hemorrhage; Humans; Pilot Projects; Thrombelastography; Wounds and Injuries | 2016 |
The effect of fibrinogen concentrate on perioperative bleeding in transurethral resection of the prostate: a double-blind placebo-controlled and randomized study.
Topics: Aged; Aged, 80 and over; Coagulants; Double-Blind Method; Fibrinogen; Hemorrhage; Hemostasis; Hemostatics; Humans; Male; Middle Aged; Postoperative Hemorrhage; Prospective Studies; Prostatic Hyperplasia; Transurethral Resection of Prostate; Treatment Outcome | 2017 |
Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial.
Topics: Blood Transfusion; Cystectomy; Fibrinogen; Hemodilution; Hemorrhage; Humans; Hydroxyethyl Starch Derivatives; Placebos; Thrombelastography; Thrombosis | 2009 |
High efficacy and low toxicity of APL induction with concurrent idarubicin/ATRA followed by a novel and simplified outpatient post-remission therapy using single doses of idarubicin and intermittent ATRA.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Idarubicin; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Pilot Projects; Remission Induction; Tretinoin; Young Adult | 2010 |
Prolonged prothrombin time after recombinant activated factor VII therapy in critically bleeding trauma patients is associated with adverse outcomes.
Topics: Adolescent; Adult; Aged; Factor VIIa; Female; Fibrinogen; Hemoglobins; Hemorrhage; Humans; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Prothrombin Time; Recombinant Proteins; ROC Curve; Treatment Outcome; Wounds and Injuries; Young Adult | 2010 |
Peroperative effects of fresh frozen plasma and antithrombin III on heparin sensitivity and coagulation during nitroglycerine infusion in coronary artery bypass surgery.
Topics: Aged; Anticoagulants; Antithrombin III; Blood Coagulation; Coronary Artery Bypass; Coronary Artery Disease; Female; Fibrinogen; Hemorrhage; Heparin; Humans; Male; Middle Aged; Nitroglycerin; Partial Thromboplastin Time; Plasma; Preoperative Period; Vasodilator Agents | 2011 |
Comparative study of the efficacy and safety of two polyvalent, caprylic acid fractionated [IgG and F(ab')2] antivenoms, in Bothrops asper bites in Colombia.
Topics: Adolescent; Animals; Antivenins; Blood Coagulation; Blood Coagulation Disorders; Bothrops; Caprylates; Chemical Fractionation; Chromatography, Ion Exchange; Colombia; Crotalid Venoms; Double-Blind Method; Drug Evaluation; Drug-Related Side Effects and Adverse Reactions; Female; Fibrinogen; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Immunoglobulin G; Incidence; Male; Pepsin A; Snake Bites; Treatment Outcome | 2012 |
Increased fibrinolysis increases bleeding in orthopedic patients receiving prophylactic fondaparinux.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biomarkers; Factor Xa Inhibitors; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fondaparinux; Hemorrhage; Humans; Male; Middle Aged; Polysaccharides; Postoperative Complications; Venous Thrombosis | 2012 |
Safety of catheter-delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion: phase I results.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; alpha-2-Antiplasmin; alpha-Macroglobulins; Arterial Occlusive Diseases; Biomarkers; Brazil; Catheterization, Peripheral; Dose-Response Relationship, Drug; Europe; Female; Fibrinogen; Fibrinolysin; Fibrinolytic Agents; Graft Occlusion, Vascular; Hemorrhage; Humans; Infusions, Intra-Arterial; Lower Extremity; Male; Middle Aged; Radiography; South Africa; Thrombolytic Therapy; Time Factors; Treatment Outcome; United States; Young Adult | 2012 |
National audit of the use of fibrinogen concentrate to correct hypofibrinogenaemia.
Topics: Adolescent; Adult; Afibrinogenemia; Aged; Aged, 80 and over; Child; Child, Preschool; Coagulants; Cohort Studies; Female; Fibrinogen; Hemorrhage; Humans; Infant; Infant, Newborn; Male; Medical Audit; Middle Aged; Prospective Studies; United Kingdom | 2012 |
Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Blood Transfusion; Burns; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Partial Thromboplastin Time; Point-of-Care Systems; Prospective Studies; Thrombelastography | 2012 |
Processing and transfusion of residual cardiopulmonary bypass volume: effects on haemostasis, complement activation, postoperative blood loss and transfusion volume.
Topics: Aged; Blood Coagulation Tests; Blood Transfusion; Cardiopulmonary Bypass; Complement Activation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Hemoglobins; Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Platelet Count; Postoperative Complications | 2003 |
Clearance of fibrinogen and von Willebrand factor in serial double-filtration plasmapheresis.
Topics: Adult; Aged; Biomarkers; Female; Fibrinogen; Filtration; Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Plasmapheresis; von Willebrand Factor | 2003 |
Eptifibatide in peripheral vascular interventions: results of the Integrilin Reduces Inflammation in Peripheral Vascular Interventions (INFLAME) trial.
Topics: Aged; Aneurysm, False; Anticoagulants; Biomarkers; Dose-Response Relationship, Drug; Eptifibatide; Female; Fibrinogen; Hemorrhage; Heparin; Humans; Inflammation; Injections, Intravenous; Male; Middle Aged; Peptides; Peripheral Vascular Diseases; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombin; Time Factors; Whole Blood Coagulation Time | 2006 |
Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.
Topics: Adult; Antigens; Arginine Vasopressin; Bleeding Time; Clinical Trials as Topic; Deamino Arginine Vasopressin; Double-Blind Method; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Platelet Function Tests; Postoperative Complications; Random Allocation; Uremia; von Willebrand Factor | 1983 |
Intracoronary thrombolysis in patients with acute myocardial infarction: comparison of the efficacy of urokinase with streptokinase.
Topics: Adult; Aged; Coronary Artery Bypass; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Streptokinase; Urokinase-Type Plasminogen Activator | 1984 |
[Modification of suprapubic prostatectomy using a biological gluing technic].
Topics: Collagen; Factor XIII; Fibrinogen; Follow-Up Studies; Hemorrhage; Humans; Length of Stay; Prostatectomy; Surgical Mesh; Thrombin; Tissue Adhesives; Wound Healing | 1983 |
Heparin treatment of deep vein thrombosis. Effects and complications after continuous or intermittent heparin administration.
Topics: Adult; Aged; Clinical Trials as Topic; Drug Administration Schedule; Female; Fibrinogen; Hemorrhage; Heparin; Humans; Male; Middle Aged; Pain; Prospective Studies; Pulmonary Embolism; Random Allocation; Thrombophlebitis; Transaminases | 1981 |
Aprotinin inhibits fibrinolysis, improves platelet adhesion and reduces blood loss. Results of a double-blind randomized clinical trial.
Topics: Aged; Aprotinin; Double-Blind Method; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Male; Middle Aged; Platelet Adhesiveness; Postoperative Complications; Prospective Studies; Receptors, Peptide; Tissue Plasminogen Activator; von Willebrand Factor | 1994 |
A pilot study of pro-urokinase in the treatment of deep vein thrombosis.
Topics: Adult; Aged; alpha-2-Antiplasmin; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pilot Projects; Plasminogen; Recombinant Proteins; Thrombolytic Therapy; Thrombophlebitis; Treatment Outcome; Urokinase-Type Plasminogen Activator | 1994 |
The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: a randomized clinical study.
Topics: Adolescent; Adult; Antithrombin III; Aprotinin; Double-Blind Method; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Intraoperative Complications; Liver Transplantation; Male; Middle Aged; Peptide Hydrolases; Prospective Studies; Tissue Plasminogen Activator; Treatment Failure | 1997 |
Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytogenetics; Dexamethasone; Disease-Free Survival; Disseminated Intravascular Coagulation; Drug Administration Schedule; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Leukemia, Promyelocytic, Acute; Male; Platelet Count; Retrospective Studies; Risk Factors; Survival; Time Factors; Tretinoin | 2000 |
Reversion of primary hyperfibrinogenolysis in patients with hormone-refractory prostate cancer using docetaxel.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Resistance, Neoplasm; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Male; Neoplasm Metastasis; Paclitaxel; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Urokinase-Type Plasminogen Activator | 2000 |
Coagulation abnormalities in serial double-filtration plasmapheresis.
Topics: Adolescent; Adult; Aged; Blood Coagulation Disorders; Blood Coagulation Tests; Catheterization; Female; Fibrinogen; Filtration; Hemorrhage; Hemostasis; Heparin; Humans; Male; Middle Aged; Myasthenia Gravis; Plasma Exchange; Plasmapheresis | 2001 |
Prophylaxis of postoperative deep venous thrombosis. Studies on low-dose heparin, blood coagulation, infection as a risk factor and the half-life of fibrinogen in patients after gastrointestinal surgery.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Blood Coagulation Tests; Clinical Trials as Topic; Digestive System Surgical Procedures; Double-Blind Method; Female; Fibrinogen; Half-Life; Hemorrhage; Heparin; Humans; Injections, Subcutaneous; Male; Middle Aged; Postoperative Complications; Risk; Thrombophlebitis | 1979 |
Prevention of venous thrombosis with small, subcutaneous doses of heparin.
Topics: Fibrinogen; Hemorrhage; Heparin; Humans; Injections, Subcutaneous; Iodine Radioisotopes; Leg; Postoperative Complications; Prospective Studies; Surgical Procedures, Operative; Thrombophlebitis | 1976 |
Dextran 70 in prophylaxis of thromboembolic disease after surgery: a clinically oriented randomized double-blind trial.
Topics: Clinical Trials as Topic; Dextrans; Fibrinogen; Hemorrhage; Heparin; Humans; Infusions, Parenteral; Iodine Radioisotopes; Postoperative Complications; Pulmonary Embolism; Thromboembolism | 1975 |
Rate of fibrinogen breakdown related to coronary patency and bleeding complications in patients with thrombolysis in acute myocardial infarction--results from the PRIMI trial.
Topics: Blood Coagulation Tests; Coronary Circulation; Coronary Thrombosis; Double-Blind Method; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Hemostasis; Humans; Myocardial Infarction; Recombinant Proteins; Recurrence; Streptokinase; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator; Vascular Patency | 1992 |
Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Recombinant Proteins; Recurrence; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Urokinase-Type Plasminogen Activator; Vascular Patency; Ventricular Function, Left | 1992 |
Dermatan sulphate: a safe approach to prevention of postoperative deep vein thrombosis.
Topics: Adult; Aged; Dermatan Sulfate; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Male; Middle Aged; Plethysmography, Impedance; Postoperative Complications; Prospective Studies; Thrombophlebitis | 1992 |
Exploration of rapid bedside monitoring of coagulation and fibrinolysis parameters during thrombolytic therapy.
Topics: Blood Coagulation; Blood Coagulation Tests; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Monitoring, Physiologic; Partial Thromboplastin Time; Pilot Projects; Prothrombin Time; Thrombolytic Therapy; Time Factors | 1992 |
Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
Topics: Aprotinin; Blood Coagulation; Cardiopulmonary Bypass; Double-Blind Method; Fibrinogen; Hemorrhage; Hemostasis; Humans; Incidence; Kallikreins; Platelet Adhesiveness; Platelet Aggregation; Platelet Membrane Glycoproteins | 1990 |
Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.
Topics: Aspirin; Coronary Artery Bypass; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Heparin; Humans; Male; Metoprolol; Myocardial Infarction; Plasminogen; Recombinant Proteins; Statistics as Topic; Thrombolytic Therapy; Tissue Plasminogen Activator | 1991 |
Safety and efficacy of a new regimen of intravenous recombinant tissue-type plasminogen activator potentially suitable for either prehospital or in-hospital administration.
Topics: Adult; Clinical Protocols; Coronary Angiography; Emergency Medical Services; Female; Fibrinogen; Hemorrhage; Hospitalization; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; New York City; Recurrence; Rhode Island; Tissue Plasminogen Activator; Vascular Patency | 1991 |
Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.
Topics: Clinical Trials as Topic; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Myocardial Infarction; Random Allocation; Recombinant Proteins; Streptokinase; Thrombocytopenia; Tissue Plasminogen Activator | 1988 |
Early clinical evaluation of the intravenous treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.
Topics: Adult; Aged; Anistreplase; Clinical Trials as Topic; Coronary Angiography; Coronary Circulation; Female; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Hemorrhage; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen; Streptokinase; Vascular Patency | 1987 |
A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Female; Fibrinogen; Hemorrhage; Heparin; Hip; Hip Prosthesis; Humans; Iodine Radioisotopes; Leg; Male; Phlebography; Postoperative Complications; Random Allocation; Thrombophlebitis | 1986 |
Heparin prophylaxis trials of venous thrombosis: a critical review.
Topics: Blood Coagulation Tests; Clinical Trials as Topic; Fibrinogen; Hematoma; Hematuria; Hemorrhage; Heparin; Humans; Phlebography; Placebos; Postoperative Complications; Pulmonary Embolism; Random Allocation; Thrombophlebitis | 1985 |
Failure of low-dose heparin to prevent deep-vein thrombosis after hip-replacement arthroplasty.
Topics: Aged; Arthroplasty; Body Weight; Calcium; Clinical Trials as Topic; Female; Femoral Vein; Fibrinogen; Hemoglobins; Hemorrhage; Heparin; Hip; Humans; Injections, Subcutaneous; Iodine Radioisotopes; Joint Prosthesis; Male; Middle Aged; Postoperative Care; Postoperative Complications; Preoperative Care; Prospective Studies; Radionuclide Imaging; Thrombophlebitis; Time Factors; Ultrasonography | 1974 |
Controlled trial of oral contraceptives in haemophilia.
Topics: Adolescent; Blood Coagulation Factors; Blood Coagulation Tests; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Fibrinogen; Gynecomastia; Hemophilia A; Hemophilia B; Hemorrhage; Humans; Lynestrenol; Male; Mestranol; Placebos; Stimulation, Chemical | 1973 |
Urokinase pulmonary embolism trial. Phase 1 results: a cooperative study.
Topics: Angiography; Female; Fibrinogen; Fibrinolytic Agents; Heart Failure; Hematocrit; Hemorrhage; Heparin; Humans; Male; Middle Aged; Plasminogen; Pulmonary Artery; Pulmonary Embolism; Radionuclide Imaging; Serum Globulins; Time Factors | 1970 |
862 other study(ies) available for fibrinogen and Hemorrhage
| Article | Year |
|---|---|
Inflammation/coagulopathy/fibrinolysis: Dynamic indicators of COVID-19 progression in patients with moderate COVID-19 in Wenzhou, China.
Topics: Adult; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; China; COVID-19; Disease Progression; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Inflammation; Male; Middle Aged; Prothrombin Time; SARS-CoV-2 | 2021 |
Comments on 'U-shaped relationship between preoperative plasma fibrinogen levels and severe peri-operative bleeding in cardiac surgery: A report from the Perioperative Events aSSessment in Adult Cardiac surgery (PESSAC) registry' by Mion et al.
Topics: Adult; Cardiac Surgical Procedures; Fibrinogen; Hemorrhage; Humans; Registries | 2021 |
The effect of a viscoelastic-guided bleeding algorithm implementation on blood products use in adult liver transplant patients. A propensity score-matched before-after study.
Topics: Adult; Algorithms; Controlled Before-After Studies; Fibrinogen; Hemorrhage; Humans; Liver Transplantation; Postoperative Complications; Propensity Score; Retrospective Studies; Thrombelastography | 2022 |
Mutations Accounting for Congenital Fibrinogen Disorders: An Update.
Topics: Afibrinogenemia; Exons; Fibrinogen; Hemorrhage; Hemostatics; Humans; Mutation | 2022 |
Impact of fibrinogen and prothrombin complex concentrate on clotting time in a model of obstetric hemorrhage.
Topics: Blood Coagulation; Blood Coagulation Factors; Female; Fibrinogen; Hemorrhage; Humans; Pregnancy; Thrombelastography | 2022 |
Acquired hypofibrinogenemia in obstetric hemorrhage.
Topics: Afibrinogenemia; Female; Fibrinogen; Hemorrhage; Humans; Postpartum Hemorrhage; Pregnancy | 2022 |
Anticoagulation practices associated with bleeding and thrombosis in pediatric extracorporeal membrane oxygenation; a multi-center secondary analysis.
Topics: Anticoagulants; Child; Extracorporeal Membrane Oxygenation; Fibrinogen; Hemorrhage; Heparin; Humans; Retrospective Studies; Thrombosis | 2023 |
Role of Fibrinogen in Trauma-Induced Coagulopathy.
Topics: Adult; Afibrinogenemia; Blood Coagulation Disorders; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Male; Thrombelastography; Wounds and Injuries | 2022 |
Post-thrombolytic coagulopathy and complications in patients with pulmonary embolism treated with fixed-dose systemic alteplase.
Topics: Blood Coagulation Disorders; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Pulmonary Embolism; Retrospective Studies; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2022 |
Dynamic use of fibrinogen under viscoelastic assessment results in reduced need for plasma and diminished overall transfusion requirements in severe trauma.
Topics: Blood Coagulation Disorders; Blood Transfusion; Fibrinogen; Hemorrhage; Hemostatics; Humans; Thrombelastography; Wounds and Injuries | 2022 |
Clinical, biological, and genetic features in an afibrinogenemia patient series in Algeria.
Topics: Adult; Afibrinogenemia; Algeria; Child; Fibrinogen; Hemorrhage; Humans; Thrombin; Thrombosis | 2022 |
Medical Management of a Mural Thrombus Inducing Repeated Ischemic Strokes in a Patient with Congenital Afibrinogenemia.
Topics: Afibrinogenemia; Female; Fibrinogen; Heart Diseases; Hemorrhage; Humans; Ischemic Stroke; Middle Aged; Thrombosis | 2022 |
CD44-fibrinogen binding promotes bleeding in acute promyelocytic leukemia by in situ fibrin(ogen) deposition.
Topics: Animals; Estrone; Fibrin; Fibrinogen; Hemorrhage; Leukemia, Promyelocytic, Acute; Mice | 2022 |
Major hemorrhage and mortality in COVID-19 patients on therapeutic anticoagulation for venous thromboembolism.
Topics: Anticoagulants; COVID-19; COVID-19 Drug Treatment; Fibrinogen; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Pulmonary Embolism; Venous Thromboembolism | 2022 |
Characterization of Biomarkers of Hemostasis and Bleeding-Related Outcomes in Children With Cirrhosis.
Topics: Adult; Biomarkers; Child; Fibrinogen; Hemorrhage; Hemostasis; Humans; Liver Cirrhosis; Retrospective Studies | 2022 |
Fibrinogen supplementation for the trauma patient: Should you choose fibrinogen concentrate over cryoprecipitate?
Topics: Adult; Anticoagulants; Blood Coagulation Disorders; Dietary Supplements; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Male; Middle Aged; Retrospective Studies; Wounds and Injuries; Young Adult | 2022 |
A Fibrinogen-Mimicking, Activated-Platelet-Sensitive Nanocoacervate Enhances Thrombus Targeting and Penetration of Tissue Plasminogen Activator for Effective Thrombolytic Therapy.
Topics: Animals; Arginine; Aspartic Acid; Chitosan; Fibrinogen; Fibrinolytic Agents; Glycine; Hemorrhage; Hemostatics; Mice; Oligopeptides; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator | 2022 |
Analysis of fibrinogen concentrate pharmacokinetics and dosing for bleeds and surgery in adults, adolescents, and children with congenital afibrinogenaemia and hypofibrinogenaemia.
Topics: Adolescent; Adult; Afibrinogenemia; Child; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Fibrinogen; Hemorrhage; Hemostatics; Humans; Prospective Studies; Rare Diseases; Young Adult | 2022 |
The Supply Side of Coagulation: Fibrinogen and Bleeding in Liver Disease and Transplantation.
Topics: Blood Coagulation; Blood Coagulation Tests; Fibrinogen; Hemorrhage; Humans; Liver Diseases | 2023 |
Application of Activators Ecarin and Factor Xa in Thrombelastography for Measurement of Anticoagulant Effect of Direct Oral Anticoagulants Using TEG 5000.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Dabigatran; Factor Xa; Factor Xa Inhibitors; Fibrinogen; Hemorrhage; Humans; Kaolin; Male; Pyridones; Rivaroxaban; Thrombelastography | 2022 |
Comparative retrospective study on the validity of point-of-care testing device for massive obstetrical hemorrhage: dry hematology vs thromboelastography.
Topics: Afibrinogenemia; Fibrinogen; Hematology; Hemorrhage; Hemostatics; Humans; Point-of-Care Testing; Retrospective Studies; Thrombelastography | 2023 |
Venom induced consumption coagulopathy and performance of 20-min whole blood clotting test for its detection in viperid envenomation.
Topics: Blood Coagulation; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Humans; Venoms | 2022 |
Major Bleeding During Thrombolytic Therapy for Acute Lower Limb Ischaemia: Value of Laboratory Tests for Clinical Decision Making, 17 Years of Experience.
Topics: Arterial Occlusive Diseases; Clinical Decision-Making; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Ischemia; Peripheral Vascular Diseases; Prospective Studies; Retrospective Studies; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Urokinase-Type Plasminogen Activator | 2023 |
Comprehensive analysis of coagulation factor delivery strategies in a cohort of trauma patients.
Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Transfusion; Fibrinogen; Hemorrhage; Hemostatics; Humans; Wounds and Injuries | 2023 |
Influence of Fibrinogen Concentrate on Neonatal Clot Structure When Administered Ex Vivo After Cardiopulmonary Bypass.
Topics: Cardiopulmonary Bypass; Fibrin; Fibrinogen; Hemorrhage; Hemostatics; Humans; Infant, Newborn; Thrombosis | 2023 |
Comment on: "The Supply Side of Coagulation: Fibrinogen and Bleeding in Liver Disease and Transplantation." The Known, the Unknown, the Possibly Known, and the Impossible.
Topics: Blood Coagulation; Blood Coagulation Tests; Fibrinogen; Hemorrhage; Humans; Liver Diseases | 2023 |
Diagnostic utility of bleeding assessment tools in congenital fibrinogen deficiencies.
Topics: Afibrinogenemia; Blood Coagulation Disorders; Fibrinogen; Hemorrhage; Humans; Iran; Rare Diseases | 2023 |
In vitro study on the effect of fibrinogen γ-chain peptide-coated ADP-encapsulated liposomes on postcardiopulmonary bypass coagulopathy using patient blood.
Topics: Adenosine Diphosphate; Animals; Blood Coagulation Disorders; Blood Platelets; Cardiopulmonary Bypass; Fibrinogen; Hemorrhage; Humans; Liposomes; Peptides; Platelet Aggregation; Rabbits | 2023 |
Fibrinogen Inhibits Metalloproteinase-9 Activation and Syndecan-1 Cleavage to Protect Lung Function in ApoE Null Mice After Hemorrhagic Shock.
Topics: Animals; Apolipoproteins E; Disease Models, Animal; Fibrinogen; Hemorrhage; Hemostatics; Lung; Lung Injury; Matrix Metalloproteinase 9; Mice; Resuscitation; Shock, Hemorrhagic; Syndecan-1 | 2023 |
Population pharmacokinetic modelling of fibrinogen in patients with congenital or acquired-chronic or acute-hypofibrinogenaemia.
Topics: Afibrinogenemia; Blood Coagulation; Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis | 2023 |
Primary hemostasis dysfunctions and bleeding risk in newly diagnosed acute myeloid leukemia.
Topics: Fibrinogen; Hemorrhage; Hemostasis; Humans; Leukemia, Myeloid, Acute; Reproducibility of Results; von Willebrand Factor | 2023 |
Cryoprecipitate for the treatment of life-threatening hemorrhage in children.
Topics: Child; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Prospective Studies; Retrospective Studies; Treatment Outcome | 2023 |
Sonorheometry versus rotational thromboelastometry in trauma: a comparison of diagnostic and prognostic performance.
Topics: Adult; Blood Coagulation Disorders; Cohort Studies; Fibrinogen; Hemorrhage; Humans; Prognosis; Thrombelastography; Thromboplastin | 2023 |
The role of D-dimer and fibrinogen testing in catheter-directed thrombolysis with urokinase for deep venous thrombosis.
Topics: Catheters; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Thrombolytic Therapy; Treatment Outcome; Urokinase-Type Plasminogen Activator; Venous Thrombosis | 2023 |
Slow Intravenous Infusion of a Novel Damage Control Cocktail Decreases Blood Loss in a Pig Polytrauma Model.
Topics: Animals; Disease Models, Animal; Fibrinogen; Fluid Therapy; Hemodynamics; Hemorrhage; Hemostatics; Hydroxyethyl Starch Derivatives; Infusions, Intravenous; Isotonic Solutions; Lactates; Multiple Trauma; Resuscitation; Shock, Hemorrhagic; Swine; Vasopressins | 2023 |
Circuit change during extracorporeal membrane oxygenation: single-center retrospective study of 48 changes.
Topics: Cohort Studies; Extracorporeal Membrane Oxygenation; Fibrinogen; Hemorrhage; Hemostatics; Humans; Retrospective Studies; Thrombosis | 2023 |
Dysfibrinogenemia: discrepant results following infusion of purified fibrinogen.
Topics: Afibrinogenemia; Fibrinogen; Hemorrhage; Hemostatics; Humans; Thrombosis | 2023 |
Over-expression of Dyrk1A affects bleeding by modulating plasma fibronectin and fibrinogen level in mice.
Topics: Animals; Blood Platelets; Down Syndrome; Dyrk Kinases; Fibrinogen; Fibronectins; Hemorrhage; Humans; Mice; Thrombocytopenia | 2023 |
What can ex vivo experiments contribute to clinical haemostasis management?
Topics: Blood Coagulation; Cardiopulmonary Bypass; Fibrinogen; Hemorrhage; Hemostasis; Hemostatics; Humans | 2023 |
Evaluation of the association of factor XIII at hospital arrival and outcomes in a cohort of severely injured patients.
Topics: Adult; Factor XIII; Factor XIII Deficiency; Fibrinogen; Hemorrhage; Hospitals; Humans; Retrospective Studies | 2023 |
Bleeding patients on extracorporeal membrane oxygenation have reduced platelet aggregation and plasma fibrinogen: a longitudinal observational study.
Topics: Adult; Extracorporeal Membrane Oxygenation; Fibrinogen; Hemorrhage; Hemostatics; Humans; Platelet Aggregation | 2023 |
Characterization of a recombinant factor IX molecule fused to coagulation factor XIII-B subunit.
Topics: Albumins; Animals; Factor IX; Factor XIII; Fibrinogen; Half-Life; Hemophilia B; Hemorrhage; Hemostatics; Joint Diseases; Mice; Rats; Recombinant Fusion Proteins; Recombinant Proteins; Vascular Diseases | 2023 |
Safety of Tigecycline in Patients on Antithrombotic Therapy: A Single-Center Retrospective Study.
Topics: Afibrinogenemia; Anti-Bacterial Agents; Cefoperazone; Fibrinogen; Fibrinolytic Agents; Hemoglobins; Hemorrhage; Humans; Retrospective Studies; Sulbactam; Tigecycline | 2023 |
Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury: The CRYOSTAT-2 Randomized Clinical Trial.
Topics: Adult; Blood Component Transfusion; Blood Transfusion; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Wounds, Penetrating | 2023 |
Predictive role of admission serum glucose, baseline NIHSS score, and fibrinogen on hemorrhagic transformation after intravenous thrombolysis with alteplase in acute ischemic stroke.
Topics: Blood Glucose; Brain Ischemia; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Ischemic Stroke; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2023 |
Systemic Coagulation Inflammation Index Associated With Bleeding in Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Aged; C-Reactive Protein; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Inflammation; Male; Middle Aged; Risk Factors | 2023 |
Relationship of thromboelastography and conventional clotting test values with severe bleeding in critically ill patients with coagulopathy: A prospective study.
Topics: Adult; Aged; Blood Coagulation Disorders; Blood Coagulation Tests; Cardiac Surgical Procedures; Critical Illness; Female; Fibrinogen; Hemorrhage; Humans; Intensive Care Units; International Normalized Ratio; Liver Failure; Male; Middle Aged; Partial Thromboplastin Time; Prospective Studies; Sensitivity and Specificity; Thrombelastography | 2019 |
Quantifiable Bleeding in Children Supported by Extracorporeal Membrane Oxygenation and Outcome.
Topics: Blood Transfusion; Body Weight; Chest Tubes; Continuous Renal Replacement Therapy; Extracorporeal Membrane Oxygenation; Female; Fibrinogen; Hemorrhage; Hospital Mortality; Humans; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Prospective Studies; Renal Dialysis | 2019 |
Comparison of Danaparoid Sodium and Synthetic Protease Inhibitors for the Treatment of Disseminated Intravascular Coagulation Associated with Hematological Malignancies: A Retrospective Analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Component Transfusion; Chondroitin Sulfates; Dermatan Sulfate; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematologic Neoplasms; Hemorrhage; Heparitin Sulfate; Humans; Male; Middle Aged; Plasma; Protease Inhibitors; Prothrombin Time; Retrospective Studies; Treatment Outcome | 2020 |
Targeted fibrinogen concentrate use in severe traumatic haemorrhage.
Topics: Australia; Blood Coagulation; Blood Transfusion; Fibrinogen; Hemorrhage; Humans; Thrombelastography; Wounds and Injuries | 2019 |
Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutations.
Topics: Adolescent; Adult; Afibrinogenemia; Aged; Child; Child, Preschool; Female; Fibrinogen; Follow-Up Studies; Hemorrhage; Heterozygote; Homozygote; Humans; Male; Mutation; Poland; Protein Isoforms; Young Adult | 2019 |
The incidence and risk factors of hypofibrinogenemia in cardiovascular surgery.
Topics: Afibrinogenemia; Aged; Aged, 80 and over; Aorta; Cardiac Surgical Procedures; Coronary Artery Bypass; Female; Fibrinogen; Heart Valves; Hemorrhage; Humans; Incidence; Intraoperative Period; Male; Middle Aged; Odds Ratio; Postoperative Complications; Retrospective Studies; Risk Factors; ROC Curve; Vascular Surgical Procedures | 2020 |
Predictors of bleeding in ECMO patients undergoing surgery.
Topics: Adult; Aged; Blood Coagulation Tests; Blood Gas Analysis; Blood Transfusion; Erythrocyte Transfusion; Extracorporeal Membrane Oxygenation; Female; Fibrinogen; Hemoglobins; Hemorrhage; Humans; Male; Middle Aged; Partial Thromboplastin Time; Perioperative Period; Platelet Count; Predictive Value of Tests; Retrospective Studies | 2020 |
Early coagulation support protocol: A valid approach in real-life management of major trauma patients. Results from two Italian centres.
Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Disorders; Blood Transfusion; Clinical Protocols; Female; Fibrinogen; Hemorrhage; Humans; Injury Severity Score; Italy; Length of Stay; Male; Middle Aged; Resuscitation; Retrospective Studies; Tranexamic Acid; Trauma Centers; Wounds and Injuries; Young Adult | 2019 |
Optimizing management of replacement fluids for therapeutic plasma exchange: Use of an automated mathematical model to predict post-procedure fibrinogen and antithrombin levels in high-risk patients.
Topics: Anticoagulants; Antithrombins; Automation; Fibrinogen; Hematocrit; Hemorrhage; Hemostasis; Homeostasis; Humans; Models, Theoretical; Plasma Exchange; Plasmapheresis; Risk; Thrombosis | 2020 |
Congenital structural and functional fibrinogen disorders: a primer for internists.
Topics: Adult; Afibrinogenemia; Blood Coagulation Tests; Female; Fibrinogen; Genetic Predisposition to Disease; Genetic Testing; Hemorrhage; Humans; Male; Middle Aged; Poland; Thrombosis; Young Adult | 2019 |
Fibrinogen Concentrate to Cardiac Surgery Patients with Ongoing Bleeding does not Increase the Risk of Thromboembolic Complications or Death.
Topics: Aged; Cardiac Surgical Procedures; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Male; Middle Aged; Multivariate Analysis; Propensity Score; Proportional Hazards Models; Retrospective Studies; Risk; Sensitivity and Specificity; Thromboembolism | 2020 |
A retrospective register study comparing fibrinogen treated trauma patients with an injury severity score matched control group.
Topics: Adult; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Propensity Score; Retrospective Studies; Trauma Severity Indices; Treatment Outcome; Wounds and Injuries; Young Adult | 2020 |
Generation and In-planta expression of a recombinant single chain antibody with broad neutralization activity on Bothrops pauloensis snake venom.
Topics: Animals; Bothrops; Brazil; Caseins; Chickens; Clone Cells; Cross Reactions; Fibrinogen; Geography; Hemorrhage; Mice; Neutralization Tests; Nicotiana; Protein Interaction Maps; Proteolysis; Recombinant Proteins; Single-Chain Antibodies; Snake Bites; Snake Venoms | 2020 |
Comparison of clinical phenotype with genetic and laboratory results in 31 patients with congenital dysfibrinogenemia in northern Slovakia.
Topics: Adolescent; Adult; Afibrinogenemia; Asymptomatic Diseases; Child; Child, Preschool; Cross-Sectional Studies; Female; Fibrinogen; Genotype; Hemorrhage; Humans; Male; Middle Aged; Phenotype; Point Mutation; Rare Diseases; Slovakia; Young Adult | 2020 |
Efficacy of resuscitation with fibrinogen concentrate and platelets in traumatic hemorrhage swine model.
Topics: Albumins; Animals; Blood Component Removal; Blood Platelets; Cardiac Output; Disease Models, Animal; Fibrinogen; Hemodynamics; Hemorrhage; Platelet Count; Resuscitation; Swine | 2020 |
D-dimer/fibrinogen ratio for the prediction of progressive hemorrhagic injury after traumatic brain injury.
Topics: Adult; Brain Injuries, Traumatic; Cohort Studies; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Humans; Male; Prognosis; Retrospective Studies; Risk Factors; ROC Curve | 2020 |
Heterogeneity of Integrin α
Topics: Adolescent; Blood Coagulation; Blood Platelets; Calcium; Calcium Signaling; Child; Child, Preschool; Cluster Analysis; Computer Simulation; Cytosol; Female; Fibrinogen; Flow Cytometry; Hemorrhage; Humans; Male; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Purpura, Thrombocytopenic, Idiopathic; Thrombasthenia; Thrombosis | 2020 |
Focal adhesion kinase and Src mediate microvascular hyperpermeability caused by fibrinogen- γC- terminal fragments.
Topics: Animals; Capillary Permeability; Cell Line; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Fibrinogen; Focal Adhesion Kinase 1; Hemorrhage; Humans; Intravital Microscopy; Lung; Male; Mesentery; Microvessels; Phosphorylation; Rats; rho GTP-Binding Proteins; RNA, Small Interfering; Signal Transduction; src-Family Kinases | 2020 |
The role of cryoprecipitate in massively transfused patients: Results from the Trauma Quality Improvement Program database may change your mind.
Topics: Adult; Blood Transfusion; Chemotherapy, Adjuvant; Databases, Factual; Emergency Service, Hospital; Factor VIII; Fibrinogen; Fibronectins; Hemorrhage; Hemostatics; Hospital Mortality; Humans; Middle Aged; Quality Improvement; Retrospective Studies; Trauma Centers; United States; Wounds and Injuries; Young Adult | 2020 |
Which is the preferred blood product for fibrinogen replacement in the bleeding patient with acquired hypofibrinogenemia-cryoprecipitate or fibrinogen concentrate?
Topics: Afibrinogenemia; Blood Safety; Factor VIII; Fibrinogen; Hemorrhage; Humans; Logistic Models | 2020 |
A prospective observational study of acute traumatic coagulopathy in traumatic bleeding from the battlefield.
Topics: Adult; Armed Conflicts; Blood Coagulation Disorders; Blood Coagulation Tests; Erythrocyte Transfusion; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Prospective Studies; Wounds and Injuries | 2020 |
Liver gene regulation of hemostasis-related factors is altered by experimental snake envenomation in mice.
Topics: Animals; Antivenins; Blood Coagulation Disorders; Blood Proteins; Bothrops; Disease Models, Animal; Fibrinogen; Gene Expression Regulation; Haptoglobins; Hemorrhage; Hemostasis; Hemostatics; Liver; Male; Mice; RNA, Messenger; Snake Bites; STAT3 Transcription Factor; Thrombocytopenia; Time Factors; Transcription Factors | 2020 |
Targeted cryoprecipitate transfusion in severe traumatic haemorrhage.
Topics: Australia; Blood Transfusion; Fibrinogen; Hemorrhage; Humans; Retrospective Studies; Thrombelastography; Wounds and Injuries; Young Adult | 2020 |
Comparison of molecular structure and fibrin polymerization between two Bβ-chain N-terminal region fibrinogen variants, Bβp.G45C and Bβp.R74C.
Topics: Adult; Afibrinogenemia; Child; Female; Fibrin; Fibrinogen; Genetic Variation; Hemorrhage; Heterozygote; Humans; Male; Molecular Structure; Polymerization; Risk; Thrombosis | 2020 |
Disorders on cardiovascular parameters in rats and in human blood cells caused by Lachesis acrochorda snake venom.
Topics: Animals; Blood Cells; Blood Coagulation; Blood Platelets; Cardiovascular System; Colombia; Fibrinogen; Hemorrhage; Humans; Hypotension; Metalloproteases; Platelet Aggregation; Prothrombin Time; Rats; Serine Endopeptidases; Serine Proteases; Serine Proteinase Inhibitors; Snake Bites; Viper Venoms; Viperidae | 2020 |
Measurement of hemorrhage-related severe maternal morbidity with billing versus electronic medical record data.
Topics: Disseminated Intravascular Coagulation; Electronic Health Records; Female; Fibrinogen; Hemorrhage; Humans; International Classification of Diseases; Male; Pregnancy; Puerperal Disorders | 2022 |
Blood component use in critical care in patients with COVID-19 infection: a single-centre experience.
Topics: Adult; Aged; Aged, 80 and over; Betacoronavirus; Blood Component Transfusion; Coronavirus Infections; COVID-19; Critical Care; Databases, Factual; Erythrocyte Transfusion; Extracorporeal Membrane Oxygenation; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; London; Male; Middle Aged; Pandemics; Plasma; Platelet Transfusion; Pneumonia, Viral; Procedures and Techniques Utilization; SARS-CoV-2 | 2020 |
Evaluation of Fibrinogen Levels during Catheter-Directed Thrombolysis for Acute Pulmonary Embolism.
Topics: Acute Disease; Adult; Aged; Anticoagulants; Biomarkers; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Pulmonary Embolism; Retrospective Studies; Risk Factors; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2020 |
Neotropical Rattlesnake (
Topics: Animals; Biological Availability; Blood Coagulation; Crotalid Venoms; Crotalus; Crotoxin; Fibrinogen; Hemorrhage; Injections, Intramuscular; Injections, Intravenous; Lymph; Male; Metalloproteases; Serine Proteases; Sheep, Domestic | 2020 |
Conformation-Specific Blockade of αIIbβ3 by a Non-RGD Peptide to Inhibit Platelet Activation without Causing Significant Bleeding and Thrombocytopenia.
Topics: Animals; Blood Platelets; Fibrinogen; Hemorrhage; Humans; Male; Mice, Inbred C57BL; Peptides; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Conformation; Thrombocytopenia | 2020 |
Successful management of COVID-19 and associated coagulopathy in a patient with durable left ventricular assist device.
Topics: Adult; Anticoagulants; Aspirin; Biomarkers; Blood Transfusion; COVID-19; Cytokine Release Syndrome; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart-Assist Devices; Hematoma; Hematuria; Hemorrhage; Heparin; Humans; Male; Platelet Aggregation Inhibitors; Retroperitoneal Space; Thrombocytopenia; Thrombosis | 2020 |
Fibrinogen-Coated Albumin Nanospheres Prevent Thrombocytopenia-Related Bleeding.
Topics: Albumins; Animals; Endothelium; Fibrinogen; Hemorrhage; Mice; Nanospheres; Platelet Aggregation; Survival Analysis; Thrombocytopenia | 2020 |
NADPH oxidase 1 is a novel pharmacological target for the development of an antiplatelet drug without bleeding side effects.
Topics: Animals; Carotid Artery Thrombosis; Cells, Cultured; Collagen; Enzyme Inhibitors; Female; Fibrinogen; Hemorrhage; Humans; Mice; Mice, Inbred C57BL; NADPH Oxidase 1; Phenothiazines; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Reactive Oxygen Species; Thrombin | 2020 |
Biochemical, pharmacological and structural characterization of BmooMP-I, a new P-I metalloproteinase from Bothrops moojeni venom.
Topics: Amino Acid Sequence; Animals; Bothrops; Calcium; Cations; Computational Biology; Crotalid Venoms; Crystallization; Crystallography, X-Ray; Databases, Protein; Fibrinogen; Gelatin; Hemorrhage; Mass Spectrometry; Metalloproteases; Mice; Models, Molecular; Sequence Alignment; Sequence Analysis, Protein; Skin | 2020 |
Flaxseed Cysteine Protease Exhibits Strong Anticoagulant, Antiplatelet, and Clot-Dissolving Properties.
Topics: Animals; Anticoagulants; Blood Coagulation; Cysteine Proteases; Edema; Fibrinogen; Flax; Hemolysis; Hemorrhage; Humans; Mice; Platelet Aggregation; Thrombin | 2020 |
Fibrinogen Columbus III: A novel c.963del frameshift mutation in the FGG gene resulting in hypofibrinogenemia with a bleeding phenotype.
Topics: Adolescent; Afibrinogenemia; Female; Fibrinogen; Fibrinogens, Abnormal; Frameshift Mutation; Hemorrhage; Humans; Phenotype | 2021 |
Terminal Phase Components of the Clotting Cascade in Patients with End-Stage Renal Disease Undergoing Hemodiafiltration or Hemodialysis Treatment.
Topics: Adolescent; Adult; Aged; alpha-2-Antiplasmin; Blood Coagulation; C-Reactive Protein; Complement Membrane Attack Complex; Factor XIII; Female; Fibrinogen; Fibrinolysis; Hemodiafiltration; Hemorrhage; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors; Thrombosis; Young Adult | 2020 |
The adhesion of clots in wounds contributes to hemostasis and can be enhanced by coagulation factor XIII.
Topics: Administration, Topical; Animals; Blood Platelets; Erythrocytes; Factor XIII; Femoral Artery; Fibrinogen; Hemorrhage; Hemostasis; Humans; Male; Rats, Sprague-Dawley; Thrombosis; Wounds and Injuries | 2020 |
Efficacy and safety of fibrinogen concentrate for on-demand treatment of bleeding and surgical prophylaxis in paediatric patients with congenital fibrinogen deficiency.
Topics: Afibrinogenemia; Blood Coagulation Tests; Child; Fibrinogen; Hemorrhage; Hemostatics; Humans | 2021 |
Clinical Simulation Model of Fibrinogen Decline During Hemorrhage in Major Noncardiac Surgery.
Topics: Aged; Aged, 80 and over; Blood Loss, Surgical; Blood Transfusion; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Models, Biological; Retrospective Studies | 2021 |
Paradoxical pulmonary hemorrhage associated with hemocoagulase batroxobin in a patient with hemoptysis: A CARE-compliant case report.
Topics: Afibrinogenemia; Aged, 80 and over; Batroxobin; Female; Fibrinogen; Hemoptysis; Hemorrhage; Hemostatics; Humans; Lung Diseases | 2021 |
Fibrinogen Degradation Speed as a Predictor of Major Bleeding Complications During Catheter Directed Thrombolysis in Patients with Acute Lower Limb Ischaemia.
Topics: Acute Disease; Biological Variation, Population; Catheters; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Ischemia; Lower Extremity; Peripheral Arterial Disease; Predictive Value of Tests; Proteolysis; Reference Values; Risk Assessment; Thrombolytic Therapy; Treatment Outcome | 2021 |
Association of Cryoprecipitate Use With Survival After Major Trauma in Children Receiving Massive Transfusion.
Topics: Adolescent; Blood Transfusion; Child; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Male; Propensity Score; Retrospective Studies; Survival Rate; Wounds, Nonpenetrating; Wounds, Penetrating | 2021 |
Major bleeding complications in critically ill patients with COVID-19 pneumonia.
Topics: Aged; Anticoagulants; Biomarkers; Blood Coagulation; COVID-19; Critical Illness; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Humans; Inflammation Mediators; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Treatment Outcome | 2021 |
Fibrinogen Replacement Therapy for Traumatic Coagulopathy: Does the Fibrinogen Source Matter?
Topics: Blood Coagulation Disorders; Coagulants; Dose-Response Relationship, Drug; Factor VIII; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Microscopy, Confocal; Thrombelastography; Thrombin; Thrombosis | 2021 |
The fibrinogen levels on admission is a predictive marker of the contrast extravasation on enhanced computed tomography in sacral fracture.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Contrast Media; Extravasation of Diagnostic and Therapeutic Materials; Feasibility Studies; Female; Fibrinogen; Hemorrhage; Humans; Injury Severity Score; Male; Middle Aged; Observational Studies as Topic; Patient Admission; Prognosis; Reference Values; Retrospective Studies; ROC Curve; Sacrum; Spinal Fractures; Tomography, X-Ray Computed | 2021 |
Emergency administration of fibrinogen concentrate for hemorrhage: A protocol for systematic review and meta-analysis.
Topics: Blood Transfusion; Controlled Clinical Trials as Topic; Emergency Treatment; Fibrinogen; Hemorrhage; Hemostatics; Hospital Mortality; Humans; Meta-Analysis as Topic; Systematic Reviews as Topic; Treatment Outcome | 2021 |
Investigating the hemostatic effect of medicinal plant Arnebia euchroma (Royle) I.M.Johnst extract in a mouse model.
Topics: Animals; Blood Platelets; Boraginaceae; Fibrinogen; Hemorrhage; Hemostatics; Male; Mice; Molecular Structure; Naphthoquinones; Phytotherapy; Plant Extracts; Platelet Adhesiveness | 2021 |
Novel variant fibrinogen γp.C352R produced hypodysfibrinogenemia leading to a bleeding episode and failure of infertility treatment.
Topics: Afibrinogenemia; Alleles; Amino Acid Substitution; Animals; Blood Coagulation; Blood Coagulation Tests; Catalysis; CHO Cells; Cricetulus; Fibrin; Fibrinogen; Hemorrhage; Humans; Infertility; Mutation; Polymerization; Thrombin | 2021 |
Fibrinogen measurement by a novel point-of-care device with whole blood: comparison of values against Clauss method.
Topics: Blood Coagulation Tests; Fibrinogen; Hemorrhage; Humans; Point-of-Care Systems; Reproducibility of Results | 2021 |
[Hemorrhage treatment: Evaluation of the proper use of fibrinogen concentrate].
Topics: Adult; Aged; Aged, 80 and over; Drug Prescriptions; Female; Fibrinogen; France; Guideline Adherence; Hemorrhage; Humans; Male; Middle Aged; Practice Guidelines as Topic; Retrospective Studies; Young Adult | 2017 |
Haemorrhagic snake venom metalloproteases and human ADAMs cleave LRP5/6, which disrupts cell-cell adhesions in vitro and induces haemorrhage in vivo.
Topics: ADAM Proteins; ADAM12 Protein; Amino Acid Sequence; Animals; Antibodies, Neutralizing; Apoptosis Regulatory Proteins; Cell Adhesion; Crotalid Venoms; Drug Resistance; Fibrinogen; Fibronectins; HeLa Cells; Hemorrhage; Human Umbilical Vein Endothelial Cells; Humans; Hydrophobic and Hydrophilic Interactions; Low Density Lipoprotein Receptor-Related Protein-5; Low Density Lipoprotein Receptor-Related Protein-6; Male; Membrane Proteins; Metalloendopeptidases; Mice; Models, Molecular; Molecular Docking Simulation; Protein Domains; Protein Structure, Secondary; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Species Specificity; Vertebrates; Wnt Signaling Pathway | 2017 |
The Clinical Efficacy of Fibrinogen Concentrate in Massive Obstetric Haemorrhage with Hypofibrinogenaemia.
Topics: Adult; Coagulation Protein Disorders; Female; Fibrinogen; Hemorrhage; Humans; Pregnancy; Pregnancy Complications; Retrospective Studies; Treatment Outcome; Young Adult | 2017 |
Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products.
Topics: Aged; Blood Coagulation; Blood Coagulation Factors; Blood Component Transfusion; Cardiac Surgical Procedures; Factor VIIa; Factor VIII; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Male; Middle Aged; Platelet Transfusion; Prospective Studies; Recombinant Proteins | 2017 |
Involvement of the heparanase procoagulant domain in bleeding and wound healing.
Topics: Animals; Blood Coagulation; Coagulants; Factor Xa; Fibrin Fibrinogen Degradation Products; Fibrinogen; Glucuronidase; Glycoproteins; Hematologic Agents; Hemorrhage; Humans; Inflammation; Male; Mice; Neoplasm Metastasis; Neovascularization, Pathologic; Partial Thromboplastin Time; Peptides; Protein Domains; Prothrombin Time; Thrombelastography; Thromboplastin; Thrombosis; Wound Healing | 2017 |
Safety and Efficacy of a Novel, Self-Adhering Dural Substitute in a Canine Supratentorial Durotomy Model.
Topics: Animals; Cerebrospinal Fluid Leak; Collagen; Dogs; Drug Combinations; Dura Mater; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Male; Models, Animal; Plastic Surgery Procedures; Polyethylene Glycols; Thrombin; Treatment Outcome | 2018 |
Congenital hypofibrinogenaemia: a presymptomatic detection of an extremely rare bleeding disorder in preterm twins.
Topics: Afibrinogenemia; Continuous Positive Airway Pressure; Diagnosis, Differential; Female; Fibrinogen; Hemorrhage; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Infusions, Intravenous; Ireland; Menorrhagia; Pregnancy; Pregnancy, Twin; Premature Birth; Pulmonary Surfactants; Rare Diseases; Respiratory Distress Syndrome, Newborn; Treatment Outcome; Twins, Monozygotic | 2017 |
Thromboelastography may predict risk of grade 2 bleeding in thrombocytopenic patients.
Topics: Adult; Blood Platelets; C-Reactive Protein; Female; Fibrinogen; Hematologic Neoplasms; Hemorrhage; Humans; Male; Pilot Projects; Platelet Count; Platelet Transfusion; Prospective Studies; Risk; Thrombelastography; Thrombocytopenia | 2017 |
Fibrinogen concentration and use of fibrinogen supplementation with cryoprecipitate in patients with critical bleeding receiving massive transfusion: a bi-national cohort study.
Topics: Afibrinogenemia; Aged; Australia; Blood Transfusion; Coagulants; Cohort Studies; Female; Fibrinogen; Hemorrhage; Hospital Mortality; Humans; Male; Middle Aged; Mortality; New Zealand; Odds Ratio; Prevalence; Registries | 2017 |
Dacin, one metalloproteinase from Deinagkistrodon acutus venom inhibiting contraction of mouse ileum muscle.
Topics: Animals; Fibrinogen; Hemorrhage; Ileum; Metalloproteases; Mice; Muscle Contraction; Viper Venoms | 2017 |
Analysis of the hemostatic potential of modern topical sealants on arterial and venous anastomoses: an experimental porcine study.
Topics: Anastomosis, Surgical; Animals; Aorta, Abdominal; Drug Combinations; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Hemostasis; Hemostasis, Surgical; Hemostatics; Male; Polyethylene Glycols; Portal Vein; Postoperative Hemorrhage; Swine; Thrombin | 2017 |
[Clinical perspectives on the management of bleeding in patients on oral anticoagulants: the DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsal)].
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Antithrombins; Blood Coagulation Tests; Blood Transfusion; Charcoal; Delphi Technique; Disease Management; Emergency Medicine; Factor VIII; Factor Xa Inhibitors; Female; Fibrinogen; Hematology; Hemorrhage; Humans; Male; Middle Aged; Physicians; Practice Patterns, Physicians' | 2017 |
Platelet dysfunction contributes to bleeding complications in patients with probable leptospirosis.
Topics: Adult; Blood Platelets; Female; Fibrinogen; Hemorrhage; Humans; Indonesia; Leptospirosis; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Protein Binding; von Willebrand Factor | 2017 |
Raised Fibrinogen Levels and Outcome in Outpatients With Peripheral Artery Disease.
Topics: Aged; Ambulatory Care; Amputation, Surgical; Brain Ischemia; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Peripheral Arterial Disease; Registries; Risk Factors; Spain; Stroke | 2018 |
Initial inferior vena cava diameter predicts massive transfusion requirements in blunt trauma patients: A retrospective cohort study.
Topics: Biomarkers; Blood Transfusion; Epidemiologic Methods; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Hospitalization; Humans; Male; Middle Aged; Tomography, X-Ray Computed; Vena Cava, Inferior; Whole Body Imaging; Wounds, Nonpenetrating | 2018 |
Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders.
Topics: Adult; Afibrinogenemia; Base Sequence; Blood Coagulation Tests; Family; Fibrinogen; Fibrinogens, Abnormal; Gene Expression; Hemorrhage; Homozygote; Humans; Male; Middle Aged; Models, Molecular; Mutation; Pedigree; Protein Structure, Secondary; Severity of Illness Index; Venous Thrombosis | 2017 |
Primary hyperfibrinolysis as the presenting sign of prostate cancer: A case report.
Topics: Adenocarcinoma; Antifibrinolytic Agents; Biomarkers; Blood Coagulation Disorders; Blood Coagulation Tests; Bone Neoplasms; Factor VIII; Fibrinogen; Fibrinolysis; Hematoma; Hemorrhage; Humans; Male; Middle Aged; Paraneoplastic Syndromes; Prostatic Neoplasms; Tranexamic Acid; Treatment Outcome | 2016 |
Acquired Hypofibrinogenemia Before Asparaginase Exposure During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia: A Report of 2 Cases and Review of the Literature.
Topics: Afibrinogenemia; Asparaginase; Child; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Induction Chemotherapy; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2018 |
Supplementary fibrinogen in the management of bleeding: re-evaluation of data from clinical trials.
Topics: Double-Blind Method; Fibrinogen; Hemorrhage; Hemostatics; Humans | 2018 |
Rotational thromboelastometry thresholds for patients at risk for massive transfusion.
Topics: Adult; Antifibrinolytic Agents; Blood Coagulation; Blood Component Transfusion; Fibrinogen; Hemorrhage; Hemostatic Techniques; Humans; Middle Aged; Patient Selection; Prospective Studies; Resuscitation; ROC Curve; Thrombelastography; Trauma Severity Indices; Wounds and Injuries | 2018 |
Effects of cupric chloride on coagulation in human plasma: role of fibrinogen.
Topics: Blood Coagulation; Copper; Factor XIII Deficiency; Fibrinogen; Heavy Metal Poisoning; Hemorrhage; Humans; Thrombelastography | 2018 |
Fibrinogen Concentrate: Is It Standard Currency or Bitcoin in Bleeding Management?
Topics: Fibrinogen; Hemorrhage; Hemostatics; Humans; Randomized Controlled Trials as Topic | 2018 |
Impact of fetal maceration grade on risk of maternal disseminated intravascular coagulation after intrauterine fetal death - A retrospective cohort study.
Topics: Adolescent; Adult; Disseminated Intravascular Coagulation; Female; Fetal Death; Fetus; Fibrinogen; Hemorrhage; Hemostasis; Humans; Middle Aged; Platelet Count; Pregnancy; Prothrombin Time; Retrospective Studies; Risk Factors; Young Adult | 2018 |
The utility of viscoelastic methods in the prevention and treatment of bleeding and hospital-associated venous thromboembolism in perioperative care: guidance from the SSC of the ISTH.
Topics: Anticoagulants; Blood Coagulation; Cardiology; Elasticity; Fibrinogen; Hemorrhage; Hemostasis; Hospitalization; Humans; Perioperative Care; Perioperative Period; Practice Guidelines as Topic; Venous Thromboembolism; Viscosity | 2018 |
Analysis of the structural and mechanical effects of procoagulant agents on neonatal fibrin networks following cardiopulmonary bypass.
Topics: Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Blood Transfusion; Cardiopulmonary Bypass; Coagulants; Factor VIIa; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostatics; Humans; Infant, Newborn; Neonatology; Recombinant Proteins; Risk | 2018 |
Hemostasis management and therapeutic plasma exchange: Results of a practice survey.
Topics: Afibrinogenemia; Factor VIII; Female; Fibrinogen; Hemorrhage; Hemostasis; Humans; Male; Plasma Exchange; Plasmapheresis; Practice Patterns, Physicians'; Serum Albumin; Surveys and Questionnaires; Thrombosis | 2018 |
Towards patient-specific management of trauma hemorrhage: the effect of resuscitation therapy on parameters of thromboelastometry.
Topics: Adult; Antifibrinolytic Agents; Clinical Decision-Making; Decision Support Techniques; Erythrocyte Transfusion; Europe; Female; Fibrinogen; Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Patient Selection; Patient-Centered Care; Platelet Transfusion; Predictive Value of Tests; Prospective Studies; Resuscitation; Thrombelastography; Time Factors; Tranexamic Acid; Treatment Outcome; Wounds and Injuries | 2019 |
Loss of fibrinogen in zebrafish results in an asymptomatic embryonic hemostatic defect and synthetic lethality with thrombocytopenia.
Topics: Afibrinogenemia; Animals; Animals, Genetically Modified; Fibrinogen; Hemorrhage; Hemostasis; Humans; NF-E2 Transcription Factor, p45 Subunit; Synthetic Lethal Mutations; Thrombocytopenia; Zebrafish; Zebrafish Proteins | 2019 |
Coagulopathy, cryoprecipitate and CRYOSTAT-2: realising the potential of a nationwide trauma system for a national clinical trial.
Topics: Biomedical Research; Blood Coagulation Disorders; Clinical Trials as Topic; Factor VIII; Fibrinogen; Hemorrhage; Humans; United Kingdom; Wounds and Injuries | 2019 |
Efficacy of a new pathogen-reduced cryoprecipitate stored 5 days after thawing to correct dilutional coagulopathy in vitro.
Topics: Adult; Blood Coagulation Disorders; Female; Fibrinogen; Healthy Volunteers; Hemorrhage; Humans; Male; Temperature; Thrombelastography | 2019 |
International assessment of massive transfusion protocol contents and indications for activation.
Topics: Adult; Blood Transfusion; Extracorporeal Membrane Oxygenation; Female; Fibrinogen; Hemorrhage; Hospitals; Humans; Male; Retrospective Studies; Trauma Centers | 2019 |
Flow cytometry for near-patient testing in premature neonates reveals variation in platelet function: a novel approach to guide platelet transfusion.
Topics: Cell Degranulation; Female; Fibrinogen; Flow Cytometry; Hemorrhage; Humans; Infant, Newborn; Infant, Premature; Male; Neonatal Sepsis; P-Selectin; Platelet Activation; Platelet Count; Platelet Function Tests; Platelet Transfusion; Thrombocytopenia, Neonatal Alloimmune | 2019 |
Haemophilia in Côte d'Ivoire (the Ivory Coast) in 2017: Extensive data collection as part of the World Federation of Hemophilia's twinning programme.
Topics: Adolescent; Adult; Child; Child, Preschool; Cote d'Ivoire; Cross-Sectional Studies; Factor VIII; Fibrinogen; Hemophilia A; Hemophilia B; Hemorrhage; Humans; Infant; Infant, Newborn; Joint Diseases; Male; Middle Aged; Pedigree; Prospective Studies; Severity of Illness Index; Young Adult | 2019 |
Effects of modification of trauma bleeding management: A before and after study.
Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Coagulants; Controlled Before-After Studies; Erythrocyte Transfusion; Female; Fibrinogen; Hemorrhage; Hemostatic Techniques; Humans; Injury Severity Score; Intensive Care Units; Length of Stay; Male; Middle Aged; Plasma; Platelet Transfusion; Propensity Score; Prothrombin; Regression Analysis; Resuscitation; Retrospective Studies; Thrombelastography; Tranexamic Acid; Wounds and Injuries; Young Adult | 2019 |
Rattlesnake venom-induced recurrent coagulopathy in first trimester pregnant women - Two Cases.
Topics: Abortion, Spontaneous; Adult; Animals; Antivenins; Blood Coagulation Disorders; Crotalid Venoms; Crotalus; Female; Fibrinogen; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Pregnancy; Pregnancy Trimester, First; Snake Bites | 2019 |
Computer simulation of transfusion with different blood product ratios in modern massive transfusion protocols.
Topics: Adult; Blood Platelets; Blood Transfusion; Computer Simulation; Erythrocyte Transfusion; Fibrinogen; Fibroblasts; Hematocrit; Hemorrhage; Hemostasis; Humans; Models, Biological; Plasma; Platelet Transfusion; Resuscitation; Shock, Hemorrhagic | 2019 |
Prediction of arterial extravasation in pelvic fracture patients with stable hemodynamics using coagulation biomarkers.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Arteries; Biomarkers; Blood Coagulation; Blood Pressure; Chi-Square Distribution; Computed Tomography Angiography; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fractures, Bone; Hemodynamics; Hemorrhage; Humans; Male; Middle Aged; Odds Ratio; Pelvic Bones; ROC Curve; Statistics, Nonparametric; Tomography, X-Ray Computed | 2019 |
Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?
Topics: Adult; Antifibrinolytic Agents; Biomarkers; Female; Fibrin Clot Lysis Time; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Retrospective Studies; Thrombelastography; Tranexamic Acid; Trauma Severity Indices; Wounds and Injuries | 2019 |
Three-factor prothrombin complex concentrates for refractory bleeding after cardiovascular surgery within an algorithmic approach to haemostasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Blood Transfusion; Cardiopulmonary Bypass; Female; Fibrinogen; Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Postoperative Period; Retrospective Studies; Thromboembolism; United States; Young Adult | 2019 |
In Vitro Effects on Thrombin of Paris Saponins and In Vivo Hemostatic Activity Evaluation of
Topics: Animals; Bleeding Time; Blood Coagulation; Chemical and Drug Induced Liver Injury; Fibrinogen; Hemorrhage; Hemostasis; Liliaceae; Lipids; Liver; Mice; Plant Extracts; Rats; Saponins; Thrombin | 2019 |
Fibrinolysis in patients with chemotherapy-induced thrombocytopenia and the effect of platelet transfusion.
Topics: Aged; alpha-2-Antiplasmin; Antineoplastic Agents; Biomarkers; Carboxypeptidase B2; Factor VIII; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Transfusion; Prospective Studies; Thrombelastography; Thrombocytopenia; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2019 |
Recombinant human prothrombin (MEDI8111) combined with fibrinogen dose-dependently improved survival time and reduced blood loss in a porcine model of dilutional coagulopathy with uncontrolled bleeding.
Topics: Animals; Blood Coagulation Disorders; Drug Therapy, Combination; Fibrinogen; Hemorrhage; Hemostasis; Humans; Prothrombin; Recombinant Proteins; Survival Analysis; Swine; Time Factors | 2019 |
Trauma-targeted delivery of tranexamic acid improves hemostasis and survival in rat liver hemorrhage model.
Topics: Animals; Antifibrinolytic Agents; Blood Platelets; Disease Models, Animal; Fibrinogen; Hemorrhage; Hemostasis; Liposomes; Liver Diseases; Molecular Mimicry; Nanoparticles; Peptides; Rats, Sprague-Dawley; Tranexamic Acid; Wounds and Injuries | 2019 |
Fibrinogen levels measured by the dry hematology method are lower than those measured by the Clauss method under a high concentration of heparin.
Topics: Female; Fibrinogen; Hematology; Hemorrhage; Heparin; Humans; Male; Middle Aged | 2019 |
Combination therapy using fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes and hemoglobin vesicles for trauma-induced massive hemorrhage in thrombocytopenic rabbits.
Topics: Adenosine Diphosphate; Animals; Blood Substitutes; Disease Models, Animal; Drug Therapy, Combination; Fibrinogen; Hemoglobins; Hemorrhage; Liposomes; Oligopeptides; Rabbits; Wounds and Injuries | 2019 |
Risk of bleeding and thrombosis in inherited qualitative fibrinogen disorders.
Topics: Adolescent; Adult; Afibrinogenemia; Aged; Alleles; Amino Acid Substitution; Blood Coagulation; Blood Coagulation Tests; Child; Child, Preschool; DNA Mutational Analysis; Female; Fibrinogen; Genotype; Hemorrhage; Humans; Male; Middle Aged; Mutation; Risk Assessment; Risk Factors; Thrombosis; Young Adult | 2019 |
Severe bleeding in surgical and trauma patients: the role of fibrinogen replacement therapy.
Topics: Blood Loss, Surgical; Coagulants; Fibrinogen; Hemorrhage; Humans; Randomized Controlled Trials as Topic; Wounds and Injuries | 2012 |
Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy.
Topics: Animals; Blood Coagulation; Blood Platelets; Chemistry, Pharmaceutical; Drug Carriers; Fibrin; Fibrinogen; Fibrinolytic Agents; Half-Life; Hemorrhage; Humans; Liposomes; Male; Nanoparticles; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Rats, Sprague-Dawley; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator | 2013 |
Fibrinogen degradation coagulopathy and bleeding complications after stroke thrombolysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation Disorders; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Prospective Studies; Risk; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Young Adult | 2013 |
Hypofibrinogenemia, dysfibrinogenemia or hypodysfibrinogenemia?: comment on 'The dilemma of inherited dysfibrinogenemia during pregnancy'.
Topics: Afibrinogenemia; Anticoagulants; Female; Fibrinogen; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnancy Complications, Hematologic; Thrombosis | 2013 |
Supplementation of fibrinogen concentrate in children with severe acquired hypofibrinogenaemia during chemotherapy for acute lymphoblastic leukaemia: our experience.
Topics: Adolescent; Afibrinogenemia; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Female; Fibrinogen; Hemorrhage; Humans; Male; Plasma; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Thrombosis | 2014 |
Early pseudoaneurysm formation after the sutureless technique for left ventricular rupture due to acute myocardial infarction.
Topics: Administration, Topical; Aged; Aneurysm, False; Aprotinin; Cardiac Tamponade; Drug Combinations; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Hemostatics; Humans; Male; Myocardial Infarction; Reoperation; Suture Techniques; Thrombin; Time Factors; Ventricular Septal Rupture | 2014 |
C560Rβ3 caused platelet integrin αII b β3 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortality.
Topics: Animals; Blood Platelets; Bone Marrow Cells; Fibrinogen; Hemorrhage; Humans; Integrin beta3; Lentivirus; Megakaryocytes; Mice; Mutation; P-Selectin; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein Conformation; Syndrome; Thrombasthenia; Thrombosis | 2013 |
[Management of massive bleeding in 2013: seven questions and answers].
Topics: Acute Disease; Blood Component Transfusion; Combined Modality Therapy; Disease Management; Erythrocyte Transfusion; Factor VIIa; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Plasma; Postoperative Hemorrhage; Postpartum Hemorrhage; Pregnancy; Recombinant Proteins; Tranexamic Acid | 2013 |
Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study.
Topics: Afghanistan; Antifibrinolytic Agents; Cohort Studies; Drug Therapy, Combination; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Male; Retrospective Studies; Survival Rate; Tranexamic Acid; United Kingdom; United States; Warfare; Wounds and Injuries; Young Adult | 2013 |
Postoperative fibrinogen level is associated with postoperative bleeding following cardiothoracic surgery and the effect of fibrinogen replacement therapy remains uncertain.
Topics: Aged; Cardiac Surgical Procedures; Databases, Factual; Female; Fibrinogen; Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Odds Ratio; Partial Thromboplastin Time; Postoperative Complications; Postoperative Hemorrhage; Prospective Studies; Retrospective Studies; Thrombin Time; Treatment Outcome | 2013 |
Cryoprecipitate use in the PROMMTT study.
Topics: Adult; Blood Transfusion; Chi-Square Distribution; Factor VIII; Female; Fibrinogen; Hemorrhage; Hospital Mortality; Humans; Injury Severity Score; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Resuscitation; Risk Factors; Statistics, Nonparametric; Time Factors; Trauma Centers; Treatment Outcome; United States; Wounds and Injuries | 2013 |
Biochemical and biological analysis of Philodryas baroni (Baron's green racer; Dipsadidae) venom: relevance to the findings of human risk assessment.
Topics: Animals; Anticoagulants; Argentina; Collagen; Colubridae; Dose-Response Relationship, Drug; Endopeptidases; Fibrinogen; Hemolytic Agents; Hemorrhage; Humans; Injections, Intradermal; Mice; Mice, Inbred Strains; Molecular Weight; Muscle, Skeletal; Necrosis; Platelet Aggregation Inhibitors; Reptilian Proteins; Risk Assessment; Snake Venoms; Substrate Specificity | 2014 |
Retrospective study of twenty-four patients with prolonged coagulopathy due to long-acting anti-vitamin K rodenticide poisoning.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Aged; Animals; Anticoagulants; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Transfusion; Child; Child, Preschool; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Plasma; Rats; Retrospective Studies; Rodenticides; Vitamin K; Young Adult | 2014 |
Estimation of plasma fibrinogen levels based on hemoglobin, base excess and Injury Severity Score upon emergency room admission.
Topics: Adult; Emergency Service, Hospital; Female; Fibrinogen; Hemoglobins; Hemorrhage; Humans; Injury Severity Score; Male; Middle Aged; Multiple Trauma; Retrospective Studies; Risk Factors | 2013 |
Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Biomarkers; Drug Monitoring; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Lower Extremity; Male; Middle Aged; Minnesota; Predictive Value of Tests; Retrospective Studies; Risk Factors; Thrombolytic Therapy; Thrombosis; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis; Young Adult | 2013 |
Complementary effect of fibrinogen and rFVIIa on clotting ex vivo in Bernard-Soulier syndrome and combined use during three deliveries.
Topics: Adult; Bernard-Soulier Syndrome; Blood Coagulation; Female; Fibrinogen; Hemorrhage; Humans; Risk Factors | 2014 |
Inhibition of venom serine proteinase and metalloproteinase activities by Renealmia alpinia (Zingiberaceae) extracts: comparison of wild and in vitro propagated plants.
Topics: Animals; Crotalid Venoms; Edema; Fibrinogen; Hemorrhage; Metalloproteases; Mice; Plant Extracts; Serine Proteases; Serine Proteinase Inhibitors; Zingiberaceae | 2013 |
Platelet hyperreactivity explains the bleeding abnormality and macrothrombocytopenia in a murine model of sitosterolemia.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 5; ATP Binding Cassette Transporter, Subfamily G, Member 8; ATP-Binding Cassette Transporters; Blood Platelets; Disease Models, Animal; Fibrinogen; Filamins; Hemorrhage; Humans; Hypercholesterolemia; Intestinal Diseases; Lipid Metabolism, Inborn Errors; Lipoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Phytosterols; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex | 2013 |
Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis.
Topics: Animals; Blood Coagulation Factors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Factor VIIa; Fibrinogen; Hemorrhage; Male; Pyrazoles; Pyridones; Rabbits; Recombinant Proteins; Thrombosis | 2013 |
Successful living-related kidney transplantation in a boy with inherited dysfibrinogenemia.
Topics: Afibrinogenemia; Blood Coagulation Tests; Child; Fibrinogen; Hemorrhage; Humans; Kidney Diseases; Kidney Transplantation; Living Donors; Male; Mutation; Phenotype; Thrombosis; Treatment Outcome | 2013 |
Cesarean section scar pregnancy treatment--case report.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Cesarean Section; Cicatrix; Female; Fertilization in Vitro; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Humans; Methotrexate; Pregnancy; Pregnancy, Ectopic; Thrombin; Ultrasonography | 2013 |
[Use of rFVIIa in intractable hemorrhage in patients on central veno-arterial ECMO].
Topics: Adult; Blood Transfusion; Drug Resistance; Extracorporeal Membrane Oxygenation; Factor VIIa; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Humans; Infant; Lactic Acid; Male; Middle Aged; Platelet Count; Recombinant Proteins; Retrospective Studies; Survival Analysis; Thrombosis; Ventilator Weaning | 2013 |
Clinical transfusion practice update: haemovigilance, complications, patient blood management and national standards.
Topics: Acute Lung Injury; Anticoagulants; Antifibrinolytic Agents; Australia; Blood Transfusion; Clinical Protocols; Disease Transmission, Infectious; Disseminated Intravascular Coagulation; Erythrocyte Transfusion; Factor VIIa; Female; Fibrinogen; Hemorrhage; Humans; Patient Safety; Perioperative Care; Plasma; Practice Guidelines as Topic; Pregnancy; Quality Assurance, Health Care; Specimen Handling; Tranexamic Acid; Transfusion Reaction; Traumatology | 2013 |
Loss of fibrinogen in zebrafish results in symptoms consistent with human hypofibrinogenemia.
Topics: Afibrinogenemia; Animals; Blood Coagulation; Disease Models, Animal; DNA Primers; Fibrinogen; Gene Knockdown Techniques; Hemorrhage; Humans; In Situ Hybridization; Morpholinos; Phenotype; Zebrafish | 2013 |
A totally recombinant human fibrin sealant.
Topics: Animals; Animals, Genetically Modified; Cattle; Cells, Cultured; Disease Models, Animal; Factor XIIIa; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Hemostasis; Humans; Lacerations; Liver; Male; Recombinant Proteins; Sus scrofa; Thrombelastography; Thrombin; Yeasts | 2014 |
Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates.
Topics: Blood Coagulation; Factor XIII; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemodilution; Hemorrhage; Humans; In Vitro Techniques; Plasma; Proteolysis; Resuscitation; Thromboplastin; Tranexamic Acid; Wounds and Injuries | 2014 |
Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
Topics: Aged; Blood Coagulation; Blood Platelets; Cardiopulmonary Bypass; Erythrocytes; Female; Fibrin; Fibrinogen; Hemodilution; Hemorrhage; Humans; Male; Middle Aged; Platelet Count; Prothrombin; Thrombelastography; Thrombin; Transfusion Reaction | 2014 |
Fibrin patch in a pig model with blunt liver injury under severe hypothermia.
Topics: Animals; Blood Coagulation; Disease Models, Animal; Drug Combinations; Fibrin Tissue Adhesive; Fibrinogen; Hemodilution; Hemodynamics; Hemorrhage; Hemostatics; Hypothermia; Liver; Male; Severity of Illness Index; Sus scrofa; Thrombelastography; Thrombin; Wounds, Nonpenetrating | 2014 |
Benign FGB (148Lys→Asn, and 448Arg→Lys), and novel causative γ211Tyr→His mutation distinguished by time of flight mass spectrometry in a family with hypofibrinogenaemia.
Topics: Afibrinogenemia; Chromatography, High Pressure Liquid; DNA Mutational Analysis; Family; Fibrinogen; Genotype; Hemorrhage; Humans; Male; Middle Aged; Molecular Weight; Mutation; New Zealand; Pedigree; Plasma; Spectrometry, Mass, Electrospray Ionization | 2014 |
Delayed splenic rupture: dating the sub-capsular hemorrhage as a useful task to evaluate causal relationships with trauma.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Erythrocytes; Female; Fibrin; Fibrinogen; Forensic Pathology; Hematoma; Hemorrhage; Hemosiderin; Humans; Immunohistochemistry; Lacerations; Macrophages; Male; Middle Aged; Monocytes; Platelet Aggregation; Retrospective Studies; Spleen; Splenic Diseases; Splenic Rupture; Staining and Labeling; Time Factors; Wounds, Nonpenetrating | 2014 |
The off-label utilization of prothrombin complex concentrate with cryoprecipitate as an alternative to plasma transfusion in bleeding patients with acute right ventricular failure.
Topics: Acute Disease; Blood Coagulation Factors; Blood Transfusion; Factor VIII; Fibrinogen; Heart Failure; Hemorrhage; Humans; Off-Label Use; Ventricular Dysfunction, Right | 2014 |
Cyclophilin A is an important mediator of platelet function by regulating integrin αIIbβ3 bidirectional signalling.
Topics: Animals; Blood Platelets; Cell Adhesion; Cells, Cultured; Chlorides; Cyclophilin A; Cytoskeleton; Ferric Compounds; Fibrinogen; Hemorrhage; Mesenteric Arteries; Mice, Inbred C57BL; Mice, Knockout; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Reactive Oxygen Species; Signal Transduction; Thrombin; Thrombosis | 2014 |
Interaction of Bothrops jararaca venom metalloproteinases with protein inhibitors.
Topics: alpha-Macroglobulins; Animals; Blood Proteins; Bothrops; Collagen; Crotalid Venoms; Fibrinogen; Glycosylation; Hemorrhage; Male; Metalloendopeptidases; Metalloproteases; Protease Inhibitors; Protein Conformation; Proteolysis | 2014 |
The effective control of a bleeding injury using a medical adhesive containing batroxobin.
Topics: Adhesives; Aldehydes; Animals; Bandages; Batroxobin; Blood Coagulation; Bothrops; Dextrans; Femoral Artery; Fibrin; Fibrinogen; Hemorrhage; Hemostasis; Hemostatics; Humans; Liver; Male; Mice; Mice, Inbred ICR; Polylysine; Rats; Rats, Sprague-Dawley; Recombinant Proteins | 2014 |
Targeted mutation of zebrafish fga models human congenital afibrinogenemia.
Topics: Afibrinogenemia; Animals; Animals, Genetically Modified; Disease Models, Animal; Fibrinogen; Hemorrhage; Humans; Larva; Mutagenesis, Site-Directed; Phenotype; Zebrafish | 2014 |
Thromboelastometry as a supplementary tool for evaluation of hemostasis in severe sepsis and septic shock.
Topics: Aged; Aged, 80 and over; Anticoagulants; Blood Cell Count; Blood Coagulation Tests; Blood Component Transfusion; Critical Care; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Hemostasis; Humans; Male; Middle Aged; Prospective Studies; Sepsis; Severity of Illness Index; Shock, Septic; Thrombelastography; Thrombin; Thrombophilia | 2014 |
III. Fibrinogen concentrate: clinical reality and cautious Cochrane recommendation.
Topics: Coagulants; Fibrinogen; Hemorrhage; Humans | 2014 |
A novel method to detect causative mutations in fibrinogen, using a small amount of blood processed through HPLC and time of flight (TOF) mass spectrometry.
Topics: Afibrinogenemia; Chromatography, High Pressure Liquid; Fibrinogen; Hemorrhage; Humans; Male; Plasma; Spectrometry, Mass, Electrospray Ionization | 2014 |
Recovery of fibrinogen concentrate after intraosseous application is equivalent to the intravenous route in a porcine model of hemodilution.
Topics: Animals; Blood Coagulation; Blood Loss, Surgical; Crystalloid Solutions; Disease Models, Animal; Fibrinogen; Hemodilution; Hemorrhage; Hemostatics; Infusions, Intraosseous; Infusions, Intravenous; Isotonic Solutions; Male; Prothrombin Time; Random Allocation; Sensitivity and Specificity; Thrombelastography | 2014 |
Early tranexamic acid use in trauma haemorrhage: why do we give it and which patients benefit most?
Topics: Antifibrinolytic Agents; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Humans; Tranexamic Acid | 2015 |
Who advocates for cryoprecipitate?
Topics: Fibrinogen; Hemorrhage; Humans | 2014 |
In reply.
Topics: Fibrinogen; Hemorrhage; Humans | 2014 |
Bothrops jararaca venom metalloproteinases are essential for coagulopathy and increase plasma tissue factor levels during envenomation.
Topics: Animals; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Bothrops; Crotalid Venoms; Edetic Acid; Fibrinogen; Hemorrhage; Lung; Male; Metalloproteases; Prothrombin; Rats; Rats, Wistar; Serine Proteases; Serine Proteinase Inhibitors; Skin; Sulfones; Thrombocytopenia; Thromboplastin | 2014 |
Detoxification of Echis ocellatus venom-induced toxicity by Annona senegalensis Pers.
Topics: Animals; Annona; Antivenins; Blood Coagulation; Fibrinogen; Flavonoids; Hemorrhage; Mice; Phytotherapy; Plant Extracts; Plant Leaves; Snake Bites; Tannins; Venoms; Viperidae | 2014 |
Purification and characterization of five snake venom metalloproteinases from Egyptian Echis pyramidum pyramidum venom.
Topics: Animals; Blood Coagulation; Caseins; Fibrinogen; Gelatin; Hemorrhage; Hemostasis; Male; Metalloproteases; Mice; Proteolysis; Substrate Specificity; Temperature; Viper Venoms; Viperidae | 2014 |
Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology.
Topics: Adult; Afibrinogenemia; Blood Coagulation Factors; Blood Coagulation Tests; Child; Coagulation Protein Disorders; Disease Management; Female; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Male; Pregnancy; Pregnancy Complications, Hematologic; Recombinant Proteins | 2014 |
Predictors of hypofibrinogenemia in blunt trauma patients on admission.
Topics: Adult; Afibrinogenemia; Age Factors; Aged; Female; Fibrinogen; Glasgow Coma Scale; Hemorrhage; Humans; Male; Middle Aged; Predictive Value of Tests; Registries; Retrospective Studies; Trauma Severity Indices; Treatment Outcome; Triage; Wounds, Nonpenetrating | 2015 |
Treatment with fibrinogen γ-chain peptide-coated, adenosine 5'-diphosphate-encapsulated liposomes as an infusible hemostatic agent against active liver bleeding in rabbits with acute thrombocytopenia.
Topics: Acute Disease; Adenosine Diphosphate; Animals; Blood Coagulation; Fibrinogen; Hemorrhage; Liposomes; Liver; Male; Platelet Aggregation Inhibitors; Rabbits; Thrombocytopenia | 2015 |
Okinalysin, a novel P-I metalloproteinase from Ovophis okinavensis: biological properties and effect on vascular endothelial cells.
Topics: Amino Acid Sequence; Animals; Caseins; Cell Survival; Cells, Cultured; Collagen Type IV; Crotalid Venoms; Endothelial Cells; Fibrinogen; Hemorrhage; Humans; Hydrolysis; Metalloproteases; Mice; Molecular Sequence Data; Muscle Fibers, Skeletal; Pulmonary Artery; Thigh; Viperidae | 2014 |
Tranexamic acid and fibrinogen restore clotting in vitro and in vivo in cardiac thrombus associated hyperfibrinolysis with overt bleedings.
Topics: Adenocarcinoma; Aged; Anemia; Antifibrinolytic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Carcinoma, Squamous Cell; Cecal Neoplasms; Disseminated Intravascular Coagulation; Fatal Outcome; Female; Fibrinogen; Fibrinolysis; Fluorouracil; Heart Diseases; Hemorrhage; Humans; Leucovorin; Lung Neoplasms; Lymphatic Metastasis; Multiple Organ Failure; Neoplasms, Multiple Primary; Organoplatinum Compounds; Postoperative Complications; Thrombosis; Tranexamic Acid; Vulvar Neoplasms | 2014 |
Novel apigenin based small molecule that targets snake venom metalloproteases.
Topics: Animals; Apigenin; Crotalid Venoms; Fibrin; Fibrinogen; Hemorrhage; Metalloendopeptidases; Metalloproteases; Mice; Molecular Docking Simulation; Snake Bites; Snake Venoms; Viperidae | 2014 |
Prevention of fluid effusion in kidney transplantation with the use of hemostatic biomaterials.
Topics: Adult; Aged; Cyanoacrylates; Drainage; Drug Combinations; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Kidney Transplantation; Lymphocele; Male; Middle Aged; Operative Time; Postoperative Complications; Starch; Thrombin | 2014 |
CcMP-II, a new hemorrhagic metalloproteinase from Cerastes cerastes snake venom: purification, biochemical characterization and amino acid sequence analysis.
Topics: Amino Acid Sequence; Animals; Caseins; Fibrin; Fibrinogen; Hemorrhage; Metalloproteases; Mice; Viper Venoms; Viperidae | 2015 |
Biochemical and functional characterization of Bothropoidin: the first haemorrhagic metalloproteinase from Bothrops pauloensis snake venom.
Topics: Amino Acid Sequence; Animals; Anticoagulants; Bothrops; Cattle; Cell Line, Tumor; Cell Survival; Chromatography, Ion Exchange; Fibrinogen; Hemorrhage; Hydrolysis; Metalloproteases; Mice, Inbred BALB C; Molecular Sequence Data; Platelet Aggregation Inhibitors; Proteolysis; Reptilian Proteins; Snake Venoms; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2015 |
Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
Topics: Arthritis, Juvenile; Biomarkers; Child; Child, Preschool; Diagnosis, Differential; Early Diagnosis; Female; Ferritins; Fibrinogen; Hemorrhage; Humans; Infant; L-Lactate Dehydrogenase; Leukocyte Count; Macrophage Activation Syndrome; Male; Respiratory Insufficiency; Retrospective Studies; Risk Factors; Splenomegaly | 2015 |
Management of bleeding and transfusion during liver transplantation before and after the introduction of a rotational thromboelastometry-based algorithm.
Topics: Algorithms; Blood Transfusion; Female; Fibrinogen; Hemorrhage; Humans; Liver Transplantation; Male; Middle Aged; Perioperative Period; Platelet Transfusion; Prospective Studies; ROC Curve; Thrombelastography; Treatment Outcome | 2015 |
Coagulopathy in newborns with hypoxic ischemic encephalopathy (HIE) treated with therapeutic hypothermia: a retrospective case-control study.
Topics: Blood Transfusion; Case-Control Studies; Female; Fibrinogen; Hemorrhage; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; International Normalized Ratio; Male; Partial Thromboplastin Time; Platelet Count; Retrospective Studies; Risk Factors | 2014 |
Fibrinogen concentrate as haemostatic therapy in acquired bleeding disorders: not only a question of dosing strategies and thresholds.
Topics: Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Male | 2015 |
The effects of in vitro hemodilution and fibrinogen concentrate substitution on thromboelastometry analysis in patients qualified for liver transplantation - preliminary results.
Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Tests; Case-Control Studies; Female; Fibrinogen; Hemodilution; Hemorrhage; Hemostasis; Hemostatics; Humans; Hydroxyethyl Starch Derivatives; In Vitro Techniques; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Prospective Studies; Thrombelastography | 2014 |
The fibrinogen but not the Factor VIII content of transfused plasma determines its effectiveness at reducing bleeding in coagulopathic mice.
Topics: Animals; Erythrocytes; Factor VIII; Female; Fibrinogen; Hemolysis; Hemorrhage; Male; Mice; Mice, Knockout; Plasma Exchange | 2015 |
Preoperative hypofibrinogenemia is associated with increased intraoperative bleeding in ruptured abdominal aortic aneurysms.
Topics: Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal; Aortic Rupture; Blood Loss, Surgical; Blood Pressure; Female; Fibrinogen; Hemorrhage; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Retrospective Studies | 2015 |
Administration of fibrinogen concentrate for refractory bleeding in massively transfused, non-trauma patients with coagulopathy: a retrospective study with comparator group.
Topics: Adult; Aged; Blood Coagulation Disorders; Blood Transfusion; Coagulants; Female; Fibrinogen; Hemorrhage; Humans; Linear Models; Male; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome | 2014 |
Immunoadsorption versus therapeutic plasma exchange. Will fibrinogen make the difference?
Topics: Female; Fibrinogen; Hemorrhage; Humans; Immunosorbent Techniques; Male; Plasma Exchange; Plasmapheresis | 2014 |
Fibrinogen reduction and bleeding complications in plasma exchange, immunoadsorption and a combination of the two.
Topics: Adult; Female; Fibrinogen; Hemorrhage; Humans; Immunosorbent Techniques; Immunosorbents; Male; Middle Aged; Multiple Sclerosis; Myasthenia Gravis; Plasma Exchange; Plasmapheresis; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Retrospective Studies | 2014 |
How I use fibrinogen replacement therapy in acquired bleeding.
Topics: Aorta, Thoracic; Blood Loss, Surgical; Blood Transfusion; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Prognosis | 2015 |
[The cryoprecipitate: that old unknown].
Topics: Afibrinogenemia; Anesthesiology; Disseminated Intravascular Coagulation; Drug Utilization; Factor VIII; Fibrinogen; Hemorrhage; Hemostatics; Humans; Multiple Trauma; Plasma; Postoperative Complications; Practice Guidelines as Topic; Spain | 2015 |
Nanocomplexation of thrombin with cationic amylose derivative for improved stability and hemostatic efficacy.
Topics: Amylose; Animals; Blood Coagulation; Cations; Drug Stability; Fibrinogen; Hemorrhage; Hemostatics; Iliac Artery; Nanostructures; Polylysine; Rats; Thrombin | 2015 |
Tranexamic acid for treatment of bleeding in hemophagocytic lymphohistiocytosis.
Topics: Adult; Antifibrinolytic Agents; Female; Fibrinogen; Hemorrhage; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Tranexamic Acid | 2015 |
Rapid evaluation of fibrinogen levels using the CG02N whole blood coagulation analyzer.
Topics: Blood Coagulation; Blood Coagulation Tests; Buffers; Equipment Design; Fibrinogen; Hemorrhage; Heparin; Homeostasis; Humans; Point-of-Care Testing; Reproducibility of Results; Thrombelastography | 2015 |
Paradoxical bleeding and thrombosis in a patient with afibrinogenemia and fibrinogen Mumbai mutation.
Topics: Adult; Afibrinogenemia; Diagnosis, Differential; Exons; Female; Fibrinogen; Fibrinogens, Abnormal; Hemorrhage; Hepatic Veins; Homozygote; Humans; Mutation, Missense; Portal Vein; Sequence Analysis, DNA; Splenic Vein; Thrombosis | 2015 |
A scientific journals' duty of neutrality.
Topics: Coagulants; Fibrinogen; Hemorrhage; Humans | 2015 |
Response to von Bormann and colleagues.
Topics: Coagulants; Fibrinogen; Hemorrhage; Humans | 2015 |
In reply.
Topics: Coagulants; Fibrinogen; Hemorrhage; Humans | 2015 |
Point-of-care haemostasis monitoring during liver transplantation reduces transfusion requirements and improves patient outcome.
Topics: Acute Kidney Injury; Erythrocyte Transfusion; Female; Fibrinogen; Hemoglobins; Hemorrhage; Hemostasis; Hemostatic Techniques; Humans; Liver Transplantation; Male; Middle Aged; Platelet Transfusion; Point-of-Care Systems; Postoperative Complications; Prospective Studies; Risk; Treatment Outcome | 2015 |
Admission fibrinogen levels in severe trauma patients: A comparison of elderly and younger patients.
Topics: Adult; Afibrinogenemia; Age Factors; Aged; Female; Fibrinogen; Hemorrhage; Humans; Injury Severity Score; Japan; Linear Models; Male; Predictive Value of Tests; Retrospective Studies; Severity of Illness Index; Trauma Centers; Wounds and Injuries | 2015 |
[Comparison of thromboelastography and routine coagulation tests for evaluation of blood coagulation function in patients].
Topics: Blood Coagulation; Fibrinogen; Hemorrhage; Hemostatics; Humans; Platelet Count; Retrospective Studies; Thrombelastography | 2015 |
Early cryoprecipitate for trauma patients is feasible, but will it improve outcome?
Topics: Blood Transfusion; Female; Fibrinogen; Hemorrhage; Humans; Male; Wounds and Injuries | 2015 |
Recombinant Factor VIIa Reduces Bleeding after Blunt Liver Injury in a Pig Model of Dilutional Coagulopathy under Severe Hypothermia.
Topics: Animals; Antithrombin III; Blood Coagulation; Disseminated Intravascular Coagulation; Factor VIIa; Fibrinogen; Hemoglobins; Hemorrhage; Hypothermia; Liver; Male; Peptide Hydrolases; Platelet Count; Recombinant Proteins; Swine; Thrombelastography; Thrombin; Wounds, Nonpenetrating | 2015 |
Assessment of Hemostasis after Plasma Exchange Using Rotational Thrombelastometry (ROTEM).
Topics: Adult; Antithrombins; Blood Coagulation; Blood Coagulation Tests; Cohort Studies; Female; Fibrinogen; Hemorrhage; Hemostasis; Humans; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Plasma Exchange; Point-of-Care Systems; Risk; Thrombelastography; Thrombin; Thrombin Time; Young Adult | 2015 |
Evaluation of Prehospital Blood Products to Attenuate Acute Coagulopathy of Trauma in a Model of Severe Injury and Shock in Anesthetized Pigs.
Topics: Anesthesia; Animals; Blood Banks; Blood Coagulation; Blood Coagulation Disorders; Disease Models, Animal; Erythrocyte Transfusion; Female; Fibrinogen; Hemorrhage; Partial Thromboplastin Time; Plasma; Prothrombin Time; Resuscitation; Shock; Swine; Thrombelastography; Time Factors; Wounds and Injuries | 2015 |
Ibrutinib Inhibits Platelet Integrin αIIbβ3 Outside-In Signaling and Thrombus Stability But Not Adhesion to Collagen.
Topics: Adenine; Adenosine Monophosphate; Agammaglobulinaemia Tyrosine Kinase; Blood Platelets; Calcium Signaling; Collagen; Dose-Response Relationship, Drug; Fibrinogen; Hemorrhage; Hemostasis; Humans; Piperidines; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Purinergic P2Y Receptor Antagonists; Pyrazoles; Pyrimidines; Risk Factors; Time Factors | 2015 |
Fibrinogen concentrate administration inhibits endogenous fibrinogen synthesis in pigs after traumatic hemorrhage.
Topics: Animals; Blood Coagulation; Blood Coagulation Tests; Blood Gas Analysis; Femoral Fractures; Fibrinogen; Gas Chromatography-Mass Spectrometry; Hemodynamics; Hemorrhage; Homeostasis; Isotonic Solutions; Random Allocation; Swine | 2015 |
Assessment of coagulation profile by thromboelastometry in adult patients with cyanotic congenital heart disease.
Topics: Adult; Aged; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Cyanosis; Female; Fibrinogen; Fibrinolysis; Heart Diseases; Hemorrhage; Hemostatic Techniques; Humans; Male; Middle Aged; Partial Thromboplastin Time; Perioperative Care; Prothrombin Time; Thrombelastography; Thrombosis; Warfarin; Young Adult | 2016 |
Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.
Topics: Arterial Occlusive Diseases; Biomarkers; Catheterization, Peripheral; Down-Regulation; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Punctures; Retrospective Studies; Risk Assessment; Risk Factors; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis | 2015 |
Commentary on Reconstituting Fibrinogen Concentrate to Maintain Blinding in a Double-blind, Randomized Trial in an Emergency Setting.
Topics: Biomedical Research; Double-Blind Method; Fibrinogen; Hemorrhage; Hemostatics; Humans; Randomized Controlled Trials as Topic; Research Design | 2016 |
Fibrinogen and base excess levels as predictive markers of the need for massive blood transfusion after blunt trauma.
Topics: Adult; Aged; Biomarkers; Blood Transfusion; Female; Fibrinogen; Hemorrhage; Humans; Lactates; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; Trauma Severity Indices; Wounds, Nonpenetrating | 2016 |
Novel point mutation in fibrinogen (Innsbruck; BβArg44Gly). Phenotypic differences compared to another mutation (fibrinogen Nijmegen) at the same position.
Topics: Adolescent; Female; Fibrinogen; Genetic Predisposition to Disease; Hemorrhage; Humans; Phenotype; Point Mutation; Polymorphism, Single Nucleotide | 2015 |
Hemorrhagic Complications Following Abdominal Paracentesis in Acute on Chronic Liver Failure: A Propensity Score Analysis.
Topics: Acute-On-Chronic Liver Failure; Adult; Female; Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis; Longitudinal Studies; Male; Middle Aged; Paracentesis; Prognosis; Propensity Score; Prothrombin; Retrospective Studies; Risk Factors | 2015 |
Thromboembolic events in patients with severe inherited fibrinogen deficiency.
Topics: Adult; Afibrinogenemia; Fibrinogen; Hemorrhage; Humans; Middle Aged; Retrospective Studies; Thromboembolism; Thrombosis | 2016 |
Recurrent VTE in a heterozygote of the fibrinogen Aα IVS4+1G>T and Aα p.Arg168Ter mutation.
Topics: Adolescent; Afibrinogenemia; Anticoagulants; Female; Fibrinogen; Fibrinogens, Abnormal; Hemorrhage; Heterozygote; Humans; Mutation; Recurrence; Venous Thromboembolism | 2016 |
Effects of peri-operative bridging with low molecular weight heparins on coagulation during interruption of vitamin K antagonists: A mechanistic study.
Topics: Acenocoumarol; Aged; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Factor VIII; Female; Fibrinogen; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Perioperative Care; Surgical Procedures, Operative; Thromboembolism; Vitamin K | 2016 |
[Influence of L-asaraginase and Pegaspargase on Coagulation Function of Adult Patients with Acute Lymphoblastic Leukemia and Analysis of Related Factors].
Topics: Adult; Antineoplastic Agents; Asparaginase; Blood Coagulation; Fibrinogen; Hemorrhage; Humans; Leukocyte Count; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Risk Factors | 2016 |
Post-translational oxidative modification of fibrinogen is associated with coagulopathy after traumatic injury.
Topics: Adult; Blood Coagulation; Female; Fibrin; Fibrinogen; Hemorrhage; Humans; Male; Methionine; Middle Aged; Oxidative Stress; Thrombosis; Wounds and Injuries | 2016 |
Cryoprecipitate AHF vs. fibrinogen concentrates for fibrinogen replacement in acquired bleeding patients - an economic evaluation.
Topics: Blood Transfusion; Cost-Benefit Analysis; Factor VIII; Fibrinogen; Hemorrhage; Humans; Models, Economic; Surveys and Questionnaires | 2016 |
Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications.
Topics: Afibrinogenemia; DNA Mutational Analysis; Family Health; Female; Fibrinogen; Fibrinogens, Abnormal; Genotype; Hemorrhage; Humans; Middle Aged; Mutation, Missense; Pedigree; Thrombosis; Tunisia | 2016 |
Preoperative hemostatic testing and the risk of postoperative bleeding in coronary artery bypass surgery patients.
Topics: Aged; Biomarkers; Blood Coagulation Tests; Coronary Artery Bypass; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Function Tests; Postoperative Complications; Predictive Value of Tests; Preoperative Period; Prospective Studies; Risk; Thrombelastography | 2016 |
α
Topics: alpha 1-Antitrypsin; Antifibrinolytic Agents; Child; Electrophoresis, Capillary; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemorrhage; Hemostasis; Humans; Phenotype; Proteolysis; Thrombin; Tissue Plasminogen Activator | 2016 |
Assessment of method reliability and determination of reference intervals for rotational thromboelastometry in horses.
Topics: Animals; Blood Coagulation; Blood Coagulation Tests; Female; Fibrinogen; Hemorrhage; Horse Diseases; Horses; Male; Partial Thromboplastin Time; Platelet Count; Prospective Studies; Prothrombin Time; Reference Values; Reproducibility of Results; Thrombelastography | 2016 |
[Use of thrombelastography to guide posttraumatic hemostatic therapy: More coagulation factor concentrates and less allogenic blood transfusion?]
Topics: Blood Coagulation Factors; Blood Transfusion; Clinical Decision-Making; Drug Monitoring; Fibrinogen; Hemorrhage; Hemostasis; Hemostatic Techniques; Hemostatics; Humans; Plasma; Postoperative Hemorrhage; Postpartum Hemorrhage; Thrombelastography; Wounds and Injuries | 2016 |
Management of congenital quantitative fibrinogen disorders: a Delphi consensus.
Topics: Afibrinogenemia; Congenital Abnormalities; Disease Management; Female; Fibrinogen; Hemorrhage; Humans; Pregnancy | 2016 |
Functional improvement of hemostatic dressing by addition of recombinant batroxobin.
Topics: Animals; Bandages; Batroxobin; Blood Coagulation; Cattle; Disease Models, Animal; Femoral Artery; Fibrinogen; Hemorrhage; Hemostatics; Liver; Microscopy, Electron, Scanning; Nephelometry and Turbidimetry; Platelet Activation; Rats, Sprague-Dawley; Recombinant Proteins | 2017 |
Analysis of thromboelastography, PT, APTT and fibrinogen in intraosseous and venous samples-an experimental study.
Topics: Animals; Blood Coagulation; Bone Marrow; Disease Models, Animal; Emergencies; Fibrinogen; Hemorrhage; Partial Thromboplastin Time; Prothrombin Time; Swine; Thrombelastography | 2016 |
Fibrinogen as an independent predictor of mortality in decompensated cirrhosis and bleeding.
Topics: Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis | 2017 |
A novel missense mutation in the FGB gene (p.Gly302Arg) leading to afibrinogenemia. Predicted structure and function consequences.
Topics: Adult; Afibrinogenemia; Base Sequence; Codon, Nonsense; Diagnosis, Differential; Fibrinogen; Genetic Predisposition to Disease; Genetic Testing; Hemorrhage; Humans; Male; Molecular Sequence Data; Rare Diseases; Structure-Activity Relationship | 2016 |
Activated Protein C Drives the Hyperfibrinolysis of Acute Traumatic Coagulopathy.
Topics: Adult; Animals; Blood Coagulation; Blood Coagulation Tests; Cohort Studies; Disease Models, Animal; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Male; Mice; Middle Aged; Prospective Studies; Protein C; Thrombelastography; Wounds and Injuries; Young Adult | 2017 |
The Value of Thromboelastography for Bleeding Risk Prediction in Hematologic Diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; China; Female; Fibrinogen; Hematologic Diseases; Hemorrhage; Humans; Incidence; Male; Middle Aged; Platelet Count; Risk Assessment; ROC Curve; Thrombelastography; Young Adult | 2016 |
A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever.
Topics: Animals; Blood Coagulation Disorders; Chlorocebus aethiops; Cricetinae; Cytokines; Disease Models, Animal; Fibrinogen; Hemorrhage; Immunity, Innate; Kaplan-Meier Estimate; Liver; Marburg Virus Disease; Marburgvirus; Mutation; Partial Thromboplastin Time; Prothrombin Time; RNA, Viral; Spleen; Vero Cells | 2016 |
Exploring hemostatic and thrombolytic potential of heynein - A cysteine protease from Ervatamia heyneana latex.
Topics: Adult; Animals; Apocynaceae; Cysteine Proteases; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Hemostasis; Hemostatics; Humans; Latex; Male; Mice; Plant Bark; Plant Extracts; Thrombosis; Young Adult | 2017 |
Combined effect of therapeutic strategies for bleeding injury on early survival, transfusion needs and correction of coagulopathy.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Coagulation Disorders; Blood Transfusion; Combined Modality Therapy; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; International Normalized Ratio; Logistic Models; Male; Middle Aged; Prospective Studies; Tranexamic Acid; Treatment Outcome; Wounds and Injuries | 2017 |
A Naphthalenic Derivative ND-1 Inhibits Thrombus Formation by Interfering the Binding of Fibrinogen to Integrin
Topics: Abciximab; Animals; Antibodies, Monoclonal; Cardiovascular Diseases; Disease Models, Animal; Eptifibatide; Fibrinogen; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Integrin alpha2; Integrin beta3; Mice; Naphthalenes; Peptides; Platelet Aggregation; Rats; Thrombocytopenia; Thrombosis; Tirofiban; Tyrosine | 2016 |
Crotalus atrox venom preconditioning increases plasma fibrinogen and reduces perioperative hemorrhage in a rat model of surgical brain injury.
Topics: Animals; Brain Injuries; Crotalus; Disease Models, Animal; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematoma; Hemorrhage; International Normalized Ratio; Intraoperative Complications; Male; Prothrombin Time; Rats; Rats, Sprague-Dawley; Snake Venoms | 2017 |
Fibrinogen level on admission is a predictor for massive transfusion in patients with severe blunt trauma: Analyses of a retrospective multicentre observational study.
Topics: Adult; Aged; Biomarkers; Blood Pressure; Blood Transfusion; Critical Care; Female; Fibrinogen; Hemorrhage; Humans; Injury Severity Score; Japan; Logistic Models; Male; Middle Aged; Patient Admission; Predictive Value of Tests; Retrospective Studies; Wounds, Nonpenetrating | 2017 |
Inhibition of Snake Venom Metalloproteinase by β-Lactoglobulin Peptide from Buffalo (Bubalus bubalis) Colostrum.
Topics: Amino Acid Sequence; Animals; Buffaloes; Caseins; Colostrum; Computer Simulation; Edema; Fibrin; Fibrinogen; Hemorrhage; Hydrolysis; Lactoglobulins; Metalloproteases; Mice; Molecular Docking Simulation; Molecular Dynamics Simulation; Oligopeptides; Peptide Fragments; Protease Inhibitors; Protein Conformation; Proteolysis; Skin; Viper Venoms; Viperidae | 2017 |
Ticagrelor reversal:
Topics: Adenosine; Blood Coagulation; Blood Platelets; Dose-Response Relationship, Drug; Factor VIIa; Fibrinogen; Fibrinolysin; Hemorrhage; Hemostatics; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Recombinant Proteins; Thrombelastography; Ticagrelor; Time Factors; Tranexamic Acid | 2017 |
Isolation and characterization of a novel metalloprotease inhibitor from Bothrops alternatus snake serum.
Topics: Amino Acid Sequence; Animals; Bothrops; Caseins; Fibrin; Fibrinogen; Hemorrhage; Metalloendopeptidases; Mice; Protease Inhibitors; Proteolysis | 2017 |
Observational study of haemostatic dysfunction and bleeding in neonates with hypoxic-ischaemic encephalopathy.
Topics: Erythrocyte Transfusion; Female; Fibrinogen; Georgia; Hemorrhage; Hemostasis; Hemostatic Disorders; Humans; Hypoxia-Ischemia, Brain; Infant, Newborn; Intensive Care Units, Neonatal; Logistic Models; Male; Multivariate Analysis; Plasma; Platelet Count; Prothrombin Time; Retrospective Studies; Risk Factors | 2017 |
Fibrinogen is an independent predictor of mortality in major trauma patients: A five-year statewide cohort study.
Topics: Adult; Biomarkers; Cohort Studies; Female; Fibrinogen; Hemorrhage; Hospital Mortality; Humans; Injury Severity Score; Logistic Models; Male; Middle Aged; Practice Guidelines as Topic; Practice Patterns, Physicians'; Predictive Value of Tests; Prospective Studies; Risk Factors; Trauma Centers; Victoria; Wounds and Injuries | 2017 |
Haemostatic effects of polymerized albumin particles carrying fibrinogen gamma-chain dodecapeptide as platelet substitutes in severely thrombocytopenic rabbits.
Topics: Albumins; Animals; Biomimetic Materials; Blood Coagulation Tests; Blood Platelets; Drug Carriers; Fibrinogen; Hemorrhage; Hemostatics; Platelet Transfusion; Polyethylene Glycols; Rabbits; Thrombocytopenia; Treatment Outcome | 2008 |
Neutralization of pharmacological and toxic activities of bothrops snake venoms by Schizolobium parahyba (Fabaceae) aqueous extract and its fractions.
Topics: Animals; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation; Bothrops; Chromatography, Gel; Fabaceae; Fibrinogen; Hemorrhage; Male; Mice; Phospholipase A2 Inhibitors; Phospholipases A2; Plant Extracts; Plant Leaves; Tannins; Viper Venoms | 2008 |
Thrombolytic-associated coagulopathy and management dilemmas: a review of two cases.
Topics: Aged; Aged, 80 and over; Case Management; Cerebral Hemorrhage; Diabetes Mellitus, Type 2; Factor VIII; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Infarction, Middle Cerebral Artery; International Normalized Ratio; Intubation, Intratracheal; Partial Thromboplastin Time; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator | 2008 |
Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Antithrombins; Asparaginase; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Thrombosis; Treatment Outcome | 2008 |
Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations.
Topics: Adolescent; Adult; Afibrinogenemia; Aged; Blood Component Transfusion; Blood Loss, Surgical; Child; Child, Preschool; Female; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Humans; Infant; Male; Middle Aged; Platelet Count; Retrospective Studies; Treatment Outcome; Young Adult | 2008 |
Fatality in a case of envenomation by Crotalus adamanteus initially successfully treated with polyvalent ovine antivenom followed by recurrence of defibrinogenation syndrome.
Topics: Animals; Antivenins; Blood Coagulation; Brain Edema; Cause of Death; Cerebral Hemorrhage; Crotalus; Fatal Outcome; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Platelet Count; Recurrence; Sheep; Snake Bites | 2008 |
Antithrombotic effects of targeting alphaIIbbeta3 signaling in platelets.
Topics: Animals; Blood Platelets; Fibrinogen; Gene Knock-In Techniques; Hemorrhage; Hemostasis; Mice; Mice, Mutant Strains; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Structure, Tertiary; Signal Transduction; src-Family Kinases; Thrombosis | 2009 |
Recombinant activated factor VII use in critically ill infants with active hemorrhage.
Topics: Blood Component Transfusion; Critical Care; Critical Illness; Factor VIIa; Factor VIII; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Infant; Male; Postoperative Hemorrhage; Recombinant Proteins; Retrospective Studies; Venous Thrombosis | 2008 |
Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis.
Topics: Adult; Budd-Chiari Syndrome; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Patient Selection; Portal Vein; Portasystemic Shunt, Transjugular Intrahepatic; Retrospective Studies; Risk Assessment; Splanchnic Circulation; Thrombolytic Therapy; Treatment Outcome; Vascular Patency; Venous Thrombosis | 2008 |
Development of fibrinogen gamma-chain peptide-coated, adenosine diphosphate-encapsulated liposomes as a synthetic platelet substitute.
Topics: Adenosine Diphosphate; Animals; Blood Coagulation; Blood Platelets; Capsules; Coated Materials, Biocompatible; Drug Delivery Systems; Fibrinogen; Hemorrhage; Hemostasis; Liposomes; Nanoparticles; Rabbits; Rats; Thrombocytopenia | 2009 |
[Haemostatic testing prior to elective surgery? Yes!].
Topics: Blood Coagulation Factors; Elective Surgical Procedures; Fibrinogen; Hemorrhage; Hemostasis; Humans; Intraoperative Complications; Medical History Taking; Partial Thromboplastin Time; Platelet Count; Preoperative Care; Prothrombin Time; von Willebrand Diseases | 2009 |
FDA approves fibrinogen concentrate product.
Topics: Afibrinogenemia; Drug Approval; Fibrinogen; Hemorrhage; Humans; United States; United States Food and Drug Administration | 2009 |
Enoxaparin attenuates endothelial damage with less bleeding compared with unfractionated heparin in endotoxemic rats.
Topics: Animals; Anticoagulants; CD13 Antigens; Endothelium; Endotoxemia; Enoxaparin; Fibrinogen; Hemorrhage; Heparin; Lipopolysaccharides; Male; Rats; Rats, Wistar | 2009 |
Control of severe portal bleeding by carrier-bound fibrin sealant.
Topics: Adult; Anastomosis, Surgical; Drug Combinations; Female; Fibrinogen; Hemorrhage; Humans; Liver Transplantation; Portal Vein; Thrombin | 2009 |
Hypodysfibrinogenemia causing mild bleeding and thrombotic complications in a compound heterozygote of AalphaIVS4+1G>T mutation and Aalpha4841delC truncation (Aalpha(Perth)).
Topics: Arterial Occlusive Diseases; Blood Coagulation Disorders, Inherited; Blood Coagulation Tests; Female; Fibrinogen; Fibrinogens, Abnormal; Genetic Testing; Hand Injuries; Hemorrhage; Heterozygote; Humans; Menorrhagia; Middle Aged; Molecular Weight; Mutation; Pedigree; Phenotype; Postpartum Hemorrhage; Thrombosis | 2009 |
Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy.
Topics: Abortion, Habitual; Abruptio Placentae; Adult; Afibrinogenemia; Enoxaparin; Female; Fibrinogen; Fibrinogens, Abnormal; Hemorrhage; Humans; Infant, Newborn; Phenotype; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Trimester, First; Prothrombin Time; Puerperal Disorders; Retrospective Studies; Thrombin Time; Thromboembolism; Thrombosis | 2009 |
TREM-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans.
Topics: Animals; Fibrinogen; Hemorrhage; Humans; Inflammation; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Aggregation; Protein Binding; Receptors, Immunologic; Recombinant Proteins; Sepsis; Solubility | 2009 |
Inhibition of local effects of Indian Daboia/Vipera russelli venom by the methanolic extract of grape (Vitis vinifera L.) seeds.
Topics: Animals; Blood Coagulation; Daboia; Fibrinogen; Hemorrhage; Humans; Hyaluronoglucosaminidase; Methanol; Mice; Plant Extracts; Seeds; Viper Venoms; Vitis | 2009 |
Lonomia obliqua caterpillar envenomation causes platelet hypoaggregation and blood incoagulability in rats.
Topics: Animals; Arthropod Venoms; Blood Coagulation; Brazil; Disease Models, Animal; Fibrinogen; Hemorrhage; Insect Bites and Stings; Larva; Male; Moths; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Time Factors | 2010 |
Novel platelet substitutes: disk-shaped biodegradable nanosheets and their enhanced effects on platelet aggregation.
Topics: Artificial Cells; Blood Platelets; Fibrinogen; Hemorrhage; Humans; Lactic Acid; Nanostructures; Oligopeptides; Platelet Activation; Platelet Aggregation; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Silicon Dioxide; Thrombocytopenia; Thrombosis | 2009 |
Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients.
Topics: Blood Component Transfusion; Cohort Studies; Crystalloid Solutions; Drug Utilization; Erythrocyte Transfusion; Factor VIII; Female; Fibrinogen; Georgia; Hemorrhage; Hospital Mortality; Humans; Isotonic Solutions; Length of Stay; Male; Plasma; Prospective Studies; Registries; Retrospective Studies; Survival Analysis; Treatment Outcome; Wounds and Injuries | 2010 |
The impact of prophylactic fresh-frozen plasma and cryoprecipitate on the incidence of central nervous system thrombosis and hemorrhage in children with acute lymphoblastic leukemia receiving asparaginase.
Topics: Adolescent; Asparaginase; British Columbia; Central Nervous System; Child; Child, Preschool; Costs and Cost Analysis; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Infant; Male; Nova Scotia; Outcome Assessment, Health Care; Plasma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Sex Factors; Thrombosis | 2009 |
Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy.
Topics: Afibrinogenemia; Antifibrinolytic Agents; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostasis; Humans; Male; Thrombelastography; Tranexamic Acid; Wounds and Injuries; Young Adult | 2010 |
HEPARINEMIA (?) : AN ANTICOAGULANT IN THE BLOOD OF DOGS WITH HEMORRHAGIC TENDENCY AFTER TOTAL BODY EXPOSURE TO ROENTGEN RAYS.
Topics: Anemia; Animals; Anticoagulants; Blood Coagulation Tests; Blood Transfusion; Dogs; Fibrinogen; Hemorrhage; Heparin; Humans; Protamines; Thrombocytopenia; X-Rays | 1948 |
Inherited dysfibrinogenemia: clinical phenotypes associated with five different fibrinogen structure defects.
Topics: Abortion, Spontaneous; Adolescent; Adult; Afibrinogenemia; Aged; Aged, 80 and over; Amino Acid Substitution; Arterial Occlusive Diseases; Blood Coagulation Tests; Child; DNA Mutational Analysis; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Mutation, Missense; Point Mutation; Postpartum Hemorrhage; Pregnancy; Pregnancy Complications, Hematologic; Protein Structure, Quaternary; Protein Subunits; Purpura; Sequence Deletion; Structure-Activity Relationship; Thrombosis; Young Adult | 2010 |
Repair of coronary artery perforation following angioplasty using TachoSil patches.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Vessels; Drainage; Drug Combinations; Female; Fibrinogen; Hemorrhage; Hemostatic Techniques; Hemostatics; Humans; Pericardial Effusion; Rupture; Thrombin; Treatment Outcome; Wounds, Penetrating | 2010 |
Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate.
Topics: Adolescent; Blood Coagulation Factors; Drug Monitoring; Drug Therapy, Combination; Female; Fibrinogen; Hemorrhage; Hemostatic Techniques; Hemostatics; Humans; Liver; Multiple Trauma; Thrombelastography | 2010 |
[Treatment of a spontaneous pancreatic pseudocyst rupture manifesting as massive hemoperitoneum].
Topics: Aged, 80 and over; Aneurysm, False; Combined Modality Therapy; Drug Combinations; Drug Implants; Emergencies; Fibrinogen; Hemoperitoneum; Hemorrhage; Hemostasis, Surgical; Hemostatics; Humans; Ligation; Male; Pancreatic Pseudocyst; Radiography; Rupture, Spontaneous; Splenectomy; Splenic Artery; Surgical Sponges; Thrombin; Valsalva Maneuver | 2010 |
The novel metalloproteinase atroxlysin-I from Peruvian Bothrops atrox (Jergón) snake venom acts both on blood vessel ECM and platelets.
Topics: Amino Acid Sequence; Animals; Blood Platelets; Blood Vessels; Bothrops; Extracellular Matrix; Fibrin; Fibrinogen; Fibronectins; Hemorrhage; Hemostasis; Humans; Integrins; Macroglobulins; Metalloproteases; Molecular Sequence Data; Snake Venoms; Substrate Specificity | 2010 |
A study on the venom of Bothrops alternatus Duméril, Bibron and Duméril, from different regions of Argentina.
Topics: Animals; Argentina; Blood Coagulation; Bothrops; Cattle; Crotalid Venoms; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Gelatin; Hemorrhage; Hydrolysis; Lethal Dose 50; Mice; Proteins; Rats; Rats, Wistar; Species Specificity | 2010 |
Purification and characterization of a fibrinogenolytic and hemorrhagic metalloproteinase isolated from Vipera lebetina venom.
Topics: Animals; Apoptosis; Chromatography, Gel; Creatine Kinase; Fibrinogen; Hemorrhage; Hydrolysis; Male; Metalloendopeptidases; Mice; Viper Venoms; Viperidae | 2010 |
Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate.
Topics: Adult; Blood Coagulation Factors; Female; Fibrinogen; Hemorrhage; Hemostatic Techniques; Humans; Male; Middle Aged; Prothrombin; Retrospective Studies; Thrombelastography; Wounds and Injuries | 2010 |
Comparison between TachoComb and TachoSil for surgical hemostasis in arterial bleeding: an animal experimental study.
Topics: Animals; Aprotinin; Drug Combinations; Female; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Pilot Projects; Random Allocation; Statistics, Nonparametric; Swine; Thrombin; Wounds, Stab | 2010 |
Effects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injury.
Topics: Animals; Blood Coagulation; Blood Coagulation Disorders; Fibrinogen; Hemodilution; Hemorrhage; Liver; Models, Animal; Random Allocation; Swine; Wounds, Nonpenetrating | 2010 |
Effect of TachoSil in a coagulopathic pig model with blunt liver injuries.
Topics: Animals; Blood Cell Count; Blood Coagulation Disorders; Disease Models, Animal; Drug Combinations; Fibrinogen; Hemodynamics; Hemorrhage; Hydroxyethyl Starch Derivatives; Isotonic Solutions; Liver; Male; Plasma Substitutes; Ringer's Lactate; Surgical Sponges; Survival Rate; Sus scrofa; Thrombelastography; Thrombin; Wounds, Nonpenetrating | 2011 |
Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality.
Topics: Activated Protein C Resistance; Antithrombin III; Blood Coagulation Factors; Blood Coagulation Tests; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Hemorrhagic Fever, Crimean; Humans; International Normalized Ratio; Male; Partial Thromboplastin Time; Platelet Count; Prognosis; Protein C; Protein S; Prothrombin Time; Risk Factors | 2010 |
Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Disease-Free Survival; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Humans; Incidence; Kaplan-Meier Estimate; L-Lactate Dehydrogenase; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Retrospective Studies; Risk Factors; Tretinoin; Young Adult | 2011 |
Purification and characterization of a new weak hemorrhagic metalloproteinase BmHF-1 from Bothrops marajoensis snake venom.
Topics: Amino Acid Sequence; Analysis of Variance; Animals; Bothrops; Chromatography, Gel; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Crotalid Venoms; Fibrinogen; Hemorrhage; Male; Metalloproteases; Mice; Molecular Sequence Data; Sequence Alignment; Sequence Analysis, Protein; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Temperament | 2010 |
High-dose fibrinogen concentrate for haemostatic therapy of a major trauma patient with recent clopidogrel and aspirin intake.
Topics: Aspirin; Clopidogrel; Drug Interactions; Fibrinogen; Glasgow Coma Scale; Hemorrhage; Hemostatics; Humans; Injections, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Thrombelastography; Ticlopidine; Treatment Outcome; Wounds and Injuries | 2010 |
Characteristics, management and outcomes of adults with major trauma taking pre-injury warfarin in a Western Australian population from 2000 to 2005: a population-based cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Blood Coagulation Factors; Causality; Cohort Studies; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Plasma; Registries; Treatment Outcome; Vitamin K; Warfarin; Western Australia; Wounds and Injuries | 2010 |
Risk factors and outcome associated with hypomagnesemia in massive transfusion.
Topics: Adult; Aged; APACHE; Bicarbonates; Blood Transfusion; Burns; Confounding Factors, Epidemiologic; Erythrocyte Transfusion; Female; Fibrinogen; Hemorrhage; Humans; Hydrogen-Ion Concentration; Hypocalcemia; Magnesium; Male; Middle Aged; Postoperative Hemorrhage; Prospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Wounds and Injuries | 2011 |
An experimental model to study isolated effects of thrombin in vivo.
Topics: Animals; Blood Platelets; Dose-Response Relationship, Drug; Fibrinogen; Fibrosis; Hemorrhage; Inflammation; Interleukin-6; Male; Models, Animal; Platelet Count; Rats; Rats, Sprague-Dawley; Rats, Wistar; Thrombin | 2010 |
Effects of fibrinogen concentrate administration during severe hemorrhage.
Topics: Adult; Aged; Aged, 80 and over; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Partial Thromboplastin Time; Prothrombin Time; Retrospective Studies | 2010 |
Recombinant factor VIIa reduces bleeding after blunt liver injury in coagulopathic, hypofibrinogenaemic pigs.
Topics: Animals; Blood Coagulation Disorders; Disease Models, Animal; Drug Evaluation, Preclinical; Factor VIIa; Fibrin; Fibrinogen; Hemodilution; Hemodynamics; Hemorrhage; Hemostatics; Liver; Male; Pilot Projects; Prothrombin Time; Recombinant Proteins; Sus scrofa; Thrombelastography; Wounds, Nonpenetrating | 2010 |
For: Fibrinogen concentrate for management of bleeding.
Topics: Animals; Blood Component Transfusion; Factor VIII; Fibrinogen; Hemorrhage; Hemostasis; Hemostatics; Humans; Risk Assessment; Treatment Outcome | 2011 |
Unexpected laboratory diagnosis: Acquired dysfibrinogenemia in a bleeding patient with liver disease.
Topics: Blood Coagulation Disorders; Blood Coagulation Tests; Female; Fibrinogen; Hemorrhage; Humans; Liver Diseases; Middle Aged | 2010 |
Against: Fibrinogen concentrate for management of bleeding: against indiscriminate use.
Topics: Animals; Blood Component Transfusion; Factor VIII; Fibrinogen; Hemorrhage; Hemostasis; Hemostatics; Humans; Risk Assessment; Treatment Outcome | 2011 |
A novel frameshift mutation in FGA (c.1846 del A) leading to congenital afibrinogenemia in a consanguineous Syrian family.
Topics: Adult; Afibrinogenemia; Consanguinity; Disease Susceptibility; Exons; Female; Fibrinogen; Frameshift Mutation; Genetic Association Studies; Genetic Testing; Genotype; Hemorrhage; Heterozygote; Homozygote; Humans; Male; Pedigree; Phenotype; Syria | 2011 |
Concentration-dependent effect of hypocalcaemia on mortality of patients with critical bleeding requiring massive transfusion: a cohort study.
Topics: Acidosis; Adult; Aged; Blood Platelets; Blood Transfusion; Calcium; Cohort Studies; Critical Illness; Female; Fibrinogen; Hemorrhage; Hospital Mortality; Humans; Hypocalcemia; Male; Middle Aged; Odds Ratio; Prospective Studies; Risk Factors; Severity of Illness Index | 2011 |
Coagulation abnormalities in patients with chronic liver disease in Pakistan.
Topics: Adolescent; Adult; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelet Disorders; Chronic Disease; Confidence Intervals; Female; Fibrinogen; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Hospitals, University; Humans; Liver Diseases; Male; Middle Aged; Pakistan; Partial Thromboplastin Time; Prothrombin Time; Risk; Risk Factors; Sex Distribution; Thrombocytopenia; Young Adult | 2011 |
Differential roles of fibrinogen and von Willebrand factor on clot formation and platelet adhesion in reconstituted and immune thrombocytopenia.
Topics: Adult; Aged; Aged, 80 and over; Female; Fibrinogen; Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Phenotype; Platelet Adhesiveness; Platelet Aggregation; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Thrombelastography; Thrombocytopenia; Thrombosis; von Willebrand Factor; Young Adult | 2011 |
Classification of Iranian patients with Glanzmann's Thrombasthenia using a flow cytometric method.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Blood Platelets; Case-Control Studies; Child; Child, Preschool; Female; Fibrinogen; Flow Cytometry; Hemorrhage; Humans; Infant; Integrin alphaV; Integrin beta3; Iran; Male; Middle Aged; Molecular Typing; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoprotein IIb; Protein Binding; Retrospective Studies; Severity of Illness Index; Thrombasthenia | 2011 |
Fibrinogen and prothrombin complex concentrate for the management of massive bleeding.
Topics: Blood Coagulation Disorders; Blood Coagulation Factors; Fibrinogen; Hemorrhage; Hemostatic Techniques; Humans; Wounds and Injuries | 2010 |
Acquired fibrinogen deficiency caused by artificial colloid plasma expanders.
Topics: Blood Coagulation Disorders; Fibrinogen; Hemorrhage; Humans; Plasma Substitutes | 2010 |
Prothrombin complex concentrate (PCC) for the treatment of coagulopathy associated with massive bleeding.
Topics: Animals; Blood Coagulation Disorders; Blood Coagulation Factors; Fibrinogen; Hemorrhage; Humans; Wounds and Injuries | 2010 |
Two different fibrinogen gene mutations associated with bleeding in the same family (A αGly13Glu and γGly16Ser) and their impact on fibrin clot properties: fibrinogen Krakow II and Krakow III.
Topics: Adult; Blood Coagulation Disorders; Child; DNA Mutational Analysis; Fibrinogen; Genetic Association Studies; Hemorrhage; Humans; Male; Middle Aged; Mutation; Pedigree; Poland; Prothrombin Time; Recurrence | 2011 |
Ammodytagin, a heterodimeric metalloproteinase from Vipera ammodytes ammodytes venom with strong hemorrhagic activity.
Topics: Amino Acid Sequence; Animals; Factor X; Fibrinogen; Hemorrhage; Humans; Metalloproteases; Mice; Molecular Sequence Data; Plasminogen; Prothrombin; Rabbits; Rats; Viper Venoms; Viperidae | 2011 |
Reducing the use of coagulation test panels.
Topics: Anticoagulants; Biomarkers; Blood Coagulation; Blood Coagulation Disorders; Fibrinogen; Hemorrhage; Humans; Partial Thromboplastin Time; Prothrombin Time; Risk Factors; Thrombin Time; Vitamin K Deficiency; Warfarin | 2011 |
Clinical use of fresh-frozen plasma and cryoprecipitate in neonatal intensive care unit.
Topics: Blood Coagulation Disorders; Blood Component Transfusion; Disseminated Intravascular Coagulation; Exchange Transfusion, Whole Blood; Factor VIII; Fibrinogen; Hemorrhage; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Plasma; Risk Assessment | 2011 |
Rare deletion from the fibrinogen Bβ gene in a patient with a provoked venous thrombotic event.
Topics: Adult; Afibrinogenemia; Chromatography, Reverse-Phase; DNA Mutational Analysis; Fibrinogen; Genotype; Hemorrhage; Humans; Male; Phenotype; Sequence Deletion; Venous Thrombosis; White People | 2011 |
Biochemical and enzymatic characterization of BpMP-I, a fibrinogenolytic metalloproteinase isolated from Bothropoides pauloensis snake venom.
Topics: Amino Acid Sequence; Animals; Blood Coagulation Tests; Caseins; Conserved Sequence; Fibrinogen; Hemorrhage; Male; Metalloproteases; Mice; Molecular Sequence Data; Proteolysis; Reptilian Proteins; Sequence Alignment; Sequence Analysis, Protein; Viper Venoms; Viperidae | 2012 |
Observational study of fibrinogen concentrate in massive hemorrhage: evaluation of a multicenter register.
Topics: Adult; Afibrinogenemia; Aged; Blood Coagulation; Blood Coagulation Disorders; Female; Fibrinogen; Germany; Hemorrhage; Hemostasis, Surgical; Humans; Intraoperative Complications; Logistic Models; Male; Middle Aged; Plasma; Prospective Studies; Thrombelastography | 2011 |
The effect of ε-aminocaproyl-S-benzyl-L-cysteine on the t-PA activity of human saliva.
Topics: Aminocaproates; Aminocaproic Acid; Animals; Antifibrinolytic Agents; Blood Coagulation; Cattle; Cysteine; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Models, Biological; Peptides; Saliva; Time Factors; Tissue Plasminogen Activator; Tranexamic Acid | 2011 |
Biological and pathological studies of rosmarinic acid as an inhibitor of hemorrhagic Trimeresurus flavoviridis (habu) venom.
Topics: Animals; Antivenins; Boraginaceae; Cell Survival; Cinnamates; Collagen Type IV; Depsides; Drug Stability; Edema; Fibrinogen; Hemorrhage; Hot Temperature; Human Umbilical Vein Endothelial Cells; Humans; Hydrolysis; Mice; Muscle, Skeletal; Phytotherapy; Plant Extracts; Rosmarinic Acid; Viper Venoms; Viperidae | 2010 |
Isolation and biochemical characterization of rubelase, a non-hemorrhagic elastase from Crotalus ruber ruber (Red Rattlesnake) venom.
Topics: Amino Acid Sequence; Amino Acids; Animals; Collagen; Crotalid Venoms; Crotalus; Fibrinogen; Hemorrhage; Human Umbilical Vein Endothelial Cells; Humans; Hydrolysis; Metalloproteases; Molecular Sequence Data; Molecular Weight; Oligopeptides; Pancreatic Elastase; Protein Conformation; Sequence Analysis; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Venoms | 2011 |
A point mutation in the EGF-4 domain of β(3) integrin is responsible for the formation of the Sec(a) platelet alloantigen and affects receptor function.
Topics: Adult; Animals; Blood Platelets; CD18 Antigens; CHO Cells; Cricetinae; Epidermal Growth Factor; Female; Fetus; Fibrinogen; Genotype; Hemorrhage; Heterozygote; Humans; Infant, Newborn; Integrin beta3; Isoantibodies; Isoantigens; Platelet Adhesiveness; Platelet Membrane Glycoprotein IIb; Point Mutation; Pregnancy; Pregnancy Complications; Sequence Analysis, DNA; Transfection | 2012 |
Purification of hemorrhagic SVMPs from venoms of three vipers of Egypt.
Topics: Animals; Cysteine Proteases; Egypt; Fibrinogen; Hemorrhage; Metalloproteases; Molecular Weight; Serine Proteases; Viper Venoms; Viperidae | 2012 |
Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation; Databases, Factual; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Platelet Count; Prothrombin Time; Risk | 2012 |
Isovolaemic hemodilution with gelatin and hydroxyethylstarch 130/0.42: effects on hemostasis in piglets.
Topics: Acid-Base Equilibrium; Algorithms; Animals; Blood Coagulation; Blood Glucose; Blood Substitutes; Blood Volume; Body Weight; Cardiac Output; Electric Impedance; Fibrinogen; Gelatin; Hematocrit; Hemodilution; Hemodynamics; Hemoglobins; Hemorrhage; Hemostasis; Hydroxyethyl Starch Derivatives; Platelet Aggregation; Swine; Thrombelastography; Whole Blood Coagulation Time | 2012 |
From life-blood streaming to hemostasis.
Topics: Animals; Fibrinogen; Hemorrhage; Hemostasis; Hemostatic Techniques; Hemostatics; Humans | 2012 |
Continuous thrombin infusion leads to a bleeding phenotype in sheep.
Topics: Administration, Intravenous; Amino Acid Sequence; Animals; Blood Coagulation; Blood Platelets; Blood Proteins; Fibrinogen; Hemorrhage; Hemostatics; Lung; Mass Spectrometry; Molecular Sequence Data; Platelet Count; Platelet Function Tests; Proteomics; Sheep; Thrombelastography; Thrombin | 2012 |
Levels of fibrinogen and thromboelastometry fibrin polymerisation following treatment with desmopressin (DDAVP).
Topics: Adult; Deamino Arginine Vasopressin; Female; Fibrin; Fibrinogen; Hemorrhage; Hemostatics; Humans; Male; Thrombelastography; Treatment Outcome | 2012 |
β-arrestin-1 participates in thrombosis and regulates integrin aIIbβ3 signalling without affecting P2Y receptors desensitisation and function.
Topics: Animals; Arrestins; beta-Arrestin 1; beta-Arrestin 2; beta-Arrestins; Blood Platelets; Calcium; Carotid Arteries; Cell Adhesion; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Hemorrhage; Mesenteric Arteries; Mice; Mice, Transgenic; Microscopy, Electron, Scanning; P-Selectin; Phosphorylation; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Purinergic P2Y; Signal Transduction; Thrombosis | 2012 |
[Observations on the use of TachoSil® in cholecystectomy - a multicentre, prospective, single-arm cohort study].
Topics: Adult; Aged; Aged, 80 and over; Anastomotic Leak; Blood Loss, Surgical; Cholecystectomy; Cholecystectomy, Laparoscopic; Cohort Studies; Drug Combinations; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Intraoperative Complications; Male; Middle Aged; Prospective Studies; Risk Factors; Surgical Sponges; Thrombin | 2012 |
Alsophinase, a new P-III metalloproteinase with α-fibrinogenolytic and hemorrhagic activity from the venom of the rear-fanged Puerto Rican Racer Alsophis portoricensis (Serpentes: Dipsadidae).
Topics: Amino Acid Sequence; Animals; Chromatography, High Pressure Liquid; Fibrinogen; Hemorrhage; Metalloproteases; Mice; Molecular Sequence Data; Phenanthrolines; Sequence Homology, Amino Acid; Snake Venoms; Snakes; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2012 |
Reduction of thrombus size in murine models of thrombosis following administration of recombinant α1-proteinase inhibitor mutant proteins.
Topics: alpha 1-Antitrypsin; Animals; Antithrombins; Carotid Artery Injuries; Chlorides; Disease Models, Animal; Dose-Response Relationship, Drug; Endotoxemia; Endotoxins; Factor Xa; Factor Xa Inhibitors; Factor XIa; Factor XIIa; Ferric Compounds; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Injections, Intravenous; Kinetics; Leukocyte Elastase; Mice; Mutation; NG-Nitroarginine Methyl Ester; Recombinant Fusion Proteins; Thrombin; Thrombosis | 2012 |
A salmon thrombin-fibrinogen dressing controls hemorrhage in a swine model compared to standard kaolin-coated gauze.
Topics: Animals; Bandages; Disease Models, Animal; Fibrinogen; Hemorrhage; Hemostatic Techniques; Kaolin; Salmon; Swine; Thrombin | 2012 |
Thrombosis in rare bleeding disorders.
Topics: Blood Coagulation Disorders, Inherited; Factor VII Deficiency; Factor XI Deficiency; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Rare Diseases; Thrombosis | 2012 |
Fibrin(ogen)-independent role of plasminogen activators in acetaminophen-induced liver injury.
Topics: Acetaminophen; Alanine Transaminase; Animals; Antithrombin III; Blood Coagulation; Chemical and Drug Induced Liver Injury; Drug Synergism; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Liver; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Peptide Hydrolases; Plasminogen Activators; Serpin E2; Thrombin; Tissue Plasminogen Activator | 2012 |
Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes.
Topics: Adult; Erythrocyte Transfusion; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Treatment Outcome; Wounds and Injuries | 2012 |
Salmon thrombin-fibrinogen dressing allows greater survival and preserves distal blood flow compared to standard kaolin gauze in coagulopathic Swine with a standardized lethal femoral artery injury.
Topics: Animals; Bandages; Disease Models, Animal; Femoral Artery; Fibrinogen; Hemorrhage; Hemostatic Techniques; Kaolin; Salmon; Swine; Thrombin | 2012 |
Evaluation of coagulation abnormalities in acute liver failure.
Topics: Adult; Aged; Aged, 80 and over; Cell-Derived Microparticles; Factor VIII; Female; Fibrinogen; Hemorrhage; Hemostasis; Heparinoids; Humans; International Normalized Ratio; Liver Failure, Acute; Male; Middle Aged; Platelet Count; Prothrombin Time; Risk Factors; Thrombelastography; Thrombin; von Willebrand Factor | 2012 |
BF066, a novel dual target antiplatelet agent without significant bleeding.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenine; Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Arachidonic Acid; Arterioles; Chlorides; Collagen; Ferric Compounds; Fibrinogen; Hemorrhage; Humans; Immobilized Proteins; Mice; Mice, Inbred C57BL; Oligopeptides; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptor, Adenosine A2A; Thrombin; Thrombosis | 2012 |
[Coagulation management of trauma patients with unstabile circulation : establishment of a hemoglobin-oriented standard operating procedure].
Topics: Aged; Algorithms; Anticoagulants; Blood Coagulation Tests; Critical Care; Crystalloid Solutions; Deamino Arginine Vasopressin; Factor VIIa; Female; Fibrinogen; Fluid Therapy; Hemodynamics; Hemoglobins; Hemorrhage; Humans; Injury Severity Score; Isotonic Solutions; Male; Middle Aged; Multiple Trauma; Plasma Substitutes; Resuscitation; Survival Rate; Tranexamic Acid | 2012 |
Prophylactic administration of fibrinogen concentrate in a pregnant woman with congenital hypofibrinogenemia and a positive obstetric history of severe bleeding in previous cesarean section.
Topics: Adult; Afibrinogenemia; Cesarean Section, Repeat; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Pedigree; Pregnancy; Pregnancy Complications, Hematologic | 2012 |
Fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes rescue thrombocytopenic rabbits from non-compressible liver hemorrhage.
Topics: Acute Disease; Adenosine Diphosphate; Animals; Blood Coagulation Tests; Blood Platelets; Disease Models, Animal; Feasibility Studies; Fibrinogen; Hemorrhage; Hemostasis; Hemostatics; Liposomes; Liver Diseases; Male; Microscopy, Immunoelectron; Oligopeptides; Platelet Aggregation; Platelet Count; Rabbits; Thrombocytopenia; Time Factors; Wounds, Penetrating | 2012 |
Isolation and characterization of two new non-hemorrhagic metalloproteinases with fibrinogenolytic activity from the mapanare (Bothrops colombiensis) venom.
Topics: Amino Acid Sequence; Animals; Bothrops; Chromatography, High Pressure Liquid; Crotalid Venoms; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Hydrogen-Ion Concentration; Male; Metalloproteases; Mice; Molecular Sequence Data; Molecular Weight; Platelet Aggregation; Sequence Homology, Amino Acid; Temperature | 2013 |
Fibrinogen in massive haemorrhage--when and how should we replace it?
Topics: Coagulants; Fibrinogen; Hemorrhage; Humans | 2012 |
The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study.
Topics: Adult; Blood Loss, Surgical; Coagulants; Delivery, Obstetric; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Ireland; Pregnancy; Prospective Studies | 2012 |
Hydroxyethyl starch in the management of obstetric haemorrhage, friend or foe?
Topics: Adult; Cesarean Section; Female; Fibrinogen; Hemorrhage; Humans; Hydroxyethyl Starch Derivatives; Plasma Substitutes; Pregnancy; Treatment Outcome | 2012 |
Successful use of recombinant factor VIIa in a child with Schoenlein-Henoch purpura presenting with compartment syndrome and severe factor XIII deficiency.
Topics: Blood Coagulation Tests; Blood Loss, Surgical; Child; Combined Modality Therapy; Compartment Syndromes; Decompression, Surgical; Factor VIIa; Factor VIII; Factor XIII; Factor XIII Deficiency; Fasciotomy; Fibrinogen; Hand Injuries; Hemorrhage; Humans; IgA Vasculitis; Immunosuppressive Agents; Male; Methylprednisolone; Preoperative Care; Recombinant Proteins; Vascular Access Devices | 2013 |
Purification and characterization of AHPM, a novel non-hemorrhagic P-IIIc metalloproteinase with α-fibrinogenolytic and platelet aggregation-inhibition activities, from Agkistrodon halys pallas venom.
Topics: Agkistrodon; Amino Acid Sequence; Animals; Caseins; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Metalloproteases; Mice; Molecular Sequence Data; Platelet Aggregation; Viper Venoms | 2013 |
Mobile Laboratory Unit: a disruptor solution for hemostasis management during major surgery. Usage in the context of face transplantation.
Topics: Adult; Blood Coagulation Tests; Blood Gas Analysis; Blood Platelets; Facial Transplantation; Fibrinogen; Hemorrhage; Humans; Male; Neurofibromatosis 1; Thrombelastography | 2012 |
The dilemma of inherited dysfibrinogenemia during pregnancy.
Topics: Afibrinogenemia; Anticoagulants; Female; Fibrinogen; Fibrinogens, Abnormal; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Injections, Intravenous; Live Birth; Pregnancy; Pregnancy Complications, Hematologic; Thrombosis; Young Adult | 2012 |
Systemic effects induced by the venom of the snake Bothrops caribbaeus in a murine model.
Topics: Animals; Bothrops; Coagulants; Crotalid Venoms; Disease Models, Animal; Edetic Acid; Fibrinogen; Hemorrhage; Humans; Injections, Intravenous; Lectins, C-Type; Longevity; Lung Diseases; Male; Metalloproteases; Mice; Platelet Aggregation; Species Specificity; Thrombocytopenia; Thrombosis | 2013 |
Malabarase, a serine protease with anticoagulant activity from Trimeresurus malabaricus venom.
Topics: Animals; Anticoagulants; Blood Coagulation; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Chromatography, Reverse-Phase; Creatine Kinase; Crotalid Venoms; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Hemorrhage; Humans; Mice; Molecular Weight; Serine Proteases; Skin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors; Trimeresurus; Whole Blood Coagulation Time | 2013 |
A fibrinogen concentrate Haemocomplettan (Riastap) or a Factor XIII concentrate Fibrogammin combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitor.
Topics: Factor XIII; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Humans; Male; Thrombin; Tranexamic Acid | 2013 |
Proteomic analysis of Bothrops pirajai snake venom and characterization of BpirMP, a new P-I metalloproteinase.
Topics: Amino Acid Sequence; Animals; Bothrops; Crotalid Venoms; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Metalloproteases; Molecular Sequence Data; Molecular Weight; Phospholipases A2; Proteomics; Sequence Alignment; Viper Venoms | 2013 |
Evaluation of binding of fibrinogen and annexin V to equine platelets in response to supramaximal treadmill exercise.
Topics: Animals; Annexin A5; Antibodies; Blood Platelets; Exercise Test; Fibrinogen; Flow Cytometry; Hemorrhage; Horse Diseases; Horses; Lung Diseases; Neutrophils; Physical Conditioning, Animal; Physical Exertion; Platelet Activation; Platelet Aggregation | 2002 |
Successful treatment with intraluminal fibrinogen injection of serous leakage from a polytetrafluoroethylene Blalock-Taussig shunt.
Topics: Biocompatible Materials; Fibrinogen; Heart Bypass, Right; Hemorrhage; Humans; Infant; Injections; Male; Pleural Effusion; Polytetrafluoroethylene; Postoperative Complications; Tetralogy of Fallot; Treatment Outcome | 2002 |
Vascular endothelial cell injury induced by Bothrops jararaca venom; non-significance of hemorrhagic metalloproteinase.
Topics: Animals; Antigens; Bothrops; Cells, Cultured; Crotalid Venoms; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Hemorrhage; Macroglobulins; Male; Metalloendopeptidases; Prothrombin Time; Rabbits; Rats; Rats, Wistar; Thrombomodulin | 2002 |
Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhage.
Topics: Animals; Antifibrinolytic Agents; Bleeding Time; Blood Coagulation; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Factor VIII; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Rabbits; Random Allocation; Safety; Single-Blind Method; Tissue Plasminogen Activator | 2003 |
Purification and characterization of alpha-mucrofibrase, a novel serine protease with alpha-fibrinogenase activity from the venom of Chinese Habu (Trimeresurus mucrosquamatus).
Topics: Amino Acid Sequence; Animals; Chromatography, DEAE-Cellulose; Chromatography, Ion Exchange; Crotalid Venoms; Enzyme Stability; Fibrinogen; Hemorrhage; Metalloendopeptidases; Mice; Molecular Sequence Data; Platelet Aggregation; Rabbits; Sequence Homology, Amino Acid; Serine Endopeptidases; Serine Proteinase Inhibitors; Substrate Specificity; Trimeresurus | 2002 |
High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Topics: Adult; Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; Biomarkers; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Hematologic Neoplasms; Hemorrhage; Humans; Infections; Interleukin-1; Interleukin-6; International Normalized Ratio; Male; Middle Aged; Multiple Organ Failure; Neoplasms; Peptide Hydrolases; Plasminogen; Plasminogen Activator Inhibitor 1; Platelet Count; Prognosis; Thrombomodulin; Thromboplastin; Thrombosis; Tissue Plasminogen Activator | 2003 |
Cross reactivity of three antivenoms against North American snake venoms.
Topics: Animals; Antivenins; Biological Assay; Collagen; Cross Reactions; Crotalid Venoms; Fibrinogen; Gelatinases; Hemorrhage; Neutralization Tests; North America; Rabbits; Skin; Species Specificity | 2003 |
The efficacy of two antivenoms against the venom of North American snakes.
Topics: Animals; Antivenins; Biological Assay; Blood Coagulation; Crotalid Venoms; Fibrinogen; Hemorrhage; Horses; Immunoglobulin Fab Fragments; Lethal Dose 50; Neutralization Tests; North America; Rabbits; Sheep; Species Specificity; Thrombosis | 2003 |
Guidelines on fibrinogen assays.
Topics: Blood Coagulation Tests; Fibrinogen; Hematologic Tests; Hemorrhage; Humans; Laboratories, Hospital; Medical Audit; Quality Control | 2003 |
Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Biomarkers; Disease-Free Survival; Drug Therapy, Combination; Eptifibatide; Female; Femoral Artery; Femoral Vein; Fibrinogen; Fibrinolytic Agents; Follow-Up Studies; Hematocrit; Hemoglobins; Hemorrhage; Humans; Iliac Artery; Iliac Vein; Lower Extremity; Male; Middle Aged; Missouri; Peptides; Peripheral Vascular Diseases; Pilot Projects; Platelet Aggregation Inhibitors; Popliteal Artery; Popliteal Vein; Prospective Studies; Tenecteplase; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Vena Cava, Inferior; Venous Thrombosis | 2003 |
Cryoprecipitate. Patterns of use.
Topics: Adult; Afibrinogenemia; Aged; Aged, 80 and over; Blood Loss, Surgical; Blood Transfusion; Factor VIII; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Humans; Liver Neoplasms; Medical Audit; Middle Aged; Retrospective Studies; Tissue Plasminogen Activator; Uremia; Warfarin | 2003 |
The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis.
Topics: Adult; Animals; Disease Susceptibility; Female; Fibrinogen; Hemorrhage; Hepatitis, Chronic; Hepatitis, Viral, Animal; Hepatitis, Viral, Human; Humans; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred C57BL; Middle Aged; RNA, Messenger; Thrombosis | 2003 |
Platelet fibrinogen in the patients with idiopathic bleeding platelet disorder.
Topics: Adult; Binding Sites; Blood Platelet Disorders; Blood Platelets; Female; Fibrinogen; Flow Cytometry; Hemorrhage; Humans; Male; Middle Aged; Receptors, Fibrinogen | 2000 |
Hemorrhagic activity of the Duvernoy's gland secretion of the xenodontine colubrid Philodryas patagoniensis from the north-east region of Argentina.
Topics: Animals; Argentina; Colubridae; Ecchymosis; Fibrinogen; Hemorrhage; Lethal Dose 50; Metalloendopeptidases; Mice; Muscle, Skeletal; Snake Venoms | 2003 |
Deficient prothrombin and fibrinogen in fatal erythroblastosis fetalis.
Topics: Erythroblastosis, Fetal; Fetus; Fibrin; Fibrinogen; Hematologic Diseases; Hemorrhage; Humans; Infant, Newborn; Prothrombin | 1953 |
Massive postpartum hemorrhage associated with coagulation defect.
Topics: Blood Coagulation; Blood Coagulation Disorders; Female; Fibrinogen; Hemorrhage; Humans; Postpartum Hemorrhage; Postpartum Period; Pregnancy | 1954 |
Acquired afibrinogenaemia complicating pregnancy; report of two cases of two cases of concealed accidental haemorrhage treated by human fibrinogen.
Topics: Abruptio Placentae; Afibrinogenemia; Female; Fibrinogen; Hemorrhage; Humans; Pregnancy; Pregnancy Complications | 1954 |
Note on afibrinogenaemia in pregnancy.
Topics: Afibrinogenemia; Female; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Placenta; Pregnancy | 1954 |
The causes and prevention of postpartum hemorrhage.
Topics: Coagulants; Female; Fibrinogen; Hemorrhage; Humans; Labor, Obstetric; Postpartum Hemorrhage; Pregnancy | 1955 |
Acquired fibrinogenopenia following tumultuous labor and pitocin induction; report of a case.
Topics: Afibrinogenemia; Female; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Labor, Obstetric; Oxytocin; Pregnancy | 1955 |
Use of dried fibrinogen (human) for the control of hemorrhage.
Topics: Coagulants; Fibrinogen; Hemorrhage; Hemostatics; Humans | 1955 |
Afibrinogenemia as a cause of hemorrhage in pregnancy.
Topics: Afibrinogenemia; Female; Fibrinogen; Hemorrhage; Humans; Labor, Obstetric; Pregnancy; Work | 1955 |
Rapid determination of plasma fibrinogen.
Topics: Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Labor, Obstetric; Placenta; Pregnancy | 1955 |
[Complications due to fibrinolysis and fibrinogenolysis in surgical and obstetrical cases].
Topics: Coagulants; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostatics; Obstetrics; Surgical Procedures, Operative | 1955 |
An unusual case of blood disease in pregnancy.
Topics: Afibrinogenemia; Female; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Labor, Obstetric; Pregnancy; Pregnancy Complications | 1955 |
Severe postpartum haemorrhage associated with fibrinogen deficiency.
Topics: Afibrinogenemia; Female; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Labor, Obstetric; Postpartum Hemorrhage; Pregnancy | 1955 |
[Fibrinogen deficiency syndromes in obstetrics].
Topics: Afibrinogenemia; Female; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Labor, Obstetric; Obstetrics; Pregnancy; Syndrome | 1955 |
[hemorrhage caused by afibrinogenemia and fibrinolysis after delivery; case report].
Topics: Afibrinogenemia; Delivery, Obstetric; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Hemorrhagic Disorders; Humans; Pregnancy | 1955 |
[Hemorrhage caused by blood incoagulability in obstetrics].
Topics: Afibrinogenemia; Female; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Labor, Obstetric; Obstetrics; Pregnancy | 1955 |
Afibrinogenaemia; associated with severe uterine haemorrhage following caesarean section.
Topics: Afibrinogenemia; Cesarean Section; Female; Fibrinogen; Hemorrhage; Humans; Labor, Obstetric; Pregnancy; Uterine Hemorrhage | 1956 |
Fibrinogenopenia and excessive fibrinolysins in the blood: a cause of severe post-partum haemorrhage.
Topics: Afibrinogenemia; Female; Fibrinogen; Fibrinolysin; Hemorrhage; Hemorrhagic Disorders; Humans; Labor, Obstetric; Postpartum Period; Pregnancy | 1956 |
Unusual uterine enlargement caused by bleeding due to hypofibrinogenemia associated with fetal death.
Topics: Afibrinogenemia; Fetal Death; Fetus; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Pregnancy; Pregnancy Complications | 1956 |
Coagulation defects in severe intrapartum and postpartum hemorrhage.
Topics: Afibrinogenemia; Female; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Labor, Obstetric; Postpartum Hemorrhage; Pregnancy | 1956 |
[Remarkable effect of intravenous fibrinogen in acute abstetrical afibrinogenemia].
Topics: Abortion, Induced; Afibrinogenemia; Coagulants; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Pregnancy; Stillbirth | 1956 |
[Thrombocytopenic hemorrhages arrested by intravenous injection of human fibrinogen].
Topics: Blood Platelets; Coagulants; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Injections, Intravenous | 1956 |
[Hemostatic action of human fibrinogen in large doses].
Topics: Coagulants; Fibrinogen; Hemorrhage; Hemostatics; Humans | 1956 |
[Blood substitution in obstetric hemorrhage].
Topics: Afibrinogenemia; Blood Substitutes; Female; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Labor, Obstetric; Pregnancy | 1956 |
Hypofibrinogenemia and obstetric hemorrhage.
Topics: Afibrinogenemia; Female; Fibrinogen; Hemorrhage; Humans; Labor, Obstetric; Pregnancy; Pregnancy Complications | 1956 |
[Acute lower nephron nephrosis as a sequel to defibrination hemorrhage].
Topics: Afibrinogenemia; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Kidney Tubular Necrosis, Acute | 1956 |
Massive fatal postpartum hemorrhage due to afibrinogenemia associated with premature separation of the placenta.
Topics: Afibrinogenemia; Female; Fibrinogen; Hemorrhage; Humans; Labor, Obstetric; Placenta; Postpartum Hemorrhage; Pregnancy | 1956 |
[Severe postpartal hemorrhage caused by afibrinogenemia].
Topics: Afibrinogenemia; Female; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Labor, Obstetric; Pregnancy; Work | 1956 |
[Studies on the presence of active thrombokinase in the amniotic fluid; a contribution to the etiology of afibrinogenemia during labor].
Topics: Afibrinogenemia; Amniotic Fluid; Factor Xa; Female; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Labor, Obstetric; Pregnancy; Thromboplastin; Work | 1956 |
Uterine hemorrhage and afibrinogenemia.
Topics: Afibrinogenemia; Female; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Pregnancy; Uterine Hemorrhage; Uterus | 1957 |
Massive post-partum haemorrhage associated with afibrinogenaemia.
Topics: Afibrinogenemia; Female; Fibrinogen; Hemorrhage; Humans; Labor, Obstetric; Postpartum Hemorrhage; Postpartum Period; Pregnancy | 1957 |
[Obstetrical hemorrhages caused by afibrinogenemia].
Topics: Afibrinogenemia; Female; Fibrinogen; Hemorrhage; Humans; Labor, Obstetric; Pregnancy; Pregnancy Complications | 1957 |
[Clinical contribution on the treatment of obstetrical hemorrhage of blood non-coagulable because of fibrinolysis].
Topics: Coagulants; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostatics; Humans; Labor, Obstetric; Pregnancy | 1957 |
[Treatment of severe hemorrhage in children with Cohn's plasma fraction I].
Topics: Blood Proteins; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Plasma | 1957 |
Factor I and gamma-aminobutyric acid: a summary.
Topics: Amino Acids; Antifibrinolytic Agents; Fibrinogen; gamma-Aminobutyric Acid; Hemorrhage | 1958 |
[Fibrinogen treatment in afibrinogenemic hemorrhage].
Topics: Afibrinogenemia; Coagulants; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Pregnancy; Pregnancy Complications | 1958 |
[Treatment of obstetric fibrinolysis].
Topics: Female; Fibrin; Fibrinogen; Hemorrhage; Hemostatics; Humans; Labor, Obstetric; Pregnancy | 1958 |
Absence of gamma-aminobutyric acid from brain extracts containing factor I.
Topics: Amino Acids; Biochemical Phenomena; Brain; Fibrinogen; gamma-Aminobutyric Acid; Hemorrhage | 1958 |
[Increased blood coagulation following venisection].
Topics: Blood Coagulation; Coagulants; Fibrinogen; Hemorrhage; Hemostatics; Humans | 1958 |
Five cases of hypofibrinogenaemic haemorrhage in pregnancy treated with fibrinogen manufactured from human plasma.
Topics: Afibrinogenemia; Coagulants; Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Pregnancy; Pregnancy Complications | 1958 |
[Cohn's plasma fraction I; its use in hemophilia, angiohemophilia and severe hemorrhages after anticoagulant therapy].
Topics: Anticoagulants; Blood Proteins; Fibrinogen; Hemophilia A; Hemorrhage; Hemorrhagic Disorders; Humans; Plasma; von Willebrand Diseases | 1959 |
[Experience with a fibrinogen preparation prepared in a central hospital].
Topics: Female; Fibrinogen; Hemorrhage; Hemostatics; Humans; Labor, Obstetric; Pregnancy | 1959 |
[Uncontrollable hemorrhages in childbirth and their therapy with human fibrinogen].
Topics: Coagulants; Female; Fibrinogen; Hemorrhage; Humans; Labor, Obstetric; Parturition; Pregnancy | 1959 |
[Fibrinogen as a principle with a general hemostatic effect in severe hemorrhage].
Topics: Coagulants; Fibrinogen; Hemorrhage; Hemostasis; Hemostatics; Humans | 1959 |
Treatment of classic hemophilia: the use of fibrinogen rich in factor VIII for hemorrhage and for surgery.
Topics: Factor VIII; Fibrinogen; Hemophilia A; Hemorrhage; Hemostatics; Humans; Surgical Procedures, Operative | 1961 |
Congenital hypofibrinogenemia in five members of a family.
Topics: Abruptio Placentae; Afibrinogenemia; Blood Coagulation; Female; Fibrinogen; Genetics, Medical; Hemorrhage; Hemostasis; Humans; Male; Pregnancy | 1963 |
The treatment of haemorrhage in von Willebrand's disease and the blood level of factor VIII (AHG).
Topics: Blood Platelet Disorders; Factor VIII; Fibrinogen; Hemorrhage; Humans; Plasma; Serum Albumin; Serum Globulins; von Willebrand Diseases | 1963 |
[Coagulopathies during and after heart surgery].
Topics: Blood Coagulation Disorders; Cardiac Surgical Procedures; Coagulants; Female; Fibrinogen; Heart, Artificial; Hemorrhage; Humans; Postpartum Hemorrhage; Postpartum Period; Thoracic Surgery; Thrombin | 1962 |
MODERN ASPECTS OF THE TREATMENT OF HEMOPHILIA. II.
Topics: Blood Transfusion; Coagulants; Communication; Extracellular Space; Factor VIII; Fibrinogen; Hemophilia A; Hemorrhage; Hemostatics; Humans; Plasma; Platelet Transfusion; Tissue Donors | 1963 |
FIBRINOGEN-I-131, T-1824, AND RED CELL-CR51 SPACES FOLLOWING HEMORRHAGE.
Topics: Animals; Blood Proteins; Blood Volume; Chromium Isotopes; Coloring Agents; Dogs; Fibrinogen; Hematocrit; Hemorrhage; Iodine Isotopes; Plasma; Research | 1963 |
FIBRINOLYSIS AND BLEEDING FOLLOWING APPENDECTOMY.
Topics: Aminocaproates; Aminocaproic Acid; Appendectomy; Blood Coagulation Tests; Blood Transfusion; Dosage Forms; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Postoperative Complications; Primary Myelofibrosis | 1963 |
[CONGENITAL AFIBRINOGENEMIA].
Topics: Afibrinogenemia; Child; Classification; Coagulants; Diagnosis, Differential; Fibrinogen; Genetics, Medical; Hemorrhage; Hemostasis; Hemostatics; Humans; Infant; Infant, Newborn; Physiology | 1963 |
[DATA ON FIBRINOGEN THERAPY OF HEMORRHAGE IN PREGNANCY].
Topics: Female; Fibrinogen; Hemorrhage; Humans; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Uterine Hemorrhage | 1963 |
THE MANAGEMENT OF OBSTETRICAL HEMORRHAGE IN THE UNITED STATES.
Topics: Abruptio Placentae; Afibrinogenemia; Cesarean Section; Female; Fetal Death; Fibrinogen; Hemorrhage; Humans; Maternal Mortality; New York; Placenta Previa; Postpartum Hemorrhage; Postpartum Period; Pregnancy; Statistics as Topic; United States | 1964 |
HEMOSTATIC MECHANISM IN EXTRACORPOREAL CIRCULATION.
Topics: Aminocaproates; Aminocaproic Acid; Anticoagulants; Antithrombins; Blood Coagulation Tests; Blood Platelets; Extracorporeal Circulation; Factor V; Factor VII; Factor VIII; Factor X; Fibrinogen; Fibrinolysis; Heart, Artificial; Hemorrhage; Hemostasis; Hemostatics; Humans; Perfusion; Physiology; Thromboplastin | 1964 |
[HYPOFIBRINOGENEMIA IN OBSTETRICAL PRACTICE].
Topics: Abortion, Induced; Abortion, Missed; Afibrinogenemia; Blood Transfusion; Female; Fibrinogen; Hemorrhage; Humans; Hysterectomy; Postpartum Hemorrhage; Postpartum Period; Pregnancy | 1964 |
[HEMORRHAGE IN VON WILLEBRAND'S DISEASE, ITS NATURE AND THERAPY].
Topics: Blood Coagulation Tests; Blood Platelet Disorders; Blood Transfusion; Fibrinogen; Hemorrhage; Humans; von Willebrand Diseases | 1964 |
ANTIFIBRINOLYTIC TREATMENT WITH EPSILON-AMINOCAPROIC ACID IN CONNECTION WITH PROSTATECTOMY.
Topics: Aminocaproates; Aminocaproic Acid; Drug Therapy; Embolism; Factor V; Factor VIII; Fibrinogen; Fibrinolysis; Geriatrics; Hemorrhage; Humans; Male; Postoperative Complications; Prostatectomy; Prothrombin; Thromboplastin; Thrombosis; Toxicology | 1964 |
[RECURRING ACUTE FIBRINOLYSIS AFTER PROSTATECTOMY].
Topics: Blood Coagulation Disorders; Fibrinogen; Fibrinolysis; Geriatrics; Hemorrhage; Humans; Male; Postoperative Complications; Prostatectomy | 1964 |
HYPOFIBRINOGENEMIA AND INTRAUTERINE FETAL DEATH.
Topics: ABO Blood-Group System; Afibrinogenemia; Blood Coagulation Tests; Blood Group Incompatibility; Blood Protein Electrophoresis; Delivery, Obstetric; Drug Therapy; Estrogens; Female; Fetal Death; Fibrinogen; Geriatrics; Hemorrhage; Humans; Pregnancy; Rh-Hr Blood-Group System; Stillbirth; Toluene | 1964 |
[ANESTHESIA AND RESUSCITATION IN HYPOFIBRINOGENEMIAS].
Topics: Afibrinogenemia; Anesthesia; Blood Transfusion; Female; Fibrinogen; Hemorrhage; Humans; Postpartum Hemorrhage; Postpartum Period; Pregnancy; Resuscitation; Shock, Hemorrhagic | 1964 |
CONTROL OF HEMORRHAGE DURING EXPERIMENTAL 6 HOUR LEFT HEART BYPASS.
Topics: Animals; Blood Cell Count; Blood Coagulation; Blood Platelets; Cardiac Surgical Procedures; Citrates; Dogs; Fibrinogen; Glucose; Heart Bypass, Left; Heart, Artificial; Hemorrhage; Heparin; Perfusion; Research; Statistics as Topic; Thoracic Surgery | 1964 |
STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS.
Topics: Aminocaproates; Aminocaproic Acid; Blood Coagulation Disorders; Blood Coagulation Tests; Deoxyribonuclease I; Dogs; Fibrinogen; Fibrinolysin; Hemorrhage; Pathology, Molecular; Pharmacology; Protamines; Research; Streptodornase and Streptokinase; Streptokinase; Trypsin Inhibitors | 1964 |
A STUDY OF NAPHTHIONIN IN THE MANAGEMENT OF THE BLEEDING DEFECT IN PATIENTS WITH THROMBOCYTOPENIA.
Topics: Biomedical Research; Blood Coagulation Tests; Congo Red; Drug Therapy; Fibrinogen; Geriatrics; Hemorrhage; Hemostasis; Hemostatics; Humans; Injections, Intravenous; Naphthalenes; Pharmacology; Prothrombin Time; Purpura; Purpura, Thrombocytopenic; Sulfonic Acids; Thrombocytopenia | 1964 |
BLOOD LOSS ASSOCIATED WITH ADMINISTRATION OF LOW MOLECULAR WEIGHT DEXTRAN.
Topics: Animals; Blood Coagulation; Blood Platelets; Coagulants; Dextrans; Dogs; Fibrinogen; Hemorrhage; Hemostatics; Infusions, Parenteral; Molecular Weight; Pharmacology; Prothrombin Time; Research | 1964 |
[A NEW TECHNIC FOR THE TREATMENT OF HEMORRHAGE FOLLOWING TONSILLECTOMY. PRELIMINARY REPORT].
Topics: Fibrinogen; Hemorrhage; Hemostasis; Hemostatics; Humans; Postoperative Complications; Tonsillectomy | 1964 |
[8 CASES OF FIBRINOLYSIS IN OBSTETRICS SUCCESSFULLY TREATED].
Topics: Blood Transfusion; Calcium Chloride; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemorrhage; Hemostatics; Humans; Obstetrics; Postpartum Hemorrhage; Postpartum Period; Pregnancy | 1965 |
[ROLE OF THROMBOGENESIS IN THE PROCESS OF ARRESTING LABOR HEMORRHAGE].
Topics: Blood Coagulation; Female; Fibrinogen; Hemorrhage; Humans; Postpartum Hemorrhage; Postpartum Period; Pregnancy | 1965 |
Fibrinogenaemia in an iso-sensitized mother carrying a dead foetus.
Topics: Afibrinogenemia; Fetal Death; Fetus; Fibrinogen; Hemorrhage; Humans; Mothers | 1955 |
Hypofibrinogenemia and postpartum hemorrhage.
Topics: Afibrinogenemia; Female; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Labor, Obstetric; Postpartum Hemorrhage; Pregnancy | 1955 |
[Hemorrhages caused by afibrinogenemia acquired during pregnancy].
Topics: Afibrinogenemia; Female; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Pregnancy; Pregnancy Complications | 1955 |
Advanced hemostatic dressing development program: animal model selection criteria and results of a study of nine hemostatic dressings in a model of severe large venous hemorrhage and hepatic injury in Swine.
Topics: Animals; Bandages; Blood Pressure; Collagen; Confidence Intervals; Disease Models, Animal; Female; Fibrinogen; Hemorrhage; Hemostatic Techniques; Hemostatics; Liver; Male; Propyl Gallate; Swine; Thrombin | 2003 |
Lung endothelium targeting for pulmonary embolism thrombolysis.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Capillaries; Drug Evaluation, Preclinical; Endothelium, Vascular; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Immunoconjugates; Lung; Membrane Proteins; Mice; Mice, Inbred BALB C; Pulmonary Embolism; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms; Thrombolytic Therapy; Tissue Distribution; Urokinase-Type Plasminogen Activator | 2003 |
Management of severe VWD with cryoprecipitate collected by repeated apheresis of a single dedicated donor.
Topics: Blood Component Removal; Blood Donors; Circumcision, Male; Cryopreservation; Erythrocyte Transfusion; Factor VIII; Fathers; Fibrinogen; Hemorrhage; Humans; Infant, Newborn; Male; Plasma Exchange; Severity of Illness Index; Time Factors; von Willebrand Diseases | 2003 |
[Direct and indirect effects of epoietin alpha in an experimental model of thrombosis and bleeding in the rabbit].
Topics: Animals; Bleeding Time; Blood Pressure; Body Temperature; Carotid Arteries; Erythrocyte Transfusion; Erythropoietin; Fibrinogen; Heart Rate; Hemobilia; Hemorrhage; Partial Thromboplastin Time; Platelet Aggregation; Rabbits; Recombinant Proteins; Regional Blood Flow; Thrombosis | 2003 |
Production and use of fibrin glue at blood transfusion service of Bellaria-Maggiore Hospital Bologna.
Topics: Aged; Blood Transfusion; Case-Control Studies; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Hemostatics; Hospitals; Humans; Italy; Male; Middle Aged; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Thrombin; Tissue Adhesives; Urology; Wound Healing | 2004 |
Lonofibrase, a novel alpha-fibrinogenase from Lonomia obliqua caterpillars.
Topics: Animals; Arthropod Venoms; Endopeptidases; Fibrinogen; Fibrinolysis; Hemorrhage; Kinetics; Larva; Moths | 2004 |
Preclinical testing of three South American antivenoms against the venoms of five medically-important Peruvian snake venoms.
Topics: Animals; Antivenins; Blood Coagulation; Crotalid Venoms; Drug Evaluation, Preclinical; Fibrinogen; Hemorrhage; Lethal Dose 50; Mice; Necrosis; Neutralization Tests; Plasma; Snake Bites; South America; Species Specificity; Viperidae | 2004 |
Application of the poly-N-acetyl glucosamine-derived rapid deployment hemostat trauma dressing in severe/lethal Swine hemorrhage trauma models.
Topics: Acetylglucosamine; Animals; Aorta, Abdominal; Aprotinin; Bandages; Blood Cell Count; Blood Volume; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Femoral Artery; Fibrinogen; Hemorrhage; Hemostatic Techniques; Hemostatics; Military Medicine; Platelet Count; Survival Rate; Swine; Thrombin; Time Factors; Wounds, Penetrating | 2004 |
Comparison of poly-N-acetyl glucosamine with commercially available topical hemostats for achieving hemostasis in coagulopathic models of splenic hemorrhage.
Topics: Acetylglucosamine; Administration, Topical; Animals; Aprotinin; Body Temperature; Cellulose, Oxidized; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Female; Fibrin Foam; Fibrin Tissue Adhesive; Fibrinogen; Hemophilia B; Hemorrhage; Hemostatic Techniques; Hemostatics; Hypothermia, Induced; Rabbits; Spleen; Swine; Thrombin; Wounds, Penetrating | 2004 |
Neutralization of venoms from two Southern Pacific Rattlesnakes (Crotalus helleri) with commercial antivenoms and endothermic animal sera.
Topics: Animals; Antivenins; California; Chromatography, Ion Exchange; Chromogenic Compounds; Crotalid Venoms; Crotalus; Electrophoresis; Fibrinogen; Gelatinases; Hemorrhage; Immunoglobulin Fab Fragments; Immunoglobulin Fragments; Insulin; Lethal Dose 50; Neutralization Tests; Organic Chemicals; Platelet Aggregation; Rodentia; Serum | 2004 |
A novel high molecular weight metalloproteinase cleaves fragment F1 of activated human prothrombin.
Topics: Amino Acid Sequence; Animals; Chromatography, Gel; Chromatography, Ion Exchange; Crotalid Venoms; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Hemorrhage; Humans; Insulin; Metalloproteases; Mice; Molecular Sequence Data; Peptide Fragments; Prothrombin; Sequence Alignment; Sequence Analysis, Protein; Trimeresurus | 2004 |
Effects of low temperature on shear-induced platelet aggregation and activation.
Topics: Analysis of Variance; Blood Proteins; Blood Viscosity; Cold Temperature; Fibrinogen; Fluid Therapy; Hemodilution; Hemorheology; Hemorrhage; Humans; Hypothermia; Multiple Organ Failure; P-Selectin; Platelet Activation; Platelet Aggregation; Resuscitation; Risk Factors; Shear Strength; Stress, Mechanical; Temperature; Thrombocytopenia; Wounds and Injuries | 2004 |
Traumatic shock. XVII. Plasma fibrinogen in hemorrhagic shock in the dog.
Topics: Animals; Dogs; Fibrinogen; Hemorrhage; Plasma; Shock; Shock, Hemorrhagic; Shock, Traumatic | 1950 |
Spontaneously developing autoantibody to factor VIII in an elderly woman: diagnostic and therapeutic challenges.
Topics: Aged; Autoantibodies; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Partial Thromboplastin Time | 2004 |
Diagnosis of underlying mechanisms of diffuse microvascular bleeding allows targeted therapy.
Topics: Antifibrinolytic Agents; Antithrombins; Blood Loss, Surgical; Deamino Arginine Vasopressin; Fibrinogen; Hematologic Diseases; Hemorrhage; Hemostatics; Humans; Monitoring, Intraoperative; Surgical Procedures, Operative | 2004 |
Clopidogrel-related refractory bleeding after coronary artery bypass graft surgery: a rationale for the use of coagulation factor concentrates?
Topics: Clopidogrel; Coronary Artery Bypass; Coronary Restenosis; Drug Administration Schedule; Factor VIIa; Factor XIII; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recombinant Proteins; Reoperation; Retreatment; Ticlopidine; Treatment Outcome | 2005 |
Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Blood Coagulation Tests; Female; Fibrinogen; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Retrospective Studies; Risk Factors; Thrombophilia; Thrombosis | 2005 |
Sutureless repair with TachoComb sheets for oozing type postinfarction cardiac rupture.
Topics: Aged; Aprotinin; Drug Combinations; Fibrinogen; Heart Rupture, Post-Infarction; Heart Ventricles; Hemorrhage; Hemostasis, Surgical; Humans; Male; Thrombin; Treatment Outcome | 2005 |
Procoagulant activity of Calotropis gigantea latex associated with fibrin(ogen)olytic activity.
Topics: Animals; Blood Coagulation; Calotropis; Fibrinogen; Hemorrhage; Humans; Hydrolysis; Latex; Mice | 2005 |
Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model.
Topics: Animals; Blood Coagulation Disorders; Blood Coagulation Tests; Colloids; Fibrinogen; Gelatin; Hemodilution; Hemorrhage; Hemostatics; Liver; Microscopy, Electron; Random Allocation; Swine; Thrombelastography | 2005 |
[Fibrinogen substitution. Use in the treatment of bleeding due to lack of fibrinogen].
Topics: Afibrinogenemia; Coagulants; Fibrinogen; Hemorrhage; Hemostatics; Humans | 2005 |
Proteolytic, edematogenic and myotoxic activities of a hemorrhagic metalloproteinase isolated from Bothrops alternatus venom.
Topics: Animals; Bothrops; Caseins; Catalysis; Chromatography, Ion Exchange; Crotalid Venoms; DEAE-Cellulose; Edema; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Hemorrhage; Metalloproteases; Mice; Muscle, Skeletal; Muscular Diseases; Necrosis | 2005 |
Association of the antagonism of von Willebrand factor but not fibrinogen by platelet alphaIIbbeta3 antagonists with prolongation of bleeding time.
Topics: Animals; Blood Coagulation Tests; Blood Platelets; Dogs; Fibrinogen; Hemorrhage; Humans; Kinetics; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; von Willebrand Factor | 2005 |
Pathophysiological manifestations in mice exposed to anthrax lethal toxin.
Topics: Animals; Anthrax; Antigens, Bacterial; Bacterial Toxins; Blood Vessels; Bronchi; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Mice; Myocardium | 2005 |
Platelet aggregation in portal hypertension and its modification by ultra-low doses of aspirin.
Topics: Adenosine Diphosphate; Animals; Aspirin; Fibrinogen; Hemorrhage; Humans; Hypertension, Portal; Injections, Subcutaneous; Male; Partial Thromboplastin Time; Platelet Aggregation; Platelet Aggregation Inhibitors; Prothrombin Time; Rats; Rats, Wistar | 2005 |
The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model.
Topics: Adult; Blood Coagulation; Blood Coagulation Disorders; Colloids; Crystalloid Solutions; Fibrinogen; Hemodilution; Hemorrhage; Hemostasis; Humans; In Vitro Techniques; Isotonic Solutions; Male; Thrombelastography | 2006 |
Dysfibrinogenemia (fibrinogen Wilmington) due to a novel Aalpha chain truncation causing decreased plasma expression and impaired fibrin polymerisation.
Topics: Adolescent; Afibrinogenemia; Codon, Nonsense; Female; Fibrin; Fibrinogen; Fibrinogens, Abnormal; Hemorrhage; Humans | 2006 |
Acute coronary artery injury in dogs following administration of CI-1034, an endothelin A receptor antagonist.
Topics: Acute Disease; Animals; Biomarkers; Calgranulin A; Calgranulin B; Caspase 3; Caspases; Coronary Vessels; Dogs; Endothelin A Receptor Antagonists; Fibrinogen; Heart Atria; Hemorrhage; Injections, Intravenous; Interleukin-6; Male; Necrosis; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Thiazines; Tunica Media | 2006 |
Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Cohort Studies; Factor XIII; Female; Fibrinogen; Hemorrhage; Humans; Leucine; Male; Middle Aged; Polymorphism, Genetic; Prospective Studies; Stroke; Thrombolytic Therapy; Treatment Outcome; Valine | 2006 |
Venom from spiders of the genus Hippasa: biochemical and pharmacological studies.
Topics: Animals; Blood Coagulation; Carcinoma, Ehrlich Tumor; Cell Survival; Creatine Kinase; Edema; Female; Fibrinogen; Hemorrhage; Humans; Hyaluronoglucosaminidase; L-Lactate Dehydrogenase; Mice; Muscle, Skeletal; Phospholipases A; Phospholipases A2; Proteins; Ranidae; Skin; Spider Venoms; Spiders; Tumor Cells, Cultured | 2006 |
Effects of hemorrhage and lactated Ringer's resuscitation on coagulation and fibrinogen metabolism in swine.
Topics: Animals; Blood Coagulation; Fibrinogen; Hematology; Hemorrhage; Isotonic Solutions; Lactic Acid; Resuscitation; Ringer's Solution; Swine | 2006 |
ADAP is required for normal alphaIIbbeta3 activation by VWF/GP Ib-IX-V and other agonists.
Topics: Adaptor Proteins, Signal Transducing; Animals; Fibrinogen; Hemorrhage; Mice; Mice, Knockout; Platelet Adhesiveness; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Signal Transduction; von Willebrand Factor | 2007 |
Management of acute bleeding in a patient with congenital afibrinogenaemia.
Topics: Adult; Afibrinogenemia; Blood Coagulation Disorders; Fibrinogen; Hemorrhage; Humans; Male; Rare Diseases | 2006 |
High levels of LDL-cholesterol rescue the neonatal mortality associated with afibrinogenemia in mice.
Topics: Afibrinogenemia; Animals; Animals, Newborn; Apolipoproteins B; Cholesterol; Cholesterol, LDL; Female; Fetal Blood; Fibrinogen; Genotype; Hemorrhage; Hybridization, Genetic; Male; Maternal-Fetal Exchange; Mice; Mice, Inbred C57BL; Mice, Knockout; P-Selectin; Platelet Activation; Pregnancy; Pregnancy Complications, Hematologic; Receptors, LDL; Umbilicus | 2007 |
A case of afibrinogenemia associated with A-alpha chain gene compound heterozygosity (HUMFIBRA c.[4110delA]+[3200+1G>T]).
Topics: Adolescent; Afibrinogenemia; Family Health; Female; Fibrinogen; Hemorrhage; Heterozygote; Humans; Inheritance Patterns; Mutation | 2007 |
Purification and characterization of patagonfibrase, a metalloproteinase showing alpha-fibrinogenolytic and hemorrhagic activities, from Philodryas patagoniensis snake venom.
Topics: Animals; Blood Coagulation; Blood Platelets; Colubridae; Edema; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Hemorrhage; Humans; Hydrogen-Ion Concentration; Inflammation; Isoelectric Focusing; Mass Spectrometry; Metalloproteases; Mice; Muscle, Skeletal; Necrosis; Platelet Aggregation; Snake Venoms; Temperature; Thrombin; Thrombin Time | 2007 |
Influence of red blood cell concentration on the initiation time of blood coagulation: risk of thrombus formation in pregnant females with anemia.
Topics: Adult; Anemia; Blood Viscosity; Erythrocyte Count; Erythrocyte Deformability; Female; Fibrinogen; Hemorheology; Hemorrhage; Humans; Partial Thromboplastin Time; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Hematologic; Prothrombin Time; Risk Factors; Thrombophilia; Thrombosis | 2007 |
Fibrinogen Aalpha312 and Bbeta448 polymorphisms are not related to bleeding during oral vitamin K-antagonist treatment.
Topics: Acenocoumarol; Administration, Oral; Anticoagulants; Case-Control Studies; Fibrinogen; Genotype; Hemorrhage; Humans; Netherlands; Odds Ratio; Phenprocoumon; Polymorphism, Single Nucleotide; Risk Assessment; Risk Factors; Vitamin K | 2007 |
The effect of fibrinogen concentrate on thrombocytopenia.
Topics: Animals; Fibrinogen; Hemorrhage; Placebos; Swine; Thrombocytopenia | 2007 |
Individual venom variability in the South American rattlesnake Crotalus durissus cumanensis.
Topics: Amides; Animals; Blood Coagulation; Chromatography, Gel; Crotalid Venoms; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostasis; Indicators and Reagents; Lethal Dose 50; Male; Mice; Proteins; South America; Venezuela | 2007 |
Triterpenoid saponins, new metalloprotease snake venom inhibitors isolated from Pentaclethra macroloba.
Topics: Animals; Baccharis; Blood Coagulation; Carbohydrate Sequence; Circular Dichroism; Crotalid Venoms; Fibrin; Fibrinogen; Hemorrhage; Magnetic Resonance Spectroscopy; Male; Mice; Molecular Sequence Data; Phospholipases A; Plant Extracts; Plants; Saponins; Serine Proteinase Inhibitors; Snake Venoms; Spectrophotometry, Ultraviolet; Triterpenes | 2007 |
[Preoperative evaluation of the bleeding history. Recommendations of the working group on perioperative coagulation of the Austrian Society for Anaesthesia, Resuscitation and Intensive Care].
Topics: Blood Coagulation Tests; Blood Transfusion; Fibrinogen; Hemorrhage; Hemostasis; Humans; Intraoperative Complications; Medical History Taking; Partial Thromboplastin Time; Platelet Count; Platelet Function Tests; Preoperative Care; Prothrombin Time; Risk Assessment; Surveys and Questionnaires | 2007 |
Prolonged hemostatic ability of polyethylene glycol-modified polymerized albumin particles carrying fibrinogen gamma-chain dodecapeptide.
Topics: Albumins; Animals; Blood Coagulation; Blood Platelets; Fibrinogen; Half-Life; Hemorrhage; Hemostatics; Peptide Fragments; Polyethylene Glycols; Rats; Thrombocytopenia | 2007 |
The antithrombotic potential of selective blockade of talin-dependent integrin alpha IIb beta 3 (platelet GPIIb-IIIa) activation.
Topics: Amino Acid Substitution; Anemia; Animals; Blood Platelets; Chlorides; Contractile Proteins; Ferric Compounds; Fibrinogen; Filamins; Hemorrhage; Homozygote; Mice; Mice, Transgenic; Microfilament Proteins; Platelet Glycoprotein GPIIb-IIIa Complex; Point Mutation; Protein Binding; Protein Structure, Tertiary; Pulmonary Embolism; Talin; Thrombosis | 2007 |
A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
Topics: Administration, Oral; Animals; Aorta; Aspirin; Bleeding Time; Blood Coagulation; Clopidogrel; Disease Models, Animal; Fibrin; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Naphthalenes; Platelet Activation; Platelet Aggregation Inhibitors; Propionates; Prosthesis Design; Receptors, Thromboxane A2, Prostaglandin H2; Stainless Steel; Stents; Swine; Thrombosis; Ticlopidine; Time Factors | 2007 |
Hemorrhagic, coagulant and fibrino(geno)lytic activities of crude venom and fractions from mapanare (Bothrops colombiensis) snakes.
Topics: Animals; Blood Coagulation; Bothrops; Chromatography, Gel; Crotalid Venoms; Dextrans; Electrophoresis, Polyacrylamide Gel; Factor Xa; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Kallikreins; Lethal Dose 50; Metalloproteases; Mice; Molecular Weight; Peptide Hydrolases; Protease Inhibitors; Skin Diseases; Thrombin; Tissue Plasminogen Activator; Venezuela | 2008 |
Fibrinogen Leipzig II (gamma351Gly-->Ser and gamma82Ala-->Gly): hypodysfibrinogenaemia due to two independent amino acid substitutions within the same polypeptide chain.
Topics: Adult; Afibrinogenemia; Alanine; Fibrinogen; Glycine; Haplotypes; Hemorrhage; Heterozygote; Humans; Male; Models, Genetic; Mutation; Serine; Spectrometry, Mass, Electrospray Ionization; Time Factors | 2007 |
Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.
Topics: ABO Blood-Group System; Administration, Oral; Aged; Alanine; Anticoagulants; Arteries; Blood Proteins; Brain Ischemia; Case-Control Studies; Confidence Intervals; Female; Fibrinogen; Genetic Variation; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Odds Ratio; Risk Factors; Threonine | 2007 |
Hemostatic efficacy of a recombinant thrombin-coated polyglycolic acid sheet coupled with liquid fibrinogen, evaluated in a canine model of pulmonary arterial hemorrhage.
Topics: Animals; Bandages; Blood Pressure; Disease Models, Animal; Dogs; Female; Fibrin; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Hemostatics; Lacerations; Polyglycolic Acid; Pulmonary Artery; Recombinant Proteins; Thrombin; Treatment Outcome | 2007 |
Fulminating eclampsia associated with fibrinogenopoenia and hemorrhage.
Topics: Blood; Eclampsia; Female; Fibrinogen; Hemorrhage; Humans; Pregnancy | 1949 |
Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding.
Topics: Adolescent; Adult; Afibrinogenemia; Aged; Aged, 80 and over; Child; Child, Preschool; Drug Tolerance; Female; Fibrinogen; Hemorrhage; Humans; Infant; Male; Middle Aged; Retrospective Studies; Risk Factors; Safety | 2008 |
In vivo efficacy of a new autologous fibrin sealant.
Topics: Animals; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Humans; Kidney; Male; Models, Animal; Models, Theoretical; Rats; Rats, Wistar; Tensile Strength; Tissue Adhesives; Wound Healing | 2008 |
Platelets in haemostasis and thrombosis.
Topics: Blood Coagulation; Blood Platelets; Fibrinogen; Hemorrhage; Humans; Thrombin; Thrombosis | 1967 |
Hydroxyethyl starch (HES) and bleeding. An experimental investigation of its effect on hemostasis.
Topics: Animals; Blood Coagulation Tests; Blood Platelets; Blood Transfusion; Dogs; Fibrinogen; Hematocrit; Hemorrhage; Hemostasis; Infusions, Parenteral; Prothrombin Time; Sodium Chloride; Starch | 1967 |
Increased blood loss associated with administration of certain plasma expanders: dextran 75, dextran 40, and hydroxyethyl starch.
Topics: Anesthesia, General; Animals; Arteries; Blood Coagulation; Blood Platelets; Dextrans; Dogs; Fibrinogen; Hemorrhage; Plasma Substitutes; Prothrombin Time; Starch | 1967 |
Benefit of fibrin sealing in great vessel surgery.
Topics: Animals; Aorta; Aprotinin; Blood Vessel Prosthesis; Dogs; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Graft Occlusion, Vascular; Hemorrhage; Postoperative Complications; Prosthesis Design; Thrombin | 1983 |
Fibrin seal application. Clinical experience.
Topics: Adult; Aorta; Aortic Diseases; Bronchi; Cardiovascular Surgical Procedures; Drug Combinations; Factor XIII; Female; Fibrin Tissue Adhesive; Fibrinogen; Heart Valve Prosthesis; Hemorrhage; Hemostatic Techniques; Humans; Infant; Middle Aged; Mitral Valve; Postoperative Complications; Thrombin; Tissue Adhesions; Tissue Adhesives; Trachea | 1982 |
Use of Tisseel in neurosurgery.
Topics: Aprotinin; Calcium Chloride; Drug Combinations; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Humans; Neurosurgery; Thrombin | 1984 |
[Is there a reliable organ-preserving operative method for lesser splenic injuries? Animal experiments and clinical experiences].
Topics: Animals; Dogs; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Spleen; Thrombin; Tissue Adhesives; Wound Healing | 1984 |
Comprehensive study of haemostasis in chronic uraemia.
Topics: Adult; Blood Coagulation Factors; Chronic Disease; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostasis; Humans; Plasminogen; Platelet Adhesiveness; Platelet Factor 3; Uremia; Urokinase-Type Plasminogen Activator | 1983 |
Use of cryoprecipitate coagulum to control tumor-bed bleeding. Case report.
Topics: Adult; Factor VIII; Female; Fibrinogen; Hemangiopericytoma; Hemorrhage; Humans; Meningeal Neoplasms; Postoperative Complications | 1984 |
Characterization of hemorrhagic principles from Trimeresurus gramineus snake venom.
Topics: Animals; Azo Compounds; Blood Coagulation; Caseins; Collagen; Crotalid Venoms; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Hemorrhage; Humans; Hydrolysis; In Vitro Techniques; Metals; Platelet Aggregation; Rabbits | 1984 |
Surgical management of musculoskeletal problems in hemophilia.
Topics: Anemia, Hemolytic; Arthrodesis; Costs and Cost Analysis; Factor VIII; Fibrinogen; Hemarthrosis; Hemophilia A; Hemorrhage; Hepatitis B; Humans; Intraoperative Care; Joint Prosthesis; Muscles; Postoperative Period; Preoperative Care; Synovectomy | 1983 |
[Diagnostic and prognostic value of indicators of the hemostasis system in closed abdominal injuries].
Topics: Abdomen; Abdominal Injuries; Adult; Blood Coagulation Tests; Female; Fibrinogen; Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Prognosis; Wounds, Nonpenetrating | 1984 |
Hematologic changes in brucellosis.
Topics: Adolescent; Adult; Aged; Anemia; Blood Coagulation; Blood Coagulation Disorders; Bone Marrow; Brucellosis; Child; Female; Fibrinogen; Hemorrhage; Humans; Leukopenia; Male; Middle Aged; Platelet Count; Thrombin Time; Thrombocytopenia | 1984 |
[Use of fibrinogen in hemorrhages in surgical practice].
Topics: Afibrinogenemia; Combined Modality Therapy; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Humans; Male; Middle Aged; Surgical Procedures, Operative | 1984 |
The value of activated coagulation time in monitoring heparin therapy during extracorporeal circulation.
Topics: Aged; Antithrombin III; Blood Coagulation Tests; Coronary Artery Bypass; Dose-Response Relationship, Drug; Extracorporeal Circulation; Fibrinogen; Hemorrhage; Heparin; Humans; Middle Aged; Monitoring, Physiologic; Postoperative Complications; Protamines; Tranexamic Acid; Whole Blood Coagulation Time | 1984 |
[Latent disorders of blood coagulation in patients with hemorrhage, detected by the micromethod of fibrinogen determination].
Topics: Afibrinogenemia; Fibrinogen; Hemorrhage; Heparin; Humans; Methods | 1983 |
Quantification of extracorporeal fibrin deposits in haemodialysis with minimal and conventional heparinization.
Topics: Adult; Female; Fibrin; Fibrinogen; Hemorrhage; Heparin; Humans; Male; Microscopy, Electron, Scanning; Middle Aged; Renal Dialysis | 1983 |
Some aspects of the molecular pathology of thrombosis and haemorrhage.
Topics: Blood Coagulation; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Models, Biological; Molecular Conformation; Thrombosis | 1984 |
Hemorrhage and the products of fibrinogen digestion after intracoronary administration of streptokinase.
Topics: Blood Coagulation Factors; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart; Hemorrhage; Humans; Injections; Partial Thromboplastin Time; Prothrombin Time; Streptokinase | 1984 |
Hemodialysis without anticoagulants: efficiency and hemostatic aspects.
Topics: Acute Kidney Injury; Adult; Creatinine; Fibrinogen; Hemorrhage; Hemostasis; Heparin; Humans; Middle Aged; Platelet Count; Prothrombin Time; Renal Dialysis; Risk; Urea | 1984 |
Low-dose streptokinase for selective thrombolysis: systemic effects and complications.
Topics: Aneurysm; Catheterization; Embolism; Female; Fibrinogen; Fibrinolysis; Hematoma; Hemorrhage; Humans; Male; Middle Aged; Radiography; Streptokinase; Thrombin Time; Thromboembolism; Time Factors | 1984 |
Technetium-fibrinogen lung scanning in canine lung contusion.
Topics: Animals; Blood; Contusions; Dogs; Female; Fibrinogen; Hematoma; Hemorrhage; Lung; Lung Injury; Male; Organotechnetium Compounds; Radionuclide Imaging; Serum Albumin, Radio-Iodinated; Technetium; Time Factors | 1984 |
Treatment of the bleeding tendency in uremia with cryoprecipitate.
Topics: Adult; Aged; Bleeding Time; Blood Coagulation Disorders; Blood Coagulation Factors; Chemical Precipitation; Cold Temperature; Factor VIII; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation; Postoperative Complications; Surgical Procedures, Operative; Uremia | 1980 |
Increased fibrinopeptide A after prothrombin complex concentrates.
Topics: Blood Coagulation Factors; Factor VIII; Fibrinogen; Fibrinopeptide A; Hemophilia A; Hemorrhage; Humans; Prothrombin | 1980 |
Idiopathic thrombocytopenic purpura with widespread haemorrhage and anuria.
Topics: Adult; Antibodies; Anuria; Blood Platelets; Female; Fibrinogen; Hemorrhage; Humans; Purpura, Thrombocytopenic; Syndrome; Vincristine | 1982 |
Streptokinase treatment of acute arterial occlusion.
Topics: Aged; Arterial Occlusive Diseases; Drug Therapy, Combination; Female; Fibrinogen; Hemorrhage; Heparin; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Streptokinase; Time Factors | 1983 |
Selective streptokinase infusion: clinical and laboratory correlates.
Topics: Angiography; Blood Coagulation; Drug Administration Schedule; Drug Evaluation; Fibrinogen; Hemorrhage; Humans; Infusions, Intra-Arterial; Plasminogen; Streptokinase; Thromboembolism | 1983 |
Bleeding and coagulation abnormalities in alcoholic cirrhotic liver disease.
Topics: Adult; Blood Coagulation Disorders; Female; Fibrinogen; Hemorrhage; Humans; Immunoelectrophoresis; Liver Cirrhosis, Alcoholic; Liver Function Tests; Male; Middle Aged | 1982 |
Intensive plasma exchange--effects on haemostasis.
Topics: Adult; Aged; Blood Coagulation Factors; Blood Coagulation Tests; Blood Flow Velocity; Female; Fibrinogen; Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Plasma Exchange; Plasma Volume; Platelet Aggregation; Platelet Count; Thrombosis | 1982 |
[Changes in the fibrinogen level and thrombocyte count in acute hemorrhagic necrotic pancreatitis (an experimental study)].
Topics: Acute Disease; Animals; Blood Platelets; Dogs; Fibrinogen; Hemorrhage; Necrosis; Pancreatitis; Platelet Count; Time Factors | 1980 |
Human factor XIII: fibrin-stabilizing factor.
Topics: Blood Coagulation; Blood Coagulation Disorders; Blood Transfusion; Calcium; Disseminated Intravascular Coagulation; Factor XIII; Factor XIII Deficiency; Female; Fibrin; Fibrinogen; Half-Life; Hemorrhage; Humans; Leukemia; Liver Diseases; Male; Plasma; Pregnancy; Thrombin; Time Factors | 1980 |
Resuscitation in uncontrolled hemorrhage.
Topics: Abdomen; Animals; Blood Pressure; Disease Models, Animal; Fibrinogen; Fluid Therapy; Hematocrit; Hemodilution; Hemorrhage; Hydroxyethyl Starch Derivatives; Hypotension; Isotonic Solutions; Male; Platelet Count; Random Allocation; Rats; Rats, Sprague-Dawley; Resuscitation; Ringer's Lactate; Shock; Survival Rate | 1994 |
Vampire bat salivary plasminogen activator evokes minimal bleeding relative to tissue-type plasminogen activator as assessed by a rabbit cuticle bleeding time model.
Topics: alpha-2-Antiplasmin; Animals; Bleeding Time; Chiroptera; Drug Evaluation, Preclinical; Factor VIII; Fibrin; Fibrinogen; Hemorrhage; Humans; Male; Plasminogen; Plasminogen Activators; Rabbits; Recombinant Proteins; Tissue Plasminogen Activator | 1995 |
Defective blood coagulation is not causative of hepatic haemorrhage induced by microcystin-LR.
Topics: Animals; Bacterial Toxins; Blood Coagulation; Chemical and Drug Induced Liver Injury; Cyanobacteria; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Liver; Liver Function Tests; Male; Marine Toxins; Microcystins; Partial Thromboplastin Time; Peptides, Cyclic; Phosphoprotein Phosphatases; Platelet Aggregation; Rats; Rats, Sprague-Dawley | 1995 |
Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice.
Topics: Afibrinogenemia; Aging; Alleles; Animals; Animals, Newborn; Base Sequence; Blood Cell Count; DNA Primers; Exons; Female; Fibrinogen; Hematocrit; Hemorrhage; Male; Mice; Mice, Transgenic; Molecular Sequence Data; Mutation; Ovarian Follicle; Platelet Aggregation; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Hematologic; Restriction Mapping | 1995 |
Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis.
Topics: alpha-2-Antiplasmin; Animals; Aprotinin; Drug Synergism; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Rabbits; Tissue Plasminogen Activator | 1993 |
Coagulopathy due to an acquired factor V inhibitor and subsequently thrombosis.
Topics: Aged; Factor V; Fibrinogen; Hemorrhage; Humans; Immunoglobulins, Intravenous; Male; Methylprednisolone; Partial Thromboplastin Time; Platelet Transfusion; Prothrombin Time; Reference Values; Thrombosis | 1995 |
[Indications of blood components and outcome of transfusion practices in hemorrhage of multiple trauma].
Topics: Blood Transfusion; Erythrocyte Transfusion; Fibrinogen; Hemorrhage; Humans; Multiple Trauma; Plasma Substitutes; Platelet Transfusion | 1994 |
Purification and characterization of a non-hemorrhagic metalloprotease from Agkistrodon halys brevicaudus venom.
Topics: Agkistrodon; Amino Acid Sequence; Amino Acids; Animals; Cations; Chelating Agents; Chromatography; Enzyme Stability; Fibrin; Fibrinogen; Hemorrhage; Hydrolysis; Metalloendopeptidases; Mice; Mice, Inbred Strains; Molecular Sequence Data; Substrate Specificity; Viper Venoms | 1995 |
Disseminated intravascular coagulation (DIC) in adult patients with acute leukaemia.
Topics: Adolescent; Adult; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemorrhage; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1995 |
Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; alpha-2-Antiplasmin; Blood Platelets; Cardiopulmonary Bypass; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemodilution; Hemorrhage; Humans; Male; Middle Aged; Plasminogen; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Tissue Plasminogen Activator | 1994 |
Isolation and characterization of five fibrin(ogen)olytic enzymes from the venom of Philodryas olfersii (green snake).
Topics: Amino Acid Sequence; Animals; Caseins; Colubridae; Electrophoresis, Polyacrylamide Gel; Fibrin; Fibrinogen; Hemorrhage; Humans; Insulin; Isoelectric Focusing; Male; Mice; Molecular Sequence Data; Rats; Snake Venoms; Thrombin Time | 1994 |
Rat protein SV-IV (seminal vesicle protein No. 4) accelerates human blood coagulation in vitro by selective inhibition of antithrombin III.
Topics: Animals; Antithrombin III; Blood Coagulation; Calcium Chloride; Dose-Response Relationship, Drug; Factor XIII; Fibrinogen; Hemorrhage; Humans; In Vitro Techniques; Prostatic Secretory Proteins; Proteins; Rats; Seminal Plasma Proteins; Serpins; Thromboplastin | 1994 |
A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding.
Topics: alpha-2-Antiplasmin; Animals; Blood Coagulation; Cerebral Hemorrhage; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Fibrin; Fibrinogen; Fibrinolysis; Half-Life; Hemorrhage; Intracranial Embolism and Thrombosis; Male; Plasminogen; Rabbits; Thrombolytic Therapy; Tissue Plasminogen Activator | 1994 |
Chemical, biochemical, pharmacokinetic, and biological properties of L-680,833: a potent, orally active monocyclic beta-lactam inhibitor of human polymorphonuclear leukocyte elastase.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; beta-Lactams; Biological Availability; Calcimycin; Cricetinae; Fibrinogen; Hemorrhage; Humans; Lactams; Leukocyte Elastase; Lung Diseases; Macaca mulatta; Mice; Molecular Sequence Data; Molecular Structure; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pancreatic Elastase; Peptide Fragments; Phenylacetates; Rats; Structure-Activity Relationship | 1993 |
Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass.
Topics: Adolescent; Adult; Aged; Blood Coagulation Tests; Blood Platelets; Blood Transfusion; Cardiopulmonary Bypass; Fibrinogen; Forecasting; Hemorrhage; Humans; Middle Aged; Partial Thromboplastin Time; Plasma; Platelet Count; Platelet Transfusion; Prospective Studies; Prothrombin Time; Risk Factors; Sensitivity and Specificity; Thrombelastography | 1993 |
Combined effects of urokinase and heparin on PTT values during thrombolytic therapy.
Topics: Aged; Drug Therapy, Combination; Female; Fibrinogen; Hematoma; Hemorrhage; Heparin; Humans; Male; Middle Aged; Partial Thromboplastin Time; Retrospective Studies; Thrombolytic Therapy; Thrombosis; Urokinase-Type Plasminogen Activator | 1993 |
Isolation of a hemorrhagic toxin from the venom of Agkistrodon contortrix laticinctus (broad-banded copperhead) and pathogenesis of the hemorrhage induced by the toxin in mice.
Topics: Animals; Capillaries; Caseins; Chromatography; Crotalid Venoms; Electrophoresis, Polyacrylamide Gel; Endopeptidases; Endothelium, Vascular; Fibrinogen; Hemorrhage; Mice; Microscopy, Electron; Molecular Weight; Toxins, Biological | 1993 |
Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding.
Topics: Blood Coagulation Factors; Epistaxis; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Male; Middle Aged; Pedigree; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator | 1993 |
Purification and characterization of piscivorase I and II, the fibrinolytic enzymes from eastern cottonmouth moccasin venom (Agkistrodon piscivorus piscivorus).
Topics: Amino Acids; Animals; Chromogenic Compounds; Crotalid Venoms; Enzyme Inhibitors; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemorrhage; Hydrogen-Ion Concentration; Metals; Platelet Aggregation; Temperature | 1995 |
Effects of isotonic saline solution resuscitation on blood coagulation in uncontrolled hemorrhage.
Topics: Animals; Blood Coagulation; Female; Fibrinogen; Hemorrhage; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; Rats; Rats, Sprague-Dawley; Resuscitation; Sodium Chloride | 1996 |
Thrombolytic therapy for acute deep venous thrombosis: how much is enough?
Topics: Acute Disease; Femoral Vein; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorheology; Hemorrhage; Humans; Iliac Vein; Injections, Intravenous; Monitoring, Physiologic; Partial Thromboplastin Time; Popliteal Vein; Prospective Studies; Remission Induction; Streptokinase; Thrombin Time; Thrombolytic Therapy; Thrombophlebitis; Thrombosis; Time Factors; Ultrasonography, Doppler, Duplex; Urokinase-Type Plasminogen Activator | 1996 |
Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparin.
Topics: Animals; Anticoagulants; Electric Stimulation; Factor Xa Inhibitors; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Ligation; Male; Oligosaccharides; Rabbits; Rats; Rats, Wistar; Thrombin; Thromboplastin; Thrombosis; Tissue Plasminogen Activator; Venae Cavae | 1996 |
Sensitivity of experimental venous and arterial thrombosis and bleeding to ancrod-induced defibrinogenation.
Topics: Ancrod; Animals; Blood Flow Velocity; Carotid Arteries; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Male; Rats; Rats, Sprague-Dawley; Thrombosis; Vena Cava, Inferior | 1996 |
Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dl.
Topics: Adult; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Humans; Leukocyte Count; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Thrombosis | 1996 |
Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3.
Topics: Amino Acid Sequence; Animals; Animals, Newborn; Base Sequence; Bleeding Time; Blood Coagulation; Cross-Linking Reagents; DNA; Female; Fibrinogen; Hemorrhage; Humans; In Vitro Techniques; Male; Mice; Mice, Transgenic; Molecular Sequence Data; Molecular Structure; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Conformation; RNA, Messenger; Sequence Deletion | 1996 |
Platelets from bleeding Simmental cattle have a long delay in both ADP-activated expression of GpIIB-IIIA receptors and fibrinogen-dependent platelet aggregation.
Topics: Adenosine Diphosphate; Animals; Blood Platelet Disorders; Cattle; Cattle Diseases; Fibrinogen; Hemorrhage; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex | 1996 |
Laboratory findings in hypertensive disorders of pregnancy.
Topics: Adolescent; Adult; Anesthesia, Conduction; Anesthesia, Obstetrical; Bilirubin; Blood Cell Count; Blood Coagulation Disorders; Delivery, Obstetric; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Forecasting; Hemorrhage; Humans; Hypertension; Liver; Partial Thromboplastin Time; Platelet Count; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Hematologic; Prothrombin Time; Retrospective Studies | 1996 |
Haemodialysis without anticoagulant: haemostasis parameters, fibrinogen kinetic, and dialysis efficiency.
Topics: Adult; Anticoagulants; Female; Fibrinogen; Hemorrhage; Hemostasis; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Renal Dialysis; Risk Factors | 1997 |
Long-term therapy for uremic bleeding: effects of conjugate estrogens on the expression of platelet surface receptors for von Willebrand factor and fibrinogen (GPIb and GPIIb/IIIa glycoproteins)
Topics: Antigens, CD; Blood Platelets; Cold Temperature; Erythropoietin; Estrogens; Fibrinogen; Hemorrhage; Humans; Injections, Intravenous; Integrin beta3; Integrins; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Renal Dialysis; Uremia; von Willebrand Factor | 1997 |
The suprapharmacologic dosing of antithrombin concentrate for Staphylococcus aureus-induced disseminated intravascular coagulation in guinea pigs: substantial reduction in mortality and morbidity.
Topics: Animals; Antithrombin III; Bacteremia; Disseminated Intravascular Coagulation; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Guinea Pigs; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Male; Partial Thromboplastin Time; Prothrombin Time; Staphylococcal Infections; Staphylococcus aureus; Thrombin | 1997 |
Predicting and treating coagulopathies after cardiopulmonary bypass in children.
Topics: Anticoagulants; Blood Coagulation Tests; Blood Component Transfusion; Body Weight; Cardiopulmonary Bypass; Chest Tubes; Child, Preschool; Drainage; Fibrinogen; Hemorrhage; Hemostasis; Heparin; Heparin Antagonists; Humans; Infant; Platelet Count; Postoperative Care; Postoperative Complications; Protamines; Regression Analysis; Risk Factors; Thrombelastography | 1997 |
Massive liver haemorrhage and rupture caused by HELLP-syndrome treated by collagen fleeces coated with fibrin glue.
Topics: Adult; Aprotinin; Drug Combinations; Female; Fibrinogen; HELLP Syndrome; Hemorrhage; Hemostasis, Surgical; Humans; Liver Diseases; Pregnancy; Rupture, Spontaneous; Thrombin | 1998 |
Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
Topics: Abciximab; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Binding Sites; Blood Platelets; Coronary Disease; Drug Therapy, Combination; Female; Fibrinogen; Gene Expression Regulation; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Ligands; Male; Middle Aged; Myocardial Ischemia; P-Selectin; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Stents; Thrombocytopenia; Ticlopidine | 1998 |
Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits.
Topics: Albumins; Animals; Blood Platelets; Blood Substitutes; Capsules; Disease Models, Animal; Fibrinogen; Hemorrhage; Humans; Rabbits; Thrombocytopenia; Thrombosis; Time Factors | 1999 |
Hematological abnormalities in neonatal patients treated with extracorporeal membrane oxygenation (ECMO).
Topics: Antifibrinolytic Agents; Antithrombin III; Antithrombins; Blood Coagulation; Blood Transfusion; Calcium; Erythrocyte Transfusion; Extracorporeal Membrane Oxygenation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemoglobins; Hemorrhage; Hemostasis; Humans; Infant, Newborn; Male; Partial Thromboplastin Time; Platelet Count; Platelet Transfusion; Prothrombin Time; Retrospective Studies; Serine Proteinase Inhibitors; Thrombelastography; Treatment Outcome; Whole Blood Coagulation Time | 1998 |
Saruplase versus other fibrinolytic agents.
Topics: Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Recombinant Proteins; Streptokinase; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator | 1998 |
Purification and characterization of two fibrinogen-clotting enzymes from five-pace snake (Agkistrodon acutus) venom.
Topics: Agkistrodon; Animals; Blood Coagulation; Chromatography, Gel; Endopeptidases; Esterases; Factor XIII; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Hemorrhage; Humans; Hydrolysis; Mice; Oxidation-Reduction; Peptide Hydrolases; Rabbits; Snake Venoms; Thrombin | 1999 |
Characterization of a thrombin-like enzyme from the venom of Trimeresurus jerdonii.
Topics: Amino Acid Sequence; Animals; Blood Coagulation; Chromatography, High Pressure Liquid; Crotalid Venoms; Electrophoresis, Polyacrylamide Gel; Factor XIII; Fibrin; Fibrinogen; Hemorrhage; Mice; Molecular Sequence Data; Molecular Weight; Platelet Aggregation; Serine Endopeptidases; Serine Proteinase Inhibitors; Spectrophotometry, Ultraviolet; Substrate Specificity; Thrombin; Trimeresurus | 2000 |
Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fibrinogen; Hemorrhage; Humans; Idarubicin; Incidence; Infant; Italy; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Morbidity; Multivariate Analysis; Platelet Count; Prospective Studies; Remission Induction; Time Factors; Tretinoin | 2000 |
Homozygous truncation of the fibrinogen A alpha chain within the coiled coil causes congenital afibrinogenemia.
Topics: Adult; Afibrinogenemia; Factor VIII; Female; Fibrinogen; Hemorrhage; Homozygote; Humans; Mutation; Pedigree; Polymerase Chain Reaction; Sequence Analysis, DNA; von Willebrand Factor | 2000 |
Elastase mediated fibrinolysis in acute promyelocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Blood Coagulation Tests; Disease Susceptibility; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Pancreatic Elastase; Sepsis | 2000 |
Human carotid artery smooth muscle cells rarely express alpha(v)beta3 integrin at sites of recent plaque rupture.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibody Specificity; Blotting, Western; Carotid Arteries; Carotid Artery Injuries; Carotid Stenosis; Endarterectomy, Carotid; Fibrin; Fibrinogen; Hemorrhage; Humans; Immunohistochemistry; Integrins; Ligands; Male; Middle Aged; Muscle, Smooth, Vascular; Receptors, Fibronectin; Receptors, Vitronectin; Thromboplastin; Tunica Intima | 2000 |
Action of metalloproteinases mutalysin I and II on several components of the hemostatic and fibrinolytic systems.
Topics: alpha-Macroglobulins; Animals; Enzyme Inhibitors; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostasis; Humans; Metalloendopeptidases; Plasminogen; Platelet Aggregation; Platelet Function Tests; Protein C; Protein Structure, Tertiary; Rabbits; Viper Venoms | 2000 |
Afibrinogenemia: first identification of a splicing mutation in the fibrinogen gamma chain gene leading to a major gamma chain truncation.
Topics: Afibrinogenemia; Amino Acid Sequence; Base Sequence; Child, Preschool; Consanguinity; Fibrinogen; HeLa Cells; Hemorrhage; Humans; Male; Molecular Sequence Data; Mutation; Pakistan; Pedigree; Polymerase Chain Reaction; RNA Splicing; RNA, Messenger; Sequence Analysis, DNA; Transfection | 2000 |
Hypofibrinogenaemia with compound heterozygosity for two gamma chain mutations - gamma 82 Ala-->Gly and an intron two GT-->AT splice site mutation.
Topics: Adult; Afibrinogenemia; Amino Acid Substitution; Base Sequence; Codon, Nonsense; DNA Mutational Analysis; Family Health; Female; Fibrinogen; Hemorrhage; Heterozygote; Humans; Introns; Male; Mutation; Phenotype; Point Mutation; Pregnancy; Pregnancy Complications, Hematologic; RNA Splice Sites | 2000 |
Activation of coagulation in C57BL/6 mice given verotoxin 2 (VT2) and the effect of co-administration of LPS with VT2.
Topics: Animals; Antithrombin III; Blood Coagulation; Blood Coagulation Tests; Brain; Cytokines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrinogen; Hemorrhage; Intracranial Hemorrhages; Kidney; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Models, Animal; Neutrophils; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Platelet Count; RNA, Messenger; Shiga Toxin 2; Shock; Thromboplastin; Time Factors; Tissue Distribution | 2000 |
Single administration of thrombopoietin to lethally irradiated mice prevents infectious and thrombotic events leading to mortality.
Topics: Animals; Bacterial Infections; Biomarkers; Blood Coagulation Disorders; Bone Marrow; Bone Marrow Diseases; Disease Susceptibility; Drug Evaluation, Preclinical; Endotoxemia; Fibrinogen; Fibrinolysis; Hemorrhage; Immunologic Deficiency Syndromes; Leukocyte Count; Male; Mice; Mice, Inbred C57BL; Neutrophils; Platelet Activation; Platelet Count; Radiation Injuries, Experimental; Recombinant Proteins; RNA, Messenger; Thrombopoietin; Thrombosis; Whole-Body Irradiation | 2001 |
Clinical approach to the patient with unexpected bleeding.
Topics: Adult; Bleeding Time; Blood Coagulation Disorders; Blood Coagulation Tests; Female; Fibrinogen; Hematocrit; Hemoglobins; Hemorrhage; Humans; Male; Medical History Taking; Platelet Count | 2000 |
Effect of fibrin bandage fibrinogen concentration on blood loss after grade V liver injury in swine.
Topics: Animals; Bandages; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Fibrin; Fibrinogen; Hemoglobins; Hemorrhage; Injury Severity Score; Liver; Partial Thromboplastin Time; Platelet Count; Prothrombin; Swine | 2001 |
Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries.
Topics: Animals; Bandages; Blood Coagulation Disorders; Blood Pressure; Combined Modality Therapy; Disease Models, Animal; Drug Evaluation, Preclinical; Exchange Transfusion, Whole Blood; Factor VII; Factor VIIa; Fibrinogen; Hemorrhage; Hypothermia, Induced; Isotonic Solutions; Liver; Partial Thromboplastin Time; Prothrombin Time; Random Allocation; Recombinant Proteins; Resuscitation; Ringer's Lactate; Single-Blind Method; Survival Analysis; Swine; Thrombosis; Time Factors; Wounds and Injuries | 2001 |
Hemorrhagic activity and muscle damaging effect of Pseudomonas aeruginosa metalloproteinase (elastase).
Topics: Animals; Cattle; Cells, Cultured; Creatine Kinase; Endopeptidases; Endothelium, Vascular; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Macrophages; Mice; Muscle, Skeletal; Muscular Diseases; Pancreatic Elastase; Pseudomonas aeruginosa | 2001 |
Clinical application of procedural platelet monitoring during percutaneous coronary intervention among patients at increased bleeding risk.
Topics: Abciximab; Adult; Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Carotid Stenosis; Clopidogrel; Comorbidity; Coronary Artery Bypass; Drug Therapy, Combination; Female; Fibrinogen; Graft Occlusion, Vascular; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Microspheres; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Risk; Stents; Ticlopidine | 2001 |
Disseminated intravascular coagulation associated with intratumoral hemorrhage of ovarian cancer.
Topics: Adult; CA-125 Antigen; CA-19-9 Antigen; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemoglobins; Hemorrhage; Humans; Magnetic Resonance Imaging; Ovarian Neoplasms; Platelet Count; Tomography, X-Ray Computed | 2001 |
A role for thrombin receptor signaling in endothelial cells during embryonic development.
Topics: Animals; Blood Coagulation; Blood Coagulation Factors; Blood Vessels; Calcium; Crosses, Genetic; Embryonic and Fetal Development; Endocardium; Endothelium, Vascular; Factor V; Female; Fibrinogen; Fibroblasts; Hemorrhage; Hemostasis; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Transgenic; Neovascularization, Physiologic; Phenotype; Prothrombin; Receptor, PAR-1; Receptors, Thrombin; Signal Transduction; Thrombin; Thromboplastin | 2001 |
Disseminated intravascular coagulation in solid tumors: clinical and pathologic study.
Topics: Adult; Aged; Aged, 80 and over; Blood Proteins; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Hemorrhage; Humans; Liver Neoplasms; Male; Middle Aged; Necrosis; Neoplasms; Thrombocytopenia; Thrombosis | 2001 |
Neutralization of proteases from Bothrops snake venoms by the aqueous extract from Casearia sylvestris (Flacourtiaceae).
Topics: Animals; Bothrops; Caseins; Crotalid Venoms; Enzyme Inhibitors; Fibrinogen; Fibrinolysis; Hemorrhage; Metalloendopeptidases; Plant Extracts; Skin Diseases | 2001 |
Pharmacological characterization and neutralization of the venoms used in the production of Bothropic antivenom in Brazil.
Topics: Animals; Antivenins; Blood Coagulation; Bothrops; Brazil; Cross Reactions; Crotalid Venoms; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Hemorrhage; Humans; Necrosis; Neutralization Tests; Peptide Hydrolases; Phospholipases A; Species Specificity | 2002 |
Morphological and biochemical evidence of blood vessel damage and fibrinogenolysis triggered by brown spider venom.
Topics: Animals; Blood Coagulation; Blood Vessels; Electrophoresis, Polyacrylamide Gel; Endothelium, Vascular; Fibrinogen; Hemorrhage; Humans; Kinetics; Microscopy, Electron; Protease Inhibitors; Rabbits; Spider Venoms; Toxins, Biological | 2002 |
Disseminated intravascular coagulation in prostatic disease.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Aged; Blood Coagulation Factors; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Male; Neoplasm Metastasis; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms | 1976 |
[In vitro studies to elucidate the fibrinolytic activity in cerebrospinal fluid altered by inflammation and hemorrhage and having pathologic protein values].
Topics: Central Nervous System Diseases; Cerebrospinal Fluid Proteins; Chronic Disease; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Hemorrhage; Humans; Inflammation; Plasminogen | 1977 |
Microvascular anastomosis using a blood product sealant-adhesive.
Topics: Animals; Blood Platelets; Cattle; Fibrinogen; Hemorrhage; Heparin; Humans; Male; Microcirculation; Postoperative Complications; Rats; Suture Techniques; Thrombin; Thrombosis; Time Factors | 1977 |
[Lethal hemorrhage after tonsillectomy in children].
Topics: Blood Transfusion; Child, Preschool; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Humans; Postoperative Complications; Tonsillectomy | 1979 |
Hemostasis in massively transfused trauma patients.
Topics: Adolescent; Adult; Aged; Blood Cell Count; Blood Coagulation Factors; Blood Transfusion; Disseminated Intravascular Coagulation; Factor V; Factor VIII; Fibrinogen; Hemorrhage; Hemostasis; Humans; Middle Aged; Plateletpheresis; Thrombocytopenia; Wounds and Injuries | 1979 |
[Haemorrhagic complications using streptokinase during 98 treatments. Place of the biological surveillance (author's transl)].
Topics: Adolescent; Adult; Aged; Arterial Occlusive Diseases; Arteries; Extremities; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Streptokinase | 1979 |
Experimental studies of the fibrinogen response to hemorrhage.
Topics: Animals; Cycloheximide; Dose-Response Relationship, Drug; Fibrinogen; Hemorrhage; Iodine Radioisotopes; Male; Mathematics; Rabbits; Time Factors | 1979 |
Problem of abnormal hemostasis in liver disease.
Topics: Acute Disease; Blood Coagulation Factors; Chronic Disease; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Hemostasis; Hepatic Encephalopathy; Hepatitis, Alcoholic; Humans; Thrombocytopenia; Thrombosis | 1979 |
Bleeding after Malayan pit viper bites.
Topics: Afibrinogenemia; Blood Vessels; Crotalid Venoms; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Malaysia; Snake Bites; Thrombocytopenia | 1979 |
Fibrinogen, fibrin degradation products and fibrinolysis in bilharzial (schistosomal) hepatic fibrosis.
Topics: Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Liver Cirrhosis; Schistosomiasis | 1977 |
[Biological aspects of the congenital dysfibrinogenaemias (author's transl)].
Topics: Afibrinogenemia; Fibrinogen; Hemorrhage; Humans; Prothrombin Time | 1978 |
Autologous blood in the treatment of intraoperative hemorrhage.
Topics: Adult; Aged; Aortic Aneurysm; Blood Cell Count; Blood Platelets; Blood Transfusion, Autologous; Collateral Circulation; Creatinine; Female; Fibrinogen; Hematocrit; Hemoglobinometry; Hemorrhage; Hemostasis, Surgical; Heparin; Humans; Middle Aged; Portacaval Shunt, Surgical; Pregnancy; Pregnancy, Ectopic; Vascular Diseases; Wounds and Injuries | 1977 |
The pathogenesis of leptospirosis I. Hemorrhages in experimental leptospirosis in guinea pigs.
Topics: Animals; Factor V; Factor VIII; Fibrinogen; Guinea Pigs; Hemorrhage; Leptospira interrogans; Leptospirosis; Liver; Lung; Male; Rodent Diseases | 1977 |
[Fibrinolytic agents in the biological fluids of a caterpillar (author's transl)].
Topics: Adult; Blood Coagulation Tests; Body Fluids; Child; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Insecta; Larva; Venoms | 1977 |
Current clotting concepts in urology.
Topics: Adult; Aged; Aminocaproates; Blood Cell Count; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Female; Fibrinogen; Fibrinolysis; Hematuria; Hemophilia A; Hemophilia B; Hemorrhage; Hemostasis; Humans; Male; Middle Aged; Postoperative Complications; Prostatectomy | 1976 |
[Changes in several plasma protein indices in dogs with acute blood loss after blood replacement with polyglucin and rheopolyglucin].
Topics: Acute Disease; Animals; Blood Proteins; Dextrans; Dogs; Fibrinogen; Hemorrhage; Time Factors | 1976 |
Prevention of venous thromboembolism in orthopaedic patients.
Topics: Adolescent; Adult; Aged; Antithrombins; Boston; Child; Dextrans; Fibrinogen; Fractures, Bone; Hemorrhage; Heparin; Hip Joint; Humans; Middle Aged; Orthopedics; Phlebography; Postoperative Complications; Pulmonary Embolism; Thromboembolism; Thrombophlebitis | 1976 |
Effects of hepatic autologous lysosomal enzymes on rat lungs.
Topics: Animals; Fibrinogen; Hemorrhage; Humans; Hypotension; Injections, Intravenous; Liver; Lung; Lysosomes; Male; Rats | 1976 |
Hypofibrinogenaemia as a cause of bleeding in chronic myeloid leukaemia.
Topics: Afibrinogenemia; Aged; Blood Cell Count; Bone Marrow Cells; Busulfan; Chronic Disease; Disseminated Intravascular Coagulation; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Hypoprothrombinemias; Immunoelectrophoresis; Leukemia, Myeloid; Thrombin | 1975 |
[Hyperfibrinolysis in maxillofacial surgery].
Topics: Face; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Maxilla | 1976 |
[Tissue adhesion and local haemostasis using fibrinogen, thrombin and clotting factor xiii. (experimental investigations--clinical experience) (author's transl)].
Topics: Animals; Cattle; Dogs; Factor XIII; Female; Fibrinogen; Granulation Tissue; Hemorrhage; Hemostasis; Liver; Male; Pleura; Rats; Species Specificity; Thrombin; Tissue Adhesives; Urinary Bladder | 1976 |
Current transfusion practices.
Topics: Anemia; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Blood Transfusion; Embolism, Air; Erythrocytes; Factor VIII; Fever; Fibrinogen; Granulocytes; Hemolysis; Hemophilia A; Hemorrhage; Hepatitis; Humans; Hypersensitivity; Malaria; Methods; Sepsis; Serum Albumin; Syphilis; Thrombocytopenia; Transfusion Reaction | 1975 |
[Use of fibrinogen in hemorrhagic manifestations of different origin].
Topics: Adolescent; Adult; Aminocaproates; Blood Transfusion; Drug Therapy, Combination; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged | 1975 |
Cardiovascular lesions in pancreatitis.
Topics: Acute Disease; Adult; Amylases; Blood Coagulation; Blood Coagulation Tests; Capillary Permeability; Chronic Disease; Coronary Disease; Electrocardiography; Female; Fibrinogen; Fibrinolysis; Glucuronidase; Hemorrhage; Humans; Middle Aged; Pancreatic Elastase; Pancreatitis; Thrombelastography; Trypsin; Trypsin Inhibitors | 1975 |
Blood availability for the trauma patient-autotransfusion.
Topics: Bilirubin; Blood Banks; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Blood Transfusion, Autologous; Fibrinogen; Hematocrit; Hemoglobins; Hemolysis; Hemorrhage; Humans; Leukocyte Count; Liver; Liver Function Tests; Postoperative Complications; Prothrombin Time; Thoracic Surgery; Thorax; Thromboplastin; Wounds and Injuries | 1975 |
The hemostatic mechanism after open-heart surgery. II. Frequency of abnormal platelet functions during and after extracorporeal circulation.
Topics: Adenosine Diphosphate; Blood Cell Count; Blood Platelet Disorders; Blood Platelets; Blood Proteins; Cardiac Surgical Procedures; Collagen; Epinephrine; Extracorporeal Circulation; Fibrin; Fibrinogen; Hemorrhage; Humans; Platelet Adhesiveness; Platelet Aggregation; Platelet Factor 3; Postoperative Complications; Prospective Studies; Protamines; Time Factors | 1975 |
Effects of somatostatin on hemostasis in baboons.
Topics: Adenosine Diphosphate; Animals; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Collagen; Epinephrine; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Hemosiderin; Hemostasis; Infusions, Parenteral; Lung; Lung Diseases; Male; Papio; Platelet Aggregation; Somatostatin; Thrombocytopenia | 1975 |
Periepicardial fibrinolytic activity: relation to cardiac bleeding.
Topics: Aminocaproates; Animals; Blood Coagulation; Blood Coagulation Tests; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cats; Electric Stimulation; Fibrin; Fibrinogen; Fibrinolysis; Heart Diseases; Hemorrhage; Injections, Intravenous; Ischemia; Pericardium; Postoperative Complications; Streptokinase; Ventricular Fibrillation | 1975 |
Changes of coagulation and fat-metabolism following pulmonary microembolism after trauma and hemorrhage.
Topics: Animals; Blood Cell Count; Blood Coagulation; Blood Platelets; Blood Volume; Cholesterol; Dogs; Fatty Acids, Nonesterified; Female; Fibrinogen; Glycerol; Hemorrhage; Lipids; Male; Platelet Adhesiveness; Pulmonary Embolism; Thrombelastography; Tibia; Triglycerides; Vascular Resistance; Wounds and Injuries | 1975 |
Editorial: Disseminated intravascular coagulation--a color of different horses.
Topics: Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Humans; Thromboplastin; Thrombosis | 1975 |
Proceedings: Abnormal fibrin monomer polymerization in liver disease.
Topics: Fibrin; Fibrinogen; Hemorrhage; Humans; Liver Cirrhosis; Liver Diseases | 1975 |
[The clinical significance of deficiency coagulopathy in relationship to consumption coagulopathy (authors' transl)].
Topics: Adult; Blood Cell Count; Blood Coagulation Disorders; Blood Platelets; Diagnosis, Differential; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemorrhage; Humans; Shock, Hemorrhagic | 1976 |
The glycosaminoglycan of recombinant human soluble thrombomodulin affects antithrombotic activity in a rat model of tissue factor-induced disseminated intravascular coagulation.
Topics: Animals; Disease Models, Animal; Disseminated Intravascular Coagulation; Enzyme-Linked Immunosorbent Assay; Fibrinogen; Fibrinolysis; Glycosaminoglycans; Hemorrhage; Heparin; Male; Platelet Count; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Thrombin; Recombinant Proteins; Solubility; Thromboplastin | 1992 |
Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Blood Platelets; Calcium; Clot Retraction; Collagen; Cyclic AMP; Epinephrine; Fibrinogen; Hemorrhage; Humans; Indomethacin; Kinetics; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Prostaglandin Endoperoxides, Synthetic; Reference Values; Thrombin; Vasoconstrictor Agents; von Willebrand Factor | 1992 |
Comparison of the potency of three Brazilian Bothrops antivenoms using in vivo rodent and in vitro assays. BIASG (Butantan Institute Antivenom Study Group).
Topics: Animals; Antivenins; Blood Coagulation; Crotalid Venoms; Fibrinogen; Hemorrhage; Immunoglobulin G; Lethal Dose 50; Mice; Necrosis; Neutralization Tests; Snake Venoms | 1992 |
Autoantibody to plasma fibrinopeptide A in a patient with a severe acquired haemorrhagic syndrome.
Topics: Autoantibodies; Binding Sites; Blood Coagulation Disorders; Fibrin; Fibrinogen; Fibrinopeptide A; Hemorrhage; Humans; Immunoglobulin G; Kidney Failure, Chronic; Male; Middle Aged; Thrombin | 1992 |
Acquired factor X deficiency and disseminated intravascular coagulation in a case of metastasizing carcinoma of the stomach and its course under chemotherapy.
Topics: Adenocarcinoma; Adult; Blood Coagulation Factors; Disseminated Intravascular Coagulation; Factor X Deficiency; Female; Fibrinogen; Hemorrhage; Heparin; Humans; Neoplasm Metastasis; Plasma; Stomach Neoplasms | 1992 |
The efficacy of heparin in the treatment of common brown snake (Pseudonaja textilis) envenomation.
Topics: Animals; Blood Coagulation Disorders; Blood Pressure; Cardiac Output; Central Venous Pressure; Dogs; Elapid Venoms; Electrocardiography; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Rate; Hemorrhage; Heparin; Prothrombin Time; Stroke Volume; Thrombocytopenia; Thrombosis; Vascular Resistance | 1992 |
Hemorrhagic, fibrinogenolytic and edema-forming activities of the venom of the colubrid snake Philodryas olfersii (green snake).
Topics: Animals; Antivenins; Caseins; Chelating Agents; Chromatography, High Pressure Liquid; Cross Reactions; Edema; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Fibrinolysis; Hemorrhage; Hydrogen-Ion Concentration; Immunodiffusion; Mice; Proteins; Skin; Skin Diseases; Snake Venoms; Sulfhydryl Compounds | 1992 |
A defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorder.
Topics: Adenosine Diphosphate; Adult; Antibodies, Monoclonal; Blood Platelets; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Epinephrine; Fibrinogen; Hemorrhage; Humans; In Vitro Techniques; Male; Microscopy, Electron; Platelet Aggregation; Platelet Membrane Glycoproteins | 1992 |
Prevention of severe bleeding by tranexamic acid in a patient with disseminated intravascular coagulation.
Topics: Aged; alpha-Macroglobulins; Aorta, Abdominal; Aortic Aneurysm; Cyclohexanecarboxylic Acids; Disseminated Intravascular Coagulation; Fibrinogen; Fibrinolysin; Hemorrhage; Heparin; Humans; Male; Tranexamic Acid | 1990 |
Fibrinolysis and the bleeding tendency in patients with hepatosplenic schistosomiasis.
Topics: alpha-Macroglobulins; Antithrombin III; Complement C1 Inactivator Proteins; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Liver Diseases, Parasitic; Plasminogen; Platelet Count; Schistosomiasis; Splenic Diseases | 1990 |
Studies on Australian snake venoms, Part II: The haematological effects of brown snake (Pseudonaja) species in the dog.
Topics: Animals; Australia; Blood; Blood Coagulation; Blood Physiological Phenomena; Dogs; Elapid Venoms; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Partial Thromboplastin Time; Prothrombin Time; Snakes; Thrombocytopenia; Time Factors | 1991 |
Systemic haemorrhage in rats induced by a haemorrhagic fraction from Bothrops jararaca venom.
Topics: Animals; Batroxobin; Blood Coagulation; Chemical Fractionation; Chromatography, High Pressure Liquid; Crotalid Venoms; Endothelium, Vascular; Fibrinogen; Hemorrhage; Male; Platelet Aggregation; Rats; Rats, Inbred Strains | 1991 |
Treatment of the severe bleeding episode in type III von Willebrand's disease by simultaneous administration of cryoprecipitate and platelet concentrate.
Topics: Adult; Blood Component Transfusion; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Platelet Transfusion; von Willebrand Diseases | 1991 |
Hemostatic changes due to the venom gland extract of the red-necked keelback snake (Rhabdophis subminiatus).
Topics: Adult; Animals; Antithrombin III; Blood Coagulation; Blood Coagulation Tests; Exocrine Glands; Factor X; Fibrinogen; Hemorrhage; Hemostasis; Heparin; Humans; Male; Plasminogen; Plasminogen Activators; Protein C; Snake Bites; Snakes; Tissue Extracts; Tissue Plasminogen Activator; Venoms | 1991 |
Tissue plasminogen activator for the treatment of thromboembolism in infants and children.
Topics: Adolescent; Child; Child, Preschool; Female; Fibrinogen; Hemorrhage; Heparin; Humans; Infant; Infant, Newborn; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Partial Thromboplastin Time; Thromboembolism; Thrombolytic Therapy; Tissue Plasminogen Activator | 1991 |
Prolonged hypofibrinogenemia and protein C activation after envenoming by Echis carinatus sochureki.
Topics: Afibrinogenemia; Aged; Antivenins; Factor VIII; Fibrinogen; Hemorrhage; Humans; Male; Protein C; Prothrombin; Snake Bites; Viper Venoms | 1991 |
Cryoprecipitate for uremic bleeding.
Topics: Deamino Arginine Vasopressin; Factor VIII; Fibrinogen; Hemorrhage; Humans; Uremia | 1991 |
Hemostatic studies in racing standardbred horses with exercise-induced pulmonary hemorrhage. Hemostatic parameters at rest and after moderate exercise.
Topics: Adenosine Diphosphate; Animals; Antithrombin III; Collagen; Factor VIII; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Hemorrhage; Hemostasis; Horse Diseases; Horses; Lung Diseases; Partial Thromboplastin Time; Physical Exertion; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Prothrombin Time; Thrombin Time; von Willebrand Factor | 1991 |
Evaluation of hemostatic defects secondary to vascular tumors in dogs: 11 cases (1983-1988).
Topics: Anemia; Animals; Blood Coagulation Disorders; Breeding; Disseminated Intravascular Coagulation; Dog Diseases; Dogs; Fibrinogen; Follow-Up Studies; Hemangioma; Hemangiosarcoma; Hemorrhage; Hemostasis; Partial Thromboplastin Time; Prothrombin Time; Retrospective Studies; Skin Neoplasms; Thrombocytopenia | 1991 |
Characterization of Ac1-Proteinase from the venom of Agkistrodon acutus (Hundred-pace snake) from Taiwan.
Topics: Amino Acid Sequence; Animals; Crotalid Venoms; Endopeptidases; Fibrinogen; Hemorrhage; Hydrolysis; Insulin; Mice; Mice, Inbred ICR; Molecular Sequence Data; Muscles; Muscular Diseases; Necrosis; Peptide Fragments; Substrate Specificity | 1991 |
Hirudin in haemodialysis.
Topics: Animals; Blood Coagulation Tests; Blood Pressure; Dogs; Female; Fibrinogen; Hemorrhage; Heparin; Hirudins; Male; Nephrectomy; Platelet Count; Recombinant Proteins; Renal Dialysis | 1990 |
Bleeding time and other laboratory tests to monitor the safety and efficacy of thrombolytic therapy.
Topics: Bleeding Time; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematologic Tests; Hemorrhage; Humans; Myocardial Infarction; Platelet Function Tests; Streptokinase; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1990 |
Isolation of two hemorrhagic toxins from Crotalus basiliscus basiliscus (Mexican west coast rattlesnake) venom and their effect on blood clotting and complement.
Topics: Animals; Blood Coagulation; Carboxylic Ester Hydrolases; Chromatography, DEAE-Cellulose; Chromogenic Compounds; Complement System Proteins; Crotalid Venoms; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Endopeptidases; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Male; Mice; Mice, Inbred BALB C; Molecular Weight; Toxins, Biological | 1990 |
Direct detection of activated platelets and platelet-derived microparticles in humans.
Topics: Adenosine Diphosphate; Antibodies, Monoclonal; Blood Platelets; Cardiopulmonary Bypass; Fibrinogen; Flow Cytometry; Hemorrhage; Humans; In Vitro Techniques; Platelet Activation; Platelet Membrane Glycoproteins | 1990 |
Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
Topics: Blood Coagulation; Blood Coagulation Tests; Cardiopulmonary Bypass; Drug Administration Schedule; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Hemodilution; Hemorrhage; Heparin; Humans; Hypothermia, Induced; Middle Aged; Partial Thromboplastin Time; Protamines; Prothrombin Time | 1990 |
Whole blood activated clotting time in infants during extracorporeal membrane oxygenation.
Topics: Blood Coagulation Tests; Extracorporeal Membrane Oxygenation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Heparin; Humans; Infant, Newborn; Monitoring, Physiologic; Platelet Count; Reproducibility of Results; Whole Blood Coagulation Time | 1990 |
[Status of fibrinolysis in systemic lupus erythematosus].
Topics: Adult; Factor VIII; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Lupus Erythematosus, Systemic; Male; Plasminogen; Serum Albumin; Thrombosis | 1986 |
A comparison of isobutyl 2-cyanoacrylate glue, fibrin adhesive, and oxidized regenerated cellulose for control of needle hole bleeding from polytetrafluoroethylene vascular prostheses.
Topics: Animals; Aprotinin; Blood Vessel Prosthesis; Cellulose; Cellulose, Oxidized; Cyanoacrylates; Dogs; Drug Combinations; Drug Evaluation, Preclinical; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Hemostasis; Hemostatics; Needles; Polytetrafluoroethylene; Postoperative Complications; Thrombin; Time Factors | 1986 |
[Organ-preserving therapy of splenic rupture in adults?].
Topics: Adult; Aprotinin; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Humans; Risk; Splenectomy; Splenic Rupture; Thrombin | 1986 |
The effectiveness of a fibrinogen-thrombin-collagen-based hemostatic agent in an experimental arterial bleeding model.
Topics: Animals; Aprotinin; Blood Pressure; Collagen; Dogs; Drug Combinations; Drug Evaluation, Preclinical; Fibrinogen; Hemorrhage; Hemostatics; Iliac Artery; Thrombin; Time Factors | 1987 |
[Fibrin occlusion (Beriplast) of the prostatic cavity after transurethral resection of the prostate. A study of the method].
Topics: Aged; Aprotinin; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Follow-Up Studies; Hemorrhage; Humans; Male; Methods; Middle Aged; Postoperative Complications; Prostate; Thrombin | 1987 |
Application of fibrin adhesive in the urinary bladder.
Topics: Animals; Aprotinin; Cystoscopy; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Radiation Injuries, Experimental; Rats; Rats, Inbred Strains; Thrombin; Tissue Adhesives; Urinary Bladder Diseases | 1987 |
Application of a fibrinogen-thrombin-collagen-based hemostyptic agent in experimental injuries of liver and spleen.
Topics: Animals; Aprotinin; Blood Coagulation; Collagen; Dogs; Drug Combinations; Fibrinogen; Hemorrhage; Hemostatics; Liver; Spleen; Thrombin | 1988 |
Preservation of the spleen using human fibrin seal.
Topics: Animals; Aprotinin; Drug Combinations; Factor XIII; Female; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Postoperative Complications; Rabbits; Random Allocation; Splenectomy; Splenic Rupture; Suture Techniques; Thrombin; Tissue Adhesives; Wound Healing | 1988 |
[The effectiveness of local hemostatic agents in arresting hemorrhage from an injured spleen in an experiment].
Topics: Animals; Aprotinin; Dogs; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Gelatin Sponge, Absorbable; Hemorrhage; Hemostatics; Spleen; Thrombin; Uronic Acids | 1988 |
Use of fibrin glue in hepatic trauma.
Topics: Animals; Aprotinin; Dogs; Drug Combinations; Evaluation Studies as Topic; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Hemostatic Techniques; Liver; Thrombin; Tissue Adhesives | 1988 |
Fibrin glue on the Cohn I fraction basis in repairing cerebral and dura defects--an experimental study on rats.
Topics: Animals; Aprotinin; Blood Proteins; Brain; Drug Combinations; Dura Mater; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Humans; Microsurgery; Plasma; Rats; Sutures; Thrombin | 1988 |
Fibrin glue sealing of polytetrafluoroethylene vascular graft anastomoses: comparison with oxidized cellulose.
Topics: Anastomosis, Surgical; Animals; Aprotinin; Biocompatible Materials; Blood Vessel Prosthesis; Cellulose; Cellulose, Oxidized; Dogs; Drug Combinations; Factor XIII; Femoral Artery; Fibrin; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Polytetrafluoroethylene; Postoperative Complications; Random Allocation; Thrombin; Tissue Adhesives; Vascular Patency; Wound Healing | 1988 |
A new technical of liver biopsy with plugging of the needle track using a double channel biopsy device. An experimental study.
Topics: Animals; Aprotinin; Biopsy, Needle; Dogs; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Liver; Male; Thrombin; Tissue Adhesives | 1988 |
Use of microcrystalline collagen powder and fibrinogen tissue adhesive for hemostasis and prevention of rebleeding in patients with hepatocellular carcinoma associated with cirrhosis of the liver.
Topics: Aprotinin; Carcinoma, Hepatocellular; Collagen; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Hepatectomy; Humans; Liver Cirrhosis; Liver Neoplasms; Powders; Thrombin; Tissue Adhesives | 1989 |
Value of fibrin sealant in heart transplantation.
Topics: Anastomosis, Surgical; Animals; Aprotinin; Dogs; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Heart Transplantation; Hemorrhage; Hemostasis, Surgical; Postoperative Complications; Thrombin | 1989 |
[Use of fibrin glue at the anterior mediastinum to reduce postoperative drainage in cardiac surgery].
Topics: Aprotinin; Cardiac Surgical Procedures; Drainage; Drug Combinations; Factor XIII; Female; Fibrin; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Humans; Male; Mediastinum; Middle Aged; Postoperative Complications; Thrombin; Tissue Adhesives | 1988 |
Laparoscopically applied fibrin glue in experimental liver trauma.
Topics: Animals; Aprotinin; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Laparoscopy; Liver; Swine; Thrombin; Tissue Adhesives; Wounds, Penetrating | 1989 |
[Use of equipment for external fixation and rehabilitation of patients with hemophilia].
Topics: Adolescent; Adult; Arthrodesis; Factor VIII; Femoral Fractures; Fibrinogen; Fracture Fixation; Hemophilia A; Hemorrhage; Humans; Joint Diseases; Knee Joint; Male; Orthopedic Fixation Devices; Preoperative Care | 1989 |
A new thrombolytic regimen for acute myocardial infarction using combination half dose tissue-type plasminogen activator with full dose streptokinase: a pilot study. KAMIT Study Group.
Topics: Aged; Coronary Angiography; Drug Therapy, Combination; Female; Fibrinogen; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Pilot Projects; Recurrence; Streptokinase; Stroke Volume; Tissue Plasminogen Activator; Vascular Patency | 1989 |
Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator.
Topics: Adult; Aged; Coronary Angiography; Electrocardiography; Female; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Recombinant Proteins; Recurrence; Tissue Plasminogen Activator; Vascular Patency | 1989 |
[Indications for blood transfusion].
Topics: Adult; Blood Proteins; Blood Transfusion; Child; Erythrocyte Transfusion; Factor VIII; Fibrinogen; Hematologic Diseases; Hemorrhage; Humans; Immunoglobulins; Infant; Infant, Newborn; Leukocyte Transfusion; Platelet Transfusion; Shock | 1989 |
[Acute appendicitis in sliding hernia in a child with hemophilia].
Topics: Acute Disease; Appendicitis; Child, Preschool; Factor VIII; Fibrinogen; Hemophilia A; Hemorrhage; Hernia, Inguinal; Humans; Intraoperative Complications; Male; Preoperative Care | 1989 |
Hemorrhagic toxin from the venom of Agkistrodon bilineatus (common cantil).
Topics: Amino Acid Sequence; Animals; Crotalid Venoms; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Hemorrhage; Hydrolysis; Insulin; Lethal Dose 50; Mice; Molecular Sequence Data; Molecular Weight; Oxidation-Reduction; Peptide Hydrolases; Thrombin; Toxins, Biological | 1989 |
Bleeding after thrombolysis in acute myocardial infarction.
Topics: Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Risk Factors; Streptokinase; Urokinase-Type Plasminogen Activator | 1989 |
Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemorrhage; Heparin; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Platelet Count; Platelet Transfusion; Remission Induction; Retrospective Studies; Risk Factors | 1989 |
[Antiplasmin drugs and factor XIII concentrates in the treatment of a patient with acute promyelocytic leukemia (M3)].
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Factor XIII; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Leukemia, Promyelocytic, Acute | 1989 |
Near-fatal coagulopathy associated with Epstein-Barr virus hepatitis.
Topics: Adolescent; Afibrinogenemia; Factor VIII; Fibrinogen; Hemorrhage; Hepatitis, Viral, Human; Herpesvirus 4, Human; Humans; Infectious Mononucleosis; Liver Function Tests; Male | 1986 |
General surgery in adult hemophiliacs.
Topics: Adolescent; Adult; Aged; Blood Transfusion; Factor VIII; Fibrinogen; Hemophilia A; Hemophilia B; Hemorrhage; Humans; Male; Middle Aged; Plasma; Postoperative Complications; Retrospective Studies; Surgical Procedures, Operative | 1986 |
Acquired inhibitor to factor VIII in a nonhemophiliac patient.
Topics: Aged; Blood Coagulation Tests; Blood Transfusion; Ecchymosis; Factor VIII; Fibrinogen; Hematoma; Hemorrhage; Humans; Male; Prednisone; Quinidine | 1986 |
Thrombolysis in myocardial infarction (TIMI): comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator.
Topics: Aged; Blood Coagulation; Coronary Circulation; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Recombinant Proteins; Time Factors; Tissue Plasminogen Activator | 1987 |
Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction.
Topics: Age Factors; Aged; Female; Fibrinogen; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Sex Factors; Tissue Plasminogen Activator | 1988 |
The effect of human recombinant tissue-type plasminogen activator on clinical and laboratory parameters of hemostasis and systemic plasminogen activation in the dog and the rat.
Topics: Animals; Blood Coagulation Tests; Dogs; Female; Fibrinogen; Hemorrhage; Hemostasis; Humans; Infusions, Intravenous; Male; Plasminogen; Protease Inhibitors; Rats; Recombinant Proteins; Species Specificity; Tissue Plasminogen Activator | 1988 |
Prophylactic cryoprecipitate in congenital afibrinogenemia.
Topics: Afibrinogenemia; Child; Female; Fibrinogen; Hemorrhage; Humans; Wounds and Injuries | 1988 |
Characterisation of a monoclonal antibody capable of neutralising the haemorrhagic activity of West African Echis carinatus (carpet viper) venom.
Topics: Animals; Antibodies, Monoclonal; Antivenins; Blood Coagulation; Clone Cells; Electrophoresis, Polyacrylamide Gel; Fibrinogen; Hemorrhage; Hybridomas; Immunoglobulin G; Immunologic Techniques; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Neutralization Tests; Rats; Viper Venoms | 1988 |
Life salvage with fibrin glue in three cases of exsanguinating hemorrhage.
Topics: Aged; Child, Preschool; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Hemorrhage; Humans; Male; Thrombin; Tissue Adhesives | 1986 |
Hemorrhagic complications during extracorporeal membrane oxygenation: prevention and treatment.
Topics: Cerebral Hemorrhage; Drug Combinations; Extracorporeal Circulation; Factor XIII; Female; Fibrin Tissue Adhesive; Fibrinogen; Fibronectins; Hemorrhage; Heparin; Humans; Hypertension; Infant; Infant, Newborn; Male; Oxygenators, Membrane; Platelet Count; Thrombin; Tissue Adhesives | 1986 |
Rapid lysis of coronary artery thrombi with anisoylated plasminogen: streptokinase activator complex. Treatment by bolus intravenous injection.
Topics: Anistreplase; Cardiac Catheterization; Coronary Angiography; Dose-Response Relationship, Drug; Female; Fibrinogen; Hemorrhage; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Plasminogen; Streptokinase; Time Factors | 1986 |
Intra-arterial thrombolytic therapy in peripheral vascular disease.
Topics: Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Infusions, Intra-Arterial; Prospective Studies; Pulmonary Embolism; Streptokinase; Thrombosis | 1987 |
Evaluation of a fully automated centrifugal analyzer for performance of hemostasis tests.
Topics: Antithrombin III; Autoanalysis; Centrifugation; Fibrinogen; Hemorrhage; Hemostasis; Humans; Light; Plasminogen; Scattering, Radiation; Thromboplastin; Thrombosis | 1987 |
[Fibrinolysis and hemorrhage after streptokinase in acute myocardial infarct].
Topics: Female; Fibrinogen; Hemorrhage; Humans; Male; Myocardial Infarction; Prothrombin Time; Streptokinase | 1987 |
Clinical significance of venom antigen levels in patients envenomed by the Malayan pit viper (Calloselasma rhodostoma).
Topics: Adolescent; Adult; Antigens; Antivenins; Blood Coagulation; Child; Child, Preschool; Crotalid Venoms; Enzyme-Linked Immunosorbent Assay; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Humans; Middle Aged; Necrosis; Snake Bites; Time Factors; Tourniquets | 1986 |
[Effect of hemosorption on blood coagulation system factors in patients with severe suppurative infection].
Topics: Adolescent; Adult; alpha-2-Antiplasmin; Antithrombin III; Blood Coagulation; Factor XIII; Fibrinogen; Hemoperfusion; Hemorrhage; Humans; Monitoring, Physiologic; Platelet Aggregation; Platelet Count; Toxemia; Wound Infection | 1986 |
Isolation and characterization of hemorrhagic toxin g from the venom of Crotalus atrox (western diamondback rattlesnake).
Topics: Amino Acids; Animals; Crotalid Venoms; Fibrinogen; Hemorrhage; Hot Temperature; Isoelectric Point; Mice; Molecular Weight | 1985 |
Isolation and characterization of hemorrhagic factors a and b from the venom of the Chinese habu snake (Trimeresurus mucrosquamatus).
Topics: Animals; Chromatography; Crotalid Venoms; Dipeptides; Electrophoresis; Fibrinogen; Hemorrhage; Mice; Molecular Weight; Necrosis; Substrate Specificity | 1985 |
Bypass surgery following thrombolytic therapy.
Topics: Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Coronary Artery Bypass; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Middle Aged; Myocardial Infarction; Recurrence; Risk | 1985 |
Toxicity of group B Streptococcus agalactiae in adult rats.
Topics: Animals; Bacterial Toxins; Complement C3; Female; Fibrinogen; Hemoglobinuria; Hemolysis; Hemorrhage; Kidney; Leukocyte Count; Liver; Lung; Platelet Count; Rats; Rats, Inbred Strains; Spleen; Streptococcus agalactiae | 1985 |
[Consumption coagulopathies observed in intensive care units (apropos of 359 cases)].
Topics: Blood Coagulation Tests; Disseminated Intravascular Coagulation; Female; Fibrinogen; France; Hemorrhage; Heparin; Humans; Intensive Care Units; Pregnancy; Shock | 1985 |
Cryoprecipitate-topical thrombin glue. Initial experience in patients undergoing cardiac operations.
Topics: Cardiac Surgical Procedures; Coronary Artery Bypass; Factor VIII; Fibrinogen; Hemorrhage; Hemostasis, Surgical; Hemostatics; Humans; Postoperative Complications; Reoperation; Tissue Adhesives | 1985 |
A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part III. Clinical pathology and pathogenesis.
Topics: Adult; Antibodies, Viral; Blood Cell Count; Complement System Proteins; Cross Infection; Disease Outbreaks; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Hemorrhagic Fever Virus, Crimean-Congo; Hemorrhagic Fever, Crimean; Humans; Liver; Prothrombin Time; Skin; South Africa | 1985 |
Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction.
Topics: Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Infusions, Intra-Arterial; Myocardial Infarction; Recurrence; Streptokinase | 1986 |
[A rare case of congenital hypodysfibrinogenemia].
Topics: Adult; Afibrinogenemia; Blood Coagulation Disorders; Female; Fibrinogen; Hemorrhage; Humans; Platelet Count | 1985 |
Congenital afibrinogenemia: an unusual case.
Topics: Adult; Afibrinogenemia; Cerebral Hemorrhage; Fibrinogen; Hemorrhage; Humans; Lung Diseases; Male; Muscular Diseases; Prothrombin Time; Tomography, X-Ray Computed | 1985 |
125I-fibrinogen estimation and unrecognised haemorrhage.
Topics: Fibrinogen; Hemorrhage; Humans; Injections, Intravenous; Iodine Radioisotopes | 1970 |
[Fibrinolytic proteases from snake venoms].
Topics: Alpha-Globulins; Animals; Antivenins; Cattle; Chromatography, DEAE-Cellulose; Chromium Isotopes; Coagulase; Electrophoresis; Electrophoresis, Disc; Erythrocytes; Fibrinogen; Fibrinolysin; Fibrinolysis; Gels; Hemorrhage; Peptide Hydrolases; Rats; Snakes; Starch; Thrombelastography; Trypsin Inhibitors; Venoms | 1971 |
[Influence of plasma substitutes on the blood loss during prostatectomy].
Topics: Aminocaproates; Blood Coagulation; Blood Transfusion; Dextrans; Fibrinogen; Hemoglobinometry; Hemorrhage; Humans; Male; Plasma Substitutes; Postoperative Complications; Prostatectomy; Prostatic Hyperplasia | 1970 |
Chlormadinone acetate and its effect on the hemostatic mechanism.
Topics: Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Chlormadinone Acetate; Contraceptives, Oral; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostasis; Humans; Immunodiffusion; Uterus | 1972 |
[New plasma derivatives].
Topics: Anemia, Neonatal; Blood Coagulation Factors; Dicumarol; Erythroblastosis, Fetal; Factor VIII; Female; Fibrinogen; Hemophilia A; Hemophilia B; Hemorrhage; Hepatitis A; Humans; Immunization, Passive; Immunoglobulins; Infant, Newborn; Infusions, Parenteral; Injections, Intravenous; Liver Diseases; Plasma; Pregnancy; Tetanus; Tissue Extracts | 1972 |
[Human thrombin inhibitors ( 2 -macroglobulin and antithrombin 3) during and after surgical and gynecologic-obstetrical intervention].
Topics: Adolescent; Adult; Aged; Antithrombins; Female; Fibrinogen; Fibrinolysin; Heart Defects, Congenital; Heart-Lung Machine; Hemorrhage; Humans; Macroglobulins; Male; Middle Aged; Plasminogen; Pregnancy; Pregnancy Complications; Protease Inhibitors; Surgical Procedures, Operative; Thrombin; Trypsin Inhibitors | 1972 |
Goodpasture syndrome. Dissociation from antibodies to glomerular basement membrane.
Topics: Adolescent; Anti-Glomerular Basement Membrane Disease; Antibodies; Antigen-Antibody Complex; Basement Membrane; Beta-Globulins; Fibrinogen; Fluorescent Antibody Technique; Glomerulonephritis; Graft Rejection; Hemorrhage; Humans; Immunoglobulin G; Immunoglobulin M; Kidney Glomerulus; Kidney Transplantation; Kidney Tubules; Lung Diseases; Male; Nephrectomy; Radiography; Renal Dialysis; Transplantation, Homologous | 1973 |
[Disseminated intravascular coagulation in blastic leukemia and certain other disorders].
Topics: Acute Disease; Antithrombins; Blood Cell Count; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Leukemia; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Liver Cirrhosis; Lymphatic Diseases; Platelet Adhesiveness; Prothrombin Time; Retinal Detachment; Thrombin; Thrombophlebitis | 1974 |
Letter: Defibrination and head injury.
Topics: Blood Coagulation Tests; Craniocerebral Trauma; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Hemorrhage; Humans; Thrombocytopenia | 1974 |
Fibrinogen-transmitted hepatitis; a controlled study.
Topics: Abruptio Placentae; Afibrinogenemia; Aortic Aneurysm; Aspartate Aminotransferases; Embolism, Amniotic Fluid; Female; Fetal Death; Fibrinogen; gamma-Globulins; Hemorrhage; Hepatitis B; Humans; Liver Cirrhosis; Placenta Previa; Pregnancy; Thoracic Surgery; Thorax; Uterine Rupture | 1966 |
Hypofibrinogenaemia without increased fibrinolysis in leukaemia.
Topics: Adult; Afibrinogenemia; Blood Cell Count; Blood Coagulation Disorders; Blood Coagulation Tests; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemorrhage; Humans; Leukemia; Leukemia, Myeloid; Male; Middle Aged; Thrombocytopenia | 1967 |
Anticoagulant therapy with a purified fraction of Malayan pit viper venom.
Topics: Adolescent; Adult; Aged; Antivenins; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Thrombophlebitis; Thrombosis; Venoms | 1968 |
Pig-to-baboon liver xenografts.
Topics: Animals; Azathioprine; Bronchopneumonia; Fibrinogen; Hemorrhage; Hominidae; Liver; Liver Transplantation; Swine; Transplantation Immunology; Transplantation, Heterologous | 1968 |
[Fibrinolytic hemorrhage in surgery and its treatment with p-aminomethylbenzoic acid].
Topics: Adult; Antifibrinolytic Agents; Benzoates; Blood Coagulation Disorders; Blood Coagulation Tests; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Male; Postoperative Complications; Surgical Procedures, Operative | 1967 |
[On the application of blood and blood fractions in combination with antifibrinolytic agents].
Topics: Afibrinogenemia; Antifibrinolytic Agents; Blood Banks; Blood Coagulation Factors; Blood Preservation; Blood Transfusion; Dextrans; Fibrinogen; Freeze Drying; gamma-Globulins; Hemorrhage; Hepatitis; Humans; Methods; Plasma; Serum Albumin; Shock | 1967 |
Fibrinogen-transmitted hepatitis in the surgical patient.
Topics: Adolescent; Adult; Age Factors; Aged; Aspartate Aminotransferases; Bilirubin; Blood Transfusion; Cardiac Surgical Procedures; Child; Child, Preschool; Female; Fibrinogen; gamma-Globulins; Hemorrhage; Hepatitis B; Humans; Infant; Male; Middle Aged; Postoperative Complications; Retrospective Studies | 1969 |
The skin in disseminated intravascular coagulation. Prospective analysis of thirty-six cases.
Topics: Adolescent; Adult; Aged; Blister; Blood Cell Count; Blood Coagulation Tests; Blood Pressure; Child; Cyanosis; Disseminated Intravascular Coagulation; Female; Fever; Fibrinogen; Hematocrit; Hematoma; Hemorrhage; Heparin; Humans; Male; Middle Aged; Neisseria meningitidis; Pneumonia, Staphylococcal; Prospective Studies; Pulse; Purpura; Skin Manifestations; Staphylococcus | 1973 |
Effects of puff-adder venom on coagulation, fibrinolysis and platelet aggregation in the baboon.
Topics: Animals; Blood Coagulation; Blood Coagulation Tests; Female; Fibrinogen; Fibrinolysis; Haplorhini; Hemorrhage; Heparin; Male; Papio; Platelet Adhesiveness; Protein Denaturation; Shock, Septic; Snakes; Thrombocytopenia; Venoms | 1974 |
Fibrinolytic activity and fibrinogen levels in Papuans and New Guineans.
Topics: Adolescent; Adult; Afibrinogenemia; Blood Coagulation Tests; Ethnology; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemorrhage; Humans; Male; New Guinea; Postpartum Hemorrhage; Pregnancy; White People | 1965 |
Blood coagulation and fibrinolysis in acute leukaemia.
Topics: Adolescent; Adult; Blood Coagulation; Child; Factor V; Factor VIII; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Male; Middle Aged; Plasminogen; Serum Globulins | 1970 |
[Blood coagulation disorders and extracorporeal circulation].
Topics: Adolescent; Adult; Aged; Aminocaproates; Blood Cell Count; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Coumarins; Extracorporeal Circulation; Factor V; Fibrinogen; Fibrinolysin; Hematocrit; Hemorrhage; Heparin; Humans; Middle Aged; Plasminogen; Postoperative Care; Postoperative Complications; Preoperative Care; Prothrombin Time | 1969 |
[Hemostatic disorders in the treatment of leukoblastosis with L-asparaginase (crasnitin)].
Topics: Antithrombins; Asparaginase; Blood Platelets; Factor VIII; Factor XIII; Fibrinogen; Fibrinolysin; Hemorrhage; Hemostasis; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Plasminogen; Prothrombin; Prothrombin Time; Serum Globulins; Thrombin; Time Factors | 1973 |
Fibrinogen and FDP-models of molecular pathology?
Topics: Blood Coagulation Disorders; Factor XIII; Fibrinogen; Fibrinolysin; Hemorrhage; Humans; Models, Biological; Thrombin | 1973 |
Fibrinolysis in thoracic surgery.
Topics: Adolescent; Adult; Blood Coagulation Disorders; Blood Coagulation Factors; Child; Disseminated Intravascular Coagulation; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Hemorrhage; Humans; Lung; Male; Middle Aged; Plasminogen; Postoperative Complications; Thoracic Surgery; Thorax | 1973 |
[Coagulation disorders after reinjection of concentrated ascitic fluid. Preliminary study].
Topics: Aminocaproates; Ascitic Fluid; Blood Coagulation Disorders; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Fibrinogen; Fibrinolysin; Hemorrhage; Humans; Infusions, Parenteral; Liver Cirrhosis; Plasminogen | 1973 |
Pre- and post-operative studies of fibrinolysis and prothrombin in cyanotic congenital heart disease.
Topics: Child; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Heart Defects, Congenital; Hemorrhage; Humans; Hypoprothrombinemias; Plasminogen; Prothrombin | 1974 |
[Acute disseminated intravascular coagulation in an obstetrical unit. Study of 9 cases. Diagnostic criteria. Therapeutic management].
Topics: Acute Disease; Aminocaproates; Blood Coagulation Factors; Blood Coagulation Tests; Blood Transfusion; Cesarean Section; Disseminated Intravascular Coagulation; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Hemostasis; Humans; Hydrocortisone; Pregnancy; Pregnancy Complications, Hematologic; Shock, Hemorrhagic | 1973 |
Action of cobalt compounds on vascular permeability, mast cells and blood clotting in rats and rabbits.
Topics: Animals; Blood Coagulation; Capillary Permeability; Cobalt; Cobalt Isotopes; Fibrinogen; Guinea Pigs; Hemorrhage; Mast Cells; Prothrombin Time; Rabbits; Rats | 1970 |
Experience with autotransfusion in the surgical management of trauma.
Topics: Adolescent; Adult; Blood Coagulation Tests; Blood Proteins; Blood Transfusion, Autologous; Female; Fibrinogen; Hemorrhage; Hemothorax; Humans; Male; Wounds and Injuries | 1974 |
Studies on blood coagulation in cancer patients.
Topics: Aged; Blood Coagulation; Blood Coagulation Tests; Child, Preschool; Female; Fibrinogen; Hemorrhage; Heparin; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Prothrombin Time | 1974 |
The tri-F titer: a rapid test for estimation of plasma fibrinogen and detection of fibrinolysis, fibrin(ogen) split products, and heparin.
Topics: Aminocaproates; Extracorporeal Circulation; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Methods; Protamines; Prothrombin Time; Sodium Chloride; Thromboplastin | 1974 |
[Hemorrhages after radical correction of tetralogy of Fallot].
Topics: Blood Coagulation Disorders; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Postoperative Complications; Prothrombin; Tetralogy of Fallot; Thrombocytopenia | 1974 |
[Autotransfusion through acute, preoperative hemodilution --1st clinical experiences].
Topics: Adult; Aged; Blood Circulation; Blood Transfusion, Autologous; Echinococcosis, Hepatic; Female; Fibrinogen; Heart Rate; Hemorrhage; Hip Joint; Humans; Lip Neoplasms; Male; Middle Aged; Oxygen; Oxygen Consumption; Partial Pressure; Postoperative Complications; Preoperative Care | 1974 |
[Hemorrhagic complications with fibrinogen changes. Practical data. Schematic description with glossary].
Topics: Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Humans; Surgical Procedures, Operative | 1974 |
Newer trends in intra-operative blood replacement.
Topics: Adult; Aged; Blood Cells; Blood Group Incompatibility; Blood Platelets; Blood Preservation; Blood Transfusion; Centrifugation; Child, Preschool; Factor IX; Female; Fibrinogen; Freezing; Hemorrhage; Hepatitis B; Humans; Leukocytes; Male; Middle Aged; Plasma; Surgical Procedures, Operative; Transfusion Reaction | 1972 |
Coagulation abnormalities in acute liver failure; pathogenetic and therapeutic implications.
Topics: Acetaminophen; Acute Disease; Bilirubin; Biopsy; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Transfusion; Chemical and Drug Induced Liver Injury; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Heparin; Humans; Iodine Radioisotopes; Liver Diseases; Prothrombin Time | 1973 |
Acute promyelocytic leukaemia.
Topics: Acid Phosphatase; Binding Sites; Bone Marrow Cells; Erythrocytes; Factor V; Factor VIII; Fibrinogen; Hematuria; Hemorrhage; Heparin; Humans; Leukemia, Myeloid; Leukocyte Count; Peroxidases; Platelet Transfusion; Prognosis; Prothrombin; Purpura; Remission, Spontaneous; Thrombocytopenia; Vitamin B 12 | 1974 |
Hemostasis in malignancy.
Topics: Blood Cell Count; Blood Coagulation; Blood Platelets; Cell Survival; Fibrinogen; Fibrinolytic Agents; Hematopoiesis; Hemorrhage; Humans; Kinetics; Neoplasms; Thrombocytopenia; Thromboembolism; Thrombophlebitis | 1974 |
The hemorrhagic phenomena associated with green pit viper (Trimeresurus erythrurus and Trimeresurus popeorum) bites in children. A report of studies to elucidate their pathogenesis.
Topics: Adolescent; Aminocaproates; Aprotinin; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Child; Child, Preschool; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Female; Fibrinogen; Hemorrhage; Heparin; Humans; Infant; Male; Snake Bites; Venoms | 1973 |
Prevention of the liquoid-induced consumption coagulopathy by the protease inhibitor aprotinin.
Topics: Animals; Aprotinin; Blood Cell Count; Blood Platelets; Disseminated Intravascular Coagulation; Factor XII; Female; Fibrinogen; Hematocrit; Hemorrhage; Lung; Male; Rabbits; Shwartzman Phenomenon; Sulfonic Acids; Surface-Active Agents | 1972 |
Hereditary giant platelet syndrome: a disorder of a new aspect of platelet function.
Topics: Adenosine Diphosphate; Adolescent; Blood Platelet Disorders; Child; Collagen; Female; Fibrinogen; Hemorrhage; Humans; Plasma; Platelet Adhesiveness; Prothrombin; Purpura, Thrombocytopenic; Ristocetin; Syndrome; Thrombin; von Willebrand Diseases | 1973 |
[Efficiency and limits of blood coagulation tests].
Topics: Antithrombins; Blood Coagulation Disorders; Blood Coagulation Tests; Fibrinogen; Hemorrhage; Heparin; Humans; Methods; Phospholipids; Prothrombin Time; Temperature; Thrombelastography; Thrombin; Thromboplastin; Time Factors | 1973 |
[Efficiency and limits of fibrinolytic system function tests].
Topics: Afibrinogenemia; Blood Coagulation Tests; Diagnosis, Differential; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Hemorrhagic Disorders; Humans; Methods; Prothrombin Time; Time Factors | 1973 |
Acute promyelocytic leukemia: a model for understanding the role of the malignant cell in hemostasis.
Topics: Blood Coagulation Tests; Bone Marrow; Bone Marrow Cells; Bone Marrow Examination; Daunorubicin; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Hemostasis; Heparin; History, 20th Century; Humans; Leukemia, Myeloid, Acute; Thromboplastin | 1974 |
[Transfusion accident due to ABO incompatibility. Heparin treatment].
Topics: Abdominal Injuries; ABO Blood-Group System; Adult; Anesthesia, General; Blood Group Incompatibility; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemorrhage; Hemostasis; Heparin; Humans; Hypotension; Suicide; Transfusion Reaction | 1972 |
[Changes in the properties of fibrinogen as a result of blood loss].
Topics: Adult; Blood Coagulation; Blood Donors; Factor XIII; Fibrinogen; Fibrinolysis; Hemorrhage; Hot Temperature; Humans; Middle Aged; Postoperative Complications; Time Factors | 1972 |
Counterelectrophoresis test for molecules immunologically similar to fibrinogen.
Topics: Afibrinogenemia; Animals; Antibodies; Fibrin; Fibrinogen; Hemorrhage; Humans; Immune Sera; Immunoelectrophoresis; Rabbits; Thromboembolism; Thrombosis | 1972 |
[Influence of single and repeated hemodialises on the blood coagulation status].
Topics: Biological Evolution; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Factor V; Factor VII; Factor X; Fibrinogen; Hemorrhage; Humans; Kidneys, Artificial; Platelet Adhesiveness; Prothrombin; Prothrombin Time; Renal Dialysis; Thrombelastography; Thrombin | 1972 |
Clinical prolonged extracorporeal circulation for respiratory insufficiency: hematological effects.
Topics: Adolescent; Adult; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Child, Preschool; Disseminated Intravascular Coagulation; Dose-Response Relationship, Drug; Extracorporeal Circulation; Fibrinogen; Heart-Lung Machine; Hemorrhage; Heparin; Humans; Middle Aged; Respiratory Insufficiency; Thrombocytopenia | 1972 |
Clinical uses of human blood fractions.
Topics: Adolescent; Adult; Agammaglobulinemia; Blood Coagulation Disorders; Blood Platelets; Blood Proteins; Blood Transfusion; Chickenpox; Child; Child, Preschool; Erythroblastosis, Fetal; Erythrocytes; Factor VIII; Female; Fibrinogen; Hemorrhage; Hepatitis B; Herpes Zoster; Humans; Immunoglobulins; Infant; Infant, Newborn; Pregnancy; Prothrombin; Serum Albumin; Smallpox; Tetanus | 1973 |
Defibrination syndrome or?
Topics: Blood Coagulation Factors; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Heparin | 1973 |
Abnormal bleeding after prostatectomy.
Topics: Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Prostatectomy | 1973 |
[Consumption coagulopathy in patients with Klippel-Trenaunay syndrome].
Topics: Angiomatosis; Bone Diseases; Child; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Heparin; Humans; Male; Plasma; Postoperative Complications | 1973 |
Hemorrhagic studies with severe hemodilution in profound hypothermia and cardiac arrest.
Topics: Albumins; Animals; Blood Cell Count; Blood Platelets; Blood Pressure; Blood Proteins; Craniotomy; Dogs; Female; Femoral Artery; Fibrinogen; Heart Arrest, Induced; Hematocrit; Hemorrhage; Humans; Hypothermia, Induced; Intracranial Aneurysm; Male; Perfusion; Plasma Substitutes; Postoperative Complications; Venous Pressure | 1973 |
Autotransfusion: perspective and critical problems.
Topics: Animals; Blood; Blood Cell Count; Blood Coagulation Tests; Blood Platelets; Blood Transfusion, Autologous; Disease Models, Animal; Dogs; Fibrinogen; Hematocrit; Hemolysis; Hemorrhage; Heparin; Humans; Hydrogen-Ion Concentration; Oxygen; Vascular Surgical Procedures; Wounds and Injuries | 1973 |
Streptokinase therapy in deep-vein thrombosis.
Topics: Adult; Aged; Blood Coagulation Tests; Catheterization; Female; Femoral Vein; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Iliac Vein; Injections, Intravenous; Male; Middle Aged; Phlebography; Postoperative Complications; Recurrence; Streptokinase; Thrombophlebitis; Time Factors | 1973 |
Evolution of blood clotting factor leves in premature infants during the first 10 days of life: a study of 96 cases with comparison between clinical status and blood clotting factor levels.
Topics: Age Factors; Blood Coagulation Factors; Capillaries; Central Nervous System Diseases; Disseminated Intravascular Coagulation; Factor V; Factor VII; Factor X; Fibrinogen; Gestational Age; Hematocrit; Hemorrhage; Humans; Hyaline Membrane Disease; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Microchemistry; Respiratory Distress Syndrome, Newborn; Vitamin K | 1973 |
A review of the obstetrical aspects of haemostasis.
Topics: Blood Coagulation Disorders; Factor VII; Factor VIII; Factor X; Female; Fibrinogen; Hemorrhage; Humans; Pregnancy; Pregnancy Complications, Hematologic; Thromboembolism | 1973 |
Intravascular coagulation: the cause of necrotic arachnidism.
Topics: Animals; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Endothelium; Female; Fibrin; Fibrinogen; Hemorrhage; Injections, Intradermal; Microscopy, Electron; Necrosis; Prothrombin Time; Rabbits; Spider Bites; Spiders; Thrombosis; Time Factors; Venoms | 1973 |
125I fibrinogen and the prevention of venous thrombosis.
Topics: Adult; Amides; Anticoagulants; Fibrinogen; Hematoma; Hemorrhage; Heparin; Hip Joint; Humans; Iodine Radioisotopes; Joint Prosthesis; Leg; Phlebography; Physical Examination; Postoperative Complications; Radionuclide Imaging; Thiazines; Thiazoles; Thrombophlebitis; Ultrasonography; Warfarin | 1973 |
Fibrinolysis in lymphangioma.
Topics: Administration, Oral; Biopsy; Blood Coagulation; Buttocks; Child, Preschool; Cyclohexanecarboxylic Acids; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Infant; Infant, Newborn; Injections, Intravenous; Lymphangioma; Male; Postoperative Complications; Surgical Wound Infection | 1973 |
[Significance of fibrin-stabilizing factor in the pathogenesis of hemorrhagic manifestations in viral hepatitis].
Topics: Adolescent; Adult; Aged; Blood Coagulation Disorders; Child; Child, Preschool; Factor XIII; Female; Fibrinogen; Hemorrhage; Hepatitis A; Humans; Infant; Male; Middle Aged; Prothrombin | 1973 |
[Survival of platelets and of fibrinogen in a case of the Wiskott-Aldrich syndrome].
Topics: Blood Platelets; Cell Survival; Fibrinogen; Hemorrhage; Humans; Infant; Male; Thrombocytopenia; Wiskott-Aldrich Syndrome | 1973 |
[Changes in certain indicators of hemocoagulation, reaction of morphological dissociation of coagulated blood and qualitative fibrinogen tests in blood loss during surgery].
Topics: Adult; Aged; Blood Coagulation Tests; Female; Fibrinogen; Gastrointestinal Diseases; Genital Diseases, Female; Hemorrhage; Humans; Male; Middle Aged; Surgical Procedures, Operative | 1973 |
[Proceedings: Hemorrhagic diseases due to insufficiency of coagulation factor XIII].
Topics: Factor XIII Deficiency; Fibrinogen; Hemorrhage; Humans | 1973 |
Influence of plasma substitutes on the blood concentration of fibrinogen during prostatic surgery.
Topics: Aged; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Plasma Substitutes; Postoperative Complications; Preoperative Care; Prostatectomy | 1973 |
A possible rôle of leukocytes in hemostasis.
Topics: Animals; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cell Aggregation; Dogs; Fibrin; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Hemostasis; Leukocytes; Mesentery; Microcirculation; Thrombin | 1973 |
Laboratory control of SK therapy.
Topics: Acute Disease; Arterial Occlusive Diseases; Blood Coagulation; Blood Coagulation Tests; Chronic Disease; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Peptide Hydrolases; Plasminogen; Recurrence; Serum Globulins; Snake Venoms; Solubility; Streptokinase; Thrombelastography; Thrombin; Time Factors | 1973 |
Blood component therapy.
Topics: ABO Blood-Group System; Blood Banks; Blood Platelets; Blood Preservation; Blood Proteins; Blood Transfusion; Erythrocytes; Fibrinogen; Freezing; Hemorrhage; Humans; Plasma; Plasma Substitutes; Plasma Volume; Postoperative Care; Serum Albumin | 1974 |
Editorial: Bleeding time, other in vivo hemostasis tests and the arrest of hemorrhage.
Topics: Afibrinogenemia; Animals; Basement Membrane; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Capillaries; Capillary Fragility; Capillary Permeability; Clot Retraction; Ecchymosis; Fibrin; Fibrinogen; Hemorrhage; Humans; Methods; Platelet Adhesiveness; Thrombocytopenia; Wound Healing | 1974 |
Fibrinogen levels in obstetric complications.
Topics: Abortion, Missed; Afibrinogenemia; Female; Fetal Death; Fibrinogen; Hemorrhage; Hepatitis A; Humans; Pregnancy; Pregnancy Complications; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious | 1974 |
Haemostatic defects in polycythaemia vera.
Topics: Adenosine Diphosphate; Adult; Aged; Antithrombins; Blood Cell Count; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Clot Retraction; Collagen; Disseminated Intravascular Coagulation; Epinephrine; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Male; Middle Aged; Plasminogen; Platelet Adhesiveness; Polycythemia Vera; Prothrombin Time; Thrombin; Thrombophlebitis | 1974 |
Bleeding disorders during surgery.
Topics: Adrenal Cortex Hormones; Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Extracorporeal Circulation; Female; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Hemostasis; Humans; Liver Diseases; Male; Neoplasms; Purpura, Thrombocytopenic; Surgical Procedures, Operative; Thrombocytopenia; Transfusion Reaction | 1974 |
Changes in coagulation and fibrinolysis after orthotopic canine liver homotransplantation.
Topics: Aminocaproates; Animals; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Dogs; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Liver Transplantation; Plasminogen; Protamines; Prothrombin; Serum Globulins; Tissue Preservation; Transplantation, Homologous | 1969 |
Liver transplantation in man--IV, Haemorrhage and thrombosis.
Topics: Adult; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Factors; Child, Preschool; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Thrombosis; Transplantation, Homologous | 1969 |
The problems of thrombosis in the deep veins of the leg.
Topics: Adult; Cineangiography; Female; Fibrinogen; Hemorrhage; Heparin; History, 18th Century; Humans; Iodine Radioisotopes; Leg; Male; Middle Aged; Postoperative Complications; Streptokinase; Thrombophlebitis; Venoms | 1969 |
Cause of abnormal bleeding after transplantation of pig liver stored by a perfusion technique.
Topics: Animals; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelet Disorders; Factor VIII; Fibrinogen; Fibrinolysis; Hemorrhage; Liver Transplantation; Perfusion; Prothrombin; Swine; Time Factors; Tissue Preservation; Transplantation, Homologous | 1970 |
Use of radioactive fibrinogen for detecting rejection of human renal transplants.
Topics: Adolescent; Adult; Biopsy; Cadaver; False Positive Reactions; Female; Fibrinogen; Hemorrhage; Histocompatibility; Humans; Iodine Radioisotopes; Kidney; Kidney Transplantation; Male; Radiometry; Transplantation Immunology; Transplantation, Homologous | 1970 |
Goodpasture's syndrome: recovery from severe pulmonary hemorrhage after bilateral nephrectomy.
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Autoantibodies; Azathioprine; Complement System Proteins; Creatinine; Disease Models, Animal; Fibrinogen; Hematocrit; Hemorrhage; Humans; Immunoglobulin G; Kidney; Kidney Glomerulus; Kidney Transplantation; Lung Diseases; Male; Microscopy, Electron; Microscopy, Fluorescence; Nephrectomy; Prednisone; Transplantation, Homologous | 1971 |
Observations on the clotting of menstrual blood and clot formation.
Topics: Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Cervix Mucus; Estrogens; Factor IX; Factor V; Factor VII; Factor VIII; Female; Fibrinogen; Fibrinolysis; Glycogen; Hemorrhage; Humans; Immunoassay; Indicators and Reagents; Menstruation; Metrorrhagia; Microscopy, Electron; Microscopy, Phase-Contrast; Mucoproteins; Pregnancy; Pregnancy, Ectopic; Prothrombin; Time Factors; Urinary Catheterization; Uterus; Vagina | 1971 |
Determination of fibrinogen degradation products in serum and urine as a new diagnostic tool.
Topics: Antigens; Blood; Blood Protein Disorders; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Kidney Diseases; Kidney Transplantation; Leukemia; Liver Diseases; Neoplasms; Pregnancy; Thromboembolism | 1971 |
Heparin therapy in septicemia with disseminated intravascular coagulation.
Topics: Afibrinogenemia; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Child; Child, Preschool; Disseminated Intravascular Coagulation; Enterobacter; Escherichia coli; Female; Fibrinogen; Haemophilus influenzae; Hemorrhage; Heparin; Humans; Hypotension; Infant; Infant, Newborn; Leptospira; Male; Neisseria meningitidis; Prognosis; Prothrombin Time; Pseudomonas; Sepsis; Shock, Septic; Staphylococcus; Streptococcus | 1970 |
Clinical experience with determination of fibrinogen degradation products.
Topics: Acute Kidney Injury; Arteritis; Female; Fibrinogen; Hemorrhage; Humans; Immunodiffusion; Kidney Failure, Chronic; Liver Diseases; Methods; Neoplasms; Pneumonia; Pregnancy; Pregnancy Complications; Thromboembolism | 1971 |
A national cooperative trial of thrombolysis in pulmonary embolism: phase I results of urokinase therapy.
Topics: Angiography; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Plasminogen; Pulmonary Artery; Pulmonary Embolism; Radionuclide Imaging | 1972 |
[Use of anticoagulants in myocardial infarct].
Topics: Adult; Aged; Anticoagulants; Blood Pressure; Evaluation Studies as Topic; Female; Fibrinogen; Heart Aneurysm; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Prothrombin; Rupture; Thrombelastography | 1972 |
Platelets, fibrinogen, and fat embolism after trauma in rabbits.
Topics: Animals; Blood Cell Count; Blood Coagulation; Blood Platelets; Contusions; Edema; Embolism, Fat; Femoral Fractures; Femur; Fibrinogen; Hematocrit; Hematoma; Hemorrhage; Platelet Adhesiveness; Pulmonary Embolism; Rabbits; Time Factors; Wounds and Injuries | 1972 |
Detection of the intravascular activation of blood clotting. II. Results of the paracoagulation test in patients undergoing open heart surgery, with extracorporeal circulation.
Topics: Blood Coagulation Tests; Cardiac Surgical Procedures; Disseminated Intravascular Coagulation; Extracorporeal Circulation; Fibrin; Fibrinogen; Hemorrhage; Heparin; Humans; Time Factors | 1972 |
Defibrinogenation after intra-amniotic injection of hypertonic saline.
Topics: Abortion, Legal; Afibrinogenemia; Amnion; Blood Coagulation; Blood Platelets; Cell Count; Female; Fibrin; Fibrinogen; Hemorrhage; Humans; Hypertonic Solutions; Injections; Pregnancy; Prothrombin Time; Sodium Chloride | 1972 |
[Physio-pathological mechanisms of hemorrhages during viruses].
Topics: Acute Disease; Antithrombins; Blood Coagulation Disorders; Fibrinogen; Hemorrhage; Humans; Thrombocytopenia; Virus Diseases | 1972 |
Fibrin split products in the severely burned patient.
Topics: Adolescent; Adult; Aged; Burns; Child; Child, Preschool; Clot Retraction; Fibrin; Fibrinogen; Hemagglutination Inhibition Tests; Hemorrhage; Humans; Immunoassay; Length of Stay; Middle Aged; Prothrombin | 1972 |
A report of a case of congenital afibrinogenemia.
Topics: Afibrinogenemia; Agar; Blood Coagulation Factors; Blood Coagulation Tests; Blood Protein Electrophoresis; Blood Transfusion; Child; Child, Preschool; Epistaxis; Female; Fibrinogen; Fibrinolysis; Gels; Hemorrhage; Humans; Immunoelectrophoresis; Infant; Pedigree; Thrombelastography | 1972 |
[Resuscitation of patients with high risk of hemorrhage and thromboembolism. Biological supervision. Indications of controlled heparin therapy].
Topics: Blood Cell Count; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Fibrinogen; Hemorrhage; Heparin; Humans; Pulmonary Embolism; Resuscitation; Thrombelastography; Thromboembolism | 1972 |
Haemorrhage as a complication of extracorporeal pig liver perfusion: studies on mechanism and prevention.
Topics: Adolescent; Adult; Ammonia; Animals; Bile; Bilirubin; Blood Coagulation; Blood Platelets; Female; Fibrinogen; Hemorrhage; Humans; Iodine Radioisotopes; Ischemia; Liver Circulation; Liver Diseases; Male; Perfusion; Sulfobromophthalein; Swine | 1972 |
Coagulation studies in severe birth asphyxia.
Topics: Adrenal Glands; Asphyxia Neonatorum; Blood Cell Count; Blood Coagulation Disorders; Blood Platelets; Disseminated Intravascular Coagulation; Embryonic and Fetal Development; Fibrin; Fibrinogen; Hemorrhage; Humans; Hypothermia; Infant, Newborn; Liver; Respiration, Artificial; Thromboembolism; Vitamin K Deficiency | 1971 |
Haemostatic failure in babies with rhesus isoimmunization.
Topics: Autopsy; Blood Cell Count; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Blood Vessels; Cerebral Hemorrhage; Disseminated Intravascular Coagulation; Erythroblastosis, Fetal; Female; Fibrin; Fibrinogen; Hemoglobins; Hemorrhage; Humans; Infant, Newborn; Liver; Lung; Pregnancy; Retrospective Studies; Subarachnoid Hemorrhage; Thrombin; Thromboplastin | 1971 |
[Clinical study of blood coagulation in open heart surgery].
Topics: Adolescent; Adult; Blood Cell Count; Blood Coagulation; Blood Platelets; Body Temperature; Cardiac Surgical Procedures; Child; Child, Preschool; Esophagus; Extracorporeal Circulation; Female; Fibrinogen; Hemorrhage; Humans; Male; Platelet Adhesiveness; Postoperative Complications; Prothrombin Time; Thrombelastography; Thromboplastin | 1971 |
[Blood coagulation and fibrinolytic system in traumatic shock].
Topics: Afibrinogenemia; Animals; Blood Cell Count; Blood Coagulation; Blood Platelets; Blood Transfusion; Dogs; Factor V; Factor VII; Factor VIII; Factor XII; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Methods; Pain; Prothrombin; Shock, Traumatic; Thrombin | 1971 |
[Post-hemorrhagic compensatory shifts in the morphologic dissociation of coagulated blood].
Topics: Adult; Blood Coagulation; Blood Donors; Erythrocyte Count; Female; Fibrinogen; Hemoglobins; Hemorrhage; Humans; Male | 1971 |
[Pathogenesis, prophylaxis and therapy of hemostatic disorders in congenital cardiopathies].
Topics: Acidosis; Adult; Blood Coagulation Disorders; Cardiac Surgical Procedures; Cyanosis; Extracorporeal Circulation; Fibrinogen; Fibrinolysis; Heart Defects, Congenital; Hematocrit; Hemorrhage; Hemostasis; Heparin; Humans; Hypoxia; Male; Microcirculation; Plasminogen; Postoperative Complications; Streptokinase; Tetralogy of Fallot; Time Factors | 1971 |
The effects of arvin on pregnancy in the mouse and the rabbit.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Animals; Body Weight; Embryonic and Fetal Development; Female; Fetal Death; Fibrinogen; Hemolysin Proteins; Hemorrhage; Mice; Mice, Inbred Strains; Ovary; Pregnancy; Pregnancy, Animal; Rabbits; Snakes; Time Factors; Vagina; Venoms | 1971 |
Disseminated intravascular coagulation in experimental heatstroke.
Topics: Animals; Blood Coagulation Factors; Blood Platelets; Blood Vessels; Body Temperature; Disseminated Intravascular Coagulation; Dogs; Fibrinogen; Fibrinolysis; Heat Exhaustion; Hematocrit; Hemorrhage; Prothrombin Time; Thrombosis | 1971 |
[Hemorrhagic crisis in children and its emergency treatment].
Topics: Child; Emergencies; Fibrinogen; Hemorrhage; Humans; Posture | 1971 |
Platelets, fibrinogen, and fat embolism after the production of hematoma in rabbits.
Topics: Animals; Blood Cell Count; Embolism, Fat; Female; Fibrinogen; Hematoma; Hemorrhage; Injections, Intramuscular; Male; Platelet Adhesiveness; Rabbits | 1971 |
Bleeding in louse-borne relapsing fever. I. Clinical studies in 37 patients.
Topics: Autopsy; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Ecchymosis; Epistaxis; Fibrinogen; Fibrinolysis; Hematuria; Hemorrhage; Humans; Purpura; Relapsing Fever; Retinal Hemorrhage; Tetracycline; Thrombocytopenia | 1971 |
Bleeding in louse-borne relapsing fever. II. Fibrinolysis following treatment.
Topics: Blood Coagulation Tests; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Male; Relapsing Fever; Tetracycline | 1971 |
[Cryptogenic anti-8 inhibitor].
Topics: Azathioprine; Blood Chemical Analysis; Blood Coagulation Disorders; Cholecystectomy; Ecchymosis; Factor VIII; Fibrinogen; Hemarthrosis; Hematoma; Hemorrhage; Hemorrhagic Disorders; Humans; Male; Middle Aged; Plasmapheresis; Postoperative Complications; Prednisone; Remission, Spontaneous | 1971 |
Disseminated intravascular coagulation.
Topics: Animals; Blood Coagulation; Blood Coagulation Factors; Blood Transfusion; Disseminated Intravascular Coagulation; Endotoxins; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Shock; Surface-Active Agents; Surgical Procedures, Operative; Thrombosis; Venoms | 1971 |
Pig liver perfusion in the treatment of fulminant hepatic necrosis.
Topics: Adolescent; Adult; Animals; Assisted Circulation; Bilirubin; Blood Platelets; Blood Transfusion; Child; Exchange Transfusion, Whole Blood; Female; Fibrinogen; Hemorrhage; Hepatic Encephalopathy; Hepatitis; Humans; Liver Circulation; Male; Necrosis; Perfusion; Swine | 1971 |
[The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].
Topics: Adult; Blood Coagulation; Blood Donors; Child; Dose-Response Relationship, Drug; Factor VIII; Female; Fibrinogen; Hemophilia A; Hemorrhage; Hemostasis; Humans; Infusions, Parenteral; Male; Middle Aged; Preoperative Care; Surgical Procedures, Operative; Wounds and Injuries | 1971 |
[Fibrinolysis in idiopathic renal hemorrhage].
Topics: Female; Fibrinogen; Fibrinolysis; Hematuria; Hemorrhage; Humans; Kidney Diseases; Male | 1967 |
[Abnormal hemorrhages in vascular surgery].
Topics: Adult; Aminocaproates; Blood Coagulation Disorders; Blood Transfusion; Female; Fibrinogen; Fibrinolysis; Hematoma; Hemorrhage; Heparin; Humans; Mitral Valve Insufficiency; Postoperative Complications; Sutures; Vascular Surgical Procedures | 1970 |
Fibrinogen after massive haemorrhage. Studies on coagulation and fibrinolysis of blood and lymph in dogs.
Topics: Aminocaproates; Animals; Blood Cell Count; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Dogs; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Lymph; Male; Plasminogen; Serum Albumin, Radio-Iodinated; Venoms | 1968 |
Traumatic pulmonary insufficiency and non-mechanical bleeding in battle casualties.
Topics: Adult; Australia; Blood Coagulation Disorders; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Humans; Male; Military Personnel; Respiratory Insufficiency; Vietnam; Warfare; Wounds, Gunshot | 1971 |
On coagulation and fibrinolysis in renal failure.
Topics: Acute Kidney Injury; Antifibrinolytic Agents; Blood Cell Count; Blood Coagulation; Cell Count; Creatinine; Dextrans; Disease Susceptibility; Factor V; Factor VIII; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hematocrit; Hemorrhage; Hemostasis; Humans; Kidney Failure, Chronic; Macroglobulins; Plasminogen; Platelet Adhesiveness; Renal Dialysis; Serum Globulins; Thrombocytopenia; Uremia | 1971 |
Acute promyelocytic leukemia with disseminated intravascular coagulation.
Topics: Adolescent; Adult; Blood Coagulation Disorders; Bone Marrow; Brain; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinogen; Hemorrhage; Humans; Kidney Glomerulus; Leukemia, Myeloid, Acute; Liver; Lymph Nodes; Male; Middle Aged; Pulmonary Edema; Skin; Spleen | 1971 |
[FDP (fibrinogen degradation products) determination by TRCHII (tanned red cell haemogglutination inhibition immunoassay) method].
Topics: Fibrinogen; Hemagglutination Inhibition Tests; Hemorrhage; Humans; Leukemia, Myeloid; Nephritis; Vascular Diseases | 1971 |
Preliminary results of the protamine sulphate test in plasma of various patients.
Topics: Blood Coagulation Tests; Extracorporeal Circulation; Fibrinogen; Hemorrhage; Heparin; Humans; Plasma; Protamines; Solubility; Time Factors | 1971 |
Anticoagulant effects of Trasylol: in vitro and in vivo studies.
Topics: Abruptio Placentae; Adult; Aprotinin; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Factor V; Factor VIII; Female; Fibrinogen; Glass; Hemorrhage; Hemorrhagic Disorders; Humans; In Vitro Techniques; Middle Aged; Plasminogen; Postoperative Complications; Pregnancy; Prothrombin; Thrombin; Thromboplastin; Time Factors | 1968 |
[Cryoprecipitates rich in factor VIII. In vitro and in vivo studies].
Topics: Blood Coagulation Tests; Blood Proteins; Chemical Precipitation; Cold Temperature; Factor VIII; Fibrinogen; Hemarthrosis; Hematuria; Hemophilia A; Hemorrhage; Platelet Adhesiveness; von Willebrand Diseases | 1969 |
Eight years of experience with massive blood transfusions.
Topics: Abdominal Injuries; Adolescent; Adult; Age Factors; Aneurysm; Blood Coagulation Disorders; Blood Group Incompatibility; Blood Platelet Disorders; Blood Transfusion; Child; Coombs Test; Factor V Deficiency; Factor VIII; Fibrinogen; Gastrointestinal Hemorrhage; Hemorrhage; Homeostasis; Humans; Infections; Liver Cirrhosis; Middle Aged; Neoplasms; Pancreatitis; Prothrombin Time; Retrospective Studies; Rupture; Shock; Vascular Diseases; Wounds and Injuries | 1971 |
[Clinical aspects and clinical course of a case of congenital hypofibrinogenemia].
Topics: Afibrinogenemia; Blood Coagulation Tests; Blood Platelet Disorders; Blood Transfusion; Diagnosis, Differential; Female; Fibrinogen; Hemorrhage; Humans; Immunoelectrophoresis; Infant; Splenomegaly | 1969 |
Effect of purified Vipera palestinae hemorrhagin on blood coagulation and platelet function.
Topics: Adenine Nucleotides; Afibrinogenemia; Animals; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Clot Retraction; Connective Tissue; Drug Antagonism; Fibrinogen; Guinea Pigs; Hemorrhage; Humans; Isoflurophate; Platelet Adhesiveness; Thrombin; Trypsin Inhibitors; Venoms | 1969 |
The therapeutic application of the plasma substitute Physiogel in anesthesiology and surgery.
Topics: Accidents, Traffic; Adult; Aged; Amputation, Surgical; Aortic Aneurysm; Aortic Coarctation; Dextrans; Diuresis; Electrolytes; Female; Fibrinogen; Gelatin; Hemorrhage; Humans; Hysterectomy; Male; Mannitol; Middle Aged; Nephrectomy; Plasma Substitutes; Pneumonectomy; Postoperative Complications; Pregnancy; Pregnancy Complications; Pulmonary Edema; Shock, Hemorrhagic | 1969 |
[Changes in the thrombelastograph following blood loss during late spontaneous abortion].
Topics: Abortion, Spontaneous; Adult; Blood Transfusion; Female; Fibrinogen; Hemorrhage; Humans; Pregnancy; Thrombelastography | 1969 |
Fibrinogen turnover after massive haemorrhage in heparinized dogs.
Topics: Animals; Blood Coagulation; Blood Proteins; Dogs; Female; Fibrinogen; Fibrinolysis; Hematocrit; Hemorrhage; Heparin; Iodine Isotopes; Male | 1969 |
Fatal disseminated herpes simplex virus infection and hemorrhage in the neonate. Coagulation studies in a case and a review.
Topics: Autopsy; Blood Cell Count; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Cytopathogenic Effect, Viral; Erythrocytes; Fibrin; Fibrinogen; Hemorrhage; Herpes Simplex; Humans; Infant, Newborn; Infant, Newborn, Diseases; Prothrombin Time | 1970 |
Thrombolytic agents and lysis of coronary artery thrombosis.
Topics: Animals; Blood Platelets; Coronary Disease; Coronary Vessels; Dogs; Femoral Vein; Fibrinogen; Fibrinolytic Agents; Heart Ventricles; Hemorrhage; Injections; Injections, Intra-Arterial; Injections, Intravenous; Plasminogen; Regional Blood Flow; Serum Globulins; Streptokinase | 1970 |
Congenital hemorrhagic diathesis with deficiency of factor XIII. A case report and a family study.
Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Blood Transfusion; Epilepsy; Factor XIII; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Iodoacetates; Male; Pedigree; Thrombelastography | 1970 |
Vitreous hemorrhage: an experimental study. I. A macroscopic and isotopic study of the evolution of whole blood and hemoglobin.
Topics: Animals; Blood; Blood Coagulation; Chlorides; Chromium Isotopes; Erythrocytes; Fibrin; Fibrinogen; Hemoglobins; Hemorrhage; Humans; Iodine Isotopes; Iron; Iron Isotopes; Photography; Rabbits; Vitreous Body | 1970 |
[Hemorrhage caused by fibrinogen deficiency in the course of an operation].
Topics: Adenoma; Adult; Afibrinogenemia; Autopsy; Female; Fibrinogen; Hemorrhage; Humans; Thyroid Neoplasms | 1970 |
Purpura fulminans. Complete recovery with intravenously administered heparin.
Topics: Blood Transfusion; Chickenpox; Child, Preschool; Fibrinogen; Hemorrhage; Heparin; Humans; Injections, Intravenous; Male; Penile Diseases; Prednisone; Priapism; Prothrombin Time; Purpura | 1970 |
Effects of plasma fraction I on post-tonsillectomy bleeding.
Topics: Adult; Blood Coagulation; Cell Count; Electrophoresis; Female; Fibrinogen; Hematocrit; Hemorrhage; Hemostasis; Hemostatics; Humans; Injections, Intravenous; Isotonic Solutions; Leukocytosis; Male; Plasma; Postoperative Complications; Tonsillectomy | 1970 |
Thrombolytic effect of streptokinase as evaluated by phlebography of deep venous thrombi of the leg.
Topics: Adult; Aged; Female; Femoral Vein; Fibrinogen; Hematocrit; Hemorrhage; Heparin; Humans; Male; Middle Aged; Phlebography; Plasminogen; Streptokinase; Thrombophlebitis | 1970 |
[Amniotic fluid embolism: 5 cases].
Topics: Adult; Birth Weight; Blood Coagulation Tests; Delivery, Obstetric; Embolism, Amniotic Fluid; Female; Fibrinogen; Hemorrhage; Humans; Infant, Newborn; Labor, Obstetric; Parity; Pregnancy; Pulmonary Circulation | 1970 |
[Observations on the fibrinogen consumption rate in thrombotic and hemorrhagic disorders].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Fibrinogen; Hemophilia A; Hemorrhage; Humans; Intracranial Embolism and Thrombosis; Male; Middle Aged; Myocardial Infarction; Raynaud Disease; Thrombophlebitis; Thrombosis | 1970 |
[Hemostasis disorders during severe viral hepatitis: clinical, anatomical and biological study].
Topics: Autopsy; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Fibrin; Fibrinogen; Fibrinolysis; Hemorrhage; Hepatitis A; Humans; Thrombocytopenia | 1971 |
Thrombosis with epsilon aminocaproic acid therapy.
Topics: Adult; Aminocaproates; Bilirubin; Blood Platelets; Blood Transfusion; Blood Urea Nitrogen; Calcium Chloride; Creatinine; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Kidney Glomerulus; Postoperative Complications; Protamines; Prothrombin Time; Tetralogy of Fallot; Thrombin; Thrombosis | 1971 |
[Defective structure of the thrombus and inhibition of thrombus formation in defibrination hemorrhages caused by non-clottable fibrinogen derivatives].
Topics: Afibrinogenemia; Blood Coagulation Tests; Blood Platelets; Embolism; Factor V; Factor VIII; Female; Fibrin; Fibrinogen; Hemorrhage; Humans; Immunoelectrophoresis; Pregnancy; Pregnancy Complications, Hematologic; Thrombelastography | 1967 |
[On the etiology and pathogenesis of intra- and postoperative mucosal and parenchymal bleedings].
Topics: Adolescent; Adult; Aged; Anesthesia; Blood Coagulation Factors; Extracorporeal Circulation; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Hypotension, Controlled; Hypothermia, Induced; Liver; Male; Middle Aged; Phenothiazines; Plasma Substitutes; Postoperative Complications; Retrospective Studies; Transfusion Reaction | 1967 |
[Fibrinolysis as the cause of postoperative hemorrhage in surgical practice].
Topics: Adult; Aged; Antifibrinolytic Agents; Blood Coagulation Disorders; Blood Transfusion; Cholecystectomy; Cholelithiasis; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Jaundice; Male; Postoperative Complications | 1967 |
[Possibilities of therapy of plasmatically caused hemorrhages with coagulation-active blood plasma fractions].
Topics: Factor IX; Factor VII; Factor VIII; Factor X; Fibrinogen; Hemorrhage; Humans; Plasma; Prothrombin | 1967 |
[Diagnosis and therapy of plasmatically caused bleeding disorders].
Topics: Blood Donors; Factor IX; Factor VII; Factor VIII; Factor X; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans | 1967 |
[On fibrinogen treatment of hemorrhage after tonsillectomy. 2].
Topics: Electrophoresis; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Humans; Postoperative Complications; Thrombelastography; Tonsillectomy | 1968 |
Fraction Io prepared in aris. Clinical use for surgery in hemophilic patients.
Topics: Factor VIII; Fibrinogen; Haemophilus; Hemorrhage; Humans; Methods; Postoperative Complications | 1968 |
Diagnosis and treatment of intravascular coagulation.
Topics: Anemia; Blood Coagulation Disorders; Blood Coagulation Tests; Coumarins; Diagnosis, Differential; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Thrombosis | 1968 |
Coagulation and fibrinolysis in blood and lymph after massive haemorrhage in dogs.
Topics: Animals; Blood Coagulation; Blood Coagulation Factors; Dogs; Female; Fibrinogen; Fibrinolysis; Hematocrit; Hemorrhage; Lymph; Male; Shock, Hemorrhagic | 1968 |
[Pathogensis of afibrinogenemic hemorrhages in amniotic fluid embolism].
Topics: Afibrinogenemia; Animals; Antifibrinolytic Agents; Embolism, Amniotic Fluid; Female; Fibrinogen; Hemorrhage; Humans; Infant, Newborn; Pregnancy | 1968 |
Successful operation for intussusception in the classic hemophiliac.
Topics: Child; Factor VIII; Fibrinogen; Hemophilia A; Hemorrhage; Hemostasis; Humans; Ileum; Intestinal Diseases; Intussusception; Male | 1968 |
Disseminated intravascular coagulation. Pathology, diagnosis and therapy of disseminated intravascular coagulation.
Topics: Aminocaproates; Animals; Blood Coagulation Disorders; Blood Transfusion; Drug-Related Side Effects and Adverse Reactions; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Rats; Streptokinase; Thrombosis; Warfarin | 1968 |
[Hemoperitoneum as a manifestation of perinatal hemorrhagic disease].
Topics: Autopsy; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Transfusion; Female; Fetal Diseases; Fibrinogen; Hemoperitoneum; Hemorrhage; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Infusions, Parenteral; Penicillins; Pregnancy; Punctures; Respiration, Artificial; Vitamin K | 1968 |
Fibrinogen in blood and lymph after massive haemorrhage in dogs.
Topics: Animals; Blood Coagulation; Blood Proteins; Dogs; Female; Fibrinogen; Hemorrhage; Intestines; Liver; Lymph; Male; Thoracic Duct | 1968 |
Fibrinogen turnover after massive haemorrhage in dogs studied with radioactively labelled fibrinogen.
Topics: Animals; Blood Coagulation; Blood Proteins; Blood Volume; Chlorides; Dogs; Female; Fibrinogen; Hematocrit; Hemorrhage; Iodine Isotopes; Lymph; Male; Serum Albumin, Radio-Iodinated; Shock, Hemorrhagic; Time Factors | 1968 |
[Local fibroinolytic hemorrhages in orthopedic operations].
Topics: Antifibrinolytic Agents; Blood Platelets; Bone and Bones; Fibrinogen; Fibrinolysis; Hemorrhage; Orthopedics; Postoperative Complications | 1968 |
[On the fibrinogen treatment of hemorrhages following tonsillectomy].
Topics: Aminocaproates; Blood Platelets; Blood Protein Electrophoresis; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Injections, Intramuscular; Injections, Intravenous; Serum Albumin; Serum Globulins; Thrombelastography; Tonsillectomy | 1968 |
Experience with FI-O-Ta.
Topics: Adult; Blood Transfusion; Factor VIII; Female; Fibrinogen; Freeze Drying; Hematoma; Hemophilia A; Hemorrhage; Humans; Male; Methods; Mouth; Plasma | 1968 |
A very thin, porous, knitted arterial prosthesis: experimental data and early clinical assessment.
Topics: Aged; Animals; Blood Coagulation Factors; Blood Vessel Prosthesis; Dogs; Embolism; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Male; Middle Aged; Polymers; Prothrombin Time; Swine; Textiles | 1969 |
[Quantitative changes in plasma fibrinogen arising as a result of surgical interruption of pregnancy].
Topics: Abortion, Legal; Blood Coagulation Disorders; Female; Fibrinogen; Hemorrhage; Humans; Pregnancy | 1969 |
[On the use of antifibrinolytic agents in urology].
Topics: Aged; Aminocaproates; Antifibrinolytic Agents; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Postoperative Complications; Prostatectomy; Urinary Bladder Neoplasms; Urologic Diseases | 1969 |
Effect of heparin and AMCA on coagulation and fibrinolysis in blood and lymph following massive haemorrhage in dogs.
Topics: Animals; Antifibrinolytic Agents; Blood Coagulation; Blood Platelets; Dogs; Factor V; Factor VIII; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Lymph; Methods; Time Factors | 1969 |
Evaluation and management of surgical patients with complicating hematologic conditions.
Topics: Anemia; Anticoagulants; Blood Cell Count; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Blood Transfusion; Fibrinogen; Fibrinolysis; Hematologic Diseases; Hemorrhage; Humans; Infant, Newborn; Postoperative Complications; Preoperative Care; Prothrombin; Prothrombin Time; Thromboplastin | 1969 |
Experimental prophylaxis of severe hemophilia with a factor VIII concentrate.
Topics: Acute Disease; Adult; Blood Pressure; Chemical Precipitation; Factor VIII; Fibrinogen; Glycine; Hemophilia A; Hemorrhage; Hemostasis; Humans; Injections, Intravenous; Male; Pulse | 1969 |
Complications and death in chicken-pox.
Topics: Afibrinogenemia; Chickenpox; Child; Child, Preschool; Encephalitis; Female; Fibrinogen; Hemorrhage; Humans; Male; Mortality | 1965 |
Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid.
Topics: Adult; Aged; Antifibrinolytic Agents; Blood Proteins; Child, Preschool; Fibrinogen; Hemorrhage; Humans; Male; Middle Aged; Plasminogen; Prostatectomy; Streptodornase and Streptokinase; Urine | 1965 |
[Severe fibrinolytic hemorrhage after bilateral ligation of the external iliac vein].
Topics: Blood Coagulation Disorders; Blood Transfusion; Caproates; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Iliac Vein; Liver Cirrhosis; Mitral Valve Insufficiency | 1965 |
Relation between haemostasis and fibrinogen.
Topics: Animals; Blood Coagulation; Blood Platelets; Fibrinogen; Hemorrhage; Hemostasis; Heparin; Mice; Venoms | 1965 |
Constitutional hypofibrinogenaemia associated with haemorrhagic episodes: a report of two cases.
Topics: Adult; Afibrinogenemia; Female; Fibrinogen; Hemorrhage; Humans; Male; Pregnancy; Pregnancy Complications, Hematologic | 1966 |
[Contribution to the research of fibrinolytic activity in hemorrhagic anemia].
Topics: Adult; Anemia; Blood Coagulation Disorders; Blood Coagulation Tests; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Male; Middle Aged; Plasminogen; Prothrombin Time | 1966 |
Hemorrhagic syndrome in dogs induced by intravenous thrombin.
Topics: Animals; Blood Coagulation Factors; Blood Coagulation Tests; Blood Platelets; Depression, Chemical; Dogs; Factor V; Factor VIII; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Infusions, Parenteral; Male; Thrombin | 1966 |
[Behavior of hematic fibrinogen in leukemias with hyperfibrinolysis].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Leukemia; Middle Aged | 1966 |
[On the clinical features and therapy of fibrinolytic hemorrhages in surgery with special consideration of the new antifibrinolytic agent p-aminomethylbenzoic acid (PAMBA)].
Topics: Adult; Aged; Aminobenzoates; Blood Coagulation Disorders; Child; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Hypoxia; Male; Middle Aged; Thrombelastography | 1966 |